{
  "AAC": {
    "p_e_ratio": 38.84,
    "peg_ratio": 1.39,
    "earnings_per_share": 0.65,
    "ebitda": 30850000.0,
    "eps_estimate_current_year": 0.83,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 22.71,
    "fifty_two_week_high": 46.6,
    "fifty_two_week_low": 15.09,
    "percent_change_from_200_day_moving_average": -0.22039999999999998,
    "percent_change_from_50_day_moving_average": 0.12029999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.46,
    "two_hundred_day_moving_average": 32.63,
    "volume": 628594.0,
    "market_cap": 570090000.0,
    "price_to_sales_ttm": 3.51,
    "price_to_book_mrq": 4.9,
    "roa_ttm": 0.10439999999999999,
    "roe_ttm": 0.17809999999999998,
    "shares_outstanding": 22410000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.636,
    "operating_cash_flow_ttm": 14660000.0,
    "levered_cash_flow_ttm": -26750000.0,
    "book_value_per_share_mrq": 5.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AAC Holdings, Inc."
  },
  "AAVL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.69,
    "ebitda": -37390000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 11.02,
    "fifty_two_week_high": 62.48,
    "fifty_two_week_low": 8.85,
    "percent_change_from_200_day_moving_average": -0.6426999999999999,
    "percent_change_from_50_day_moving_average": -0.1714,
    "shares_owned": "N/A",
    "short_ratio": 2.46,
    "two_hundred_day_moving_average": 25.55,
    "volume": 689984.0,
    "market_cap": 234420000.0,
    "price_to_sales_ttm": 258.53,
    "price_to_book_mrq": 0.93,
    "roa_ttm": -0.13949999999999999,
    "roe_ttm": -0.2414,
    "shares_outstanding": 25680000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1038,
    "operating_cash_flow_ttm": -27020000.0,
    "levered_cash_flow_ttm": -13310000.0,
    "book_value_per_share_mrq": 10.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Avalanche Biotechnologies, Inc."
  },
  "ABAX": {
    "p_e_ratio": 36.04,
    "peg_ratio": 1.95,
    "earnings_per_share": 1.29,
    "ebitda": 43830000.0,
    "eps_estimate_current_year": 1.25,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 47.74,
    "fifty_two_week_high": 66.89,
    "fifty_two_week_low": 44.07,
    "percent_change_from_200_day_moving_average": -0.1402,
    "percent_change_from_50_day_moving_average": -0.024700000000000003,
    "shares_owned": "N/A",
    "short_ratio": 19.12,
    "two_hundred_day_moving_average": 54.15,
    "volume": 193859.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 5.03,
    "price_to_book_mrq": 4.73,
    "roa_ttm": 0.0947,
    "roe_ttm": 0.10769999999999999,
    "shares_outstanding": 22720000.0,
    "pcnt_held_by_insiders": 0.0582,
    "pcnt_held_by_institutions": 1.04,
    "pcnt_short_of_float": 0.2141,
    "operating_cash_flow_ttm": 27810000.0,
    "levered_cash_flow_ttm": 35690000.0,
    "book_value_per_share_mrq": 9.91,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Abaxis, Inc."
  },
  "ABEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.6,
    "ebitda": -6970000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.06,
    "fifty_two_week_high": 16.5,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.15380000000000002,
    "percent_change_from_50_day_moving_average": -0.094,
    "shares_owned": "N/A",
    "short_ratio": 7.14,
    "two_hundred_day_moving_average": 5.41,
    "volume": 193976.0,
    "market_cap": 149720000.0,
    "price_to_sales_ttm": 159.57,
    "price_to_book_mrq": 2.46,
    "roa_ttm": -0.11710000000000001,
    "roe_ttm": -0.8906000000000001,
    "shares_outstanding": 32689999.999999996,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.4072,
    "operating_cash_flow_ttm": -6280000.0,
    "levered_cash_flow_ttm": -11320000.0,
    "book_value_per_share_mrq": 2.01,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Abeona Therapeutics Inc."
  },
  "ABIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.18,
    "ebitda": -10340000.0,
    "eps_estimate_current_year": -1.75,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.38,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 4.55,
    "percent_change_from_200_day_moving_average": -0.17079999999999998,
    "percent_change_from_50_day_moving_average": -0.1548,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 6.5,
    "volume": 40916.0,
    "market_cap": 48680000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.22,
    "roa_ttm": -0.1972,
    "roe_ttm": -0.3284,
    "shares_outstanding": 9030000.0,
    "pcnt_held_by_insiders": 0.2536,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.0447,
    "operating_cash_flow_ttm": -9470000.0,
    "levered_cash_flow_ttm": -5510000.0,
    "book_value_per_share_mrq": 4.85,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ARCA biopharma, Inc."
  },
  "ABMD": {
    "p_e_ratio": 33.69,
    "peg_ratio": 8.08,
    "earnings_per_share": 2.82,
    "ebitda": 49810000.0,
    "eps_estimate_current_year": 0.75,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 98.8,
    "fifty_two_week_high": 110.68,
    "fifty_two_week_low": 21.84,
    "percent_change_from_200_day_moving_average": 0.2584,
    "percent_change_from_50_day_moving_average": -0.0373,
    "shares_owned": "N/A",
    "short_ratio": 1.69,
    "two_hundred_day_moving_average": 75.58,
    "volume": 777384.0,
    "market_cap": 4000000000.0,
    "price_to_sales_ttm": 15.94,
    "price_to_book_mrq": 13.2,
    "roa_ttm": 0.1052,
    "roe_ttm": 0.5195000000000001,
    "shares_outstanding": 42050000.0,
    "pcnt_held_by_insiders": 0.096,
    "pcnt_held_by_institutions": 1.067,
    "pcnt_short_of_float": 0.056100000000000004,
    "operating_cash_flow_ttm": 51010000.0,
    "levered_cash_flow_ttm": 676500.0,
    "book_value_per_share_mrq": 7.39,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ABIOMED, Inc."
  },
  "ABUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -34550000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 7.49,
    "fifty_two_week_low": 6.52,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 7.13,
    "two_hundred_day_moving_average": 0.0,
    "volume": 665878.0,
    "market_cap": 359650000.0,
    "price_to_sales_ttm": 23.56,
    "price_to_book_mrq": 0.67,
    "roa_ttm": -0.0484,
    "roe_ttm": -0.1201,
    "shares_outstanding": 54330000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1032,
    "operating_cash_flow_ttm": -49210000.0,
    "levered_cash_flow_ttm": -22000000.0,
    "book_value_per_share_mrq": 10.84,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arbutus Biopharma Corporation"
  },
  "ACAD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.38,
    "earnings_per_share": -1.34,
    "ebitda": -124070000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 38.68,
    "fifty_two_week_high": 51.99,
    "fifty_two_week_low": 22.04,
    "percent_change_from_200_day_moving_average": -0.1411,
    "percent_change_from_50_day_moving_average": -0.11720000000000001,
    "shares_owned": "N/A",
    "short_ratio": 10.61,
    "two_hundred_day_moving_average": 39.76,
    "volume": 1830726.0,
    "market_cap": 3440000000.0,
    "price_to_sales_ttm": 55558.05,
    "price_to_book_mrq": 14.52,
    "roa_ttm": -0.24530000000000002,
    "roe_ttm": -0.4387,
    "shares_outstanding": 100720000.0,
    "pcnt_held_by_insiders": 0.2584,
    "pcnt_held_by_institutions": 0.669,
    "pcnt_short_of_float": 0.2183,
    "operating_cash_flow_ttm": -90500000.0,
    "levered_cash_flow_ttm": -36790000.0,
    "book_value_per_share_mrq": 2.55,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ACADIA Pharmaceuticals Inc."
  },
  "ACHC": {
    "p_e_ratio": 45.85,
    "peg_ratio": 1.28,
    "earnings_per_share": 1.53,
    "ebitda": 300870000.0,
    "eps_estimate_current_year": 2.18,
    "eps_estimate_next_quarter": 0.59,
    "fifty_day_moving_average": 75.67,
    "fifty_two_week_high": 85.62,
    "fifty_two_week_low": 46.87,
    "percent_change_from_200_day_moving_average": -0.052300000000000006,
    "percent_change_from_50_day_moving_average": -0.07,
    "shares_owned": "N/A",
    "short_ratio": 2.93,
    "two_hundred_day_moving_average": 74.27,
    "volume": 1005296.0,
    "market_cap": 5040000000.0,
    "price_to_sales_ttm": 3.73,
    "price_to_book_mrq": 3.1,
    "roa_ttm": 0.057,
    "roe_ttm": 0.0751,
    "shares_outstanding": 71640000.0,
    "pcnt_held_by_insiders": 0.2447,
    "pcnt_held_by_institutions": 0.7090000000000001,
    "pcnt_short_of_float": 0.056100000000000004,
    "operating_cash_flow_ttm": 177190000.0,
    "levered_cash_flow_ttm": -20800000.0,
    "book_value_per_share_mrq": 23.6,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Acadia Healthcare Company, Inc."
  },
  "ACHN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.74,
    "earnings_per_share": -0.798,
    "ebitda": -85430000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 7.846,
    "fifty_two_week_high": 16.87,
    "fifty_two_week_low": 6.71,
    "percent_change_from_200_day_moving_average": -0.16299,
    "percent_change_from_50_day_moving_average": -0.03199,
    "shares_owned": "N/A",
    "short_ratio": 9.22,
    "two_hundred_day_moving_average": 9.074,
    "volume": 3466720.0,
    "market_cap": 1040000000.0,
    "price_to_sales_ttm": 1620.94,
    "price_to_book_mrq": 4.12,
    "roa_ttm": -0.26789999999999997,
    "roe_ttm": -0.4648,
    "shares_outstanding": 136390000.0,
    "pcnt_held_by_insiders": 0.4411,
    "pcnt_held_by_institutions": 0.586,
    "pcnt_short_of_float": 0.2147,
    "operating_cash_flow_ttm": -62590000.0,
    "levered_cash_flow_ttm": -31940000.0,
    "book_value_per_share_mrq": 2.05,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achillion Pharmaceuticals, Inc."
  },
  "ACOR": {
    "p_e_ratio": 115.0,
    "peg_ratio": 1.43,
    "earnings_per_share": 0.24,
    "ebitda": 59660000.0,
    "eps_estimate_current_year": 0.71,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 31.51,
    "fifty_two_week_high": 45.45,
    "fifty_two_week_low": 27.06,
    "percent_change_from_200_day_moving_average": -0.14679999999999999,
    "percent_change_from_50_day_moving_average": -0.11689999999999999,
    "shares_owned": "N/A",
    "short_ratio": 9.07,
    "two_hundred_day_moving_average": 32.62,
    "volume": 653067.0,
    "market_cap": 1190000000.0,
    "price_to_sales_ttm": 2.89,
    "price_to_book_mrq": 2.26,
    "roa_ttm": 0.028900000000000002,
    "roe_ttm": 0.0192,
    "shares_outstanding": 42850000.0,
    "pcnt_held_by_insiders": 0.02,
    "pcnt_held_by_institutions": 1.026,
    "pcnt_short_of_float": 0.2305,
    "operating_cash_flow_ttm": 46010000.0,
    "levered_cash_flow_ttm": 40320000.0,
    "book_value_per_share_mrq": 13.09,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acorda Therapeutics, Inc."
  },
  "ACRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -34070000.0,
    "eps_estimate_current_year": -0.54,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 4.13,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 2.96,
    "percent_change_from_200_day_moving_average": -0.1578,
    "percent_change_from_50_day_moving_average": -0.1769,
    "shares_owned": "N/A",
    "short_ratio": 13.26,
    "two_hundred_day_moving_average": 4.04,
    "volume": 830351.0,
    "market_cap": 150870000.0,
    "price_to_sales_ttm": 23.56,
    "price_to_book_mrq": 5.05,
    "roa_ttm": -0.2716,
    "roe_ttm": -0.7211,
    "shares_outstanding": 44370000.0,
    "pcnt_held_by_insiders": 0.3567,
    "pcnt_held_by_institutions": 0.5710000000000001,
    "pcnt_short_of_float": 0.20420000000000002,
    "operating_cash_flow_ttm": -35950000.0,
    "levered_cash_flow_ttm": -25640000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AcelRx Pharmaceuticals, Inc."
  },
  "ACST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.03,
    "ebitda": -7300000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.35,
    "fifty_two_week_high": 0.93,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.1161,
    "percent_change_from_50_day_moving_average": -0.0333,
    "shares_owned": "N/A",
    "short_ratio": 0.62,
    "two_hundred_day_moving_average": 0.38,
    "volume": 76143.0,
    "market_cap": 36250000.0,
    "price_to_sales_ttm": 222.62,
    "price_to_book_mrq": 1.51,
    "roa_ttm": -0.19039999999999999,
    "roe_ttm": -0.1175,
    "shares_outstanding": 106610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -5770000.0,
    "levered_cash_flow_ttm": -2490000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acasti Pharma Inc."
  },
  "ACUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.72,
    "ebitda": -5610000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 2.95,
    "fifty_two_week_high": 6.75,
    "fifty_two_week_low": 2.05,
    "percent_change_from_200_day_moving_average": -0.30219999999999997,
    "percent_change_from_50_day_moving_average": -0.1051,
    "shares_owned": "N/A",
    "short_ratio": 1.11,
    "two_hundred_day_moving_average": 3.78,
    "volume": 5852.0,
    "market_cap": 31160000.0,
    "price_to_sales_ttm": 4.83,
    "price_to_book_mrq": 6.13,
    "roa_ttm": -0.2032,
    "roe_ttm": -0.9695999999999999,
    "shares_outstanding": 11800000.0,
    "pcnt_held_by_insiders": 0.3452,
    "pcnt_held_by_institutions": 0.249,
    "pcnt_short_of_float": 0.0042,
    "operating_cash_flow_ttm": -5490000.0,
    "levered_cash_flow_ttm": -3610000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Acura Pharmaceuticals, Inc."
  },
  "ADAP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.86,
    "earnings_per_share": -1.66,
    "ebitda": -15100000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 12.47,
    "fifty_two_week_high": 21.57,
    "fifty_two_week_low": 10.01,
    "percent_change_from_200_day_moving_average": -0.24969999999999998,
    "percent_change_from_50_day_moving_average": -0.0745,
    "shares_owned": "N/A",
    "short_ratio": 6.29,
    "two_hundred_day_moving_average": 15.38,
    "volume": 168377.0,
    "market_cap": 816860000.0,
    "price_to_sales_ttm": 200.15,
    "price_to_book_mrq": 0.04,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 70780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 24320000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 299.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Adaptimmune Therapeutics plc"
  },
  "ADHD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.61,
    "ebitda": -27780000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 7.96,
    "fifty_two_week_high": 19.5,
    "fifty_two_week_low": 3.12,
    "percent_change_from_200_day_moving_average": 0.0045000000000000005,
    "percent_change_from_50_day_moving_average": -0.1243,
    "shares_owned": "N/A",
    "short_ratio": 9.23,
    "two_hundred_day_moving_average": 6.94,
    "volume": 161478.0,
    "market_cap": 140810000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.1,
    "roa_ttm": -0.425,
    "roe_ttm": -0.7437999999999999,
    "shares_outstanding": 20200000.0,
    "pcnt_held_by_insiders": 0.4631,
    "pcnt_held_by_institutions": 0.302,
    "pcnt_short_of_float": 0.0613,
    "operating_cash_flow_ttm": -25720000.0,
    "levered_cash_flow_ttm": -15580000.0,
    "book_value_per_share_mrq": 1.83,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-28"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alcobra Ltd."
  },
  "ADK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.16,
    "ebitda": 14910000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.61,
    "fifty_two_week_high": 4.83,
    "fifty_two_week_low": 3.32,
    "percent_change_from_200_day_moving_average": -0.1229,
    "percent_change_from_50_day_moving_average": -0.0668,
    "shares_owned": "N/A",
    "short_ratio": 5.52,
    "two_hundred_day_moving_average": 3.84,
    "volume": 26260.0,
    "market_cap": 66989999.99999999,
    "price_to_sales_ttm": 0.34,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0202,
    "roe_ttm": -0.23170000000000002,
    "shares_outstanding": 19880000.0,
    "pcnt_held_by_insiders": 0.2481,
    "pcnt_held_by_institutions": 0.20199999999999999,
    "pcnt_short_of_float": 0.009399999999999999,
    "operating_cash_flow_ttm": -5430000.0,
    "levered_cash_flow_ttm": -138750.0,
    "book_value_per_share_mrq": -0.33,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "AdCare Health Systems, Inc."
  },
  "ADMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.56,
    "ebitda": -13080000.0,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 9.18,
    "fifty_two_week_high": 14.0,
    "fifty_two_week_low": 7.51,
    "percent_change_from_200_day_moving_average": 0.009300000000000001,
    "percent_change_from_50_day_moving_average": -0.016,
    "shares_owned": "N/A",
    "short_ratio": 7.12,
    "two_hundred_day_moving_average": 8.95,
    "volume": 25808.0,
    "market_cap": 96670000.0,
    "price_to_sales_ttm": 17.26,
    "price_to_book_mrq": 10.28,
    "roa_ttm": -0.2918,
    "roe_ttm": -1.3961000000000001,
    "shares_outstanding": 10710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0197,
    "operating_cash_flow_ttm": -14040000.0,
    "levered_cash_flow_ttm": -11000000.0,
    "book_value_per_share_mrq": 0.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ADMA Biologics, Inc."
  },
  "ADMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.31,
    "ebitda": -12930000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.89,
    "fifty_two_week_high": 7.26,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.051399999999999994,
    "percent_change_from_50_day_moving_average": 0.0541,
    "shares_owned": "N/A",
    "short_ratio": 3.85,
    "two_hundred_day_moving_average": 4.32,
    "volume": 23937.0,
    "market_cap": 55070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.95,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13430000.0,
    "pcnt_held_by_insiders": 0.3071,
    "pcnt_held_by_institutions": 0.11,
    "pcnt_short_of_float": 0.0196,
    "operating_cash_flow_ttm": -9510000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Adamis Pharmaceuticals Corporation"
  },
  "ADMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -1.45,
    "ebitda": -18640000.0,
    "eps_estimate_current_year": -3.15,
    "eps_estimate_next_quarter": -0.84,
    "fifty_day_moving_average": 20.5,
    "fifty_two_week_high": 30.86,
    "fifty_two_week_low": 13.6,
    "percent_change_from_200_day_moving_average": -0.14550000000000002,
    "percent_change_from_50_day_moving_average": -0.1343,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 20.77,
    "volume": 181898.0,
    "market_cap": 326670000.0,
    "price_to_sales_ttm": 11.09,
    "price_to_book_mrq": 2.55,
    "roa_ttm": -0.0805,
    "roe_ttm": -0.1895,
    "shares_outstanding": 18400000.0,
    "pcnt_held_by_insiders": 0.4058,
    "pcnt_held_by_institutions": 0.115,
    "pcnt_short_of_float": 0.0622,
    "operating_cash_flow_ttm": -12020000.0,
    "levered_cash_flow_ttm": -942050.0,
    "book_value_per_share_mrq": 7.36,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Adamas Pharmaceuticals, Inc."
  },
  "ADPT": {
    "p_e_ratio": 98.42,
    "peg_ratio": 1.1,
    "earnings_per_share": 0.97,
    "ebitda": 33980000.0,
    "eps_estimate_current_year": 1.22,
    "eps_estimate_next_quarter": 0.35,
    "fifty_day_moving_average": 105.94,
    "fifty_two_week_high": 123.97,
    "fifty_two_week_low": 24.22,
    "percent_change_from_200_day_moving_average": 0.1732,
    "percent_change_from_50_day_moving_average": -0.09519999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.07,
    "two_hundred_day_moving_average": 81.71,
    "volume": 1017549.0,
    "market_cap": 1360000000.0,
    "price_to_sales_ttm": 4.21,
    "price_to_book_mrq": 22.18,
    "roa_ttm": 0.029900000000000003,
    "roe_ttm": 0.20629999999999998,
    "shares_outstanding": 14210000.0,
    "pcnt_held_by_insiders": 0.1648,
    "pcnt_held_by_institutions": 0.14400000000000002,
    "pcnt_short_of_float": 0.3258,
    "operating_cash_flow_ttm": -16910000.0,
    "levered_cash_flow_ttm": -48820000.0,
    "book_value_per_share_mrq": 4.91,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Adeptus Health Inc."
  },
  "ADRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.86,
    "earnings_per_share": -1.24,
    "ebitda": -22930000.0,
    "eps_estimate_current_year": -1.18,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 20.86,
    "fifty_two_week_high": 49.25,
    "fifty_two_week_low": 16.28,
    "percent_change_from_200_day_moving_average": -0.2774,
    "percent_change_from_50_day_moving_average": -0.0213,
    "shares_owned": "N/A",
    "short_ratio": 7.23,
    "two_hundred_day_moving_average": 28.26,
    "volume": 246503.0,
    "market_cap": 1270000000.0,
    "price_to_sales_ttm": 42.31,
    "price_to_book_mrq": 5.59,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 62280000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0767,
    "operating_cash_flow_ttm": 189130000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aduro BioTech, Inc."
  },
  "ADUS": {
    "p_e_ratio": 29.13,
    "peg_ratio": 1.82,
    "earnings_per_share": 1.12,
    "ebitda": 24520000.0,
    "eps_estimate_current_year": 1.24,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 30.52,
    "fifty_two_week_high": 35.83,
    "fifty_two_week_low": 17.02,
    "percent_change_from_200_day_moving_average": 0.1862,
    "percent_change_from_50_day_moving_average": 0.0738,
    "shares_owned": "N/A",
    "short_ratio": 2.42,
    "two_hundred_day_moving_average": 27.63,
    "volume": 87262.0,
    "market_cap": 361430000.0,
    "price_to_sales_ttm": 1.15,
    "price_to_book_mrq": 2.83,
    "roa_ttm": 0.0707,
    "roe_ttm": 0.0968,
    "shares_outstanding": 11030000.0,
    "pcnt_held_by_insiders": 0.4543,
    "pcnt_held_by_institutions": 0.518,
    "pcnt_short_of_float": 0.0248,
    "operating_cash_flow_ttm": 27070000.0,
    "levered_cash_flow_ttm": 18150000.0,
    "book_value_per_share_mrq": 12.23,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Addus HomeCare Corporation"
  },
  "ADXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.53,
    "ebitda": -39000000.0,
    "eps_estimate_current_year": -1.61,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 15.46,
    "fifty_two_week_high": 30.13,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.2371,
    "percent_change_from_50_day_moving_average": -0.1082,
    "shares_owned": "N/A",
    "short_ratio": 7.64,
    "two_hundred_day_moving_average": 18.08,
    "volume": 1622047.0,
    "market_cap": 460110000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.87,
    "roa_ttm": -0.38189999999999996,
    "roe_ttm": -0.6241,
    "shares_outstanding": 33369999.999999996,
    "pcnt_held_by_insiders": 0.0911,
    "pcnt_held_by_institutions": 0.096,
    "pcnt_short_of_float": 0.36450000000000005,
    "operating_cash_flow_ttm": -20030000.0,
    "levered_cash_flow_ttm": -8270000.0,
    "book_value_per_share_mrq": 3.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Advaxis, Inc."
  },
  "AEGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.65,
    "earnings_per_share": -1.43,
    "ebitda": -639999.0,
    "eps_estimate_current_year": -1.99,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 17.54,
    "fifty_two_week_high": 36.19,
    "fifty_two_week_low": 15.13,
    "percent_change_from_200_day_moving_average": -0.2593,
    "percent_change_from_50_day_moving_average": -0.1272,
    "shares_owned": "N/A",
    "short_ratio": 14.89,
    "two_hundred_day_moving_average": 20.67,
    "volume": 710517.0,
    "market_cap": 438180000.0,
    "price_to_sales_ttm": 2.19,
    "price_to_book_mrq": 3.2,
    "roa_ttm": -0.0262,
    "roe_ttm": -0.3196,
    "shares_outstanding": 28620000.0,
    "pcnt_held_by_insiders": 0.2502,
    "pcnt_held_by_institutions": 0.937,
    "pcnt_short_of_float": 0.5257999999999999,
    "operating_cash_flow_ttm": 27720000.0,
    "levered_cash_flow_ttm": -25120000.0,
    "book_value_per_share_mrq": 5.24,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aegerion Pharmaceuticals, Inc."
  },
  "AEMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.7,
    "ebitda": -3870000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.75,
    "fifty_two_week_high": 36.0,
    "fifty_two_week_low": 5.5,
    "percent_change_from_200_day_moving_average": -0.201,
    "percent_change_from_50_day_moving_average": -0.0805,
    "shares_owned": "N/A",
    "short_ratio": 1.96,
    "two_hundred_day_moving_average": 8.92,
    "volume": 118388.0,
    "market_cap": 54260000.0,
    "price_to_sales_ttm": 66.03,
    "price_to_book_mrq": 11.75,
    "roa_ttm": -0.6867,
    "roe_ttm": -5.7715,
    "shares_outstanding": 7610000.0,
    "pcnt_held_by_insiders": 0.12029999999999999,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0276,
    "operating_cash_flow_ttm": -5080000.0,
    "levered_cash_flow_ttm": -4030000.0000000005,
    "book_value_per_share_mrq": 0.67,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Aethlon Medical, Inc."
  },
  "AERI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.65,
    "ebitda": -66819999.99999999,
    "eps_estimate_current_year": -2.58,
    "eps_estimate_next_quarter": -0.71,
    "fifty_day_moving_average": 18.02,
    "fifty_two_week_high": 35.89,
    "fifty_two_week_low": 8.84,
    "percent_change_from_200_day_moving_average": 0.0712,
    "percent_change_from_50_day_moving_average": 0.1646,
    "shares_owned": "N/A",
    "short_ratio": 9.21,
    "two_hundred_day_moving_average": 19.59,
    "volume": 861348.0,
    "market_cap": 539280000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 16.96,
    "roa_ttm": -0.3574,
    "roe_ttm": -1.5146000000000002,
    "shares_outstanding": 25690000.0,
    "pcnt_held_by_insiders": 0.4757,
    "pcnt_held_by_institutions": 0.336,
    "pcnt_short_of_float": 0.2827,
    "operating_cash_flow_ttm": -50390000.0,
    "levered_cash_flow_ttm": -19520000.0,
    "book_value_per_share_mrq": 1.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aerie Pharmaceuticals, Inc."
  },
  "AEZS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.417,
    "ebitda": -34080000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.0989,
    "fifty_two_week_high": 1.36,
    "fifty_two_week_low": 0.05,
    "percent_change_from_200_day_moving_average": -0.7222700000000001,
    "percent_change_from_50_day_moving_average": -0.10881500000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 0.3172,
    "volume": 23457698.0,
    "market_cap": 16059999.999999998,
    "price_to_sales_ttm": 55.14,
    "price_to_book_mrq": 1.27,
    "roa_ttm": -0.3837,
    "roe_ttm": -3.2985,
    "shares_outstanding": 182290000.0,
    "pcnt_held_by_insiders": 0.0886,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.0664,
    "operating_cash_flow_ttm": -33430000.0,
    "levered_cash_flow_ttm": -16379999.999999998,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aeterna Zentaris Inc."
  },
  "AFAM": {
    "p_e_ratio": 23.03,
    "peg_ratio": 1.88,
    "earnings_per_share": 1.88,
    "ebitda": 36570000.0,
    "eps_estimate_current_year": 2.14,
    "eps_estimate_next_quarter": 0.55,
    "fifty_day_moving_average": 46.29,
    "fifty_two_week_high": 50.48,
    "fifty_two_week_low": 25.01,
    "percent_change_from_200_day_moving_average": 0.0189,
    "percent_change_from_50_day_moving_average": -0.06269999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.28,
    "two_hundred_day_moving_average": 42.58,
    "volume": 170027.0,
    "market_cap": 426100000.0,
    "price_to_sales_ttm": 0.85,
    "price_to_book_mrq": 1.8,
    "roa_ttm": 0.0572,
    "roe_ttm": 0.0742,
    "shares_outstanding": 9820000.0,
    "pcnt_held_by_insiders": 0.2706,
    "pcnt_held_by_institutions": 0.5379999999999999,
    "pcnt_short_of_float": 0.0779,
    "operating_cash_flow_ttm": 13780000.0,
    "levered_cash_flow_ttm": 8800000.0,
    "book_value_per_share_mrq": 25.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Almost Family Inc."
  },
  "AFMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -16950000.0,
    "eps_estimate_current_year": -0.81,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 9.84,
    "fifty_two_week_high": 24.2,
    "fifty_two_week_low": 3.55,
    "percent_change_from_200_day_moving_average": -0.34700000000000003,
    "percent_change_from_50_day_moving_average": -0.2937,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 10.64,
    "volume": 262505.0,
    "market_cap": 206650000.0,
    "price_to_sales_ttm": 26.31,
    "price_to_book_mrq": 3.19,
    "roa_ttm": -0.26289999999999997,
    "roe_ttm": "N/A",
    "shares_outstanding": 29730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0959,
    "operating_cash_flow_ttm": -16570000.0,
    "levered_cash_flow_ttm": -20620000.0,
    "book_value_per_share_mrq": 2.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Affimed N.V."
  },
  "AGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.39,
    "ebitda": -54720000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 6.87,
    "fifty_two_week_high": 10.16,
    "fifty_two_week_low": 2.56,
    "percent_change_from_200_day_moving_average": -0.3002,
    "percent_change_from_50_day_moving_average": -0.2666,
    "shares_owned": "N/A",
    "short_ratio": 9.23,
    "two_hundred_day_moving_average": 7.2,
    "volume": 2938281.0,
    "market_cap": 426420000.0,
    "price_to_sales_ttm": 36.19,
    "price_to_book_mrq": 5.6,
    "roa_ttm": -0.25239999999999996,
    "roe_ttm": -1.2875999999999999,
    "shares_outstanding": 84610000.0,
    "pcnt_held_by_insiders": 0.0667,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.16390000000000002,
    "operating_cash_flow_ttm": -28190000.0,
    "levered_cash_flow_ttm": -19740000.0,
    "book_value_per_share_mrq": 1.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agenus Inc."
  },
  "AGIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.66,
    "ebitda": -58990000.0,
    "eps_estimate_current_year": -2.34,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 89.89,
    "fifty_two_week_high": 138.85,
    "fifty_two_week_low": 58.55,
    "percent_change_from_200_day_moving_average": -0.21850000000000003,
    "percent_change_from_50_day_moving_average": -0.1013,
    "shares_owned": "N/A",
    "short_ratio": 7.34,
    "two_hundred_day_moving_average": 103.38,
    "volume": 684607.0,
    "market_cap": 3030000000.0,
    "price_to_sales_ttm": 33.45,
    "price_to_book_mrq": 7.93,
    "roa_ttm": -0.10189999999999999,
    "roe_ttm": -0.1978,
    "shares_outstanding": 37440000.0,
    "pcnt_held_by_insiders": 0.2956,
    "pcnt_held_by_institutions": 0.613,
    "pcnt_short_of_float": 0.2006,
    "operating_cash_flow_ttm": -52850000.0,
    "levered_cash_flow_ttm": -45230000.0,
    "book_value_per_share_mrq": 10.81,
    "next_earnings_announcement_date": "2015-11-02",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Agios Pharmaceuticals, Inc."
  },
  "AGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -27510000.0,
    "eps_estimate_current_year": -1.6,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 8.29,
    "fifty_two_week_high": 13.19,
    "fifty_two_week_low": 5.77,
    "percent_change_from_200_day_moving_average": -0.2891,
    "percent_change_from_50_day_moving_average": -0.15960000000000002,
    "shares_owned": "N/A",
    "short_ratio": 10.11,
    "two_hundred_day_moving_average": 9.8,
    "volume": 65656.0,
    "market_cap": 155230000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.06,
    "roa_ttm": -0.26899999999999996,
    "roe_ttm": -0.6751,
    "shares_outstanding": 22270000.0,
    "pcnt_held_by_insiders": 0.7406999999999999,
    "pcnt_held_by_institutions": 0.016,
    "pcnt_short_of_float": 0.0581,
    "operating_cash_flow_ttm": -26480000.0,
    "levered_cash_flow_ttm": -14490000.0,
    "book_value_per_share_mrq": 1.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Agile Therapeutics, Inc."
  },
  "AGTC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -24160000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 15.59,
    "fifty_two_week_high": 28.24,
    "fifty_two_week_low": 12.47,
    "percent_change_from_200_day_moving_average": -0.29359999999999997,
    "percent_change_from_50_day_moving_average": -0.166,
    "shares_owned": "N/A",
    "short_ratio": 6.05,
    "two_hundred_day_moving_average": 18.4,
    "volume": 199655.0,
    "market_cap": 233400000.0,
    "price_to_sales_ttm": 105.25,
    "price_to_book_mrq": 2.66,
    "roa_ttm": -0.183,
    "roe_ttm": -0.3032,
    "shares_outstanding": 17950000.0,
    "pcnt_held_by_insiders": 0.4521,
    "pcnt_held_by_institutions": 0.10800000000000001,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -19490000.0,
    "levered_cash_flow_ttm": -10480000.0,
    "book_value_per_share_mrq": 5.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Applied Genetic Technologies Corporation"
  },
  "AHPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.2,
    "ebitda": -294564.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.43,
    "fifty_two_week_high": 3.7,
    "fifty_two_week_low": 1.21,
    "percent_change_from_200_day_moving_average": -0.1957,
    "percent_change_from_50_day_moving_average": -0.1482,
    "shares_owned": "N/A",
    "short_ratio": 13.4,
    "two_hundred_day_moving_average": 1.52,
    "volume": 1025.0,
    "market_cap": 9790000.0,
    "price_to_sales_ttm": 0.28,
    "price_to_book_mrq": 0.47,
    "roa_ttm": -0.038,
    "roe_ttm": -0.0728,
    "shares_outstanding": 8029999.999999999,
    "pcnt_held_by_insiders": 0.4454,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.0089,
    "operating_cash_flow_ttm": 498880.0,
    "levered_cash_flow_ttm": 955180.0,
    "book_value_per_share_mrq": 2.64,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Allied Healthcare Products Inc."
  },
  "AHS": {
    "p_e_ratio": 37.42,
    "peg_ratio": 2.43,
    "earnings_per_share": 0.96,
    "ebitda": 111190000.0,
    "eps_estimate_current_year": 1.23,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 34.96,
    "fifty_two_week_high": 37.47,
    "fifty_two_week_low": 15.04,
    "percent_change_from_200_day_moving_average": 0.2503,
    "percent_change_from_50_day_moving_average": 0.0273,
    "shares_owned": "N/A",
    "short_ratio": 1.77,
    "two_hundred_day_moving_average": 28.73,
    "volume": 897420.0,
    "market_cap": 1710000000.0,
    "price_to_sales_ttm": 1.43,
    "price_to_book_mrq": 6.08,
    "roa_ttm": 0.0806,
    "roe_ttm": 0.1782,
    "shares_outstanding": 47650000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.943,
    "pcnt_short_of_float": 0.0392,
    "operating_cash_flow_ttm": 54320000.0,
    "levered_cash_flow_ttm": 24420000.0,
    "book_value_per_share_mrq": 6.05,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AMN Healthcare Services Inc."
  },
  "AIMT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": -17530000.0,
    "eps_estimate_current_year": -1.2,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 25.74,
    "fifty_two_week_low": 24.25,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.17,
    "two_hundred_day_moving_average": 0.0,
    "volume": 140750.0,
    "market_cap": 1030000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 42250000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.003,
    "operating_cash_flow_ttm": -14290000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aimmune Therapeutics, Inc."
  },
  "AIQ": {
    "p_e_ratio": 19.02,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.53,
    "ebitda": 114600000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 14.0,
    "fifty_two_week_high": 25.83,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": -0.45799999999999996,
    "percent_change_from_50_day_moving_average": -0.2815,
    "shares_owned": "N/A",
    "short_ratio": 7.47,
    "two_hundred_day_moving_average": 18.56,
    "volume": 54605.0,
    "market_cap": 106560000.0,
    "price_to_sales_ttm": 0.25,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0695,
    "roe_ttm": "N/A",
    "shares_outstanding": 10590000.0,
    "pcnt_held_by_insiders": 0.5356000000000001,
    "pcnt_held_by_institutions": 0.42200000000000004,
    "pcnt_short_of_float": 0.0288,
    "operating_cash_flow_ttm": 105440000.0,
    "levered_cash_flow_ttm": 33920000.0,
    "book_value_per_share_mrq": -16.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alliance Healthcare Services, Inc."
  },
  "AKAO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.13,
    "ebitda": -19990000.0,
    "eps_estimate_current_year": -1.43,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 6.89,
    "fifty_two_week_high": 14.19,
    "fifty_two_week_low": 5.3,
    "percent_change_from_200_day_moving_average": -0.0572,
    "percent_change_from_50_day_moving_average": -0.0518,
    "shares_owned": "N/A",
    "short_ratio": 4.88,
    "two_hundred_day_moving_average": 6.93,
    "volume": 69014.0,
    "market_cap": 118290000.0,
    "price_to_sales_ttm": 4.93,
    "price_to_book_mrq": 2.1,
    "roa_ttm": -0.1711,
    "roe_ttm": -0.2973,
    "shares_outstanding": 18120000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0554,
    "operating_cash_flow_ttm": -13760000.0,
    "levered_cash_flow_ttm": -7650000.0,
    "book_value_per_share_mrq": 3.33,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Achaogen, Inc."
  },
  "AKBA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.9,
    "ebitda": -41750000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 8.63,
    "fifty_two_week_high": 23.41,
    "fifty_two_week_low": 5.91,
    "percent_change_from_200_day_moving_average": 0.15410000000000001,
    "percent_change_from_50_day_moving_average": 0.22640000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 9.17,
    "volume": 885851.0,
    "market_cap": 305580000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.98,
    "roa_ttm": -0.18539999999999998,
    "roe_ttm": -0.303,
    "shares_outstanding": 28880000.0,
    "pcnt_held_by_insiders": 0.33,
    "pcnt_held_by_institutions": 0.122,
    "pcnt_short_of_float": 0.12380000000000001,
    "operating_cash_flow_ttm": -35270000.0,
    "levered_cash_flow_ttm": -21240000.0,
    "book_value_per_share_mrq": 5.63,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Akebia Therapeutics, Inc."
  },
  "AKER": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.08,
    "ebitda": -5220000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.08,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 2.27,
    "percent_change_from_200_day_moving_average": -0.21359999999999998,
    "percent_change_from_50_day_moving_average": 0.0276,
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 4.03,
    "volume": 4232.0,
    "market_cap": 16309999.999999998,
    "price_to_sales_ttm": 5.16,
    "price_to_book_mrq": 1.44,
    "roa_ttm": -0.2235,
    "roe_ttm": -0.37829999999999997,
    "shares_outstanding": 5140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0095,
    "operating_cash_flow_ttm": -5050000.0,
    "levered_cash_flow_ttm": -2120000.0,
    "book_value_per_share_mrq": 2.36,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Akers Biosciences Inc."
  },
  "AKRX": {
    "p_e_ratio": 95.99,
    "peg_ratio": 0.78,
    "earnings_per_share": 0.33,
    "ebitda": 208270000.0,
    "eps_estimate_current_year": 1.95,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 39.98,
    "fifty_two_week_high": 57.1,
    "fifty_two_week_low": 31.51,
    "percent_change_from_200_day_moving_average": -0.2781,
    "percent_change_from_50_day_moving_average": -0.198,
    "shares_owned": "N/A",
    "short_ratio": 6.5,
    "two_hundred_day_moving_average": 44.41,
    "volume": 1807960.0,
    "market_cap": 3670000000.0,
    "price_to_sales_ttm": 6.79,
    "price_to_book_mrq": 10.21,
    "roa_ttm": 0.08,
    "roe_ttm": 0.1108,
    "shares_outstanding": 114430000.0,
    "pcnt_held_by_insiders": 0.23879999999999998,
    "pcnt_held_by_institutions": 0.78,
    "pcnt_short_of_float": 0.0802,
    "operating_cash_flow_ttm": 30920000.0,
    "levered_cash_flow_ttm": -201080000.0,
    "book_value_per_share_mrq": 3.46,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Akorn, Inc."
  },
  "ALDR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.96,
    "earnings_per_share": -0.31,
    "ebitda": -10390000.0,
    "eps_estimate_current_year": -1.9,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 39.39,
    "fifty_two_week_high": 54.9,
    "fifty_two_week_low": 10.52,
    "percent_change_from_200_day_moving_average": -0.11630000000000001,
    "percent_change_from_50_day_moving_average": -0.1404,
    "shares_owned": "N/A",
    "short_ratio": 5.84,
    "two_hundred_day_moving_average": 38.31,
    "volume": 1275498.0,
    "market_cap": 1470000000.0,
    "price_to_sales_ttm": 35.9,
    "price_to_book_mrq": 3.72,
    "roa_ttm": -0.0263,
    "roe_ttm": -0.0449,
    "shares_outstanding": 43510000.0,
    "pcnt_held_by_insiders": 0.2712,
    "pcnt_held_by_institutions": 0.078,
    "pcnt_short_of_float": 0.1868,
    "operating_cash_flow_ttm": -58970000.0,
    "levered_cash_flow_ttm": -29940000.0,
    "book_value_per_share_mrq": 10.04,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alder Biopharmaceuticals Inc."
  },
  "ALDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.34,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 7.24,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 5.39,
    "percent_change_from_200_day_moving_average": -0.212,
    "percent_change_from_50_day_moving_average": -0.0702,
    "shares_owned": "N/A",
    "short_ratio": 1.45,
    "two_hundred_day_moving_average": 8.54,
    "volume": 6250.0,
    "market_cap": 65370000.00000001,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.12,
    "roa_ttm": -0.2378,
    "roe_ttm": -0.4268,
    "shares_outstanding": 9710000.0,
    "pcnt_held_by_insiders": 0.1465,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.015700000000000002,
    "operating_cash_flow_ttm": -6260000.0,
    "levered_cash_flow_ttm": -3160000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aldeyra Therapeutics, Inc."
  },
  "ALGN": {
    "p_e_ratio": 31.81,
    "peg_ratio": 2.1,
    "earnings_per_share": 1.78,
    "ebitda": 211650000.0,
    "eps_estimate_current_year": 1.59,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 57.29,
    "fifty_two_week_high": 66.53,
    "fifty_two_week_low": 43.27,
    "percent_change_from_200_day_moving_average": -0.04019999999999999,
    "percent_change_from_50_day_moving_average": -0.0111,
    "shares_owned": "N/A",
    "short_ratio": 12.53,
    "two_hundred_day_moving_average": 59.02,
    "volume": 702553.0,
    "market_cap": 4540000000.0,
    "price_to_sales_ttm": 5.73,
    "price_to_book_mrq": 5.92,
    "roa_ttm": 0.12689999999999999,
    "roe_ttm": 0.201,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.1518,
    "pcnt_held_by_institutions": 0.802,
    "pcnt_short_of_float": 0.10099999999999999,
    "operating_cash_flow_ttm": 237760000.0,
    "levered_cash_flow_ttm": 147980000.0,
    "book_value_per_share_mrq": 9.61,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Align Technology Inc."
  },
  "ALIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.81,
    "ebitda": -38540000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 3.2,
    "fifty_two_week_high": 6.48,
    "fifty_two_week_low": 2.21,
    "percent_change_from_200_day_moving_average": -0.4815,
    "percent_change_from_50_day_moving_average": -0.3036,
    "shares_owned": "N/A",
    "short_ratio": 18.82,
    "two_hundred_day_moving_average": 4.3,
    "volume": 207254.0,
    "market_cap": 99040000.0,
    "price_to_sales_ttm": 8.14,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.37079999999999996,
    "roe_ttm": -1.475,
    "shares_outstanding": 44410000.0,
    "pcnt_held_by_insiders": 0.5171,
    "pcnt_held_by_institutions": 0.425,
    "pcnt_short_of_float": 0.0892,
    "operating_cash_flow_ttm": -41760000.0,
    "levered_cash_flow_ttm": -51360000.0,
    "book_value_per_share_mrq": -0.8,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alimera Sciences, Inc."
  },
  "ALNY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.62,
    "earnings_per_share": -2.35,
    "ebitda": -200910000.0,
    "eps_estimate_current_year": -3.27,
    "eps_estimate_next_quarter": -0.92,
    "fifty_day_moving_average": 102.66,
    "fifty_two_week_high": 140.0,
    "fifty_two_week_low": 72.8,
    "percent_change_from_200_day_moving_average": -0.2753,
    "percent_change_from_50_day_moving_average": -0.1845,
    "shares_owned": "N/A",
    "short_ratio": 5.29,
    "two_hundred_day_moving_average": 115.53,
    "volume": 1667870.0,
    "market_cap": 7080000000.0,
    "price_to_sales_ttm": 123.45,
    "price_to_book_mrq": 5.45,
    "roa_ttm": -0.1054,
    "roe_ttm": -0.15990000000000001,
    "shares_outstanding": 84620000.0,
    "pcnt_held_by_insiders": 0.21850000000000003,
    "pcnt_held_by_institutions": 0.732,
    "pcnt_short_of_float": 0.0848,
    "operating_cash_flow_ttm": -159050000.0,
    "levered_cash_flow_ttm": -92200000.0,
    "book_value_per_share_mrq": 16.66,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Alnylam Pharmaceuticals, Inc."
  },
  "ALOG": {
    "p_e_ratio": 32.1,
    "peg_ratio": 1.35,
    "earnings_per_share": 2.66,
    "ebitda": 63450000.0,
    "eps_estimate_current_year": 4.3,
    "eps_estimate_next_quarter": 1.04,
    "fifty_day_moving_average": 81.97,
    "fifty_two_week_high": 92.31,
    "fifty_two_week_low": 63.28,
    "percent_change_from_200_day_moving_average": 0.023799999999999998,
    "percent_change_from_50_day_moving_average": 0.0416,
    "shares_owned": "N/A",
    "short_ratio": 10.16,
    "two_hundred_day_moving_average": 83.39,
    "volume": 178130.0,
    "market_cap": 1060000000.0,
    "price_to_sales_ttm": 1.97,
    "price_to_book_mrq": 2.0,
    "roa_ttm": 0.0406,
    "roe_ttm": 0.0641,
    "shares_outstanding": 12440000.0,
    "pcnt_held_by_insiders": 0.0083,
    "pcnt_held_by_institutions": 0.976,
    "pcnt_short_of_float": 0.0922,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 42.77,
    "next_earnings_announcement_date": [
      "2015-12-07",
      "2015-12-11"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Analogic Corporation"
  },
  "ALQA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -1.34,
    "ebitda": -21310000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 4.42,
    "fifty_two_week_high": 6.55,
    "fifty_two_week_low": 3.6,
    "percent_change_from_200_day_moving_average": -0.2376,
    "percent_change_from_50_day_moving_average": -0.1592,
    "shares_owned": "N/A",
    "short_ratio": 5.94,
    "two_hundred_day_moving_average": 4.88,
    "volume": 73216.0,
    "market_cap": 102930000.0,
    "price_to_sales_ttm": 12.8,
    "price_to_book_mrq": 1.81,
    "roa_ttm": -0.2089,
    "roe_ttm": -0.5646,
    "shares_outstanding": 27670000.0,
    "pcnt_held_by_insiders": 0.4465,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.0204,
    "operating_cash_flow_ttm": -19280000.0,
    "levered_cash_flow_ttm": 777130.0,
    "book_value_per_share_mrq": 2.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Alliqua BioMedical, Inc."
  },
  "ALR": {
    "p_e_ratio": 18.67,
    "peg_ratio": 2.15,
    "earnings_per_share": 2.62,
    "ebitda": 538360000.0,
    "eps_estimate_current_year": 2.42,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 52.51,
    "fifty_two_week_high": 55.99,
    "fifty_two_week_low": 35.62,
    "percent_change_from_200_day_moving_average": -0.036000000000000004,
    "percent_change_from_50_day_moving_average": -0.0669,
    "shares_owned": "N/A",
    "short_ratio": 4.45,
    "two_hundred_day_moving_average": 50.83,
    "volume": 750998.0,
    "market_cap": 4200000000.0,
    "price_to_sales_ttm": 1.74,
    "price_to_book_mrq": 2.85,
    "roa_ttm": 0.020499999999999997,
    "roe_ttm": -0.048499999999999995,
    "shares_outstanding": 85730000.0,
    "pcnt_held_by_insiders": 0.0816,
    "pcnt_held_by_institutions": 0.897,
    "pcnt_short_of_float": 0.0379,
    "operating_cash_flow_ttm": 138950000.0,
    "levered_cash_flow_ttm": -204760000.0,
    "book_value_per_share_mrq": 18.14,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Alere Inc."
  },
  "ALXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.73,
    "ebitda": -33810000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 1.24,
    "fifty_two_week_high": 2.96,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.0622,
    "percent_change_from_50_day_moving_average": 0.0736,
    "shares_owned": "N/A",
    "short_ratio": 20.6,
    "two_hundred_day_moving_average": 1.42,
    "volume": 87848.0,
    "market_cap": 25860000.0,
    "price_to_sales_ttm": 5.89,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.426,
    "roe_ttm": "N/A",
    "shares_outstanding": 19440000.0,
    "pcnt_held_by_insiders": 0.0417,
    "pcnt_held_by_institutions": 0.47200000000000003,
    "pcnt_short_of_float": 0.0412,
    "operating_cash_flow_ttm": -37770000.0,
    "levered_cash_flow_ttm": -18030000.0,
    "book_value_per_share_mrq": -3.29,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Alexza Pharmaceuticals Inc."
  },
  "AMAG": {
    "p_e_ratio": 7.72,
    "peg_ratio": 0.03,
    "earnings_per_share": 5.66,
    "ebitda": 153980000.0,
    "eps_estimate_current_year": 5.24,
    "eps_estimate_next_quarter": 1.67,
    "fifty_day_moving_average": 58.11,
    "fifty_two_week_high": 77.73,
    "fifty_two_week_low": 26.02,
    "percent_change_from_200_day_moving_average": -0.29710000000000003,
    "percent_change_from_50_day_moving_average": -0.2475,
    "shares_owned": "N/A",
    "short_ratio": 7.03,
    "two_hundred_day_moving_average": 62.21,
    "volume": 2630518.0,
    "market_cap": 1490000000.0,
    "price_to_sales_ttm": 5.05,
    "price_to_book_mrq": 2.07,
    "roa_ttm": 0.0676,
    "roe_ttm": 0.4208,
    "shares_outstanding": 34020000.0,
    "pcnt_held_by_insiders": 0.0704,
    "pcnt_held_by_institutions": 1.092,
    "pcnt_short_of_float": 0.2086,
    "operating_cash_flow_ttm": 93340000.0,
    "levered_cash_flow_ttm": 147150000.0,
    "book_value_per_share_mrq": 23.1,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "AMAG Pharmaceuticals, Inc."
  },
  "AMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.926,
    "ebitda": -13800000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.4497,
    "fifty_two_week_high": 3.43,
    "fifty_two_week_low": 0.204,
    "percent_change_from_200_day_moving_average": -0.17409300000000003,
    "percent_change_from_50_day_moving_average": -0.21444,
    "shares_owned": "N/A",
    "short_ratio": 2.12,
    "two_hundred_day_moving_average": 0.4278,
    "volume": 1159125.0,
    "market_cap": 27890000.0,
    "price_to_sales_ttm": 1.16,
    "price_to_book_mrq": 2.95,
    "roa_ttm": -0.2414,
    "roe_ttm": -2.2538,
    "shares_outstanding": 78940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1419,
    "operating_cash_flow_ttm": -11440000.0,
    "levered_cash_flow_ttm": -5010000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Amedica Corporation"
  },
  "AMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.39,
    "earnings_per_share": -0.21,
    "ebitda": 89340000.0,
    "eps_estimate_current_year": 1.42,
    "eps_estimate_next_quarter": 0.35,
    "fifty_day_moving_average": 41.76,
    "fifty_two_week_high": 48.34,
    "fifty_two_week_low": 19.03,
    "percent_change_from_200_day_moving_average": 0.153,
    "percent_change_from_50_day_moving_average": -0.0172,
    "shares_owned": "N/A",
    "short_ratio": 3.41,
    "two_hundred_day_moving_average": 35.6,
    "volume": 339207.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 1.19,
    "price_to_book_mrq": 3.76,
    "roa_ttm": 0.0604,
    "roe_ttm": -0.0161,
    "shares_outstanding": 33670000.0,
    "pcnt_held_by_insiders": 0.1308,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.06480000000000001,
    "operating_cash_flow_ttm": 86970000.0,
    "levered_cash_flow_ttm": 43590000.0,
    "book_value_per_share_mrq": 11.27,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Amedisys Inc."
  },
  "AMEH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -536161.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.48,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 0.45,
    "percent_change_from_200_day_moving_average": -0.08449999999999999,
    "percent_change_from_50_day_moving_average": -0.1907,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 6.61,
    "volume": 0.0,
    "market_cap": 29420000.0,
    "price_to_sales_ttm": 0.75,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.052300000000000006,
    "roe_ttm": "N/A",
    "shares_outstanding": 4860000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": 298190.0,
    "levered_cash_flow_ttm": 2880000.0,
    "book_value_per_share_mrq": -1.07,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Apollo Medical Holdings, Inc."
  },
  "AMPE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -34160000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.93,
    "fifty_two_week_high": 9.01,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": -0.1081,
    "percent_change_from_50_day_moving_average": 0.12140000000000001,
    "shares_owned": "N/A",
    "short_ratio": 24.05,
    "two_hundred_day_moving_average": 3.69,
    "volume": 570785.0,
    "market_cap": 171070000.0,
    "price_to_sales_ttm": 740.07,
    "price_to_book_mrq": 3.59,
    "roa_ttm": -0.306,
    "roe_ttm": -0.5246999999999999,
    "shares_outstanding": 52000000.0,
    "pcnt_held_by_insiders": 0.10949999999999999,
    "pcnt_held_by_institutions": 0.309,
    "pcnt_short_of_float": 0.1394,
    "operating_cash_flow_ttm": -24950000.0,
    "levered_cash_flow_ttm": -16170000.000000002,
    "book_value_per_share_mrq": 0.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ampio Pharmaceuticals, Inc."
  },
  "AMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -14930000.0,
    "eps_estimate_current_year": 2.91,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 13.91,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 9.76,
    "percent_change_from_200_day_moving_average": -0.25730000000000003,
    "percent_change_from_50_day_moving_average": -0.1804,
    "shares_owned": "N/A",
    "short_ratio": 5.97,
    "two_hundred_day_moving_average": 15.35,
    "volume": 285049.0,
    "market_cap": 516850000.0,
    "price_to_sales_ttm": 2.49,
    "price_to_book_mrq": 1.97,
    "roa_ttm": -0.0455,
    "roe_ttm": -0.053099999999999994,
    "shares_outstanding": 45340000.0,
    "pcnt_held_by_insiders": 0.0898,
    "pcnt_held_by_institutions": 0.4,
    "pcnt_short_of_float": 0.0377,
    "operating_cash_flow_ttm": 29790000.0,
    "levered_cash_flow_ttm": 16629999.999999998,
    "book_value_per_share_mrq": 6.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amphastar Pharmaceuticals, Inc."
  },
  "AMRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.24,
    "earnings_per_share": -0.33,
    "ebitda": 34830000.0,
    "eps_estimate_current_year": 0.9,
    "eps_estimate_next_quarter": 0.32,
    "fifty_day_moving_average": 20.35,
    "fifty_two_week_high": 23.95,
    "fifty_two_week_low": 13.73,
    "percent_change_from_200_day_moving_average": -0.0693,
    "percent_change_from_50_day_moving_average": -0.0981,
    "shares_owned": "N/A",
    "short_ratio": 21.49,
    "two_hundred_day_moving_average": 19.72,
    "volume": 498944.0,
    "market_cap": 650560000.0,
    "price_to_sales_ttm": 1.92,
    "price_to_book_mrq": 2.47,
    "roa_ttm": 0.014199999999999999,
    "roe_ttm": -0.0415,
    "shares_outstanding": 35450000.0,
    "pcnt_held_by_insiders": 0.14300000000000002,
    "pcnt_held_by_institutions": 0.88,
    "pcnt_short_of_float": 0.3039,
    "operating_cash_flow_ttm": 17550000.0,
    "levered_cash_flow_ttm": -6790000.0,
    "book_value_per_share_mrq": 7.73,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Albany Molecular Research Inc."
  },
  "AMRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -0.82,
    "ebitda": -98110000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.26,
    "fifty_two_week_high": 3.33,
    "fifty_two_week_low": 0.78,
    "percent_change_from_200_day_moving_average": -0.0373,
    "percent_change_from_50_day_moving_average": -0.0278,
    "shares_owned": "N/A",
    "short_ratio": 10.3,
    "two_hundred_day_moving_average": 2.29,
    "volume": 1252441.0,
    "market_cap": 403170000.0,
    "price_to_sales_ttm": 6.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3084,
    "roe_ttm": "N/A",
    "shares_outstanding": 183260000.0,
    "pcnt_held_by_insiders": 0.0393,
    "pcnt_held_by_institutions": 0.33299999999999996,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -71120000.0,
    "levered_cash_flow_ttm": -63760000.0,
    "book_value_per_share_mrq": -0.62,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Amarin Corporation plc"
  },
  "AMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": 9190000.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.2,
    "fifty_two_week_high": 3.05,
    "fifty_two_week_low": 1.81,
    "percent_change_from_200_day_moving_average": -0.1972,
    "percent_change_from_50_day_moving_average": -0.0962,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 2.48,
    "volume": 4545.0,
    "market_cap": 10670000.0,
    "price_to_sales_ttm": 0.61,
    "price_to_book_mrq": 0.51,
    "roa_ttm": 0.0304,
    "roe_ttm": -0.0347,
    "shares_outstanding": 5360000.0,
    "pcnt_held_by_insiders": 0.3713,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0011,
    "operating_cash_flow_ttm": 8250000.0,
    "levered_cash_flow_ttm": 760120.0,
    "book_value_per_share_mrq": 3.67,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "American Shared Hospital Services"
  },
  "AMSG": {
    "p_e_ratio": 61.91,
    "peg_ratio": 1.21,
    "earnings_per_share": 1.34,
    "ebitda": 607510000.0,
    "eps_estimate_current_year": 3.55,
    "eps_estimate_next_quarter": 1.04,
    "fifty_day_moving_average": 81.58,
    "fifty_two_week_high": 87.42,
    "fifty_two_week_low": 47.68,
    "percent_change_from_200_day_moving_average": 0.1678,
    "percent_change_from_50_day_moving_average": 0.0138,
    "shares_owned": "N/A",
    "short_ratio": 4.4,
    "two_hundred_day_moving_average": 70.83,
    "volume": 533814.0,
    "market_cap": 4010000000.0,
    "price_to_sales_ttm": 1.77,
    "price_to_book_mrq": 2.58,
    "roa_ttm": 0.08199999999999999,
    "roe_ttm": 0.1476,
    "shares_outstanding": 48440000.0,
    "pcnt_held_by_insiders": 0.11460000000000001,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.0581,
    "operating_cash_flow_ttm": 510180000.0,
    "levered_cash_flow_ttm": 331410000.0,
    "book_value_per_share_mrq": 32.93,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "AmSurg Corp."
  },
  "ANAC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 8.79,
    "earnings_per_share": -1.57,
    "ebitda": -71190000.0,
    "eps_estimate_current_year": -1.06,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 133.93,
    "fifty_two_week_high": 156.93,
    "fifty_two_week_low": 22.29,
    "percent_change_from_200_day_moving_average": 0.295,
    "percent_change_from_50_day_moving_average": -0.1017,
    "shares_owned": "N/A",
    "short_ratio": 4.46,
    "two_hundred_day_moving_average": 92.9,
    "volume": 897839.0,
    "market_cap": 5300000000.0,
    "price_to_sales_ttm": 111.04,
    "price_to_book_mrq": 85.37,
    "roa_ttm": -0.26899999999999996,
    "roe_ttm": -0.9020999999999999,
    "shares_outstanding": 44020000.0,
    "pcnt_held_by_insiders": 0.2071,
    "pcnt_held_by_institutions": 0.812,
    "pcnt_short_of_float": 0.0924,
    "operating_cash_flow_ttm": -21060000.0,
    "levered_cash_flow_ttm": -28870000.0,
    "book_value_per_share_mrq": 1.48,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anacor Pharmaceuticals, Inc."
  },
  "ANCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.74,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.45,
    "fifty_two_week_high": 3.88,
    "fifty_two_week_low": 1.02,
    "percent_change_from_200_day_moving_average": -0.37549999999999994,
    "percent_change_from_50_day_moving_average": -0.1698,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 1.92,
    "volume": 0.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": null,
    "sector": null,
    "industry": null
  },
  "ANGO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.5,
    "earnings_per_share": -0.09,
    "ebitda": 51200000.0,
    "eps_estimate_current_year": 0.64,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 14.66,
    "fifty_two_week_high": 19.8,
    "fifty_two_week_low": 13.5,
    "percent_change_from_200_day_moving_average": -0.12390000000000001,
    "percent_change_from_50_day_moving_average": -0.0352,
    "shares_owned": "N/A",
    "short_ratio": 9.38,
    "two_hundred_day_moving_average": 16.14,
    "volume": 323311.0,
    "market_cap": 512020000.0,
    "price_to_sales_ttm": 1.47,
    "price_to_book_mrq": 0.95,
    "roa_ttm": 0.0177,
    "roe_ttm": -0.006,
    "shares_outstanding": 36210000.0,
    "pcnt_held_by_insiders": 0.2797,
    "pcnt_held_by_institutions": 0.639,
    "pcnt_short_of_float": 0.0492,
    "operating_cash_flow_ttm": 26240000.0,
    "levered_cash_flow_ttm": 22610000.0,
    "book_value_per_share_mrq": 15.18,
    "next_earnings_announcement_date": [
      "2015-10-07",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AngioDynamics Inc."
  },
  "ANIK": {
    "p_e_ratio": 19.59,
    "peg_ratio": 0.8,
    "earnings_per_share": 1.67,
    "ebitda": 44470000.0,
    "eps_estimate_current_year": 1.48,
    "eps_estimate_next_quarter": 0.4,
    "fifty_day_moving_average": 35.2,
    "fifty_two_week_high": 45.35,
    "fifty_two_week_low": 31.36,
    "percent_change_from_200_day_moving_average": -0.0897,
    "percent_change_from_50_day_moving_average": -0.0711,
    "shares_owned": "N/A",
    "short_ratio": 17.45,
    "two_hundred_day_moving_average": 35.92,
    "volume": 131537.0,
    "market_cap": 478470000.0,
    "price_to_sales_ttm": 5.84,
    "price_to_book_mrq": 2.63,
    "roa_ttm": 0.13019999999999998,
    "roe_ttm": 0.1435,
    "shares_outstanding": 14630000.0,
    "pcnt_held_by_insiders": 0.033,
    "pcnt_held_by_institutions": 0.687,
    "pcnt_short_of_float": 0.19079999999999997,
    "operating_cash_flow_ttm": 37030000.0,
    "levered_cash_flow_ttm": 31190000.0,
    "book_value_per_share_mrq": 12.7,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anika Therapeutics Inc."
  },
  "ANIP": {
    "p_e_ratio": 13.99,
    "peg_ratio": 0.82,
    "earnings_per_share": 3.09,
    "ebitda": 40860000.0,
    "eps_estimate_current_year": 2.46,
    "eps_estimate_next_quarter": 0.72,
    "fifty_day_moving_average": 51.88,
    "fifty_two_week_high": 73.54,
    "fifty_two_week_low": 24.24,
    "percent_change_from_200_day_moving_average": -0.2701,
    "percent_change_from_50_day_moving_average": -0.16699999999999998,
    "shares_owned": "N/A",
    "short_ratio": 4.19,
    "two_hundred_day_moving_average": 59.2,
    "volume": 996609.0,
    "market_cap": 494810000.0,
    "price_to_sales_ttm": 6.89,
    "price_to_book_mrq": 3.54,
    "roa_ttm": 0.1219,
    "roe_ttm": 0.2961,
    "shares_outstanding": 11450000.0,
    "pcnt_held_by_insiders": 0.4501,
    "pcnt_held_by_institutions": 0.317,
    "pcnt_short_of_float": 0.17190000000000003,
    "operating_cash_flow_ttm": 17230000.0,
    "levered_cash_flow_ttm": -26040000.0,
    "book_value_per_share_mrq": 13.07,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ANI Pharmaceuticals, Inc."
  },
  "ANTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.14,
    "ebitda": -28780000.0,
    "eps_estimate_current_year": -1.09,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 8.25,
    "fifty_two_week_high": 11.65,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": 0.0739,
    "percent_change_from_50_day_moving_average": -0.0882,
    "shares_owned": "N/A",
    "short_ratio": 2.15,
    "two_hundred_day_moving_average": 7.0,
    "volume": 846372.0,
    "market_cap": 299710000.0,
    "price_to_sales_ttm": 626.77,
    "price_to_book_mrq": 11.24,
    "roa_ttm": -0.595,
    "roe_ttm": -1.6581000000000001,
    "shares_outstanding": 39850000.0,
    "pcnt_held_by_insiders": 0.1463,
    "pcnt_held_by_institutions": 0.419,
    "pcnt_short_of_float": 0.0633,
    "operating_cash_flow_ttm": -25170000.0,
    "levered_cash_flow_ttm": -12850000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Anthera Pharmaceuticals, Inc."
  },
  "APHB": {
    "p_e_ratio": 1.91,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.6,
    "ebitda": -10630000.0,
    "eps_estimate_current_year": -2.73,
    "eps_estimate_next_quarter": -1.78,
    "fifty_day_moving_average": 0.18,
    "fifty_two_week_high": 5.42,
    "fifty_two_week_low": 0.07,
    "percent_change_from_200_day_moving_average": 23.3017,
    "percent_change_from_50_day_moving_average": 25.8731,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.2,
    "volume": 20539.0,
    "market_cap": 28690000.0,
    "price_to_sales_ttm": 77.96,
    "price_to_book_mrq": 2.4,
    "roa_ttm": -0.2,
    "roe_ttm": 0.7606,
    "shares_outstanding": 5780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": -10790000.0,
    "levered_cash_flow_ttm": -4470000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AmpliPhi Biosciences Corporation"
  },
  "APPY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -0.29,
    "ebitda": -8830000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.4,
    "fifty_two_week_high": 2.09,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.2685,
    "percent_change_from_50_day_moving_average": -0.1318,
    "shares_owned": "N/A",
    "short_ratio": 8.62,
    "two_hundred_day_moving_average": 0.48,
    "volume": 162475.0,
    "market_cap": 10850000.0,
    "price_to_sales_ttm": 75.92,
    "price_to_book_mrq": 0.57,
    "roa_ttm": -0.1975,
    "roe_ttm": -0.3762,
    "shares_outstanding": 30990000.0,
    "pcnt_held_by_insiders": 0.0069,
    "pcnt_held_by_institutions": 0.217,
    "pcnt_short_of_float": 0.0393,
    "operating_cash_flow_ttm": -8070000.0,
    "levered_cash_flow_ttm": -5050000.0,
    "book_value_per_share_mrq": 0.65,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Venaxis, Inc."
  },
  "APRI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -31930000.0,
    "eps_estimate_current_year": -0.48,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 2.75,
    "fifty_two_week_low": 0.92,
    "percent_change_from_200_day_moving_average": -0.0301,
    "percent_change_from_50_day_moving_average": 0.08990000000000001,
    "shares_owned": "N/A",
    "short_ratio": 10.1,
    "two_hundred_day_moving_average": 1.64,
    "volume": 146547.0,
    "market_cap": 80160000.0,
    "price_to_sales_ttm": 16.27,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.271,
    "roe_ttm": -7.4624,
    "shares_outstanding": 50410000.0,
    "pcnt_held_by_insiders": 0.0084,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": -27930000.0,
    "levered_cash_flow_ttm": -21870000.0,
    "book_value_per_share_mrq": -0.06,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Apricus Biosciences, Inc."
  },
  "AQXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.38,
    "ebitda": -24850000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 17.75,
    "fifty_two_week_high": 55.75,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": 0.8072,
    "percent_change_from_50_day_moving_average": -0.028399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.2,
    "two_hundred_day_moving_average": 9.55,
    "volume": 265255.0,
    "market_cap": 279920000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.61,
    "roa_ttm": -0.37670000000000003,
    "roe_ttm": -0.6735,
    "shares_outstanding": 16230000.0,
    "pcnt_held_by_insiders": 0.41590000000000005,
    "pcnt_held_by_institutions": 0.462,
    "pcnt_short_of_float": 0.1955,
    "operating_cash_flow_ttm": -23290000.0,
    "levered_cash_flow_ttm": -13430000.0,
    "book_value_per_share_mrq": 2.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Aquinox Pharmaceuticals Inc."
  },
  "ARAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.09,
    "earnings_per_share": -0.51,
    "ebitda": -7180000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 6.34,
    "fifty_two_week_high": 10.01,
    "fifty_two_week_low": 5.55,
    "percent_change_from_200_day_moving_average": -0.221,
    "percent_change_from_50_day_moving_average": -0.1149,
    "shares_owned": "N/A",
    "short_ratio": 10.09,
    "two_hundred_day_moving_average": 7.2,
    "volume": 1149805.0,
    "market_cap": 447370000.0,
    "price_to_sales_ttm": 1.25,
    "price_to_book_mrq": 6.24,
    "roa_ttm": -0.024300000000000002,
    "roe_ttm": -0.46130000000000004,
    "shares_outstanding": 79750000.0,
    "pcnt_held_by_insiders": 0.022099999999999998,
    "pcnt_held_by_institutions": 1.079,
    "pcnt_short_of_float": 0.2296,
    "operating_cash_flow_ttm": -16730000.0,
    "levered_cash_flow_ttm": -22890000.0,
    "book_value_per_share_mrq": 0.95,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Accuray Incorporated"
  },
  "ARDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -3640000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 7.25,
    "fifty_two_week_high": 9.9,
    "fifty_two_week_low": 6.17,
    "percent_change_from_200_day_moving_average": 0.0587,
    "percent_change_from_50_day_moving_average": 0.0347,
    "shares_owned": "N/A",
    "short_ratio": 0.3,
    "two_hundred_day_moving_average": 7.08,
    "volume": 8319.0,
    "market_cap": 110450000.0,
    "price_to_sales_ttm": 3.3,
    "price_to_book_mrq": 2.95,
    "roa_ttm": -0.0449,
    "roe_ttm": -0.1041,
    "shares_outstanding": 14730000.0,
    "pcnt_held_by_insiders": 0.8362,
    "pcnt_held_by_institutions": 0.002,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -1390000.0,
    "levered_cash_flow_ttm": 110120.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Aradigm Corporation"
  },
  "ARDX": {
    "p_e_ratio": 168.74,
    "peg_ratio": -0.65,
    "earnings_per_share": 0.12,
    "ebitda": 2170000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 19.38,
    "fifty_two_week_high": 35.48,
    "fifty_two_week_low": 7.95,
    "percent_change_from_200_day_moving_average": 0.292,
    "percent_change_from_50_day_moving_average": 0.036000000000000004,
    "shares_owned": "N/A",
    "short_ratio": 8.16,
    "two_hundred_day_moving_average": 15.54,
    "volume": 156661.0,
    "market_cap": 520559999.99999994,
    "price_to_sales_ttm": 14.77,
    "price_to_book_mrq": 3.94,
    "roa_ttm": 0.0079,
    "roe_ttm": 0.015700000000000002,
    "shares_outstanding": 25920000.0,
    "pcnt_held_by_insiders": 0.44689999999999996,
    "pcnt_held_by_institutions": 0.08900000000000001,
    "pcnt_short_of_float": 0.1349,
    "operating_cash_flow_ttm": -47910000.0,
    "levered_cash_flow_ttm": -19070000.0,
    "book_value_per_share_mrq": 5.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ardelyx, Inc."
  },
  "ARGS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.44,
    "ebitda": -65750000.0,
    "eps_estimate_current_year": -3.52,
    "eps_estimate_next_quarter": -0.88,
    "fifty_day_moving_average": 5.76,
    "fifty_two_week_high": 10.56,
    "fifty_two_week_low": 4.11,
    "percent_change_from_200_day_moving_average": -0.22699999999999998,
    "percent_change_from_50_day_moving_average": -0.029500000000000002,
    "shares_owned": "N/A",
    "short_ratio": 8.42,
    "two_hundred_day_moving_average": 7.23,
    "volume": 12212.0,
    "market_cap": 115650000.0,
    "price_to_sales_ttm": 118.08,
    "price_to_book_mrq": 24.63,
    "roa_ttm": -0.6711,
    "roe_ttm": -2.0976,
    "shares_outstanding": 20690000.0,
    "pcnt_held_by_insiders": 0.6225,
    "pcnt_held_by_institutions": 0.22399999999999998,
    "pcnt_short_of_float": 0.0659,
    "operating_cash_flow_ttm": -54960000.0,
    "levered_cash_flow_ttm": -41450000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Argos Therapeutics, Inc."
  },
  "ARIA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -0.92,
    "ebitda": -157150000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 7.6,
    "fifty_two_week_high": 10.07,
    "fifty_two_week_low": 4.9,
    "percent_change_from_200_day_moving_average": -0.1917,
    "percent_change_from_50_day_moving_average": -0.11349999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.91,
    "two_hundred_day_moving_average": 8.34,
    "volume": 6241831.0,
    "market_cap": 1270000000.0,
    "price_to_sales_ttm": 9.87,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1989,
    "roe_ttm": -3.1504000000000003,
    "shares_outstanding": 188900000.0,
    "pcnt_held_by_insiders": 0.0803,
    "pcnt_held_by_institutions": 0.583,
    "pcnt_short_of_float": 0.2664,
    "operating_cash_flow_ttm": -40320000.0,
    "levered_cash_flow_ttm": -55100000.0,
    "book_value_per_share_mrq": -0.07,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ariad Pharmaceuticals Inc."
  },
  "ARNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.29,
    "earnings_per_share": -0.41,
    "ebitda": -95380000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 2.88,
    "fifty_two_week_high": 6.28,
    "fifty_two_week_low": 2.18,
    "percent_change_from_200_day_moving_average": -0.4387,
    "percent_change_from_50_day_moving_average": -0.2228,
    "shares_owned": "N/A",
    "short_ratio": 8.38,
    "two_hundred_day_moving_average": 3.99,
    "volume": 3378336.0,
    "market_cap": 542620000.0,
    "price_to_sales_ttm": 16.17,
    "price_to_book_mrq": 5.85,
    "roa_ttm": -0.1979,
    "roe_ttm": -0.8928,
    "shares_outstanding": 242240000.0,
    "pcnt_held_by_insiders": 0.0046,
    "pcnt_held_by_institutions": 0.466,
    "pcnt_short_of_float": 0.11939999999999999,
    "operating_cash_flow_ttm": -95340000.0,
    "levered_cash_flow_ttm": -37110000.0,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arena Pharmaceuticals, Inc."
  },
  "ARQL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -0.29,
    "ebitda": -19190000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.75,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.04,
    "percent_change_from_200_day_moving_average": 0.0682,
    "percent_change_from_50_day_moving_average": 0.14029999999999998,
    "shares_owned": "N/A",
    "short_ratio": 6.94,
    "two_hundred_day_moving_average": 1.87,
    "volume": 264226.0,
    "market_cap": 125760000.0,
    "price_to_sales_ttm": 11.13,
    "price_to_book_mrq": 3.84,
    "roa_ttm": -0.1881,
    "roe_ttm": -0.44880000000000003,
    "shares_outstanding": 62880000.0,
    "pcnt_held_by_insiders": 0.1257,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.0158,
    "operating_cash_flow_ttm": -27740000.0,
    "levered_cash_flow_ttm": -12360000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ArQule Inc."
  },
  "ARRY": {
    "p_e_ratio": 71.45,
    "peg_ratio": -0.89,
    "earnings_per_share": 0.07,
    "ebitda": -101260000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 5.64,
    "fifty_two_week_high": 8.59,
    "fifty_two_week_low": 2.98,
    "percent_change_from_200_day_moving_average": -0.2781,
    "percent_change_from_50_day_moving_average": -0.1264,
    "shares_owned": "N/A",
    "short_ratio": 14.95,
    "two_hundred_day_moving_average": 6.83,
    "volume": 3315279.0,
    "market_cap": 701650000.0,
    "price_to_sales_ttm": 13.94,
    "price_to_book_mrq": 16.97,
    "roa_ttm": -0.3918,
    "roe_ttm": 1.1067,
    "shares_outstanding": 142320000.0,
    "pcnt_held_by_insiders": 0.16469999999999999,
    "pcnt_held_by_institutions": 0.861,
    "pcnt_short_of_float": 0.2586,
    "operating_cash_flow_ttm": -5790000.0,
    "levered_cash_flow_ttm": -69300000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Array BioPharma Inc."
  },
  "ARWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.65,
    "earnings_per_share": -1.61,
    "ebitda": -76660000.0,
    "eps_estimate_current_year": -1.58,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 6.11,
    "fifty_two_week_high": 15.35,
    "fifty_two_week_low": 4.35,
    "percent_change_from_200_day_moving_average": 0.0885,
    "percent_change_from_50_day_moving_average": 0.188,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 6.67,
    "volume": 5667707.0,
    "market_cap": 431980000.0,
    "price_to_sales_ttm": 1119.91,
    "price_to_book_mrq": 3.26,
    "roa_ttm": -0.2867,
    "roe_ttm": -0.5663,
    "shares_outstanding": 59500000.0,
    "pcnt_held_by_insiders": 0.060599999999999994,
    "pcnt_held_by_institutions": 0.764,
    "pcnt_short_of_float": 0.2639,
    "operating_cash_flow_ttm": -64610000.0,
    "levered_cash_flow_ttm": -41000000.0,
    "book_value_per_share_mrq": 2.21,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Arrowhead Research Corp."
  },
  "ASMB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.66,
    "ebitda": -31190000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.34,
    "fifty_two_week_high": 20.5,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": -0.3289,
    "percent_change_from_50_day_moving_average": -0.23070000000000002,
    "shares_owned": "N/A",
    "short_ratio": 7.01,
    "two_hundred_day_moving_average": 15.29,
    "volume": 173529.0,
    "market_cap": 176370000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.53,
    "roa_ttm": -0.2345,
    "roe_ttm": -0.4146,
    "shares_outstanding": 17190000.0,
    "pcnt_held_by_insiders": 0.0097,
    "pcnt_held_by_institutions": 0.204,
    "pcnt_short_of_float": 0.0834,
    "operating_cash_flow_ttm": -15520000.0,
    "levered_cash_flow_ttm": -3120000.0,
    "book_value_per_share_mrq": 7.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Assembly Biosciences, Inc."
  },
  "ASND": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.37,
    "earnings_per_share": -0.95,
    "ebitda": -32560000.000000004,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.67,
    "fifty_day_moving_average": 19.23,
    "fifty_two_week_high": 23.81,
    "fifty_two_week_low": 14.75,
    "percent_change_from_200_day_moving_average": -0.0852,
    "percent_change_from_50_day_moving_average": -0.1226,
    "shares_owned": "N/A",
    "short_ratio": 3.53,
    "two_hundred_day_moving_average": 18.44,
    "volume": 62774.0,
    "market_cap": 408190000.0,
    "price_to_sales_ttm": 40.89,
    "price_to_book_mrq": 3.04,
    "roa_ttm": -0.2214,
    "roe_ttm": -0.29510000000000003,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -35680000.0,
    "levered_cash_flow_ttm": -26600000.0,
    "book_value_per_share_mrq": 6.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ascendis Pharma A/S"
  },
  "AST": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.36,
    "ebitda": -13620000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.54,
    "fifty_two_week_high": 15.1,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.3542,
    "percent_change_from_50_day_moving_average": 0.0225,
    "shares_owned": "N/A",
    "short_ratio": 12.54,
    "two_hundred_day_moving_average": 7.18,
    "volume": 106294.0,
    "market_cap": 174470000.0,
    "price_to_sales_ttm": 71.64,
    "price_to_book_mrq": 4.13,
    "roa_ttm": -0.193,
    "roe_ttm": -0.28859999999999997,
    "shares_outstanding": 37600000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1769,
    "operating_cash_flow_ttm": -14390000.0,
    "levered_cash_flow_ttm": -15460000.0,
    "book_value_per_share_mrq": 1.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Asterias Biotherapeutics, Inc."
  },
  "ATEC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.22,
    "earnings_per_share": -0.15,
    "ebitda": 23010000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 0.54,
    "fifty_two_week_high": 1.73,
    "fifty_two_week_low": 0.33,
    "percent_change_from_200_day_moving_average": -0.7001999999999999,
    "percent_change_from_50_day_moving_average": -0.3539,
    "shares_owned": "N/A",
    "short_ratio": 7.93,
    "two_hundred_day_moving_average": 1.17,
    "volume": 121378.0,
    "market_cap": 34950000.0,
    "price_to_sales_ttm": 0.17,
    "price_to_book_mrq": 0.26,
    "roa_ttm": 0.0085,
    "roe_ttm": -0.06860000000000001,
    "shares_outstanding": 99850000.0,
    "pcnt_held_by_insiders": 0.35,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.0426,
    "operating_cash_flow_ttm": 8180000.0,
    "levered_cash_flow_ttm": 142880.0,
    "book_value_per_share_mrq": 1.35,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Alphatec Holdings, Inc."
  },
  "ATHX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.16,
    "earnings_per_share": -0.33,
    "ebitda": -27950000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.2,
    "fifty_two_week_high": 3.43,
    "fifty_two_week_low": 0.9,
    "percent_change_from_200_day_moving_average": -0.21420000000000003,
    "percent_change_from_50_day_moving_average": 0.016399999999999998,
    "shares_owned": "N/A",
    "short_ratio": 8.22,
    "two_hundred_day_moving_average": 1.55,
    "volume": 503224.0,
    "market_cap": 101400000.0,
    "price_to_sales_ttm": 73.25,
    "price_to_book_mrq": 5.06,
    "roa_ttm": -0.45530000000000004,
    "roe_ttm": -0.9488,
    "shares_outstanding": 83120000.0,
    "pcnt_held_by_insiders": 0.19469999999999998,
    "pcnt_held_by_institutions": 0.174,
    "pcnt_short_of_float": 0.0388,
    "operating_cash_flow_ttm": -17110000.0,
    "levered_cash_flow_ttm": -6820000.0,
    "book_value_per_share_mrq": 0.26,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Athersys, Inc."
  },
  "ATNM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -29130000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 2.21,
    "fifty_two_week_high": 8.12,
    "fifty_two_week_low": 1.52,
    "percent_change_from_200_day_moving_average": -0.16829999999999998,
    "percent_change_from_50_day_moving_average": -0.0336,
    "shares_owned": "N/A",
    "short_ratio": 2.74,
    "two_hundred_day_moving_average": 2.57,
    "volume": 607662.0,
    "market_cap": 86960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.03,
    "roa_ttm": -0.8733,
    "roe_ttm": -1.5966999999999998,
    "shares_outstanding": 40640000.0,
    "pcnt_held_by_insiders": 0.22510000000000002,
    "pcnt_held_by_institutions": 0.051,
    "pcnt_short_of_float": 0.1002,
    "operating_cash_flow_ttm": -20370000.0,
    "levered_cash_flow_ttm": -17660000.0,
    "book_value_per_share_mrq": 0.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Actinium Pharmaceuticals, Inc."
  },
  "ATOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.617,
    "ebitda": -12720000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.8731,
    "fifty_two_week_high": 2.65,
    "fifty_two_week_low": 0.7,
    "percent_change_from_200_day_moving_average": -0.383253,
    "percent_change_from_50_day_moving_average": -0.08365500000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.18,
    "two_hundred_day_moving_average": 1.2973,
    "volume": 109168.0,
    "market_cap": 23240000.0,
    "price_to_sales_ttm": 4.54,
    "price_to_book_mrq": 1.75,
    "roa_ttm": -0.4525,
    "roe_ttm": -0.9904000000000001,
    "shares_outstanding": 29050000.0,
    "pcnt_held_by_insiders": 0.1956,
    "pcnt_held_by_institutions": 0.024,
    "pcnt_short_of_float": 0.0268,
    "operating_cash_flow_ttm": -12220000.0,
    "levered_cash_flow_ttm": -7510000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Atossa Genetics, Inc."
  },
  "ATRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.55,
    "ebitda": -36450000.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 44.72,
    "fifty_two_week_high": 65.56,
    "fifty_two_week_low": 9.66,
    "percent_change_from_200_day_moving_average": -0.13419999999999999,
    "percent_change_from_50_day_moving_average": -0.1036,
    "shares_owned": "N/A",
    "short_ratio": 6.89,
    "two_hundred_day_moving_average": 46.31,
    "volume": 371443.0,
    "market_cap": 1140000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.04,
    "roa_ttm": -0.2076,
    "roe_ttm": -0.3947,
    "shares_outstanding": 28510000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1186,
    "operating_cash_flow_ttm": -21910000.0,
    "levered_cash_flow_ttm": -6980000.0,
    "book_value_per_share_mrq": 6.18,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Atara Biotherapeutics, Inc."
  },
  "ATRC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.39,
    "earnings_per_share": -0.59,
    "ebitda": -18120000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 25.36,
    "fifty_two_week_high": 28.15,
    "fifty_two_week_low": 13.19,
    "percent_change_from_200_day_moving_average": -0.1393,
    "percent_change_from_50_day_moving_average": -0.2078,
    "shares_owned": "N/A",
    "short_ratio": 16.67,
    "two_hundred_day_moving_average": 23.34,
    "volume": 389038.0,
    "market_cap": 573310000.0,
    "price_to_sales_ttm": 5.53,
    "price_to_book_mrq": 5.07,
    "roa_ttm": -0.09269999999999999,
    "roe_ttm": -0.1215,
    "shares_outstanding": 28540000.0,
    "pcnt_held_by_insiders": 0.087,
    "pcnt_held_by_institutions": 0.826,
    "pcnt_short_of_float": 0.1176,
    "operating_cash_flow_ttm": -9620000.0,
    "levered_cash_flow_ttm": -10700000.0,
    "book_value_per_share_mrq": 4.51,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "AtriCure, Inc."
  },
  "ATRI": {
    "p_e_ratio": 25.15,
    "peg_ratio": 0.0,
    "earnings_per_share": 14.97,
    "ebitda": 51230000.0,
    "eps_estimate_current_year": 9.9,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 386.88,
    "fifty_two_week_high": 428.85,
    "fifty_two_week_low": 288.5,
    "percent_change_from_200_day_moving_average": 0.0217,
    "percent_change_from_50_day_moving_average": -0.027000000000000003,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 368.46,
    "volume": 4968.0,
    "market_cap": 692070000.0,
    "price_to_sales_ttm": 4.89,
    "price_to_book_mrq": 5.15,
    "roa_ttm": 0.15990000000000001,
    "roe_ttm": 0.2,
    "shares_outstanding": 1840000.0,
    "pcnt_held_by_insiders": 0.2073,
    "pcnt_held_by_institutions": 0.514,
    "pcnt_short_of_float": 0.0537,
    "operating_cash_flow_ttm": 33910000.0,
    "levered_cash_flow_ttm": 20040000.0,
    "book_value_per_share_mrq": 75.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ATRION Corp."
  },
  "ATRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.19,
    "earnings_per_share": -0.19,
    "ebitda": -23930000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.86,
    "fifty_two_week_high": 3.04,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.192,
    "percent_change_from_50_day_moving_average": -0.0203,
    "shares_owned": "N/A",
    "short_ratio": 14.37,
    "two_hundred_day_moving_average": 2.25,
    "volume": 1275725.0,
    "market_cap": 281750000.0,
    "price_to_sales_ttm": 7.63,
    "price_to_book_mrq": 3.72,
    "roa_ttm": -0.18230000000000002,
    "roe_ttm": -0.3849,
    "shares_outstanding": 154810000.0,
    "pcnt_held_by_insiders": 0.109,
    "pcnt_held_by_institutions": 0.389,
    "pcnt_short_of_float": 0.0784,
    "operating_cash_flow_ttm": -33060000.000000004,
    "levered_cash_flow_ttm": -31740000.0,
    "book_value_per_share_mrq": 0.5,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Antares Pharma Inc."
  },
  "AUPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -19080000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 3.35,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": -0.17800000000000002,
    "percent_change_from_50_day_moving_average": -0.0908,
    "shares_owned": "N/A",
    "short_ratio": 2.28,
    "two_hundred_day_moving_average": 3.71,
    "volume": 86031.0,
    "market_cap": 98410000.0,
    "price_to_sales_ttm": 409.2,
    "price_to_book_mrq": 3.81,
    "roa_ttm": -0.24600000000000002,
    "roe_ttm": -0.3274,
    "shares_outstanding": 32270000.000000004,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -15090000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": 0.87,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Aurinia Pharmaceuticals Inc."
  },
  "AVEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -24610000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.38,
    "fifty_two_week_high": 3.5,
    "fifty_two_week_low": 0.61,
    "percent_change_from_200_day_moving_average": -0.18989999999999999,
    "percent_change_from_50_day_moving_average": -0.0603,
    "shares_owned": "N/A",
    "short_ratio": 0.76,
    "two_hundred_day_moving_average": 1.6,
    "volume": 431219.0,
    "market_cap": 72430000.0,
    "price_to_sales_ttm": 58.95,
    "price_to_book_mrq": 6.58,
    "roa_ttm": -0.3154,
    "roe_ttm": -1.5349000000000002,
    "shares_outstanding": 55720000.0,
    "pcnt_held_by_insiders": 0.0438,
    "pcnt_held_by_institutions": 0.489,
    "pcnt_short_of_float": 0.04,
    "operating_cash_flow_ttm": -46280000.0,
    "levered_cash_flow_ttm": -13370000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "AVEO Pharmaceuticals, Inc."
  },
  "AVGR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.57,
    "ebitda": -30330000.0,
    "eps_estimate_current_year": -3.79,
    "eps_estimate_next_quarter": -0.89,
    "fifty_day_moving_average": 14.83,
    "fifty_two_week_high": 17.47,
    "fifty_two_week_low": 9.35,
    "percent_change_from_200_day_moving_average": 0.1859,
    "percent_change_from_50_day_moving_average": 0.0231,
    "shares_owned": "N/A",
    "short_ratio": 12.47,
    "two_hundred_day_moving_average": 12.79,
    "volume": 94947.0,
    "market_cap": 185680000.0,
    "price_to_sales_ttm": 16.93,
    "price_to_book_mrq": 5.45,
    "roa_ttm": -0.45549999999999996,
    "roe_ttm": "-1,298.70%",
    "shares_outstanding": 12240000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.091,
    "operating_cash_flow_ttm": -28140000.0,
    "levered_cash_flow_ttm": -16620000.000000002,
    "book_value_per_share_mrq": 2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Avinger, Inc."
  },
  "AXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -38130000.0,
    "eps_estimate_current_year": -1.12,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 18.81,
    "fifty_two_week_high": 31.29,
    "fifty_two_week_low": 16.5,
    "percent_change_from_200_day_moving_average": -0.23870000000000002,
    "percent_change_from_50_day_moving_average": -0.0821,
    "shares_owned": "N/A",
    "short_ratio": 19.22,
    "two_hundred_day_moving_average": 22.68,
    "volume": 245943.0,
    "market_cap": 772360000.0,
    "price_to_sales_ttm": 6292.53,
    "price_to_book_mrq": 16.31,
    "roa_ttm": -0.36469999999999997,
    "roe_ttm": -0.6049,
    "shares_outstanding": 44720000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.3239,
    "operating_cash_flow_ttm": -27340000.0,
    "levered_cash_flow_ttm": -17540000.0,
    "book_value_per_share_mrq": 1.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Accelerate Diagnostics, Inc."
  },
  "AXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.79,
    "ebitda": -8990000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.49,
    "fifty_two_week_high": 5.74,
    "fifty_two_week_low": 2.22,
    "percent_change_from_200_day_moving_average": 0.1864,
    "percent_change_from_50_day_moving_average": -0.053399999999999996,
    "shares_owned": "N/A",
    "short_ratio": 0.82,
    "two_hundred_day_moving_average": 3.58,
    "volume": 290082.0,
    "market_cap": 126620000.0,
    "price_to_sales_ttm": 5.55,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2407,
    "roe_ttm": "N/A",
    "shares_outstanding": 29790000.0,
    "pcnt_held_by_insiders": 0.4265,
    "pcnt_held_by_institutions": 0.19699999999999998,
    "pcnt_short_of_float": 0.0027,
    "operating_cash_flow_ttm": -10740000.0,
    "levered_cash_flow_ttm": -8700000.0,
    "book_value_per_share_mrq": -0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "AxoGen, Inc."
  },
  "AXN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.02,
    "ebitda": 5630000.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.58,
    "fifty_two_week_high": 3.48,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": -0.027999999999999997,
    "percent_change_from_50_day_moving_average": 0.0363,
    "shares_owned": "N/A",
    "short_ratio": 7.36,
    "two_hundred_day_moving_average": 1.69,
    "volume": 221474.0,
    "market_cap": 114500000.0,
    "price_to_sales_ttm": 5.83,
    "price_to_book_mrq": 21.75,
    "roa_ttm": 0.0669,
    "roe_ttm": -0.8066,
    "shares_outstanding": 69820000.0,
    "pcnt_held_by_insiders": 0.4359,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0252,
    "operating_cash_flow_ttm": 4590000.0,
    "levered_cash_flow_ttm": -3580000.0,
    "book_value_per_share_mrq": 0.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Aoxing Pharmaceutical Company, Inc."
  },
  "AXON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.16,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.18,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 13.29,
    "fifty_two_week_high": 31.17,
    "fifty_two_week_low": 9.99,
    "percent_change_from_200_day_moving_average": -0.0801,
    "percent_change_from_50_day_moving_average": 0.1052,
    "shares_owned": "N/A",
    "short_ratio": 6.53,
    "two_hundred_day_moving_average": 15.97,
    "volume": 527766.0,
    "market_cap": 1460000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.72,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 99150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1935,
    "operating_cash_flow_ttm": -1640000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Axovant Sciences Ltd."
  },
  "BABY": {
    "p_e_ratio": 36.59,
    "peg_ratio": 1.29,
    "earnings_per_share": 1.12,
    "ebitda": 71970000.0,
    "eps_estimate_current_year": 1.51,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 41.94,
    "fifty_two_week_high": 46.98,
    "fifty_two_week_low": 28.12,
    "percent_change_from_200_day_moving_average": 0.0028000000000000004,
    "percent_change_from_50_day_moving_average": -0.0239,
    "shares_owned": "N/A",
    "short_ratio": 10.69,
    "two_hundred_day_moving_average": 40.83,
    "volume": 228960.0,
    "market_cap": 1330000000.0,
    "price_to_sales_ttm": 3.74,
    "price_to_book_mrq": 3.66,
    "roa_ttm": 0.086,
    "roe_ttm": 0.1043,
    "shares_outstanding": 32500000.0,
    "pcnt_held_by_insiders": 0.043,
    "pcnt_held_by_institutions": 0.84,
    "pcnt_short_of_float": 0.0718,
    "operating_cash_flow_ttm": 42520000.0,
    "levered_cash_flow_ttm": 36310000.0,
    "book_value_per_share_mrq": 11.58,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Natus Medical Inc."
  },
  "BCLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.58,
    "ebitda": -9560000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.04,
    "fifty_two_week_high": 8.47,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.23309999999999997,
    "percent_change_from_50_day_moving_average": -0.07429999999999999,
    "shares_owned": "N/A",
    "short_ratio": 4.71,
    "two_hundred_day_moving_average": 3.66,
    "volume": 60522.0,
    "market_cap": 51930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.99,
    "roa_ttm": -0.36729999999999996,
    "roe_ttm": -0.6788,
    "shares_outstanding": 18480000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 0.002,
    "pcnt_short_of_float": 0.0431,
    "operating_cash_flow_ttm": -6710000.0,
    "levered_cash_flow_ttm": -3170000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Brainstorm Cell Therapeutics Inc."
  },
  "BCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.9,
    "earnings_per_share": -0.43,
    "ebitda": -35680000.0,
    "eps_estimate_current_year": -0.62,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 11.97,
    "fifty_two_week_high": 16.83,
    "fifty_two_week_low": 7.85,
    "percent_change_from_200_day_moving_average": -0.0711,
    "percent_change_from_50_day_moving_average": -0.0663,
    "shares_owned": "N/A",
    "short_ratio": 8.01,
    "two_hundred_day_moving_average": 12.04,
    "volume": 1112876.0,
    "market_cap": 818820000.0,
    "price_to_sales_ttm": 21.89,
    "price_to_book_mrq": 11.88,
    "roa_ttm": -0.1534,
    "roe_ttm": -0.3691,
    "shares_outstanding": 73240000.0,
    "pcnt_held_by_insiders": 0.2481,
    "pcnt_held_by_institutions": 0.583,
    "pcnt_short_of_float": 0.20370000000000002,
    "operating_cash_flow_ttm": -8119999.999999999,
    "levered_cash_flow_ttm": -2810000.0,
    "book_value_per_share_mrq": 1.04,
    "next_earnings_announcement_date": "2015-11-05",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioCryst Pharmaceuticals, Inc."
  },
  "BDSI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.2,
    "earnings_per_share": -1.37,
    "ebitda": -62660000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": 0.62,
    "fifty_day_moving_average": 6.74,
    "fifty_two_week_high": 18.33,
    "fifty_two_week_low": 5.89,
    "percent_change_from_200_day_moving_average": -0.3064,
    "percent_change_from_50_day_moving_average": -0.1015,
    "shares_owned": "N/A",
    "short_ratio": 8.41,
    "two_hundred_day_moving_average": 8.74,
    "volume": 1916712.0,
    "market_cap": 317920000.0,
    "price_to_sales_ttm": 18.16,
    "price_to_book_mrq": 9.95,
    "roa_ttm": -0.42310000000000003,
    "roe_ttm": -1.4539,
    "shares_outstanding": 52460000.0,
    "pcnt_held_by_insiders": 0.0909,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.2477,
    "operating_cash_flow_ttm": -39440000.0,
    "levered_cash_flow_ttm": -22200000.0,
    "book_value_per_share_mrq": 0.67,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioDelivery Sciences International, Inc."
  },
  "BEAT": {
    "p_e_ratio": 984.62,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.01,
    "ebitda": 21540000.0,
    "eps_estimate_current_year": 0.41,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 14.13,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 6.46,
    "percent_change_from_200_day_moving_average": 0.1788,
    "percent_change_from_50_day_moving_average": -0.0943,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 10.86,
    "volume": 785620.0,
    "market_cap": 347120000.0,
    "price_to_sales_ttm": 2.22,
    "price_to_book_mrq": 5.49,
    "roa_ttm": 0.0473,
    "roe_ttm": 0.006500000000000001,
    "shares_outstanding": 27120000.0,
    "pcnt_held_by_insiders": 0.1559,
    "pcnt_held_by_institutions": 0.648,
    "pcnt_short_of_float": 0.0537,
    "operating_cash_flow_ttm": 7930000.0,
    "levered_cash_flow_ttm": 1470000.0,
    "book_value_per_share_mrq": 2.48,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BioTelemetry, Inc."
  },
  "BGMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.822,
    "ebitda": -5530000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.743,
    "fifty_two_week_high": 4.88,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.7993300000000001,
    "percent_change_from_50_day_moving_average": -0.40008000000000005,
    "shares_owned": "N/A",
    "short_ratio": 2.66,
    "two_hundred_day_moving_average": 2.223,
    "volume": 105686.0,
    "market_cap": 3860000.0,
    "price_to_sales_ttm": 1.69,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5596,
    "roe_ttm": -8.828899999999999,
    "shares_outstanding": 8660000.0,
    "pcnt_held_by_insiders": 0.3711,
    "pcnt_held_by_institutions": 0.127,
    "pcnt_short_of_float": 0.1014,
    "operating_cash_flow_ttm": -5390000.0,
    "levered_cash_flow_ttm": -2710000.0,
    "book_value_per_share_mrq": -0.27,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "BG Medicine, Inc."
  },
  "BIND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.91,
    "ebitda": -32880000.000000004,
    "eps_estimate_current_year": -1.91,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 4.64,
    "fifty_two_week_high": 10.75,
    "fifty_two_week_low": 4.09,
    "percent_change_from_200_day_moving_average": -0.2164,
    "percent_change_from_50_day_moving_average": -0.057699999999999994,
    "shares_owned": "N/A",
    "short_ratio": 6.86,
    "two_hundred_day_moving_average": 5.58,
    "volume": 136996.0,
    "market_cap": 90660000.0,
    "price_to_sales_ttm": 7.17,
    "price_to_book_mrq": 2.82,
    "roa_ttm": -0.315,
    "roe_ttm": -0.7876000000000001,
    "shares_outstanding": 20750000.0,
    "pcnt_held_by_insiders": 0.4163,
    "pcnt_held_by_institutions": 0.281,
    "pcnt_short_of_float": 0.044800000000000006,
    "operating_cash_flow_ttm": -32159999.999999996,
    "levered_cash_flow_ttm": -21160000.0,
    "book_value_per_share_mrq": 1.63,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BIND Therapeutics, Inc."
  },
  "BIO": {
    "p_e_ratio": 40.8,
    "peg_ratio": 3.95,
    "earnings_per_share": 3.31,
    "ebitda": 312020000.0,
    "eps_estimate_current_year": 3.54,
    "eps_estimate_next_quarter": 1.34,
    "fifty_day_moving_average": 140.78,
    "fifty_two_week_high": 152.38,
    "fifty_two_week_low": 102.71,
    "percent_change_from_200_day_moving_average": -0.054400000000000004,
    "percent_change_from_50_day_moving_average": -0.040999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 7.4,
    "two_hundred_day_moving_average": 142.76,
    "volume": 195060.0,
    "market_cap": 3940000000.0,
    "price_to_sales_ttm": 1.89,
    "price_to_book_mrq": 1.69,
    "roa_ttm": 0.0305,
    "roe_ttm": 0.042,
    "shares_outstanding": 24050000.0,
    "pcnt_held_by_insiders": 0.9390999999999999,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.051,
    "operating_cash_flow_ttm": 198850000.0,
    "levered_cash_flow_ttm": 152290000.0,
    "book_value_per_share_mrq": 80.89,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bio-Rad Laboratories, Inc."
  },
  "BIOC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.06,
    "earnings_per_share": -1.67,
    "ebitda": -14730000.0,
    "eps_estimate_current_year": 0.4,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.13,
    "fifty_two_week_high": 4.91,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": 0.039599999999999996,
    "percent_change_from_50_day_moving_average": 0.2564,
    "shares_owned": "N/A",
    "short_ratio": 3.34,
    "two_hundred_day_moving_average": 2.58,
    "volume": 254140.0,
    "market_cap": 50130000.0,
    "price_to_sales_ttm": 162.71,
    "price_to_book_mrq": 4.59,
    "roa_ttm": -0.5913,
    "roe_ttm": -1.7372,
    "shares_outstanding": 18700000.0,
    "pcnt_held_by_insiders": 0.4715,
    "pcnt_held_by_institutions": 0.091,
    "pcnt_short_of_float": 0.1378,
    "operating_cash_flow_ttm": -13860000.0,
    "levered_cash_flow_ttm": -7420000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Biocept, Inc."
  },
  "BIOD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.57,
    "ebitda": -19690000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 0.73,
    "fifty_two_week_high": 2.0,
    "fifty_two_week_low": 0.55,
    "percent_change_from_200_day_moving_average": -0.38539999999999996,
    "percent_change_from_50_day_moving_average": -0.13699999999999998,
    "shares_owned": "N/A",
    "short_ratio": 5.37,
    "two_hundred_day_moving_average": 1.02,
    "volume": 183801.0,
    "market_cap": 39160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.93,
    "roa_ttm": -0.35350000000000004,
    "roe_ttm": -0.5579999999999999,
    "shares_outstanding": 62150000.0,
    "pcnt_held_by_insiders": 0.10210000000000001,
    "pcnt_held_by_institutions": 0.23800000000000002,
    "pcnt_short_of_float": 0.0425,
    "operating_cash_flow_ttm": -18080000.0,
    "levered_cash_flow_ttm": -10630000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": [
      "2015-12-15",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Biodel Inc."
  },
  "BIOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -0.38,
    "ebitda": -15160000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.48,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.38299999999999995,
    "percent_change_from_50_day_moving_average": -0.2647,
    "shares_owned": "N/A",
    "short_ratio": 53.96,
    "two_hundred_day_moving_average": 1.77,
    "volume": 65808.0,
    "market_cap": 63430000.0,
    "price_to_sales_ttm": 1.43,
    "price_to_book_mrq": 2.23,
    "roa_ttm": -0.2546,
    "roe_ttm": -1.1825,
    "shares_outstanding": 58190000.0,
    "pcnt_held_by_insiders": 0.3111,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.0848,
    "operating_cash_flow_ttm": -24340000.0,
    "levered_cash_flow_ttm": -14960000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "BIOLASE, Inc."
  },
  "BIOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.55,
    "earnings_per_share": -5.426,
    "ebitda": -52130000.0,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 2.296,
    "fifty_two_week_high": 7.01,
    "fifty_two_week_low": 1.3,
    "percent_change_from_200_day_moving_average": -0.35101999999999994,
    "percent_change_from_50_day_moving_average": -0.00927,
    "shares_owned": "N/A",
    "short_ratio": 11.6,
    "two_hundred_day_moving_average": 3.506,
    "volume": 2040722.0,
    "market_cap": 156360000.0,
    "price_to_sales_ttm": 0.17,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0623,
    "roe_ttm": -2.1751,
    "shares_outstanding": 68730000.0,
    "pcnt_held_by_insiders": 0.0816,
    "pcnt_held_by_institutions": 0.94,
    "pcnt_short_of_float": 0.3257,
    "operating_cash_flow_ttm": -46600000.0,
    "levered_cash_flow_ttm": 13200000.0,
    "book_value_per_share_mrq": -0.63,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "BioScrip, Inc."
  },
  "BITI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.108,
    "ebitda": -18950000.0,
    "eps_estimate_current_year": -2.88,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 17.0457,
    "fifty_two_week_high": 25.39,
    "fifty_two_week_low": 14.7,
    "percent_change_from_200_day_moving_average": -0.19170500000000001,
    "percent_change_from_50_day_moving_average": -0.129405,
    "shares_owned": "N/A",
    "short_ratio": 2.13,
    "two_hundred_day_moving_average": 18.3595,
    "volume": 86571.0,
    "market_cap": 181950000.0,
    "price_to_sales_ttm": 14.62,
    "price_to_book_mrq": 109.63,
    "roa_ttm": -0.0794,
    "roe_ttm": -0.4535,
    "shares_outstanding": 12260000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -19510000.0,
    "levered_cash_flow_ttm": -8279999.999999999,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Biotie Therapies Corp."
  },
  "BKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.69,
    "earnings_per_share": -2.02,
    "ebitda": 791890000.0,
    "eps_estimate_current_year": 2.41,
    "eps_estimate_next_quarter": 0.6,
    "fifty_day_moving_average": 27.58,
    "fifty_two_week_high": 39.89,
    "fifty_two_week_low": 24.15,
    "percent_change_from_200_day_moving_average": -0.281,
    "percent_change_from_50_day_moving_average": -0.1153,
    "shares_owned": "N/A",
    "short_ratio": 2.86,
    "two_hundred_day_moving_average": 33.94,
    "volume": 4064051.0,
    "market_cap": 4500000000.0,
    "price_to_sales_ttm": 1.11,
    "price_to_book_mrq": 1.72,
    "roa_ttm": -0.0034999999999999996,
    "roe_ttm": -0.1934,
    "shares_outstanding": 184520000.0,
    "pcnt_held_by_insiders": 0.0579,
    "pcnt_held_by_institutions": 0.635,
    "pcnt_short_of_float": 0.0617,
    "operating_cash_flow_ttm": 209260000.0,
    "levered_cash_flow_ttm": -228560000.0,
    "book_value_per_share_mrq": 14.55,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Brookdale Senior Living Inc."
  },
  "BLCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.62,
    "ebitda": -26870000.0,
    "eps_estimate_current_year": -1.42,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 17.67,
    "fifty_two_week_high": 33.63,
    "fifty_two_week_low": 15.05,
    "percent_change_from_200_day_moving_average": -0.24050000000000002,
    "percent_change_from_50_day_moving_average": -0.061399999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.76,
    "two_hundred_day_moving_average": 21.83,
    "volume": 347474.0,
    "market_cap": 439260000.0,
    "price_to_sales_ttm": 541.17,
    "price_to_book_mrq": 2.64,
    "roa_ttm": -0.1753,
    "roe_ttm": -1.013,
    "shares_outstanding": 26490000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1425,
    "operating_cash_flow_ttm": -67250000.0,
    "levered_cash_flow_ttm": -15590000.0,
    "book_value_per_share_mrq": 6.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellicum Pharmaceuticals, Inc."
  },
  "BLFS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -3890000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.18,
    "fifty_two_week_high": 4.44,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": 0.0462,
    "percent_change_from_50_day_moving_average": -0.0187,
    "shares_owned": "N/A",
    "short_ratio": 0.21,
    "two_hundred_day_moving_average": 2.05,
    "volume": 28474.0,
    "market_cap": 26010000.0,
    "price_to_sales_ttm": 4.48,
    "price_to_book_mrq": 2.65,
    "roa_ttm": -0.18289999999999998,
    "roe_ttm": -0.3292,
    "shares_outstanding": 12150000.0,
    "pcnt_held_by_insiders": 0.4826,
    "pcnt_held_by_institutions": 0.009000000000000001,
    "pcnt_short_of_float": 0.0401,
    "operating_cash_flow_ttm": -3930000.0,
    "levered_cash_flow_ttm": -3380000.0,
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "BioLife Solutions, Inc."
  },
  "BLPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.42,
    "ebitda": -52440000.0,
    "eps_estimate_current_year": -3.93,
    "eps_estimate_next_quarter": -0.92,
    "fifty_day_moving_average": 4.3,
    "fifty_two_week_high": 12.92,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.1604,
    "percent_change_from_50_day_moving_average": 0.4637,
    "shares_owned": "N/A",
    "short_ratio": 1.64,
    "two_hundred_day_moving_average": 7.5,
    "volume": 16226590.0,
    "market_cap": 81340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.94,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.016,
    "operating_cash_flow_ttm": -45190000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bellerophon Therapeutics LLC"
  },
  "BLRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -16469999.999999998,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.59,
    "fifty_two_week_high": 3.28,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.1371,
    "percent_change_from_50_day_moving_average": 0.058499999999999996,
    "shares_owned": "N/A",
    "short_ratio": 2.07,
    "two_hundred_day_moving_average": 1.95,
    "volume": 135754.0,
    "market_cap": 91650000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.77,
    "roa_ttm": -0.2243,
    "roe_ttm": -0.33130000000000004,
    "shares_outstanding": 54560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -14350000.0,
    "levered_cash_flow_ttm": -9670000.0,
    "book_value_per_share_mrq": 0.95,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "BioLineRx, Ltd."
  },
  "BLUE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -3.68,
    "ebitda": -93620000.0,
    "eps_estimate_current_year": -4.16,
    "eps_estimate_next_quarter": -0.98,
    "fifty_day_moving_average": 129.52,
    "fifty_two_week_high": 197.35,
    "fifty_two_week_low": 29.73,
    "percent_change_from_200_day_moving_average": -0.318,
    "percent_change_from_50_day_moving_average": -0.2263,
    "shares_owned": "N/A",
    "short_ratio": 3.06,
    "two_hundred_day_moving_average": 146.94,
    "volume": 1831139.0,
    "market_cap": 3630000000.0,
    "price_to_sales_ttm": 167.5,
    "price_to_book_mrq": 4.34,
    "roa_ttm": -0.1012,
    "roe_ttm": -0.2086,
    "shares_outstanding": 36260000.0,
    "pcnt_held_by_insiders": 0.19699999999999998,
    "pcnt_held_by_institutions": 0.664,
    "pcnt_short_of_float": 0.1288,
    "operating_cash_flow_ttm": -72710000.0,
    "levered_cash_flow_ttm": -44630000.0,
    "book_value_per_share_mrq": 25.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "bluebird bio, Inc."
  },
  "BONE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.73,
    "ebitda": -4890000.0,
    "eps_estimate_current_year": -1.38,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 3.71,
    "fifty_two_week_high": 4.75,
    "fifty_two_week_low": 2.19,
    "percent_change_from_200_day_moving_average": -0.04,
    "percent_change_from_50_day_moving_average": -0.0302,
    "shares_owned": "N/A",
    "short_ratio": 0.71,
    "two_hundred_day_moving_average": 3.75,
    "volume": 1958.0,
    "market_cap": 42290000.0,
    "price_to_sales_ttm": 1.19,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.13570000000000002,
    "roe_ttm": "N/A",
    "shares_outstanding": 11750000.0,
    "pcnt_held_by_insiders": 0.2391,
    "pcnt_held_by_institutions": 0.23199999999999998,
    "pcnt_short_of_float": 0.0113,
    "operating_cash_flow_ttm": -7540000.0,
    "levered_cash_flow_ttm": -3020000.0,
    "book_value_per_share_mrq": -1.59,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Xtant Medical Holdings, Inc."
  },
  "BOTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -7100000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.16,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.85,
    "percent_change_from_200_day_moving_average": -0.1748,
    "percent_change_from_50_day_moving_average": -0.1423,
    "shares_owned": "N/A",
    "short_ratio": 0.56,
    "two_hundred_day_moving_average": 2.24,
    "volume": 92119.0,
    "market_cap": 71430000.0,
    "price_to_sales_ttm": 3.08,
    "price_to_book_mrq": 1.09,
    "roa_ttm": -0.053,
    "roe_ttm": -0.24420000000000003,
    "shares_outstanding": 38610000.0,
    "pcnt_held_by_insiders": 0.1324,
    "pcnt_held_by_institutions": 0.43,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -9600000.0,
    "levered_cash_flow_ttm": -13930000.0,
    "book_value_per_share_mrq": 1.8,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Biota Pharmaceuticals, Inc."
  },
  "BPMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.92,
    "ebitda": -47570000.0,
    "eps_estimate_current_year": -2.65,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 27.6,
    "fifty_two_week_high": 37.17,
    "fifty_two_week_low": 19.96,
    "percent_change_from_200_day_moving_average": -0.2528,
    "percent_change_from_50_day_moving_average": -0.2229,
    "shares_owned": "N/A",
    "short_ratio": 12.37,
    "two_hundred_day_moving_average": 28.71,
    "volume": 203668.0,
    "market_cap": 581550000.0,
    "price_to_sales_ttm": 190.33,
    "price_to_book_mrq": 3.69,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08310000000000001,
    "operating_cash_flow_ttm": -26310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Blueprint Medicines Corporation"
  },
  "BPMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.47,
    "ebitda": -17350000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 1.62,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 1.2,
    "percent_change_from_200_day_moving_average": -0.35369999999999996,
    "percent_change_from_50_day_moving_average": -0.11810000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.01,
    "two_hundred_day_moving_average": 2.21,
    "volume": 10750.0,
    "market_cap": 30050000.0,
    "price_to_sales_ttm": 1430.68,
    "price_to_book_mrq": 6.91,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21010000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.006999999999999999,
    "operating_cash_flow_ttm": -11410000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioPharmX Corporation"
  },
  "BPTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": -5080000.0,
    "eps_estimate_current_year": -0.04,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.13,
    "fifty_two_week_high": 3.02,
    "fifty_two_week_low": 0.99,
    "percent_change_from_200_day_moving_average": -0.2249,
    "percent_change_from_50_day_moving_average": -0.09029999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.18,
    "two_hundred_day_moving_average": 1.33,
    "volume": 254324.0,
    "market_cap": 92460000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.36,
    "roa_ttm": -0.2148,
    "roe_ttm": -0.35409999999999997,
    "shares_outstanding": 89760000.0,
    "pcnt_held_by_insiders": 0.2323,
    "pcnt_held_by_institutions": 0.23199999999999998,
    "pcnt_short_of_float": 0.0078000000000000005,
    "operating_cash_flow_ttm": -4950000.0,
    "levered_cash_flow_ttm": -3120000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Bio-Path Holdings, Inc."
  },
  "BRKR": {
    "p_e_ratio": 48.74,
    "peg_ratio": 1.78,
    "earnings_per_share": 0.35,
    "ebitda": 207500000.0,
    "eps_estimate_current_year": 0.76,
    "eps_estimate_next_quarter": 0.3,
    "fifty_day_moving_average": 18.65,
    "fifty_two_week_high": 22.32,
    "fifty_two_week_low": 16.82,
    "percent_change_from_200_day_moving_average": -0.1375,
    "percent_change_from_50_day_moving_average": -0.0851,
    "shares_owned": "N/A",
    "short_ratio": 6.72,
    "two_hundred_day_moving_average": 19.78,
    "volume": 384476.0,
    "market_cap": 2870000000.0,
    "price_to_sales_ttm": 1.74,
    "price_to_book_mrq": 3.84,
    "roa_ttm": 0.049400000000000006,
    "roe_ttm": 0.076,
    "shares_outstanding": 168150000.0,
    "pcnt_held_by_insiders": 0.3439,
    "pcnt_held_by_institutions": 0.6779999999999999,
    "pcnt_short_of_float": 0.057300000000000004,
    "operating_cash_flow_ttm": 108300000.0,
    "levered_cash_flow_ttm": 168060000.0,
    "book_value_per_share_mrq": 4.53,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Bruker Corporation"
  },
  "BSPM": {
    "p_e_ratio": 5.139,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.146,
    "ebitda": 2120000.0,
    "eps_estimate_current_year": 0.6,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.682,
    "fifty_two_week_high": 1.84,
    "fifty_two_week_low": 0.61,
    "percent_change_from_200_day_moving_average": -0.291742,
    "percent_change_from_50_day_moving_average": 0.100147,
    "shares_owned": "N/A",
    "short_ratio": 4.35,
    "two_hundred_day_moving_average": 1.0594,
    "volume": 30858.0,
    "market_cap": 11610000.0,
    "price_to_sales_ttm": 0.24,
    "price_to_book_mrq": 0.16,
    "roa_ttm": -0.0028000000000000004,
    "roe_ttm": 0.0321,
    "shares_outstanding": 15480000.0,
    "pcnt_held_by_insiders": 0.21530000000000002,
    "pcnt_held_by_institutions": 0.05,
    "pcnt_short_of_float": 0.0125,
    "operating_cash_flow_ttm": 2710000.0,
    "levered_cash_flow_ttm": -4380000.0,
    "book_value_per_share_mrq": 4.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Biostar Pharmaceuticals, Inc."
  },
  "BSTC": {
    "p_e_ratio": 47.2,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.04,
    "ebitda": 11420000.0,
    "eps_estimate_current_year": 1.89,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 52.0,
    "fifty_two_week_high": 72.07,
    "fifty_two_week_low": 32.88,
    "percent_change_from_200_day_moving_average": 0.035,
    "percent_change_from_50_day_moving_average": -0.0579,
    "shares_owned": "N/A",
    "short_ratio": 2.33,
    "two_hundred_day_moving_average": 47.33,
    "volume": 136937.0,
    "market_cap": 335430000.0,
    "price_to_sales_ttm": 19.94,
    "price_to_book_mrq": 10.17,
    "roa_ttm": 0.2207,
    "roe_ttm": 0.2402,
    "shares_outstanding": 6850000.0,
    "pcnt_held_by_insiders": 0.4757,
    "pcnt_held_by_institutions": 0.309,
    "pcnt_short_of_float": 0.0698,
    "operating_cash_flow_ttm": 7250000.0,
    "levered_cash_flow_ttm": 6370000.0,
    "book_value_per_share_mrq": 5.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioSpecifics Technologies Corp."
  },
  "BTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -45210000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.13,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 2.2,
    "percent_change_from_200_day_moving_average": -0.1472,
    "percent_change_from_50_day_moving_average": 0.1166,
    "shares_owned": "N/A",
    "short_ratio": 26.03,
    "two_hundred_day_moving_average": 4.1,
    "volume": 354013.0,
    "market_cap": 277420000.0,
    "price_to_sales_ttm": 44.89,
    "price_to_book_mrq": 21.1,
    "roa_ttm": -0.4594,
    "roe_ttm": -0.8477,
    "shares_outstanding": 79260000.0,
    "pcnt_held_by_insiders": 0.5173,
    "pcnt_held_by_institutions": 0.11699999999999999,
    "pcnt_short_of_float": 0.1149,
    "operating_cash_flow_ttm": -36760000.0,
    "levered_cash_flow_ttm": -20760000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "BioTime, Inc."
  },
  "BUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.15,
    "ebitda": -5340000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.88,
    "fifty_two_week_high": 3.05,
    "fifty_two_week_low": 1.66,
    "percent_change_from_200_day_moving_average": -0.1764,
    "percent_change_from_50_day_moving_average": -0.0444,
    "shares_owned": "N/A",
    "short_ratio": 1.64,
    "two_hundred_day_moving_average": 2.19,
    "volume": 6033.0,
    "market_cap": 64250000.0,
    "price_to_sales_ttm": 810.98,
    "price_to_book_mrq": 11.38,
    "roa_ttm": -0.531,
    "roe_ttm": -0.8893000000000001,
    "shares_outstanding": 35700000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -3870000.0,
    "levered_cash_flow_ttm": -2210000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Burcon Nutrascience Corporation"
  },
  "BVX": {
    "p_e_ratio": 30.71,
    "peg_ratio": -0.53,
    "earnings_per_share": 0.07,
    "ebitda": -7140000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.31,
    "fifty_two_week_high": 4.3,
    "fifty_two_week_low": 2.06,
    "percent_change_from_200_day_moving_average": -0.1516,
    "percent_change_from_50_day_moving_average": -0.0704,
    "shares_owned": "N/A",
    "short_ratio": 2.2,
    "two_hundred_day_moving_average": 2.53,
    "volume": 28017.0,
    "market_cap": 58470000.0,
    "price_to_sales_ttm": 2.1,
    "price_to_book_mrq": 2.23,
    "roa_ttm": -0.1518,
    "roe_ttm": -0.5365,
    "shares_outstanding": 27190000.0,
    "pcnt_held_by_insiders": 0.2205,
    "pcnt_held_by_institutions": 0.055,
    "pcnt_short_of_float": 0.0039000000000000003,
    "operating_cash_flow_ttm": -3220000.0,
    "levered_cash_flow_ttm": -2290000.0,
    "book_value_per_share_mrq": 0.97,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Bovie Medical Corporation"
  },
  "CALA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.05,
    "ebitda": -27390000.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 5.85,
    "fifty_two_week_high": 33.48,
    "fifty_two_week_low": 4.31,
    "percent_change_from_200_day_moving_average": -0.386,
    "percent_change_from_50_day_moving_average": 0.030299999999999997,
    "shares_owned": "N/A",
    "short_ratio": 6.21,
    "two_hundred_day_moving_average": 9.82,
    "volume": 275850.0,
    "market_cap": 109220000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.26,
    "roa_ttm": -0.2864,
    "roe_ttm": -0.502,
    "shares_outstanding": 18110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.5676,
    "operating_cash_flow_ttm": -23750000.0,
    "levered_cash_flow_ttm": -17850000.0,
    "book_value_per_share_mrq": 4.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Calithera Biosciences, Inc."
  },
  "CANF": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.5,
    "ebitda": -6030000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 2.27,
    "fifty_two_week_high": 7.85,
    "fifty_two_week_low": 1.46,
    "percent_change_from_200_day_moving_average": 0.8992,
    "percent_change_from_50_day_moving_average": 1.0898999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.61,
    "two_hundred_day_moving_average": 2.5,
    "volume": 5977896.0,
    "market_cap": 50630000.0,
    "price_to_sales_ttm": 778.94,
    "price_to_book_mrq": 11.9,
    "roa_ttm": -0.5482,
    "roe_ttm": -1.1715,
    "shares_outstanding": 10660000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4680000.0,
    "levered_cash_flow_ttm": -3680000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Can-Fite BioPharma Ltd."
  },
  "CAPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.19,
    "ebitda": -8590000.0,
    "eps_estimate_current_year": -0.76,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.31,
    "fifty_two_week_high": 9.9,
    "fifty_two_week_low": 1.02,
    "percent_change_from_200_day_moving_average": -0.4072,
    "percent_change_from_50_day_moving_average": 0.0458,
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 4.08,
    "volume": 392866.0,
    "market_cap": 19310000.0,
    "price_to_sales_ttm": 177.04,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.9884999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 7980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1655,
    "operating_cash_flow_ttm": -6880000.0,
    "levered_cash_flow_ttm": 8260000.0,
    "book_value_per_share_mrq": -1.0,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Capnia, Inc."
  },
  "CAPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.74,
    "ebitda": -9750000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.26,
    "fifty_day_moving_average": 4.26,
    "fifty_two_week_high": 10.68,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.3186,
    "percent_change_from_50_day_moving_average": -0.0781,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 5.77,
    "volume": 60143.0,
    "market_cap": 63880000.0,
    "price_to_sales_ttm": 12.68,
    "price_to_book_mrq": 16.05,
    "roa_ttm": -0.2916,
    "roe_ttm": "-1,369.74%",
    "shares_outstanding": 16260000.000000002,
    "pcnt_held_by_insiders": 0.2815,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0052,
    "operating_cash_flow_ttm": -8300000.000000001,
    "levered_cash_flow_ttm": -1320000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Capricor Therapeutics, Inc."
  },
  "CARA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.93,
    "ebitda": -20610000.0,
    "eps_estimate_current_year": -1.03,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 20.35,
    "fifty_two_week_high": 23.61,
    "fifty_two_week_low": 7.53,
    "percent_change_from_200_day_moving_average": 0.1386,
    "percent_change_from_50_day_moving_average": -0.20629999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.95,
    "two_hundred_day_moving_average": 14.18,
    "volume": 785889.0,
    "market_cap": 438710000.0,
    "price_to_sales_ttm": 159.93,
    "price_to_book_mrq": 10.77,
    "roa_ttm": -0.2332,
    "roe_ttm": -0.4054,
    "shares_outstanding": 27160000.0,
    "pcnt_held_by_insiders": 0.4578,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.053200000000000004,
    "operating_cash_flow_ttm": -19810000.0,
    "levered_cash_flow_ttm": -11910000.0,
    "book_value_per_share_mrq": 1.86,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cara Therapeutics Inc."
  },
  "CASI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -7210000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.31,
    "fifty_two_week_high": 2.13,
    "fifty_two_week_low": 0.83,
    "percent_change_from_200_day_moving_average": -0.257,
    "percent_change_from_50_day_moving_average": -0.15810000000000002,
    "shares_owned": "N/A",
    "short_ratio": 7.91,
    "two_hundred_day_moving_average": 1.48,
    "volume": 39169.0,
    "market_cap": 35690000.0,
    "price_to_sales_ttm": 490.5,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4119,
    "roe_ttm": -5.8197,
    "shares_outstanding": 32450000.000000004,
    "pcnt_held_by_insiders": 0.37450000000000006,
    "pcnt_held_by_institutions": 0.14,
    "pcnt_short_of_float": 0.0040999999999999995,
    "operating_cash_flow_ttm": -4820000.0,
    "levered_cash_flow_ttm": -2350000.0,
    "book_value_per_share_mrq": -0.11,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CASI Pharmaceuticals, Inc."
  },
  "CASM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.24,
    "earnings_per_share": -0.38,
    "ebitda": -4520000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 1.98,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": 0.0333,
    "percent_change_from_50_day_moving_average": 0.111,
    "shares_owned": "N/A",
    "short_ratio": 0.39,
    "two_hundred_day_moving_average": 1.25,
    "volume": 14321.0,
    "market_cap": 34400000.0,
    "price_to_sales_ttm": 1.45,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.20129999999999998,
    "roe_ttm": -0.9394,
    "shares_outstanding": 26670000.0,
    "pcnt_held_by_insiders": 0.0946,
    "pcnt_held_by_institutions": 0.439,
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": -3750000.0,
    "levered_cash_flow_ttm": -2500000.0,
    "book_value_per_share_mrq": -0.2,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "CAS Medical Systems Inc."
  },
  "CATB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -44.38,
    "ebitda": -25760000.0,
    "eps_estimate_current_year": -4.04,
    "eps_estimate_next_quarter": -0.73,
    "fifty_day_moving_average": 11.16,
    "fifty_two_week_high": 16.96,
    "fifty_two_week_low": 7.5,
    "percent_change_from_200_day_moving_average": -0.3489,
    "percent_change_from_50_day_moving_average": -0.2922,
    "shares_owned": "N/A",
    "short_ratio": 0.18,
    "two_hundred_day_moving_average": 12.13,
    "volume": 75845.0,
    "market_cap": 120850000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.15,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": -23870000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catabasis Pharmaceuticals, Inc."
  },
  "CBAY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.2,
    "ebitda": -26440000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 2.72,
    "fifty_two_week_high": 13.39,
    "fifty_two_week_low": 2.28,
    "percent_change_from_200_day_moving_average": -0.4097,
    "percent_change_from_50_day_moving_average": -0.1387,
    "shares_owned": "N/A",
    "short_ratio": 2.17,
    "two_hundred_day_moving_average": 3.96,
    "volume": 369350.0,
    "market_cap": 52340000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.6047,
    "roe_ttm": -1.7103,
    "shares_outstanding": 22370000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0191,
    "operating_cash_flow_ttm": -22830000.0,
    "levered_cash_flow_ttm": -20300000.0,
    "book_value_per_share_mrq": 1.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cymabay Therapeutics, Inc."
  },
  "CBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8,
    "ebitda": -8100000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 5.72,
    "fifty_two_week_low": 5.16,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 0.0,
    "volume": 22856.0,
    "market_cap": 60280000.0,
    "price_to_sales_ttm": 23.54,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11420000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0038,
    "operating_cash_flow_ttm": -7670000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -11.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Catalyst Biosciences, Inc."
  },
  "CBLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -13410000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.25,
    "fifty_two_week_high": 10.2,
    "fifty_two_week_low": 1.84,
    "percent_change_from_200_day_moving_average": 0.2591,
    "percent_change_from_50_day_moving_average": 0.050499999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 3.54,
    "volume": 108254.0,
    "market_cap": 47850000.0,
    "price_to_sales_ttm": 19.05,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.7391,
    "roe_ttm": -7.965800000000001,
    "shares_outstanding": 10730000.0,
    "pcnt_held_by_insiders": 0.154,
    "pcnt_held_by_institutions": 0.094,
    "pcnt_short_of_float": 0.2954,
    "operating_cash_flow_ttm": -11700000.0,
    "levered_cash_flow_ttm": -3410000.0,
    "book_value_per_share_mrq": -2.49,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cleveland BioLabs, Inc."
  },
  "CBM": {
    "p_e_ratio": 22.17,
    "peg_ratio": 1.59,
    "earnings_per_share": 2.0,
    "ebitda": 105620000.0,
    "eps_estimate_current_year": 2.05,
    "eps_estimate_next_quarter": 0.76,
    "fifty_day_moving_average": 46.72,
    "fifty_two_week_high": 54.6,
    "fifty_two_week_low": 15.76,
    "percent_change_from_200_day_moving_average": 0.0273,
    "percent_change_from_50_day_moving_average": -0.0493,
    "shares_owned": "N/A",
    "short_ratio": 2.23,
    "two_hundred_day_moving_average": 43.24,
    "volume": 624423.0,
    "market_cap": 1390000000.0,
    "price_to_sales_ttm": 3.51,
    "price_to_book_mrq": 5.09,
    "roa_ttm": 0.10490000000000001,
    "roe_ttm": 0.2557,
    "shares_outstanding": 31370000.0,
    "pcnt_held_by_insiders": 0.0255,
    "pcnt_held_by_institutions": 0.978,
    "pcnt_short_of_float": 0.0356,
    "operating_cash_flow_ttm": 92640000.0,
    "levered_cash_flow_ttm": 53070000.0,
    "book_value_per_share_mrq": 8.68,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cambrex Corporation."
  },
  "CBMG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.7,
    "ebitda": -13670000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 22.49,
    "fifty_two_week_high": 49.0,
    "fifty_two_week_low": 11.5,
    "percent_change_from_200_day_moving_average": -0.41590000000000005,
    "percent_change_from_50_day_moving_average": -0.2132,
    "shares_owned": "N/A",
    "short_ratio": 6.14,
    "two_hundred_day_moving_average": 30.3,
    "volume": 131194.0,
    "market_cap": 205670000.0,
    "price_to_sales_ttm": 138.95,
    "price_to_book_mrq": 3.71,
    "roa_ttm": -0.2057,
    "roe_ttm": -0.4114,
    "shares_outstanding": 11620000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.044500000000000005,
    "operating_cash_flow_ttm": -11280000.0,
    "levered_cash_flow_ttm": -6310000.0,
    "book_value_per_share_mrq": 5.31,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellular Biomedicine Group Inc."
  },
  "CBMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.72,
    "ebitda": -5970000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 1.2,
    "fifty_two_week_high": 2.16,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.18489999999999998,
    "percent_change_from_50_day_moving_average": 0.0783,
    "shares_owned": "N/A",
    "short_ratio": 0.93,
    "two_hundred_day_moving_average": 1.58,
    "volume": 6156.0,
    "market_cap": 16360000.0,
    "price_to_sales_ttm": 1.76,
    "price_to_book_mrq": 1.84,
    "roa_ttm": -0.32189999999999996,
    "roe_ttm": -0.7595000000000001,
    "shares_outstanding": 12680000.0,
    "pcnt_held_by_insiders": 0.0702,
    "pcnt_held_by_institutions": 0.031,
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -7240000.0,
    "levered_cash_flow_ttm": -3860000.0,
    "book_value_per_share_mrq": 0.69,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "CombiMatrix Corporation"
  },
  "CBPO": {
    "p_e_ratio": 26.8,
    "peg_ratio": 1.02,
    "earnings_per_share": 3.11,
    "ebitda": 137920000.0,
    "eps_estimate_current_year": 3.43,
    "eps_estimate_next_quarter": 0.54,
    "fifty_day_moving_average": 99.28,
    "fifty_two_week_high": 128.0,
    "fifty_two_week_low": 47.23,
    "percent_change_from_200_day_moving_average": -0.1962,
    "percent_change_from_50_day_moving_average": -0.1617,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 103.55,
    "volume": 185395.0,
    "market_cap": 2140000000.0000002,
    "price_to_sales_ttm": 8.28,
    "price_to_book_mrq": 6.58,
    "roa_ttm": 0.1693,
    "roe_ttm": 0.307,
    "shares_outstanding": 25710000.0,
    "pcnt_held_by_insiders": 0.21710000000000002,
    "pcnt_held_by_institutions": 0.49700000000000005,
    "pcnt_short_of_float": 0.0137,
    "operating_cash_flow_ttm": 89050000.0,
    "levered_cash_flow_ttm": 49110000.0,
    "book_value_per_share_mrq": 13.53,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "China Biologic Products, Inc."
  },
  "CBYL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -17850000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 5.53,
    "fifty_two_week_high": 9.22,
    "fifty_two_week_low": 4.1,
    "percent_change_from_200_day_moving_average": -0.34729999999999994,
    "percent_change_from_50_day_moving_average": -0.217,
    "shares_owned": "N/A",
    "short_ratio": 9.77,
    "two_hundred_day_moving_average": 6.63,
    "volume": 100091.0,
    "market_cap": 113980000.0,
    "price_to_sales_ttm": 3849.59,
    "price_to_book_mrq": 2.08,
    "roa_ttm": -0.2983,
    "roe_ttm": -0.7482,
    "shares_outstanding": 26320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0253,
    "operating_cash_flow_ttm": -18050000.0,
    "levered_cash_flow_ttm": -10350000.0,
    "book_value_per_share_mrq": 2.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Carbylan Therapeutics, Inc."
  },
  "CCM": {
    "p_e_ratio": 9.12,
    "peg_ratio": 1.12,
    "earnings_per_share": 0.53,
    "ebitda": 52950000.0,
    "eps_estimate_current_year": 0.23,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.02,
    "fifty_two_week_high": 8.23,
    "fifty_two_week_low": 4.51,
    "percent_change_from_200_day_moving_average": -0.2225,
    "percent_change_from_50_day_moving_average": -0.030600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.84,
    "two_hundred_day_moving_average": 6.26,
    "volume": 14949.0,
    "market_cap": 72960000.0,
    "price_to_sales_ttm": 0.94,
    "price_to_book_mrq": 0.25,
    "roa_ttm": 0.0231,
    "roe_ttm": 0.045599999999999995,
    "shares_outstanding": 14980000.0,
    "pcnt_held_by_insiders": 0.2904,
    "pcnt_held_by_institutions": 0.39299999999999996,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 19.52,
    "next_earnings_announcement_date": [
      "2015-11-17",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Concord Medical Services Holdings Limited"
  },
  "CCXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.09,
    "ebitda": -47110000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 6.47,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 4.06,
    "percent_change_from_200_day_moving_average": -0.21239999999999998,
    "percent_change_from_50_day_moving_average": -0.0676,
    "shares_owned": "N/A",
    "short_ratio": 33.18,
    "two_hundred_day_moving_average": 7.66,
    "volume": 151694.0,
    "market_cap": 265760000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.14,
    "roa_ttm": -0.2568,
    "roe_ttm": -0.4325,
    "shares_outstanding": 44070000.0,
    "pcnt_held_by_insiders": 0.4244,
    "pcnt_held_by_institutions": 0.616,
    "pcnt_short_of_float": 0.18510000000000001,
    "operating_cash_flow_ttm": -39220000.0,
    "levered_cash_flow_ttm": -23520000.0,
    "book_value_per_share_mrq": 2.06,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ChemoCentryx, Inc."
  },
  "CDTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.61,
    "ebitda": -20800000.0,
    "eps_estimate_current_year": -3.94,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 14.31,
    "fifty_two_week_high": 19.13,
    "fifty_two_week_low": 13.0,
    "percent_change_from_200_day_moving_average": -0.0909,
    "percent_change_from_50_day_moving_average": -0.056900000000000006,
    "shares_owned": "N/A",
    "short_ratio": 11.25,
    "two_hundred_day_moving_average": 14.85,
    "volume": 117629.0,
    "market_cap": 184600000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.58,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13670000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0463,
    "operating_cash_flow_ttm": -18310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 8.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cidara Therapeutics, Inc."
  },
  "CDXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -0.39,
    "ebitda": -8540000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": 0.18,
    "fifty_day_moving_average": 3.74,
    "fifty_two_week_high": 5.65,
    "fifty_two_week_low": 2.05,
    "percent_change_from_200_day_moving_average": -0.182,
    "percent_change_from_50_day_moving_average": -0.10890000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.59,
    "two_hundred_day_moving_average": 4.07,
    "volume": 22827.0,
    "market_cap": 134050000.00000001,
    "price_to_sales_ttm": 4.14,
    "price_to_book_mrq": 8.35,
    "roa_ttm": -0.22089999999999999,
    "roe_ttm": -0.6520999999999999,
    "shares_outstanding": 40250000.0,
    "pcnt_held_by_insiders": 0.3468,
    "pcnt_held_by_institutions": 0.285,
    "pcnt_short_of_float": 0.009399999999999999,
    "operating_cash_flow_ttm": -1300000.0,
    "levered_cash_flow_ttm": 3530000.0,
    "book_value_per_share_mrq": 0.43,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Codexis, Inc."
  },
  "CEMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.59,
    "earnings_per_share": -0.22,
    "ebitda": -1650000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 4.25,
    "fifty_two_week_high": 5.25,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": -0.0862,
    "percent_change_from_50_day_moving_average": -0.0252,
    "shares_owned": "N/A",
    "short_ratio": 0.68,
    "two_hundred_day_moving_average": 4.53,
    "volume": 151695.0,
    "market_cap": 39860000.0,
    "price_to_sales_ttm": 1.37,
    "price_to_book_mrq": 2.01,
    "roa_ttm": -0.0712,
    "roe_ttm": -0.1069,
    "shares_outstanding": 9630000.0,
    "pcnt_held_by_insiders": 0.2673,
    "pcnt_held_by_institutions": 0.073,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": -3450000.0,
    "levered_cash_flow_ttm": -4430000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Chembio Diagnostics, Inc."
  },
  "CEMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.81,
    "ebitda": -68070000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 35.6,
    "fifty_two_week_high": 46.99,
    "fifty_two_week_low": 10.35,
    "percent_change_from_200_day_moving_average": -0.0944,
    "percent_change_from_50_day_moving_average": -0.07200000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.7,
    "two_hundred_day_moving_average": 36.48,
    "volume": 796304.0,
    "market_cap": 1450000000.0,
    "price_to_sales_ttm": 53.23,
    "price_to_book_mrq": 9.57,
    "roa_ttm": -0.30260000000000004,
    "roe_ttm": -0.7006999999999999,
    "shares_outstanding": 43880000.0,
    "pcnt_held_by_insiders": 0.4675,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.0932,
    "operating_cash_flow_ttm": -55560000.0,
    "levered_cash_flow_ttm": -35150000.0,
    "book_value_per_share_mrq": 3.71,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cempra, Inc."
  },
  "CERS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.66,
    "ebitda": -52540000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.14,
    "fifty_two_week_high": 7.03,
    "fifty_two_week_low": 3.6,
    "percent_change_from_200_day_moving_average": 0.0443,
    "percent_change_from_50_day_moving_average": -0.009000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 19.16,
    "two_hundred_day_moving_average": 4.87,
    "volume": 945042.0,
    "market_cap": 492590000.0,
    "price_to_sales_ttm": 14.3,
    "price_to_book_mrq": 4.72,
    "roa_ttm": -0.2967,
    "roe_ttm": -0.7286,
    "shares_outstanding": 96780000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.635,
    "pcnt_short_of_float": 0.2384,
    "operating_cash_flow_ttm": -50860000.0,
    "levered_cash_flow_ttm": -30760000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerus Corporation"
  },
  "CERU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.43,
    "ebitda": -29630000.0,
    "eps_estimate_current_year": -1.58,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 4.16,
    "fifty_two_week_high": 10.87,
    "fifty_two_week_low": 2.77,
    "percent_change_from_200_day_moving_average": -0.1727,
    "percent_change_from_50_day_moving_average": 0.0833,
    "shares_owned": "N/A",
    "short_ratio": 4.72,
    "two_hundred_day_moving_average": 5.45,
    "volume": 43994.0,
    "market_cap": 123150000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.99,
    "roa_ttm": -0.2419,
    "roe_ttm": -0.49770000000000003,
    "shares_outstanding": 27310000.0,
    "pcnt_held_by_insiders": 0.5550999999999999,
    "pcnt_held_by_institutions": 0.027999999999999997,
    "pcnt_short_of_float": 0.0139,
    "operating_cash_flow_ttm": -26900000.0,
    "levered_cash_flow_ttm": -16300000.0,
    "book_value_per_share_mrq": 2.5,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cerulean Pharma Inc."
  },
  "CFMS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.12,
    "earnings_per_share": -11.09,
    "ebitda": -44970000.0,
    "eps_estimate_current_year": -2.52,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 18.4,
    "fifty_two_week_high": 26.93,
    "fifty_two_week_low": 13.33,
    "percent_change_from_200_day_moving_average": -0.15439999999999998,
    "percent_change_from_50_day_moving_average": -0.07339999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.79,
    "two_hundred_day_moving_average": 20.16,
    "volume": 340977.0,
    "market_cap": 693750000.0,
    "price_to_sales_ttm": 12.69,
    "price_to_book_mrq": 2.96,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40690000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0405,
    "operating_cash_flow_ttm": -42150000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ConforMIS, Inc."
  },
  "CFRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.76,
    "ebitda": -20190000.0,
    "eps_estimate_current_year": -0.98,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 4.89,
    "fifty_two_week_high": 6.24,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.1684,
    "percent_change_from_50_day_moving_average": -0.14529999999999998,
    "shares_owned": "N/A",
    "short_ratio": 3.24,
    "two_hundred_day_moving_average": 5.03,
    "volume": 70080.0,
    "market_cap": 104830000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.46,
    "roa_ttm": -0.5592,
    "roe_ttm": -8.819700000000001,
    "shares_outstanding": 25080000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0118,
    "operating_cash_flow_ttm": -20360000.0,
    "levered_cash_flow_ttm": -15300000.0,
    "book_value_per_share_mrq": 1.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraFect Corporation"
  },
  "CGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -18100000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 5.38,
    "fifty_two_week_high": 9.65,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": -0.2323,
    "percent_change_from_50_day_moving_average": -0.061799999999999994,
    "shares_owned": "N/A",
    "short_ratio": 11.69,
    "two_hundred_day_moving_average": 6.58,
    "volume": 189409.0,
    "market_cap": 254830000.0,
    "price_to_sales_ttm": 30.54,
    "price_to_book_mrq": 2.88,
    "roa_ttm": -0.1056,
    "roe_ttm": -0.20489999999999997,
    "shares_outstanding": 50460000.0,
    "pcnt_held_by_insiders": 0.10039999999999999,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.0404,
    "operating_cash_flow_ttm": -17430000.0,
    "levered_cash_flow_ttm": -10430000.0,
    "book_value_per_share_mrq": 1.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Compugen Ltd."
  },
  "CGIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -2.01,
    "ebitda": -18280000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 9.8,
    "fifty_two_week_high": 12.75,
    "fifty_two_week_low": 4.83,
    "percent_change_from_200_day_moving_average": -0.048499999999999995,
    "percent_change_from_50_day_moving_average": -0.0259,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 10.04,
    "volume": 26529.0,
    "market_cap": 94070000.0,
    "price_to_sales_ttm": 5.99,
    "price_to_book_mrq": 3.53,
    "roa_ttm": -0.2738,
    "roe_ttm": -0.5711999999999999,
    "shares_outstanding": 9850000.0,
    "pcnt_held_by_insiders": 0.32409999999999994,
    "pcnt_held_by_institutions": 0.254,
    "pcnt_short_of_float": 0.025699999999999997,
    "operating_cash_flow_ttm": -13880000.0,
    "levered_cash_flow_ttm": -10410000.0,
    "book_value_per_share_mrq": 2.72,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cancer Genetics, Inc."
  },
  "CGNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -0.5,
    "ebitda": -4980000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.49,
    "fifty_two_week_high": 6.1,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.2288,
    "percent_change_from_50_day_moving_average": -0.14800000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 1.65,
    "volume": 27799.0,
    "market_cap": 33259999.999999996,
    "price_to_sales_ttm": 1.03,
    "price_to_book_mrq": 1.65,
    "roa_ttm": -0.107,
    "roe_ttm": -0.5898,
    "shares_outstanding": 26190000.0,
    "pcnt_held_by_insiders": 0.0789,
    "pcnt_held_by_institutions": 0.551,
    "pcnt_short_of_float": 0.0060999999999999995,
    "operating_cash_flow_ttm": -5750000.0,
    "levered_cash_flow_ttm": -4930000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cogentix Medical, Inc."
  },
  "CHE": {
    "p_e_ratio": 22.43,
    "peg_ratio": 2.05,
    "earnings_per_share": 6.06,
    "ebitda": 204870000.0,
    "eps_estimate_current_year": 6.75,
    "eps_estimate_next_quarter": 1.9,
    "fifty_day_moving_average": 141.32,
    "fifty_two_week_high": 153.98,
    "fifty_two_week_low": 97.85,
    "percent_change_from_200_day_moving_average": 0.0421,
    "percent_change_from_50_day_moving_average": -0.0383,
    "shares_owned": "N/A",
    "short_ratio": 13.64,
    "two_hundred_day_moving_average": 130.42,
    "volume": 157609.0,
    "market_cap": 2300000000.0,
    "price_to_sales_ttm": 1.57,
    "price_to_book_mrq": 4.91,
    "roa_ttm": 0.1285,
    "roe_ttm": 0.2296,
    "shares_outstanding": 16920000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 1.3530000000000002,
    "pcnt_short_of_float": 0.1673,
    "operating_cash_flow_ttm": 134800000.0,
    "levered_cash_flow_ttm": 94010000.0,
    "book_value_per_share_mrq": 28.24,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "Chemed Corp."
  },
  "CHEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.49,
    "ebitda": -8960000.0,
    "eps_estimate_current_year": -1.34,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 2.81,
    "fifty_two_week_high": 6.3,
    "fifty_two_week_low": 1.82,
    "percent_change_from_200_day_moving_average": -0.2864,
    "percent_change_from_50_day_moving_average": 0.0253,
    "shares_owned": "N/A",
    "short_ratio": 0.36,
    "two_hundred_day_moving_average": 4.04,
    "volume": 9502.0,
    "market_cap": 31100000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.3,
    "roa_ttm": -0.491,
    "roe_ttm": -1.3014,
    "shares_outstanding": 10800000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Check-Cap Ltd."
  },
  "CHMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -266.98,
    "ebitda": -20270000.0,
    "eps_estimate_current_year": -2.45,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 26.13,
    "fifty_two_week_high": 30.52,
    "fifty_two_week_low": 19.0,
    "percent_change_from_200_day_moving_average": -0.1027,
    "percent_change_from_50_day_moving_average": -0.1363,
    "shares_owned": "N/A",
    "short_ratio": 2.48,
    "two_hundred_day_moving_average": 25.15,
    "volume": 189895.0,
    "market_cap": 540100000.0,
    "price_to_sales_ttm": 223.91,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0235,
    "operating_cash_flow_ttm": -17970000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -396.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chiasma, Inc."
  },
  "CHRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.72,
    "ebitda": -127430000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 28.6,
    "fifty_two_week_high": 38.1,
    "fifty_two_week_low": 12.38,
    "percent_change_from_200_day_moving_average": -0.1741,
    "percent_change_from_50_day_moving_average": -0.1892,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 28.08,
    "volume": 284571.0,
    "market_cap": 890780000.0,
    "price_to_sales_ttm": 28.56,
    "price_to_book_mrq": 10.38,
    "roa_ttm": -0.43090000000000006,
    "roe_ttm": -2.4101,
    "shares_outstanding": 38410000.0,
    "pcnt_held_by_insiders": 0.01,
    "pcnt_held_by_institutions": 0.858,
    "pcnt_short_of_float": 0.1151,
    "operating_cash_flow_ttm": -92360000.0,
    "levered_cash_flow_ttm": -70160000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Coherus Biosciences, Inc."
  },
  "CIVI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.21,
    "ebitda": 142680000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 25.06,
    "fifty_two_week_high": 27.85,
    "fifty_two_week_low": 11.88,
    "percent_change_from_200_day_moving_average": 0.1585,
    "percent_change_from_50_day_moving_average": 0.0166,
    "shares_owned": "N/A",
    "short_ratio": 5.35,
    "two_hundred_day_moving_average": 21.99,
    "volume": 87655.0,
    "market_cap": 941980000.0,
    "price_to_sales_ttm": 0.73,
    "price_to_book_mrq": 8.13,
    "roa_ttm": 0.0432,
    "roe_ttm": -0.16260000000000002,
    "shares_outstanding": 36970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08410000000000001,
    "operating_cash_flow_ttm": 67960000.0,
    "levered_cash_flow_ttm": 42570000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": [
      "2015-12-15",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Civitas Solutions, Inc."
  },
  "CLBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -1.69,
    "ebitda": -63710000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 1.59,
    "fifty_two_week_high": 7.22,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.26780000000000004,
    "percent_change_from_50_day_moving_average": 0.026099999999999998,
    "shares_owned": "N/A",
    "short_ratio": 6.81,
    "two_hundred_day_moving_average": 2.23,
    "volume": 186192.0,
    "market_cap": 90220000.0,
    "price_to_sales_ttm": 5.25,
    "price_to_book_mrq": 1.46,
    "roa_ttm": -0.3157,
    "roe_ttm": -0.9111,
    "shares_outstanding": 55350000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.047,
    "operating_cash_flow_ttm": -46220000.0,
    "levered_cash_flow_ttm": -27260000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Caladrius Biosciences, Inc."
  },
  "CLCD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.63,
    "ebitda": -11830000.0,
    "eps_estimate_current_year": -3.38,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 6.81,
    "fifty_two_week_high": 9.46,
    "fifty_two_week_low": 5.25,
    "percent_change_from_200_day_moving_average": -0.3347,
    "percent_change_from_50_day_moving_average": -0.223,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 7.95,
    "volume": 129557.0,
    "market_cap": 80160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.22,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15150000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -8160000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CoLucid Pharmaceuticals, Inc."
  },
  "CLDN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -48130000.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.14,
    "fifty_two_week_high": 28.25,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": -0.8014,
    "percent_change_from_50_day_moving_average": 0.0537,
    "shares_owned": "N/A",
    "short_ratio": 4.75,
    "two_hundred_day_moving_average": 6.04,
    "volume": 239204.0,
    "market_cap": 28700000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.68,
    "roa_ttm": -0.5388000000000001,
    "roe_ttm": -1.1592,
    "shares_outstanding": 23910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0661,
    "operating_cash_flow_ttm": -43570000.0,
    "levered_cash_flow_ttm": -23780000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celladon Corporation"
  },
  "CLDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.32,
    "ebitda": -122500000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 15.18,
    "fifty_two_week_high": 32.82,
    "fifty_two_week_low": 11.9,
    "percent_change_from_200_day_moving_average": -0.4843,
    "percent_change_from_50_day_moving_average": -0.19760000000000003,
    "shares_owned": "N/A",
    "short_ratio": 6.96,
    "two_hundred_day_moving_average": 23.62,
    "volume": 2199740.0,
    "market_cap": 1200000000.0,
    "price_to_sales_ttm": 251.66,
    "price_to_book_mrq": 3.81,
    "roa_ttm": -0.2316,
    "roe_ttm": -0.4006,
    "shares_outstanding": 98600000.0,
    "pcnt_held_by_insiders": 0.0028000000000000004,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.19140000000000001,
    "operating_cash_flow_ttm": -106160000.0,
    "levered_cash_flow_ttm": -67080000.0,
    "book_value_per_share_mrq": 3.51,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celldex Therapeutics, Inc."
  },
  "CLLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -15860000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 32.41,
    "fifty_two_week_high": 50.0,
    "fifty_two_week_low": 27.21,
    "percent_change_from_200_day_moving_average": -0.1358,
    "percent_change_from_50_day_moving_average": -0.0789,
    "shares_owned": "N/A",
    "short_ratio": 6.54,
    "two_hundred_day_moving_average": 34.54,
    "volume": 139371.0,
    "market_cap": 1050000000.0,
    "price_to_sales_ttm": 29.6,
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.0564,
    "roe_ttm": -0.0699,
    "shares_outstanding": 35060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 33670000.0,
    "levered_cash_flow_ttm": 38630000.0,
    "book_value_per_share_mrq": 7.71,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cellectis S.A."
  },
  "CLRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.1,
    "ebitda": -8950000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.03,
    "fifty_two_week_high": 3.89,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": -0.0478,
    "percent_change_from_50_day_moving_average": -0.0645,
    "shares_owned": "N/A",
    "short_ratio": 1.65,
    "two_hundred_day_moving_average": 2.97,
    "volume": 3051.0,
    "market_cap": 21410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 8.85,
    "roa_ttm": -0.8047,
    "roe_ttm": "N/A",
    "shares_outstanding": 7560000.0,
    "pcnt_held_by_insiders": 0.0338,
    "pcnt_held_by_institutions": 0.011000000000000001,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": -8790000.0,
    "levered_cash_flow_ttm": -2950000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cellectar Biosciences, Inc."
  },
  "CLSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -21720000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 2.07,
    "fifty_two_week_high": 3.57,
    "fifty_two_week_low": 1.8,
    "percent_change_from_200_day_moving_average": -0.2094,
    "percent_change_from_50_day_moving_average": -0.0711,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 2.43,
    "volume": 134338.0,
    "market_cap": 44210000.0,
    "price_to_sales_ttm": 91.65,
    "price_to_book_mrq": 1.57,
    "roa_ttm": -0.1977,
    "roe_ttm": -0.7004,
    "shares_outstanding": 23030000.0,
    "pcnt_held_by_insiders": 0.2634,
    "pcnt_held_by_institutions": 0.16699999999999998,
    "pcnt_short_of_float": 0.0321,
    "operating_cash_flow_ttm": -23960000.0,
    "levered_cash_flow_ttm": -12260000.0,
    "book_value_per_share_mrq": 1.27,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celsion Corp."
  },
  "CLTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -17.59,
    "ebitda": -9750000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.59,
    "fifty_two_week_high": 62.5,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 2.8133,
    "percent_change_from_50_day_moving_average": 1.0468000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.14,
    "two_hundred_day_moving_average": 9.44,
    "volume": 0.0,
    "market_cap": 20020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 20.59,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 556000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -8580000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Celsus Therapeutics Plc"
  },
  "CLVS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.74,
    "ebitda": -229220000.0,
    "eps_estimate_current_year": -8.26,
    "eps_estimate_next_quarter": -2.24,
    "fifty_day_moving_average": 87.51,
    "fifty_two_week_high": 116.75,
    "fifty_two_week_low": 40.66,
    "percent_change_from_200_day_moving_average": 0.0984,
    "percent_change_from_50_day_moving_average": 0.0668,
    "shares_owned": "N/A",
    "short_ratio": 7.88,
    "two_hundred_day_moving_average": 84.99,
    "volume": 740452.0,
    "market_cap": 3570000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 17.08,
    "roa_ttm": -0.22829999999999998,
    "roe_ttm": -0.7149,
    "shares_outstanding": 38210000.0,
    "pcnt_held_by_insiders": 0.2615,
    "pcnt_held_by_institutions": 0.818,
    "pcnt_short_of_float": 0.2155,
    "operating_cash_flow_ttm": -173800000.0,
    "levered_cash_flow_ttm": -86080000.0,
    "book_value_per_share_mrq": 5.85,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Clovis Oncology, Inc."
  },
  "CMN": {
    "p_e_ratio": 47.74,
    "peg_ratio": 2.55,
    "earnings_per_share": 1.08,
    "ebitda": 104250000.0,
    "eps_estimate_current_year": 1.14,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 51.74,
    "fifty_two_week_high": 58.04,
    "fifty_two_week_low": 33.7,
    "percent_change_from_200_day_moving_average": 0.0252,
    "percent_change_from_50_day_moving_average": -0.0034999999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.32,
    "two_hundred_day_moving_average": 50.29,
    "volume": 210893.0,
    "market_cap": 2140000000.0000002,
    "price_to_sales_ttm": 4.04,
    "price_to_book_mrq": 5.55,
    "roa_ttm": 0.09519999999999999,
    "roe_ttm": 0.12119999999999999,
    "shares_outstanding": 41550000.0,
    "pcnt_held_by_insiders": 0.1776,
    "pcnt_held_by_institutions": 0.7859999999999999,
    "pcnt_short_of_float": 0.031,
    "operating_cash_flow_ttm": 56920000.0,
    "levered_cash_flow_ttm": 51830000.0,
    "book_value_per_share_mrq": 9.57,
    "next_earnings_announcement_date": "2015-09-29",
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cantel Medical Corp."
  },
  "CMRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.13,
    "ebitda": -84910000.0,
    "eps_estimate_current_year": -2.33,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 49.4,
    "fifty_two_week_high": 58.04,
    "fifty_two_week_low": 27.45,
    "percent_change_from_200_day_moving_average": -0.036000000000000004,
    "percent_change_from_50_day_moving_average": -0.1348,
    "shares_owned": "N/A",
    "short_ratio": 8.63,
    "two_hundred_day_moving_average": 44.34,
    "volume": 537596.0,
    "market_cap": 1970000000.0,
    "price_to_sales_ttm": 270.25,
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.1704,
    "roe_ttm": -0.2857,
    "shares_outstanding": 46070000.0,
    "pcnt_held_by_insiders": 0.2781,
    "pcnt_held_by_institutions": 0.445,
    "pcnt_short_of_float": 0.109,
    "operating_cash_flow_ttm": -70180000.0,
    "levered_cash_flow_ttm": -39840000.0,
    "book_value_per_share_mrq": 8.71,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Chimerix, Inc."
  },
  "CNAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.11,
    "earnings_per_share": -1.44,
    "ebitda": -23700000.0,
    "eps_estimate_current_year": -1.42,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 4.25,
    "fifty_two_week_high": 11.74,
    "fifty_two_week_low": 3.44,
    "percent_change_from_200_day_moving_average": -0.0335,
    "percent_change_from_50_day_moving_average": 0.21350000000000002,
    "shares_owned": "N/A",
    "short_ratio": 9.59,
    "two_hundred_day_moving_average": 5.34,
    "volume": 1959593.0,
    "market_cap": 101750000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.59,
    "roa_ttm": -0.3065,
    "roe_ttm": -0.5418999999999999,
    "shares_outstanding": 19720000.0,
    "pcnt_held_by_insiders": 0.4947,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.0913,
    "operating_cash_flow_ttm": -19500000.0,
    "levered_cash_flow_ttm": -11340000.0,
    "book_value_per_share_mrq": 2.26,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Conatus Pharmaceuticals Inc."
  },
  "CNC": {
    "p_e_ratio": 21.02,
    "peg_ratio": 1.47,
    "earnings_per_share": 2.79,
    "ebitda": 732000000.0,
    "eps_estimate_current_year": 2.82,
    "eps_estimate_next_quarter": 0.79,
    "fifty_day_moving_average": 64.39,
    "fifty_two_week_high": 83.0,
    "fifty_two_week_low": 37.53,
    "percent_change_from_200_day_moving_average": -0.1575,
    "percent_change_from_50_day_moving_average": -0.0897,
    "shares_owned": "N/A",
    "short_ratio": 5.36,
    "two_hundred_day_moving_average": 69.57,
    "volume": 1823383.0,
    "market_cap": 6980000000.0,
    "price_to_sales_ttm": 0.39,
    "price_to_book_mrq": 3.78,
    "roa_ttm": 0.0675,
    "roe_ttm": 0.1805,
    "shares_outstanding": 119090000.0,
    "pcnt_held_by_insiders": 0.025099999999999997,
    "pcnt_held_by_institutions": 0.9420000000000001,
    "pcnt_short_of_float": 0.0726,
    "operating_cash_flow_ttm": 1210000000.0,
    "levered_cash_flow_ttm": 1000000000.0,
    "book_value_per_share_mrq": 16.29,
    "next_earnings_announcement_date": "2015-10-27",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Centene Corp."
  },
  "CNCE": {
    "p_e_ratio": 24.69,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.77,
    "ebitda": -32920000.0,
    "eps_estimate_current_year": 0.97,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 17.32,
    "fifty_two_week_high": 22.8,
    "fifty_two_week_low": 10.31,
    "percent_change_from_200_day_moving_average": 0.1943,
    "percent_change_from_50_day_moving_average": 0.1005,
    "shares_owned": "N/A",
    "short_ratio": 4.68,
    "two_hundred_day_moving_average": 15.96,
    "volume": 502116.0,
    "market_cap": 417810000.0,
    "price_to_sales_ttm": 44.59,
    "price_to_book_mrq": 3.37,
    "roa_ttm": -0.162,
    "roe_ttm": 0.14880000000000002,
    "shares_outstanding": 21920000.0,
    "pcnt_held_by_insiders": 0.2789,
    "pcnt_held_by_institutions": 0.325,
    "pcnt_short_of_float": 0.0731,
    "operating_cash_flow_ttm": 15390000.0,
    "levered_cash_flow_ttm": -21670000.0,
    "book_value_per_share_mrq": 6.21,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Concert Pharmaceuticals, Inc."
  },
  "CNMD": {
    "p_e_ratio": 50.34,
    "peg_ratio": 1.99,
    "earnings_per_share": 0.97,
    "ebitda": 122500000.0,
    "eps_estimate_current_year": 1.83,
    "eps_estimate_next_quarter": 0.61,
    "fifty_day_moving_average": 53.03,
    "fifty_two_week_high": 60.66,
    "fifty_two_week_low": 36.62,
    "percent_change_from_200_day_moving_average": -0.0986,
    "percent_change_from_50_day_moving_average": -0.07919999999999999,
    "shares_owned": "N/A",
    "short_ratio": 9.44,
    "two_hundred_day_moving_average": 54.17,
    "volume": 196936.0,
    "market_cap": 1350000000.0,
    "price_to_sales_ttm": 1.94,
    "price_to_book_mrq": 2.43,
    "roa_ttm": 0.0446,
    "roe_ttm": 0.045899999999999996,
    "shares_outstanding": 27700000.0,
    "pcnt_held_by_insiders": 0.0753,
    "pcnt_held_by_institutions": 0.902,
    "pcnt_short_of_float": 0.051699999999999996,
    "operating_cash_flow_ttm": 65319999.99999999,
    "levered_cash_flow_ttm": 103550000.0,
    "book_value_per_share_mrq": 20.87,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CONMED Corporation"
  },
  "CNXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -0.77,
    "ebitda": -805000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": 0.31,
    "fifty_day_moving_average": 6.33,
    "fifty_two_week_high": 14.39,
    "fifty_two_week_low": 4.25,
    "percent_change_from_200_day_moving_average": -0.5552,
    "percent_change_from_50_day_moving_average": -0.3282,
    "shares_owned": "N/A",
    "short_ratio": 9.03,
    "two_hundred_day_moving_average": 9.55,
    "volume": 261364.0,
    "market_cap": 92970000.0,
    "price_to_sales_ttm": 1.15,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0394,
    "roe_ttm": "N/A",
    "shares_outstanding": 21870000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.141,
    "operating_cash_flow_ttm": -17420000.0,
    "levered_cash_flow_ttm": -14660000.0,
    "book_value_per_share_mrq": -1.65,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Connecture, Inc."
  },
  "CO": {
    "p_e_ratio": 34.1,
    "peg_ratio": 1.26,
    "earnings_per_share": 0.18,
    "ebitda": 43460000.0,
    "eps_estimate_current_year": 0.17,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 6.62,
    "fifty_two_week_high": 7.69,
    "fifty_two_week_low": 4.1,
    "percent_change_from_200_day_moving_average": 0.0255,
    "percent_change_from_50_day_moving_average": -0.057699999999999994,
    "shares_owned": "N/A",
    "short_ratio": 0.51,
    "two_hundred_day_moving_average": 6.09,
    "volume": 139734.0,
    "market_cap": 499720000.0,
    "price_to_sales_ttm": 4.45,
    "price_to_book_mrq": 1.83,
    "roa_ttm": 0.035,
    "roe_ttm": 0.06,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.8759999999999999,
    "pcnt_held_by_institutions": 0.114,
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.39,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "China Cord Blood Corporation"
  },
  "COLL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.25,
    "ebitda": -17850000.0,
    "eps_estimate_current_year": -1.65,
    "eps_estimate_next_quarter": -0.47,
    "fifty_day_moving_average": 17.22,
    "fifty_two_week_high": 24.88,
    "fifty_two_week_low": 11.92,
    "percent_change_from_200_day_moving_average": 0.2054,
    "percent_change_from_50_day_moving_average": 0.2357,
    "shares_owned": "N/A",
    "short_ratio": 4.69,
    "two_hundred_day_moving_average": 17.65,
    "volume": 188434.0,
    "market_cap": 440240000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.38,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 20690000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0174,
    "operating_cash_flow_ttm": -18070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.95,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Collegium Pharmaceutical, Inc."
  },
  "COO": {
    "p_e_ratio": 37.33,
    "peg_ratio": 1.32,
    "earnings_per_share": 4.01,
    "ebitda": 546340000.0,
    "eps_estimate_current_year": 7.56,
    "eps_estimate_next_quarter": 1.98,
    "fifty_day_moving_average": 160.22,
    "fifty_two_week_high": 190.0,
    "fifty_two_week_low": 142.11,
    "percent_change_from_200_day_moving_average": -0.1439,
    "percent_change_from_50_day_moving_average": -0.0646,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 175.06,
    "volume": 702352.0,
    "market_cap": 7290000000.0,
    "price_to_sales_ttm": 4.13,
    "price_to_book_mrq": 2.78,
    "roa_ttm": 0.0582,
    "roe_ttm": 0.07429999999999999,
    "shares_outstanding": 48610000.0,
    "pcnt_held_by_insiders": 0.0068000000000000005,
    "pcnt_held_by_institutions": 1.022,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": 438510000.0,
    "levered_cash_flow_ttm": 152200000.0,
    "book_value_per_share_mrq": 55.28,
    "next_earnings_announcement_date": [
      "2015-12-02",
      "2015-12-07"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "The Cooper Companies Inc."
  },
  "CORI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.45,
    "ebitda": -16430000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 10.87,
    "fifty_two_week_high": 16.29,
    "fifty_two_week_low": 4.3,
    "percent_change_from_200_day_moving_average": -0.2094,
    "percent_change_from_50_day_moving_average": -0.19079999999999997,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 11.13,
    "volume": 78676.0,
    "market_cap": 195000000.0,
    "price_to_sales_ttm": 4.45,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1783,
    "roe_ttm": -4.3358,
    "shares_outstanding": 22160000.0,
    "pcnt_held_by_insiders": 0.0766,
    "pcnt_held_by_institutions": 0.087,
    "pcnt_short_of_float": 0.0552,
    "operating_cash_flow_ttm": -20590000.0,
    "levered_cash_flow_ttm": -14080000.0,
    "book_value_per_share_mrq": -0.3,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corium International, Inc."
  },
  "CORT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.39,
    "earnings_per_share": -0.16,
    "ebitda": -13200000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 4.97,
    "fifty_two_week_high": 7.67,
    "fifty_two_week_low": 2.59,
    "percent_change_from_200_day_moving_average": -0.2727,
    "percent_change_from_50_day_moving_average": -0.1855,
    "shares_owned": "N/A",
    "short_ratio": 12.41,
    "two_hundred_day_moving_average": 5.57,
    "volume": 359048.0,
    "market_cap": 438890000.0,
    "price_to_sales_ttm": 12.63,
    "price_to_book_mrq": 42.17,
    "roa_ttm": -0.18030000000000002,
    "roe_ttm": -2.2257,
    "shares_outstanding": 108370000.0,
    "pcnt_held_by_insiders": 0.3521,
    "pcnt_held_by_institutions": 0.375,
    "pcnt_short_of_float": 0.0781,
    "operating_cash_flow_ttm": -9250000.0,
    "levered_cash_flow_ttm": -7380000.0,
    "book_value_per_share_mrq": 0.11,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corcept Therapeutics Incorporated"
  },
  "CPHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -20510000.0,
    "eps_estimate_current_year": 0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.229,
    "fifty_two_week_high": 0.56,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.3726,
    "percent_change_from_50_day_moving_average": -0.1675,
    "shares_owned": "N/A",
    "short_ratio": 0.51,
    "two_hundred_day_moving_average": 0.304,
    "volume": 25430.0,
    "market_cap": 8320000.0,
    "price_to_sales_ttm": 0.4,
    "price_to_book_mrq": 0.1,
    "roa_ttm": -0.1103,
    "roe_ttm": -0.251,
    "shares_outstanding": 43580000.0,
    "pcnt_held_by_insiders": 0.5025999999999999,
    "pcnt_held_by_institutions": 0.095,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": 1640000.0,
    "levered_cash_flow_ttm": 11650000.0,
    "book_value_per_share_mrq": 2.18,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "China Pharma Holdings, Inc."
  },
  "CPHR": {
    "p_e_ratio": 9.49,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.41,
    "ebitda": 13480000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.87,
    "fifty_two_week_high": 18.0,
    "fifty_two_week_low": 3.87,
    "percent_change_from_200_day_moving_average": -0.5531,
    "percent_change_from_50_day_moving_average": -0.3317,
    "shares_owned": "N/A",
    "short_ratio": 1.76,
    "two_hundred_day_moving_average": 8.77,
    "volume": 35946.0,
    "market_cap": 101790000.0,
    "price_to_sales_ttm": 4.14,
    "price_to_book_mrq": 2.11,
    "roa_ttm": 0.091,
    "roe_ttm": 0.22030000000000002,
    "shares_outstanding": 25970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 13670000.0,
    "levered_cash_flow_ttm": 3730000.0,
    "book_value_per_share_mrq": 2.04,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Cipher Pharmaceuticals Inc."
  },
  "CPIX": {
    "p_e_ratio": 55.05,
    "peg_ratio": 2.23,
    "earnings_per_share": 0.11,
    "ebitda": 4650000.0,
    "eps_estimate_current_year": 0.09,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.99,
    "fifty_two_week_high": 7.78,
    "fifty_two_week_low": 4.5,
    "percent_change_from_200_day_moving_average": -0.0959,
    "percent_change_from_50_day_moving_average": 0.001,
    "shares_owned": "N/A",
    "short_ratio": 15.64,
    "two_hundred_day_moving_average": 6.64,
    "volume": 12924.0,
    "market_cap": 99770000.0,
    "price_to_sales_ttm": 2.71,
    "price_to_book_mrq": 1.27,
    "roa_ttm": 0.0155,
    "roe_ttm": 0.0226,
    "shares_outstanding": 16629999.999999998,
    "pcnt_held_by_insiders": 0.36939999999999995,
    "pcnt_held_by_institutions": 0.385,
    "pcnt_short_of_float": 0.030600000000000002,
    "operating_cash_flow_ttm": 8940000.0,
    "levered_cash_flow_ttm": 746380.0,
    "book_value_per_share_mrq": 4.71,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cumberland Pharmaceuticals, Inc."
  },
  "CPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.25,
    "ebitda": -17250000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 3.93,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 2.26,
    "percent_change_from_200_day_moving_average": -0.1014,
    "percent_change_from_50_day_moving_average": -0.0404,
    "shares_owned": "N/A",
    "short_ratio": 9.02,
    "two_hundred_day_moving_average": 4.2,
    "volume": 668844.0,
    "market_cap": 310930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.35,
    "roa_ttm": -0.1891,
    "roe_ttm": -0.3552,
    "shares_outstanding": 82480000.0,
    "pcnt_held_by_insiders": 0.1895,
    "pcnt_held_by_institutions": 0.20199999999999999,
    "pcnt_short_of_float": 0.08410000000000001,
    "operating_cash_flow_ttm": -15570000.0,
    "levered_cash_flow_ttm": -9220000.0,
    "book_value_per_share_mrq": 0.77,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalyst Pharmaceuticals, Inc."
  },
  "CPXX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -17660000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 2.23,
    "fifty_two_week_high": 3.53,
    "fifty_two_week_low": 1.58,
    "percent_change_from_200_day_moving_average": -0.12619999999999998,
    "percent_change_from_50_day_moving_average": -0.1081,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 2.28,
    "volume": 328455.0,
    "market_cap": 67260000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.25,
    "roa_ttm": -0.36840000000000006,
    "roe_ttm": -1.2154,
    "shares_outstanding": 33800000.0,
    "pcnt_held_by_insiders": 0.5244,
    "pcnt_held_by_institutions": 0.133,
    "pcnt_short_of_float": 0.0308,
    "operating_cash_flow_ttm": -15020000.0,
    "levered_cash_flow_ttm": -9590000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Celator Pharmaceuticals, Inc."
  },
  "CRBP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -6150000.0,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 4.95,
    "fifty_two_week_low": 1.77,
    "percent_change_from_200_day_moving_average": -0.2926,
    "percent_change_from_50_day_moving_average": -0.0002,
    "shares_owned": "N/A",
    "short_ratio": 0.23,
    "two_hundred_day_moving_average": 2.8,
    "volume": 195347.0,
    "market_cap": 74320000.0,
    "price_to_sales_ttm": 560.21,
    "price_to_book_mrq": 9.05,
    "roa_ttm": -0.4265,
    "roe_ttm": -0.8465,
    "shares_outstanding": 37540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0322,
    "operating_cash_flow_ttm": -3160000.0,
    "levered_cash_flow_ttm": -1470000.0,
    "book_value_per_share_mrq": 0.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Corbus Pharmaceuticals Holdings, Inc."
  },
  "CRDC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.215,
    "ebitda": -17400000.0,
    "eps_estimate_current_year": -0.19,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.3597,
    "fifty_two_week_high": 1.12,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.22555599999999998,
    "percent_change_from_50_day_moving_average": -0.038403,
    "shares_owned": "N/A",
    "short_ratio": 3.39,
    "two_hundred_day_moving_average": 0.4466,
    "volume": 117238.0,
    "market_cap": 30790000.0,
    "price_to_sales_ttm": 10.12,
    "price_to_book_mrq": 1.37,
    "roa_ttm": -0.3054,
    "roe_ttm": -0.6161,
    "shares_outstanding": 89000000.0,
    "pcnt_held_by_insiders": 0.2364,
    "pcnt_held_by_institutions": 0.256,
    "pcnt_short_of_float": 0.0058,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Cardica Inc."
  },
  "CRIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.5,
    "ebitda": -23440000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 2.58,
    "fifty_two_week_high": 3.75,
    "fifty_two_week_low": 1.09,
    "percent_change_from_200_day_moving_average": -0.2401,
    "percent_change_from_50_day_moving_average": -0.1382,
    "shares_owned": "N/A",
    "short_ratio": 8.81,
    "two_hundred_day_moving_average": 2.92,
    "volume": 504593.0,
    "market_cap": 287740000.0,
    "price_to_sales_ttm": 42.12,
    "price_to_book_mrq": 3.92,
    "roa_ttm": -0.1591,
    "roe_ttm": -0.8542000000000001,
    "shares_outstanding": 129610000.00000001,
    "pcnt_held_by_insiders": 0.0227,
    "pcnt_held_by_institutions": 0.523,
    "pcnt_short_of_float": 0.0736,
    "operating_cash_flow_ttm": -21320000.0,
    "levered_cash_flow_ttm": -11060000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Curis, Inc."
  },
  "CRL": {
    "p_e_ratio": 22.05,
    "peg_ratio": 2.01,
    "earnings_per_share": 2.93,
    "ebitda": 290540000.0,
    "eps_estimate_current_year": 3.64,
    "eps_estimate_next_quarter": 0.95,
    "fifty_day_moving_average": 70.81,
    "fifty_two_week_high": 84.69,
    "fifty_two_week_low": 55.47,
    "percent_change_from_200_day_moving_average": -0.126,
    "percent_change_from_50_day_moving_average": -0.0863,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 74.03,
    "volume": 461523.0,
    "market_cap": 3030000000.0,
    "price_to_sales_ttm": 2.42,
    "price_to_book_mrq": 4.54,
    "roa_ttm": 0.0658,
    "roe_ttm": 0.19760000000000003,
    "shares_outstanding": 46780000.0,
    "pcnt_held_by_insiders": 0.018500000000000003,
    "pcnt_held_by_institutions": 1.038,
    "pcnt_short_of_float": 0.0461,
    "operating_cash_flow_ttm": 262980000.00000003,
    "levered_cash_flow_ttm": 207710000.0,
    "book_value_per_share_mrq": 14.98,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Charles River Laboratories International, Inc."
  },
  "CRMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.68,
    "ebitda": -13550000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.81,
    "fifty_two_week_high": 10.4,
    "fifty_two_week_low": 1.25,
    "percent_change_from_200_day_moving_average": -0.551,
    "percent_change_from_50_day_moving_average": -0.1396,
    "shares_owned": "N/A",
    "short_ratio": 15.32,
    "two_hundred_day_moving_average": 5.39,
    "volume": 556578.0,
    "market_cap": 82840000.0,
    "price_to_sales_ttm": 308.43,
    "price_to_book_mrq": 2.41,
    "roa_ttm": -0.3605,
    "roe_ttm": -0.8104,
    "shares_outstanding": 34230000.0,
    "pcnt_held_by_insiders": 0.1631,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.2341,
    "operating_cash_flow_ttm": -9330000.0,
    "levered_cash_flow_ttm": -6090000.0,
    "book_value_per_share_mrq": 1.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CorMedix, Inc."
  },
  "CRME": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.36,
    "earnings_per_share": -1.32,
    "ebitda": -17840000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 9.5,
    "fifty_two_week_high": 11.31,
    "fifty_two_week_low": 7.12,
    "percent_change_from_200_day_moving_average": 0.0364,
    "percent_change_from_50_day_moving_average": 0.006500000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.1,
    "two_hundred_day_moving_average": 9.22,
    "volume": 38957.0,
    "market_cap": 164840000.0,
    "price_to_sales_ttm": 6.46,
    "price_to_book_mrq": 16.4,
    "roa_ttm": -0.2847,
    "roe_ttm": -1.1522,
    "shares_outstanding": 17240000.0,
    "pcnt_held_by_insiders": 0.10369999999999999,
    "pcnt_held_by_institutions": 0.76,
    "pcnt_short_of_float": 0.0167,
    "operating_cash_flow_ttm": -13660000.0,
    "levered_cash_flow_ttm": -7260000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Cardiome Pharma Corp."
  },
  "CRY": {
    "p_e_ratio": 86.4,
    "peg_ratio": -15.85,
    "earnings_per_share": 0.11,
    "ebitda": 10510000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 9.92,
    "fifty_two_week_high": 12.29,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": -0.0638,
    "percent_change_from_50_day_moving_average": -0.0072,
    "shares_owned": "N/A",
    "short_ratio": 15.28,
    "two_hundred_day_moving_average": 10.52,
    "volume": 128662.0,
    "market_cap": 292060000.0,
    "price_to_sales_ttm": 1.93,
    "price_to_book_mrq": 1.85,
    "roa_ttm": 0.0154,
    "roe_ttm": 0.0225,
    "shares_outstanding": 29650000.0,
    "pcnt_held_by_insiders": 0.0946,
    "pcnt_held_by_institutions": 0.595,
    "pcnt_short_of_float": 0.0395,
    "operating_cash_flow_ttm": 12480000.0,
    "levered_cash_flow_ttm": 10450000.0,
    "book_value_per_share_mrq": 5.28,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "CryoLife Inc."
  },
  "CSBR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.96,
    "ebitda": -12210000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.13,
    "fifty_two_week_high": 10.08,
    "fifty_two_week_low": 2.4,
    "percent_change_from_200_day_moving_average": -0.1257,
    "percent_change_from_50_day_moving_average": -0.0471,
    "shares_owned": "N/A",
    "short_ratio": 1.86,
    "two_hundred_day_moving_average": 6.68,
    "volume": 300.0,
    "market_cap": 50820000.0,
    "price_to_sales_ttm": 5.39,
    "price_to_book_mrq": 8.93,
    "roa_ttm": -0.9987999999999999,
    "roe_ttm": -3.9436,
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.5997,
    "pcnt_held_by_institutions": 0.026000000000000002,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": -9390000.0,
    "levered_cash_flow_ttm": -4610000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Champions Oncology, Inc."
  },
  "CSII": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.56,
    "earnings_per_share": -1.04,
    "ebitda": -30320000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 22.95,
    "fifty_two_week_high": 41.28,
    "fifty_two_week_low": 17.51,
    "percent_change_from_200_day_moving_average": -0.4029,
    "percent_change_from_50_day_moving_average": -0.2186,
    "shares_owned": "N/A",
    "short_ratio": 5.57,
    "two_hundred_day_moving_average": 30.03,
    "volume": 622215.0,
    "market_cap": 582370000.0,
    "price_to_sales_ttm": 3.56,
    "price_to_book_mrq": 4.48,
    "roa_ttm": -0.1155,
    "roe_ttm": -0.22519999999999998,
    "shares_outstanding": 32479999.999999996,
    "pcnt_held_by_insiders": 0.0895,
    "pcnt_held_by_institutions": 0.6409999999999999,
    "pcnt_short_of_float": 0.0882,
    "operating_cash_flow_ttm": -22360000.0,
    "levered_cash_flow_ttm": -36030000.0,
    "book_value_per_share_mrq": 4.37,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cardiovascular Systems Inc."
  },
  "CSU": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.14,
    "earnings_per_share": -0.71,
    "ebitda": 69820000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 21.35,
    "fifty_two_week_high": 27.75,
    "fifty_two_week_low": 20.11,
    "percent_change_from_200_day_moving_average": -0.10980000000000001,
    "percent_change_from_50_day_moving_average": 0.0072,
    "shares_owned": "N/A",
    "short_ratio": 7.35,
    "two_hundred_day_moving_average": 24.15,
    "volume": 365198.0,
    "market_cap": 634260000.0,
    "price_to_sales_ttm": 1.59,
    "price_to_book_mrq": 4.7,
    "roa_ttm": 0.011200000000000002,
    "roe_ttm": -0.1479,
    "shares_outstanding": 29500000.0,
    "pcnt_held_by_insiders": 0.1164,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.061399999999999996,
    "operating_cash_flow_ttm": 49390000.0,
    "levered_cash_flow_ttm": 35190000.0,
    "book_value_per_share_mrq": 4.68,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Capital Senior Living Corp."
  },
  "CTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -64840000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 1.63,
    "fifty_two_week_high": 2.94,
    "fifty_two_week_low": 1.42,
    "percent_change_from_200_day_moving_average": -0.1673,
    "percent_change_from_50_day_moving_average": -0.0464,
    "shares_owned": "N/A",
    "short_ratio": 10.88,
    "two_hundred_day_moving_average": 1.86,
    "volume": 1902728.0,
    "market_cap": 280020000.0,
    "price_to_sales_ttm": 4.65,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6393,
    "roe_ttm": "N/A",
    "shares_outstanding": 180660000.0,
    "pcnt_held_by_insiders": 0.1677,
    "pcnt_held_by_institutions": 0.289,
    "pcnt_short_of_float": 0.0858,
    "operating_cash_flow_ttm": -50070000.0,
    "levered_cash_flow_ttm": -16690000.000000002,
    "book_value_per_share_mrq": -0.07,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CTI BioPharma Corp."
  },
  "CTLT": {
    "p_e_ratio": 14.78,
    "peg_ratio": 1.99,
    "earnings_per_share": 1.75,
    "ebitda": 418800000.0,
    "eps_estimate_current_year": 1.71,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 30.44,
    "fifty_two_week_high": 34.42,
    "fifty_two_week_low": 22.85,
    "percent_change_from_200_day_moving_average": -0.1494,
    "percent_change_from_50_day_moving_average": -0.1497,
    "shares_owned": "N/A",
    "short_ratio": 3.84,
    "two_hundred_day_moving_average": 30.43,
    "volume": 620717.0,
    "market_cap": 3220000000.0,
    "price_to_sales_ttm": 1.83,
    "price_to_book_mrq": 5.28,
    "roa_ttm": 0.0557,
    "roe_ttm": 1.5428,
    "shares_outstanding": 124520000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1061,
    "operating_cash_flow_ttm": 171800000.0,
    "levered_cash_flow_ttm": 107220000.0,
    "book_value_per_share_mrq": 5.1,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Catalent, Inc."
  },
  "CTRV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.62,
    "ebitda": 0.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 3.71,
    "fifty_two_week_high": 5.76,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.2901,
    "percent_change_from_50_day_moving_average": -0.2501,
    "shares_owned": "N/A",
    "short_ratio": 4.09,
    "two_hundred_day_moving_average": 3.92,
    "volume": 18723.0,
    "market_cap": 61920000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 22270000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0060999999999999995,
    "operating_cash_flow_ttm": -6030000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -0.26,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ContraVir Pharmaceuticals, Inc."
  },
  "CTSO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.79,
    "ebitda": -9200000.0,
    "eps_estimate_current_year": -0.36,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 6.87,
    "fifty_two_week_high": 15.24,
    "fifty_two_week_low": 4.4,
    "percent_change_from_200_day_moving_average": -0.13369999999999999,
    "percent_change_from_50_day_moving_average": -0.055099999999999996,
    "shares_owned": "N/A",
    "short_ratio": 10.17,
    "two_hundred_day_moving_average": 7.49,
    "volume": 98572.0,
    "market_cap": 162560000.0,
    "price_to_sales_ttm": 44.54,
    "price_to_book_mrq": 14.24,
    "roa_ttm": -0.4567,
    "roe_ttm": -0.9747,
    "shares_outstanding": 25050000.0,
    "pcnt_held_by_insiders": 0.006,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.056900000000000006,
    "operating_cash_flow_ttm": -8960000.0,
    "levered_cash_flow_ttm": -5750000.0,
    "book_value_per_share_mrq": 0.47,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Cytosorbents Corporation"
  },
  "CUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -18020000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 1.47,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 1.25,
    "percent_change_from_200_day_moving_average": 0.0036,
    "percent_change_from_50_day_moving_average": 0.2332,
    "shares_owned": "N/A",
    "short_ratio": 28.23,
    "two_hundred_day_moving_average": 1.8,
    "volume": 1804665.0,
    "market_cap": 166130000.0,
    "price_to_sales_ttm": 11744.81,
    "price_to_book_mrq": 11.99,
    "roa_ttm": -0.3889,
    "roe_ttm": -1.061,
    "shares_outstanding": 91790000.0,
    "pcnt_held_by_insiders": 0.042699999999999995,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.1412,
    "operating_cash_flow_ttm": -16110000.0,
    "levered_cash_flow_ttm": -8780000.0,
    "book_value_per_share_mrq": 0.16,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neuralstem, Inc."
  },
  "CUTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -5.62,
    "earnings_per_share": -0.67,
    "ebitda": -7720000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.1,
    "fifty_day_moving_average": 14.74,
    "fifty_two_week_high": 16.37,
    "fifty_two_week_low": 9.51,
    "percent_change_from_200_day_moving_average": -0.0751,
    "percent_change_from_50_day_moving_average": -0.091,
    "shares_owned": "N/A",
    "short_ratio": 5.71,
    "two_hundred_day_moving_average": 14.49,
    "volume": 84163.0,
    "market_cap": 189440000.0,
    "price_to_sales_ttm": 2.37,
    "price_to_book_mrq": 3.03,
    "roa_ttm": -0.0564,
    "roe_ttm": -0.1311,
    "shares_outstanding": 14140000.0,
    "pcnt_held_by_insiders": 0.061200000000000004,
    "pcnt_held_by_institutions": 0.6729999999999999,
    "pcnt_short_of_float": 0.042800000000000005,
    "operating_cash_flow_ttm": -5430000.0,
    "levered_cash_flow_ttm": -1700000.0,
    "book_value_per_share_mrq": 4.76,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cutera, Inc."
  },
  "CVM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.432,
    "ebitda": -34250000.0,
    "eps_estimate_current_year": -0.42,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.598,
    "fifty_two_week_high": 1.23,
    "fifty_two_week_low": 0.48,
    "percent_change_from_200_day_moving_average": -0.11686999999999999,
    "percent_change_from_50_day_moving_average": 0.13545,
    "shares_owned": "N/A",
    "short_ratio": 5.76,
    "two_hundred_day_moving_average": 0.769,
    "volume": 617802.0,
    "market_cap": 76100000.0,
    "price_to_sales_ttm": 98.42,
    "price_to_book_mrq": 19.86,
    "roa_ttm": -0.9235,
    "roe_ttm": -3.3804000000000003,
    "shares_outstanding": 112080000.0,
    "pcnt_held_by_insiders": 0.055999999999999994,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.0263,
    "operating_cash_flow_ttm": -24220000.0,
    "levered_cash_flow_ttm": -12940000.0,
    "book_value_per_share_mrq": 0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CEL-SCI Corporation"
  },
  "CVRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -23680000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 3.58,
    "fifty_two_week_high": 4.58,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": -0.1439,
    "percent_change_from_50_day_moving_average": -0.0512,
    "shares_owned": "N/A",
    "short_ratio": 18.55,
    "two_hundred_day_moving_average": 3.97,
    "volume": 132572.0,
    "market_cap": 403010000.0,
    "price_to_sales_ttm": 147.59,
    "price_to_book_mrq": 8.36,
    "roa_ttm": -0.4071,
    "roe_ttm": -1.1645999999999999,
    "shares_outstanding": 118530000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0344,
    "operating_cash_flow_ttm": -25070000.0,
    "levered_cash_flow_ttm": -14720000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Corindus Vascular Robotics Inc."
  },
  "CYAN": {
    "p_e_ratio": 127.311,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.045,
    "ebitda": 3340000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.829,
    "fifty_two_week_high": 10.85,
    "fifty_two_week_low": 4.27,
    "percent_change_from_200_day_moving_average": -0.3226,
    "percent_change_from_50_day_moving_average": -0.16113,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 8.457,
    "volume": 6371.0,
    "market_cap": 31880000.0,
    "price_to_sales_ttm": 0.98,
    "price_to_book_mrq": 1.54,
    "roa_ttm": 0.0412,
    "roe_ttm": 0.012,
    "shares_outstanding": 5570000.0,
    "pcnt_held_by_insiders": 0.3583,
    "pcnt_held_by_institutions": 0.21899999999999997,
    "pcnt_short_of_float": 0.0023,
    "operating_cash_flow_ttm": 1220000.0,
    "levered_cash_flow_ttm": -2830000.0,
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyanotech Corp."
  },
  "CYBX": {
    "p_e_ratio": 31.26,
    "peg_ratio": 1.41,
    "earnings_per_share": 2.14,
    "ebitda": 110340000.0,
    "eps_estimate_current_year": 2.81,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 64.8,
    "fifty_two_week_high": 76.48,
    "fifty_two_week_low": 48.19,
    "percent_change_from_200_day_moving_average": 0.057300000000000004,
    "percent_change_from_50_day_moving_average": 0.0326,
    "shares_owned": "N/A",
    "short_ratio": 5.6,
    "two_hundred_day_moving_average": 63.29,
    "volume": 358761.0,
    "market_cap": 1740000000.0,
    "price_to_sales_ttm": 5.76,
    "price_to_book_mrq": 5.9,
    "roa_ttm": 0.2077,
    "roe_ttm": 0.2036,
    "shares_outstanding": 26000000.0,
    "pcnt_held_by_insiders": 0.023,
    "pcnt_held_by_institutions": 1.0270000000000001,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": 80320000.0,
    "levered_cash_flow_ttm": 76440000.0,
    "book_value_per_share_mrq": 11.28,
    "next_earnings_announcement_date": [
      "2015-11-18",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cyberonics Inc."
  },
  "CYCC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.684,
    "ebitda": -20140000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.5774,
    "fifty_two_week_high": 3.72,
    "fifty_two_week_low": 0.49,
    "percent_change_from_200_day_moving_average": -0.305048,
    "percent_change_from_50_day_moving_average": -0.08196500000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.91,
    "two_hundred_day_moving_average": 0.7628,
    "volume": 103563.0,
    "market_cap": 18400000.0,
    "price_to_sales_ttm": 11.05,
    "price_to_book_mrq": 0.81,
    "roa_ttm": -0.3722,
    "roe_ttm": -0.6694,
    "shares_outstanding": 34700000.0,
    "pcnt_held_by_insiders": 0.0747,
    "pcnt_held_by_institutions": 0.092,
    "pcnt_short_of_float": 0.014499999999999999,
    "operating_cash_flow_ttm": -17550000.0,
    "levered_cash_flow_ttm": -12630000.0,
    "book_value_per_share_mrq": 0.7,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cyclacel Pharmaceuticals, Inc."
  },
  "CYH": {
    "p_e_ratio": 14.72,
    "peg_ratio": 1.2,
    "earnings_per_share": 3.02,
    "ebitda": 2920000000.0,
    "eps_estimate_current_year": 4.05,
    "eps_estimate_next_quarter": 1.19,
    "fifty_day_moving_average": 53.13,
    "fifty_two_week_high": 65.0,
    "fifty_two_week_low": 44.28,
    "percent_change_from_200_day_moving_average": -0.1882,
    "percent_change_from_50_day_moving_average": -0.1625,
    "shares_owned": "N/A",
    "short_ratio": 2.61,
    "two_hundred_day_moving_average": 54.81,
    "volume": 2609142.0,
    "market_cap": 5260000000.0,
    "price_to_sales_ttm": 0.27,
    "price_to_book_mrq": 1.27,
    "roa_ttm": 0.040999999999999995,
    "roe_ttm": 0.1092,
    "shares_outstanding": 118160000.0,
    "pcnt_held_by_insiders": 0.030699999999999998,
    "pcnt_held_by_institutions": 0.966,
    "pcnt_short_of_float": 0.0424,
    "operating_cash_flow_ttm": 1600000000.0,
    "levered_cash_flow_ttm": 647750000.0,
    "book_value_per_share_mrq": 36.44,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Community Health Systems, Inc."
  },
  "CYNO": {
    "p_e_ratio": 22.22,
    "peg_ratio": 1.39,
    "earnings_per_share": 1.42,
    "ebitda": 43250000.0,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.44,
    "fifty_day_moving_average": 33.69,
    "fifty_two_week_high": 42.97,
    "fifty_two_week_low": 19.04,
    "percent_change_from_200_day_moving_average": -0.0977,
    "percent_change_from_50_day_moving_average": -0.0621,
    "shares_owned": "N/A",
    "short_ratio": 4.71,
    "two_hundred_day_moving_average": 35.02,
    "volume": 271139.0,
    "market_cap": 717390000.0,
    "price_to_sales_ttm": 2.3,
    "price_to_book_mrq": 1.88,
    "roa_ttm": 0.0337,
    "roe_ttm": 0.08710000000000001,
    "shares_outstanding": 22700000.0,
    "pcnt_held_by_insiders": 0.0472,
    "pcnt_held_by_institutions": 0.852,
    "pcnt_short_of_float": 0.0525,
    "operating_cash_flow_ttm": 37340000.0,
    "levered_cash_flow_ttm": 14280000.0,
    "book_value_per_share_mrq": 17.0,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cynosure, Inc."
  },
  "CYTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.44,
    "earnings_per_share": -0.45,
    "ebitda": -16520000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 6.99,
    "fifty_two_week_high": 8.61,
    "fifty_two_week_low": 3.05,
    "percent_change_from_200_day_moving_average": -0.0052,
    "percent_change_from_50_day_moving_average": -0.032799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 6.1,
    "two_hundred_day_moving_average": 6.8,
    "volume": 387908.0,
    "market_cap": 261990000.0,
    "price_to_sales_ttm": 6.88,
    "price_to_book_mrq": 3.87,
    "roa_ttm": -0.10220000000000001,
    "roe_ttm": -0.2208,
    "shares_outstanding": 38760000.0,
    "pcnt_held_by_insiders": 0.3482,
    "pcnt_held_by_institutions": 0.499,
    "pcnt_short_of_float": 0.0487,
    "operating_cash_flow_ttm": 7530000.0,
    "levered_cash_flow_ttm": 4910000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytokinetics, Incorporated"
  },
  "CYTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.87,
    "ebitda": -55760000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 2.5,
    "fifty_two_week_high": 5.42,
    "fifty_two_week_low": 1.98,
    "percent_change_from_200_day_moving_average": -0.2846,
    "percent_change_from_50_day_moving_average": -0.0017000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 12.63,
    "two_hundred_day_moving_average": 3.49,
    "volume": 776692.0,
    "market_cap": 166200000.0,
    "price_to_sales_ttm": 1841.5,
    "price_to_book_mrq": 3.64,
    "roa_ttm": -0.4165,
    "roe_ttm": -0.7696999999999999,
    "shares_outstanding": 66480000.00000001,
    "pcnt_held_by_insiders": 0.2192,
    "pcnt_held_by_institutions": 0.391,
    "pcnt_short_of_float": 0.1787,
    "operating_cash_flow_ttm": -47450000.0,
    "levered_cash_flow_ttm": -33940000.0,
    "book_value_per_share_mrq": 0.76,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "CytRx Corporation"
  },
  "CYTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -24510000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.38,
    "fifty_two_week_high": 1.47,
    "fifty_two_week_low": 0.28,
    "percent_change_from_200_day_moving_average": -0.4782,
    "percent_change_from_50_day_moving_average": -0.0646,
    "shares_owned": "N/A",
    "short_ratio": 5.55,
    "two_hundred_day_moving_average": 0.69,
    "volume": 2354013.0,
    "market_cap": 59740000.0,
    "price_to_sales_ttm": 5.13,
    "price_to_book_mrq": 24.2,
    "roa_ttm": -0.3754,
    "roe_ttm": "-1,891.05%",
    "shares_outstanding": 165960000.0,
    "pcnt_held_by_insiders": 0.1702,
    "pcnt_held_by_institutions": 0.184,
    "pcnt_short_of_float": 0.0536,
    "operating_cash_flow_ttm": -21980000.0,
    "levered_cash_flow_ttm": -12770000.0,
    "book_value_per_share_mrq": 0.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Cytori Therapeutics, Inc."
  },
  "DARA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.49,
    "ebitda": -9020000.0,
    "eps_estimate_current_year": -0.55,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 0.86,
    "fifty_two_week_high": 1.11,
    "fifty_two_week_low": 0.67,
    "percent_change_from_200_day_moving_average": 0.0594,
    "percent_change_from_50_day_moving_average": 0.0321,
    "shares_owned": "N/A",
    "short_ratio": 0.98,
    "two_hundred_day_moving_average": 0.84,
    "volume": 36995.0,
    "market_cap": 17580000.0,
    "price_to_sales_ttm": 5.74,
    "price_to_book_mrq": 1.95,
    "roa_ttm": -0.37579999999999997,
    "roe_ttm": -0.7439,
    "shares_outstanding": 19760000.0,
    "pcnt_held_by_insiders": 0.1435,
    "pcnt_held_by_institutions": 0.111,
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": -8700000.0,
    "levered_cash_flow_ttm": -4059999.9999999995,
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "DARA BioSciences, Inc"
  },
  "DBVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.82,
    "ebitda": -29430000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 39.65,
    "fifty_two_week_high": 44.76,
    "fifty_two_week_low": 20.26,
    "percent_change_from_200_day_moving_average": 0.253,
    "percent_change_from_50_day_moving_average": -0.0076,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 31.41,
    "volume": 246366.0,
    "market_cap": 1810000000.0,
    "price_to_sales_ttm": 325.12,
    "price_to_book_mrq": 13.86,
    "roa_ttm": -0.21760000000000002,
    "roe_ttm": -0.3895,
    "shares_outstanding": 46000000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -25060000.0,
    "levered_cash_flow_ttm": -16739999.999999998,
    "book_value_per_share_mrq": 2.99,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "DBV Technologies S.A."
  },
  "DCTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.393,
    "ebitda": -14650000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.476,
    "fifty_two_week_high": 2.07,
    "fifty_two_week_low": 0.36,
    "percent_change_from_200_day_moving_average": -0.39683,
    "percent_change_from_50_day_moving_average": 0.04559,
    "shares_owned": "N/A",
    "short_ratio": 2.67,
    "two_hundred_day_moving_average": 0.826,
    "volume": 88536.0,
    "market_cap": 10840000.0,
    "price_to_sales_ttm": 7.4,
    "price_to_book_mrq": 0.46,
    "roa_ttm": -0.397,
    "roe_ttm": -0.7674,
    "shares_outstanding": 21760000.0,
    "pcnt_held_by_insiders": 0.015,
    "pcnt_held_by_institutions": 0.165,
    "pcnt_short_of_float": 0.065,
    "operating_cash_flow_ttm": -16020000.0,
    "levered_cash_flow_ttm": -10870000.0,
    "book_value_per_share_mrq": 1.06,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Delcath Systems, Inc."
  },
  "DEPO": {
    "p_e_ratio": 20.94,
    "peg_ratio": 1.32,
    "earnings_per_share": 1.09,
    "ebitda": 201630000.0,
    "eps_estimate_current_year": 0.61,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 28.25,
    "fifty_two_week_high": 33.74,
    "fifty_two_week_low": 13.55,
    "percent_change_from_200_day_moving_average": -0.11220000000000001,
    "percent_change_from_50_day_moving_average": -0.1943,
    "shares_owned": "N/A",
    "short_ratio": 7.95,
    "two_hundred_day_moving_average": 25.64,
    "volume": 1562437.0,
    "market_cap": 1370000000.0,
    "price_to_sales_ttm": 3.61,
    "price_to_book_mrq": 3.89,
    "roa_ttm": 0.1161,
    "roe_ttm": 0.2581,
    "shares_outstanding": 60370000.0,
    "pcnt_held_by_insiders": 0.0046,
    "pcnt_held_by_institutions": 0.773,
    "pcnt_short_of_float": 0.2054,
    "operating_cash_flow_ttm": 39550000.0,
    "levered_cash_flow_ttm": 134230000.0,
    "book_value_per_share_mrq": 5.74,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DepoMed Inc."
  },
  "DERM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.5,
    "ebitda": -46020000.0,
    "eps_estimate_current_year": -2.99,
    "eps_estimate_next_quarter": -0.97,
    "fifty_day_moving_average": 26.57,
    "fifty_two_week_high": 32.13,
    "fifty_two_week_low": 12.68,
    "percent_change_from_200_day_moving_average": 0.35810000000000003,
    "percent_change_from_50_day_moving_average": -0.0129,
    "shares_owned": "N/A",
    "short_ratio": 1.3,
    "two_hundred_day_moving_average": 19.31,
    "volume": 407975.0,
    "market_cap": 765150000.0,
    "price_to_sales_ttm": 101.06,
    "price_to_book_mrq": 5.88,
    "roa_ttm": -0.2657,
    "roe_ttm": -0.5326,
    "shares_outstanding": 29170000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0368,
    "operating_cash_flow_ttm": -33290000.0,
    "levered_cash_flow_ttm": -19920000.0,
    "book_value_per_share_mrq": 5.07,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dermira, Inc."
  },
  "DGX": {
    "p_e_ratio": 18.87,
    "peg_ratio": 1.43,
    "earnings_per_share": 3.41,
    "ebitda": 1470000000.0,
    "eps_estimate_current_year": 4.76,
    "eps_estimate_next_quarter": 1.21,
    "fifty_day_moving_average": 68.46,
    "fifty_two_week_high": 89.0,
    "fifty_two_week_low": 56.27,
    "percent_change_from_200_day_moving_average": -0.11109999999999999,
    "percent_change_from_50_day_moving_average": -0.0592,
    "shares_owned": "N/A",
    "short_ratio": 10.12,
    "two_hundred_day_moving_average": 72.46,
    "volume": 1055023.0,
    "market_cap": 9250000000.0,
    "price_to_sales_ttm": 1.25,
    "price_to_book_mrq": 2.19,
    "roa_ttm": 0.07429999999999999,
    "roe_ttm": 0.126,
    "shares_outstanding": 143550000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 1.03,
    "pcnt_short_of_float": 0.0788,
    "operating_cash_flow_ttm": 901000000.0,
    "levered_cash_flow_ttm": 691750000.0,
    "book_value_per_share_mrq": 29.96,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quest Diagnostics Inc."
  },
  "DHRM": {
    "p_e_ratio": 8.72,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.18,
    "ebitda": -1080000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.67,
    "fifty_two_week_high": 5.15,
    "fifty_two_week_low": 1.39,
    "percent_change_from_200_day_moving_average": -0.3488,
    "percent_change_from_50_day_moving_average": -0.0584,
    "shares_owned": "N/A",
    "short_ratio": 1.09,
    "two_hundred_day_moving_average": 2.41,
    "volume": 1744.0,
    "market_cap": 9180000.0,
    "price_to_sales_ttm": 0.79,
    "price_to_book_mrq": 0.23,
    "roa_ttm": -0.0241,
    "roe_ttm": 0.016399999999999998,
    "shares_outstanding": 5850000.0,
    "pcnt_held_by_insiders": 0.24359999999999998,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0029,
    "operating_cash_flow_ttm": 4139999.9999999995,
    "levered_cash_flow_ttm": -5960000.0,
    "book_value_per_share_mrq": 7.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dehaier Medical Systems Limited"
  },
  "DNAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.32,
    "earnings_per_share": -141.05,
    "ebitda": -31050000.0,
    "eps_estimate_current_year": -4.04,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 28.6,
    "fifty_two_week_high": 33.75,
    "fifty_two_week_low": 22.67,
    "percent_change_from_200_day_moving_average": -0.10550000000000001,
    "percent_change_from_50_day_moving_average": -0.10550000000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 28.6,
    "volume": 97371.0,
    "market_cap": 768890000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 30060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0338,
    "operating_cash_flow_ttm": -19090000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -174.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProNAi Therapeutics, Inc."
  },
  "DPLO": {
    "p_e_ratio": 176.96,
    "peg_ratio": 1.91,
    "earnings_per_share": 0.18,
    "ebitda": 43940000.0,
    "eps_estimate_current_year": 0.59,
    "eps_estimate_next_quarter": 0.18,
    "fifty_day_moving_average": 40.42,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 15.04,
    "percent_change_from_200_day_moving_average": -0.17129999999999998,
    "percent_change_from_50_day_moving_average": -0.1945,
    "shares_owned": "N/A",
    "short_ratio": 8.79,
    "two_hundred_day_moving_average": 39.29,
    "volume": 449597.0,
    "market_cap": 2069999999.9999998,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 4.51,
    "roa_ttm": 0.0276,
    "roe_ttm": 0.030299999999999997,
    "shares_outstanding": 63640000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1598,
    "operating_cash_flow_ttm": -70950000.0,
    "levered_cash_flow_ttm": -73250000.0,
    "book_value_per_share_mrq": 7.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Diplomat Pharmacy, Inc."
  },
  "DPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -1.79,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.79,
    "eps_estimate_next_quarter": -0.43,
    "fifty_day_moving_average": 13.76,
    "fifty_two_week_high": 17.1,
    "fifty_two_week_low": 9.5,
    "percent_change_from_200_day_moving_average": 0.1003,
    "percent_change_from_50_day_moving_average": 0.09050000000000001,
    "shares_owned": "N/A",
    "short_ratio": 1.94,
    "two_hundred_day_moving_average": 13.63,
    "volume": 79534.0,
    "market_cap": 154520000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.91,
    "roa_ttm": -0.2597,
    "roe_ttm": -0.4261,
    "shares_outstanding": 10300000.0,
    "pcnt_held_by_insiders": 0.4629,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.015600000000000001,
    "operating_cash_flow_ttm": -11840000.0,
    "levered_cash_flow_ttm": -5930000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dipexium Pharmaceuticals, Inc."
  },
  "DRAD": {
    "p_e_ratio": 21.17,
    "peg_ratio": 1.34,
    "earnings_per_share": 0.18,
    "ebitda": 5880000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 3.91,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": -0.0833,
    "percent_change_from_50_day_moving_average": -0.025,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 4.16,
    "volume": 5934.0,
    "market_cap": 73750000.0,
    "price_to_sales_ttm": 1.28,
    "price_to_book_mrq": 2.05,
    "roa_ttm": 0.0545,
    "roe_ttm": 0.10640000000000001,
    "shares_outstanding": 19360000.0,
    "pcnt_held_by_insiders": 0.2217,
    "pcnt_held_by_institutions": 0.431,
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": 5300000.0,
    "levered_cash_flow_ttm": 3770000.0,
    "book_value_per_share_mrq": 1.86,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Digirad Corporation"
  },
  "DRNA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.1,
    "ebitda": -55380000.0,
    "eps_estimate_current_year": -3.35,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 10.64,
    "fifty_two_week_high": 27.33,
    "fifty_two_week_low": 8.0,
    "percent_change_from_200_day_moving_average": -0.40049999999999997,
    "percent_change_from_50_day_moving_average": -0.0875,
    "shares_owned": "N/A",
    "short_ratio": 7.59,
    "two_hundred_day_moving_average": 16.2,
    "volume": 180329.0,
    "market_cap": 199960000.0,
    "price_to_sales_ttm": 1179.62,
    "price_to_book_mrq": 1.83,
    "roa_ttm": -0.2789,
    "roe_ttm": -0.4692,
    "shares_outstanding": 20590000.0,
    "pcnt_held_by_insiders": 0.2125,
    "pcnt_held_by_institutions": 0.6940000000000001,
    "pcnt_short_of_float": 0.1096,
    "operating_cash_flow_ttm": -42710000.0,
    "levered_cash_flow_ttm": -23120000.0,
    "book_value_per_share_mrq": 5.77,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dicerna Pharmaceuticals, Inc."
  },
  "DRRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.65,
    "earnings_per_share": -0.21,
    "ebitda": -20760000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.18,
    "fifty_two_week_high": 3.42,
    "fifty_two_week_low": 0.68,
    "percent_change_from_200_day_moving_average": -0.054299999999999994,
    "percent_change_from_50_day_moving_average": -0.0242,
    "shares_owned": "N/A",
    "short_ratio": 11.52,
    "two_hundred_day_moving_average": 2.25,
    "volume": 254785.0,
    "market_cap": 256630000.0,
    "price_to_sales_ttm": 15.48,
    "price_to_book_mrq": 12.0,
    "roa_ttm": -0.2501,
    "roe_ttm": -0.9749,
    "shares_outstanding": 120480000.0,
    "pcnt_held_by_insiders": 0.13390000000000002,
    "pcnt_held_by_institutions": 0.41200000000000003,
    "pcnt_short_of_float": 0.0527,
    "operating_cash_flow_ttm": -16719999.999999998,
    "levered_cash_flow_ttm": -11000000.0,
    "book_value_per_share_mrq": 0.19,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "DURECT Corporation"
  },
  "DSCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.6,
    "ebitda": -37760000.0,
    "eps_estimate_current_year": -1.64,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 6.24,
    "fifty_two_week_high": 9.89,
    "fifty_two_week_low": 5.56,
    "percent_change_from_200_day_moving_average": -0.21239999999999998,
    "percent_change_from_50_day_moving_average": -0.0928,
    "shares_owned": "N/A",
    "short_ratio": 8.67,
    "two_hundred_day_moving_average": 7.19,
    "volume": 208306.0,
    "market_cap": 146060000.0,
    "price_to_sales_ttm": 1.89,
    "price_to_book_mrq": 1.46,
    "roa_ttm": -0.1819,
    "roe_ttm": -0.3191,
    "shares_outstanding": 25810000.0,
    "pcnt_held_by_insiders": 0.0567,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.0339,
    "operating_cash_flow_ttm": -29460000.0,
    "levered_cash_flow_ttm": -16040000.0,
    "book_value_per_share_mrq": 4.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Derma Sciences Inc."
  },
  "DSCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -41660000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.42,
    "fifty_two_week_high": 2.01,
    "fifty_two_week_low": 0.31,
    "percent_change_from_200_day_moving_average": -0.585,
    "percent_change_from_50_day_moving_average": -0.1833,
    "shares_owned": "N/A",
    "short_ratio": 3.83,
    "two_hundred_day_moving_average": 0.82,
    "volume": 813360.0,
    "market_cap": 37740000.0,
    "price_to_sales_ttm": 19.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.546,
    "roe_ttm": -2.5168,
    "shares_outstanding": 111000000.0,
    "pcnt_held_by_insiders": 0.0027,
    "pcnt_held_by_institutions": 0.64,
    "pcnt_short_of_float": 0.023,
    "operating_cash_flow_ttm": -39250000.0,
    "levered_cash_flow_ttm": -24400000.0,
    "book_value_per_share_mrq": -0.04,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Discovery Laboratories Inc."
  },
  "DVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.67,
    "ebitda": -100820000.0,
    "eps_estimate_current_year": -3.26,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 28.97,
    "fifty_two_week_high": 32.49,
    "fifty_two_week_low": 13.4,
    "percent_change_from_200_day_moving_average": 0.0681,
    "percent_change_from_50_day_moving_average": -0.08380000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.43,
    "two_hundred_day_moving_average": 24.85,
    "volume": 773134.0,
    "market_cap": 1020000000.0,
    "price_to_sales_ttm": 160.34,
    "price_to_book_mrq": 11.29,
    "roa_ttm": -0.4514,
    "roe_ttm": -0.9051,
    "shares_outstanding": 38400000.0,
    "pcnt_held_by_insiders": 0.0064,
    "pcnt_held_by_institutions": 0.736,
    "pcnt_short_of_float": 0.1494,
    "operating_cash_flow_ttm": -87670000.0,
    "levered_cash_flow_ttm": -55820000.0,
    "book_value_per_share_mrq": 2.47,
    "next_earnings_announcement_date": "2015-11-02",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dynavax Technologies Corporation"
  },
  "DVCR": {
    "p_e_ratio": 13.35,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.76,
    "ebitda": 21410000.0,
    "eps_estimate_current_year": 0.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.94,
    "fifty_two_week_high": 17.15,
    "fifty_two_week_low": 8.14,
    "percent_change_from_200_day_moving_average": -0.2289,
    "percent_change_from_50_day_moving_average": -0.0738,
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 13.14,
    "volume": 3306.0,
    "market_cap": 63430000.0,
    "price_to_sales_ttm": 0.17,
    "price_to_book_mrq": 5.31,
    "roa_ttm": 0.061500000000000006,
    "roe_ttm": 0.14029999999999998,
    "shares_outstanding": 6260000.0,
    "pcnt_held_by_insiders": 0.4424,
    "pcnt_held_by_institutions": 0.20600000000000002,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": 2380000.0,
    "levered_cash_flow_ttm": -930880.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Diversicare Healthcare Services Inc."
  },
  "DXCM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -23.64,
    "earnings_per_share": -0.26,
    "ebitda": -10300000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 94.19,
    "fifty_two_week_high": 103.29,
    "fifty_two_week_low": 38.77,
    "percent_change_from_200_day_moving_average": 0.1867,
    "percent_change_from_50_day_moving_average": -0.0226,
    "shares_owned": "N/A",
    "short_ratio": 1.57,
    "two_hundred_day_moving_average": 77.57,
    "volume": 1070709.0,
    "market_cap": 7370000000.0,
    "price_to_sales_ttm": 24.34,
    "price_to_book_mrq": 45.47,
    "roa_ttm": -0.0695,
    "roe_ttm": -0.1517,
    "shares_outstanding": 80080000.0,
    "pcnt_held_by_insiders": 0.0226,
    "pcnt_held_by_institutions": 0.9470000000000001,
    "pcnt_short_of_float": 0.0239,
    "operating_cash_flow_ttm": 39600000.0,
    "levered_cash_flow_ttm": 18830000.0,
    "book_value_per_share_mrq": 2.13,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "DexCom, Inc."
  },
  "DXR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.28,
    "ebitda": 0.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.78,
    "fifty_two_week_high": 9.18,
    "fifty_two_week_low": 5.4,
    "percent_change_from_200_day_moving_average": 0.21280000000000002,
    "percent_change_from_50_day_moving_average": 0.2236,
    "shares_owned": "N/A",
    "short_ratio": 12.36,
    "two_hundred_day_moving_average": 6.84,
    "volume": 4063.0,
    "market_cap": 32420000.0,
    "price_to_sales_ttm": 21.89,
    "price_to_book_mrq": 1.67,
    "roa_ttm": 0.0176,
    "roe_ttm": -0.2214,
    "shares_outstanding": 3910000.0,
    "pcnt_held_by_insiders": 0.7757999999999999,
    "pcnt_held_by_institutions": 0.063,
    "pcnt_short_of_float": 0.053099999999999994,
    "operating_cash_flow_ttm": 10210000.0,
    "levered_cash_flow_ttm": -5180000.0,
    "book_value_per_share_mrq": 5.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Daxor Corp."
  },
  "DYAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.6,
    "earnings_per_share": -0.14,
    "ebitda": -7430000.0,
    "eps_estimate_current_year": -0.28,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 22.86,
    "fifty_two_week_high": 30.55,
    "fifty_two_week_low": 9.19,
    "percent_change_from_200_day_moving_average": -0.1655,
    "percent_change_from_50_day_moving_average": -0.1101,
    "shares_owned": "N/A",
    "short_ratio": 6.32,
    "two_hundred_day_moving_average": 24.37,
    "volume": 1395197.0,
    "market_cap": 2980000000.0,
    "price_to_sales_ttm": 34.49,
    "price_to_book_mrq": 10.3,
    "roa_ttm": -0.016399999999999998,
    "roe_ttm": -0.0894,
    "shares_outstanding": 146360000.0,
    "pcnt_held_by_insiders": 0.08779999999999999,
    "pcnt_held_by_institutions": 0.883,
    "pcnt_short_of_float": 0.0449,
    "operating_cash_flow_ttm": -11340000.0,
    "levered_cash_flow_ttm": -2660000.0,
    "book_value_per_share_mrq": 2.17,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Dyax Corp."
  },
  "DYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": 598676.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.0286,
    "fifty_two_week_high": 5.76,
    "fifty_two_week_low": 2.7,
    "percent_change_from_200_day_moving_average": 0.011485,
    "percent_change_from_50_day_moving_average": 0.009982,
    "shares_owned": "N/A",
    "short_ratio": 0.03,
    "two_hundred_day_moving_average": 3.0241,
    "volume": 1749.0,
    "market_cap": 7710000.0,
    "price_to_sales_ttm": 0.27,
    "price_to_book_mrq": 1.33,
    "roa_ttm": -0.002,
    "roe_ttm": -0.0587,
    "shares_outstanding": 2520000.0,
    "pcnt_held_by_insiders": 0.24239999999999998,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": -740240.0,
    "levered_cash_flow_ttm": 1340000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Dynatronics Corp."
  },
  "EARS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8,
    "ebitda": -28800000.0,
    "eps_estimate_current_year": -1.22,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 4.66,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 3.3,
    "percent_change_from_200_day_moving_average": -0.1539,
    "percent_change_from_50_day_moving_average": -0.07490000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.87,
    "two_hundred_day_moving_average": 5.09,
    "volume": 87984.0,
    "market_cap": 147810000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.77,
    "roa_ttm": -0.4484,
    "roe_ttm": -0.7906,
    "shares_outstanding": 34290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -22840000.0,
    "levered_cash_flow_ttm": -15910000.0,
    "book_value_per_share_mrq": 1.65,
    "next_earnings_announcement_date": [
      "2015-12-01",
      "2015-12-07"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Auris Medical Holding AG"
  },
  "EBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.85,
    "ebitda": -33299999.999999996,
    "eps_estimate_current_year": -1.41,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 3.32,
    "fifty_two_week_high": 13.77,
    "fifty_two_week_low": 2.25,
    "percent_change_from_200_day_moving_average": -0.5196000000000001,
    "percent_change_from_50_day_moving_average": -0.1839,
    "shares_owned": "N/A",
    "short_ratio": 0.58,
    "two_hundred_day_moving_average": 5.64,
    "volume": 182370.0,
    "market_cap": 52520000.0,
    "price_to_sales_ttm": 34.61,
    "price_to_book_mrq": 1.48,
    "roa_ttm": -0.4132,
    "roe_ttm": -0.8503000000000001,
    "shares_outstanding": 19380000.0,
    "pcnt_held_by_insiders": 0.2693,
    "pcnt_held_by_institutions": 0.598,
    "pcnt_short_of_float": 0.128,
    "operating_cash_flow_ttm": -33330000.0,
    "levered_cash_flow_ttm": -20260000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eleven Biotherapeutics, Inc."
  },
  "EBS": {
    "p_e_ratio": 30.5,
    "peg_ratio": 2.24,
    "earnings_per_share": 0.96,
    "ebitda": 110080000.0,
    "eps_estimate_current_year": 1.45,
    "eps_estimate_next_quarter": 0.88,
    "fifty_day_moving_average": 33.05,
    "fifty_two_week_high": 36.2,
    "fifty_two_week_low": 19.31,
    "percent_change_from_200_day_moving_average": -0.0722,
    "percent_change_from_50_day_moving_average": -0.10949999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.47,
    "two_hundred_day_moving_average": 31.72,
    "volume": 251401.0,
    "market_cap": 1140000000.0,
    "price_to_sales_ttm": 2.52,
    "price_to_book_mrq": 2.13,
    "roa_ttm": 0.053099999999999994,
    "roe_ttm": 0.0848,
    "shares_outstanding": 38800000.0,
    "pcnt_held_by_insiders": 0.2702,
    "pcnt_held_by_institutions": 0.754,
    "pcnt_short_of_float": 0.11789999999999999,
    "operating_cash_flow_ttm": 67370000.0,
    "levered_cash_flow_ttm": 18660000.0,
    "book_value_per_share_mrq": 14.51,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Emergent BioSolutions, Inc."
  },
  "ECTE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.33,
    "ebitda": -10010000.0,
    "eps_estimate_current_year": -1.19,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.53,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 0.5,
    "percent_change_from_200_day_moving_average": -0.0863,
    "percent_change_from_50_day_moving_average": 0.039599999999999996,
    "shares_owned": "N/A",
    "short_ratio": 5.51,
    "two_hundred_day_moving_average": 1.74,
    "volume": 21737.0,
    "market_cap": 17690000.0,
    "price_to_sales_ttm": 896.9,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6759999999999999,
    "roe_ttm": -3.8989999999999996,
    "shares_outstanding": 11130000.0,
    "pcnt_held_by_insiders": 0.2059,
    "pcnt_held_by_institutions": 0.071,
    "pcnt_short_of_float": 0.0435,
    "operating_cash_flow_ttm": -7360000.0,
    "levered_cash_flow_ttm": -2390000.0,
    "book_value_per_share_mrq": -0.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Echo Therapeutics, Inc."
  },
  "ECYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -34120000.0,
    "eps_estimate_current_year": -1.08,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 5.24,
    "fifty_two_week_high": 8.09,
    "fifty_two_week_low": 4.61,
    "percent_change_from_200_day_moving_average": -0.13570000000000002,
    "percent_change_from_50_day_moving_average": -0.058499999999999996,
    "shares_owned": "N/A",
    "short_ratio": 14.92,
    "two_hundred_day_moving_average": 5.7,
    "volume": 636952.0,
    "market_cap": 206930000.0,
    "price_to_sales_ttm": 54.85,
    "price_to_book_mrq": 1.15,
    "roa_ttm": -0.10300000000000001,
    "roe_ttm": -0.1751,
    "shares_outstanding": 41970000.0,
    "pcnt_held_by_insiders": 0.1884,
    "pcnt_held_by_institutions": 0.542,
    "pcnt_short_of_float": 0.15039999999999998,
    "operating_cash_flow_ttm": -29740000.0,
    "levered_cash_flow_ttm": -18740000.0,
    "book_value_per_share_mrq": 4.47,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Endocyte, Inc."
  },
  "EDAP": {
    "p_e_ratio": 64.94,
    "peg_ratio": -19.5,
    "earnings_per_share": 0.09,
    "ebitda": -1310000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 3.97,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 1.15,
    "percent_change_from_200_day_moving_average": 0.5995,
    "percent_change_from_50_day_moving_average": 0.424,
    "shares_owned": "N/A",
    "short_ratio": 15.05,
    "two_hundred_day_moving_average": 3.53,
    "volume": 1606344.0,
    "market_cap": 141010000.0,
    "price_to_sales_ttm": 4.34,
    "price_to_book_mrq": 7.68,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24960000.0,
    "pcnt_held_by_insiders": 0.11359999999999999,
    "pcnt_held_by_institutions": 0.109,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EDAP TMS SA"
  },
  "EGLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.2,
    "ebitda": -49220000.0,
    "eps_estimate_current_year": -3.04,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 13.12,
    "fifty_two_week_high": 17.03,
    "fifty_two_week_low": 3.81,
    "percent_change_from_200_day_moving_average": 0.2208,
    "percent_change_from_50_day_moving_average": 0.12789999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.97,
    "two_hundred_day_moving_average": 12.12,
    "volume": 224717.0,
    "market_cap": 369860000.0,
    "price_to_sales_ttm": 85.94,
    "price_to_book_mrq": 7.84,
    "roa_ttm": -0.3097,
    "roe_ttm": -1.1255,
    "shares_outstanding": 24990000.0,
    "pcnt_held_by_insiders": 0.7775,
    "pcnt_held_by_institutions": 0.209,
    "pcnt_short_of_float": 0.1352,
    "operating_cash_flow_ttm": -16300000.0,
    "levered_cash_flow_ttm": -15820000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Egalet Corporation"
  },
  "EGRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -7900000.0,
    "eps_estimate_current_year": 0.95,
    "eps_estimate_next_quarter": 0.71,
    "fifty_day_moving_average": 79.39,
    "fifty_two_week_high": 104.17,
    "fifty_two_week_low": 10.81,
    "percent_change_from_200_day_moving_average": 0.1045,
    "percent_change_from_50_day_moving_average": -0.0192,
    "shares_owned": "N/A",
    "short_ratio": 3.38,
    "two_hundred_day_moving_average": 70.49,
    "volume": 359132.0,
    "market_cap": 1210000000.0,
    "price_to_sales_ttm": 24.67,
    "price_to_book_mrq": 13.79,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15590000.0,
    "pcnt_held_by_insiders": 0.3503,
    "pcnt_held_by_institutions": 0.139,
    "pcnt_short_of_float": 0.1865,
    "operating_cash_flow_ttm": -11050000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Eagle Pharmaceuticals Inc."
  },
  "ELGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.62,
    "earnings_per_share": -0.78,
    "ebitda": -36870000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 13.11,
    "fifty_two_week_high": 18.07,
    "fifty_two_week_low": 10.29,
    "percent_change_from_200_day_moving_average": -0.23149999999999998,
    "percent_change_from_50_day_moving_average": -0.10710000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.02,
    "two_hundred_day_moving_average": 15.24,
    "volume": 1929759.0,
    "market_cap": 793720000.0,
    "price_to_sales_ttm": 5.66,
    "price_to_book_mrq": 8.05,
    "roa_ttm": -0.1058,
    "roe_ttm": -0.4217,
    "shares_outstanding": 67780000.0,
    "pcnt_held_by_insiders": 0.018600000000000002,
    "pcnt_held_by_institutions": 0.917,
    "pcnt_short_of_float": 0.1386,
    "operating_cash_flow_ttm": -32560000.000000004,
    "levered_cash_flow_ttm": -29120000.0,
    "book_value_per_share_mrq": 1.58,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Endologix Inc."
  },
  "ELMD": {
    "p_e_ratio": 14.138,
    "peg_ratio": 1.57,
    "earnings_per_share": 0.13,
    "ebitda": 2160000.0,
    "eps_estimate_current_year": 0.12,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.787,
    "fifty_two_week_high": 2.84,
    "fifty_two_week_low": 1.23,
    "percent_change_from_200_day_moving_average": -0.09937,
    "percent_change_from_50_day_moving_average": 0.028290000000000003,
    "shares_owned": "N/A",
    "short_ratio": 1.9,
    "two_hundred_day_moving_average": 2.041,
    "volume": 14453.0,
    "market_cap": 15010000.0,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 1.1,
    "roa_ttm": 0.0537,
    "roe_ttm": 0.08199999999999999,
    "shares_outstanding": 8160000.0,
    "pcnt_held_by_insiders": 0.3635,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0031,
    "operating_cash_flow_ttm": 2780000.0,
    "levered_cash_flow_ttm": 1670000.0,
    "book_value_per_share_mrq": 1.71,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Electromed, Inc."
  },
  "ELOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.99,
    "earnings_per_share": -0.15,
    "ebitda": 10590000.0,
    "eps_estimate_current_year": 0.25,
    "eps_estimate_next_quarter": 0.14,
    "fifty_day_moving_average": 9.23,
    "fifty_two_week_high": 12.9,
    "fifty_two_week_low": 7.83,
    "percent_change_from_200_day_moving_average": -0.2777,
    "percent_change_from_50_day_moving_average": -0.1492,
    "shares_owned": "N/A",
    "short_ratio": 2.02,
    "two_hundred_day_moving_average": 10.87,
    "volume": 614709.0,
    "market_cap": 286740000.0,
    "price_to_sales_ttm": 1.11,
    "price_to_book_mrq": 1.34,
    "roa_ttm": 0.0037,
    "roe_ttm": -0.023799999999999998,
    "shares_outstanding": 36530000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.72,
    "pcnt_short_of_float": 0.008,
    "operating_cash_flow_ttm": 5850000.0,
    "levered_cash_flow_ttm": 5380000.0,
    "book_value_per_share_mrq": 6.15,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Syneron Medical Ltd."
  },
  "ENSG": {
    "p_e_ratio": 23.84,
    "peg_ratio": 1.24,
    "earnings_per_share": 2.0,
    "ebitda": 95880000.0,
    "eps_estimate_current_year": 2.52,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 47.81,
    "fifty_two_week_high": 54.08,
    "fifty_two_week_low": 33.17,
    "percent_change_from_200_day_moving_average": -0.0021,
    "percent_change_from_50_day_moving_average": -0.0027,
    "shares_owned": "N/A",
    "short_ratio": 7.63,
    "two_hundred_day_moving_average": 47.78,
    "volume": 193296.0,
    "market_cap": 1220000000.0,
    "price_to_sales_ttm": 1.04,
    "price_to_book_mrq": 3.03,
    "roa_ttm": 0.0906,
    "roe_ttm": 0.1502,
    "shares_outstanding": 25560000.0,
    "pcnt_held_by_insiders": 0.1039,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": 54610000.0,
    "levered_cash_flow_ttm": -1930000.0,
    "book_value_per_share_mrq": 15.59,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "The Ensign Group, Inc."
  },
  "ENTA": {
    "p_e_ratio": 10.16,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.55,
    "ebitda": 115690000.0,
    "eps_estimate_current_year": 3.98,
    "eps_estimate_next_quarter": 1.39,
    "fifty_day_moving_average": 40.21,
    "fifty_two_week_high": 52.58,
    "fifty_two_week_low": 30.13,
    "percent_change_from_200_day_moving_average": -0.1041,
    "percent_change_from_50_day_moving_average": -0.1041,
    "shares_owned": "N/A",
    "short_ratio": 12.97,
    "two_hundred_day_moving_average": 40.21,
    "volume": 292213.0,
    "market_cap": 674080000.0,
    "price_to_sales_ttm": 4.75,
    "price_to_book_mrq": 3.1,
    "roa_ttm": 0.36229999999999996,
    "roe_ttm": 0.3546,
    "shares_outstanding": 18710000.0,
    "pcnt_held_by_insiders": 0.4962,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.2483,
    "operating_cash_flow_ttm": 74120000.0,
    "levered_cash_flow_ttm": 76580000.0,
    "book_value_per_share_mrq": 12.2,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enanta Pharmaceuticals, Inc."
  },
  "ENTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.67,
    "earnings_per_share": -1.21,
    "ebitda": -7400000.0,
    "eps_estimate_current_year": -0.92,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 22.05,
    "fifty_two_week_high": 28.81,
    "fifty_two_week_low": 18.03,
    "percent_change_from_200_day_moving_average": -0.14880000000000002,
    "percent_change_from_50_day_moving_average": -0.0895,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 23.59,
    "volume": 56426.0,
    "market_cap": 376020000.0,
    "price_to_sales_ttm": 7.09,
    "price_to_book_mrq": 5.81,
    "roa_ttm": -0.0908,
    "roe_ttm": -0.34409999999999996,
    "shares_outstanding": 18730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0678,
    "operating_cash_flow_ttm": -8510000.0,
    "levered_cash_flow_ttm": -7700000.0,
    "book_value_per_share_mrq": 3.57,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Entellus Medical, Inc."
  },
  "ENZ": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -8480000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.0,
    "fifty_two_week_high": 5.38,
    "fifty_two_week_low": 2.26,
    "percent_change_from_200_day_moving_average": 0.0949,
    "percent_change_from_50_day_moving_average": 0.069,
    "shares_owned": "N/A",
    "short_ratio": 7.16,
    "two_hundred_day_moving_average": 2.93,
    "volume": 151141.0,
    "market_cap": 147850000.0,
    "price_to_sales_ttm": 1.62,
    "price_to_book_mrq": 4.61,
    "roa_ttm": -0.1264,
    "roe_ttm": -0.3861,
    "shares_outstanding": 46060000.0,
    "pcnt_held_by_insiders": 0.1752,
    "pcnt_held_by_institutions": 0.344,
    "pcnt_short_of_float": 0.0171,
    "operating_cash_flow_ttm": -7130000.0,
    "levered_cash_flow_ttm": -2380000.0,
    "book_value_per_share_mrq": 0.74,
    "next_earnings_announcement_date": [
      "2015-10-07",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Enzo Biochem Inc."
  },
  "ENZN": {
    "p_e_ratio": 1.82,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.55,
    "ebitda": 0.0,
    "eps_estimate_current_year": 0.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.08,
    "fifty_two_week_high": 1.88,
    "fifty_two_week_low": 0.86,
    "percent_change_from_200_day_moving_average": -0.18960000000000002,
    "percent_change_from_50_day_moving_average": -0.0738,
    "shares_owned": "N/A",
    "short_ratio": 1.93,
    "two_hundred_day_moving_average": 1.23,
    "volume": 237908.0,
    "market_cap": 44180000.0,
    "price_to_sales_ttm": 1.79,
    "price_to_book_mrq": 2.39,
    "roa_ttm": 0.46090000000000003,
    "roe_ttm": 1.2454,
    "shares_outstanding": 44180000.0,
    "pcnt_held_by_insiders": 0.1013,
    "pcnt_held_by_institutions": 0.58,
    "pcnt_short_of_float": 0.047400000000000005,
    "operating_cash_flow_ttm": 26360000.0,
    "levered_cash_flow_ttm": 36090000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzon Pharmaceuticals Inc."
  },
  "ENZY": {
    "p_e_ratio": 33.26,
    "peg_ratio": 1.1,
    "earnings_per_share": 0.28,
    "ebitda": 7510000.0,
    "eps_estimate_current_year": 0.3,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 9.62,
    "fifty_two_week_high": 10.83,
    "fifty_two_week_low": 5.38,
    "percent_change_from_200_day_moving_average": 0.0513,
    "percent_change_from_50_day_moving_average": -0.0354,
    "shares_owned": "N/A",
    "short_ratio": 2.58,
    "two_hundred_day_moving_average": 8.83,
    "volume": 76742.0,
    "market_cap": 208640000.0,
    "price_to_sales_ttm": 5.09,
    "price_to_book_mrq": 1.72,
    "roa_ttm": 0.023799999999999998,
    "roe_ttm": 0.0492,
    "shares_outstanding": 22480000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0048,
    "operating_cash_flow_ttm": 4830000.0,
    "levered_cash_flow_ttm": -3580000.0,
    "book_value_per_share_mrq": 5.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Enzymotec Ltd."
  },
  "EPRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -2.82,
    "ebitda": -34430000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 5.39,
    "fifty_two_week_high": 11.75,
    "fifty_two_week_low": 3.78,
    "percent_change_from_200_day_moving_average": -0.1646,
    "percent_change_from_50_day_moving_average": 0.044199999999999996,
    "shares_owned": "N/A",
    "short_ratio": 7.28,
    "two_hundred_day_moving_average": 6.74,
    "volume": 88717.0,
    "market_cap": 132710000.00000001,
    "price_to_sales_ttm": 1884.3,
    "price_to_book_mrq": 2.36,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23570000.0,
    "pcnt_held_by_insiders": 0.3461,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0529,
    "operating_cash_flow_ttm": -42230000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "EPIRUS Biopharmaceuticals, Inc."
  },
  "EPZM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.39,
    "ebitda": -120960000.0,
    "eps_estimate_current_year": -3.75,
    "eps_estimate_next_quarter": -0.75,
    "fifty_day_moving_average": 18.93,
    "fifty_two_week_high": 30.26,
    "fifty_two_week_low": 13.67,
    "percent_change_from_200_day_moving_average": -0.1045,
    "percent_change_from_50_day_moving_average": -0.054900000000000004,
    "shares_owned": "N/A",
    "short_ratio": 17.29,
    "two_hundred_day_moving_average": 19.98,
    "volume": 408404.0,
    "market_cap": 739390000.0,
    "price_to_sales_ttm": 40.18,
    "price_to_book_mrq": 3.87,
    "roa_ttm": -0.3155,
    "roe_ttm": -0.6114,
    "shares_outstanding": 41330000.0,
    "pcnt_held_by_insiders": 0.3422,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.7321,
    "operating_cash_flow_ttm": -83820000.0,
    "levered_cash_flow_ttm": -117150000.0,
    "book_value_per_share_mrq": 5.07,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Epizyme, Inc."
  },
  "ERB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.04,
    "ebitda": 58614.0,
    "eps_estimate_current_year": -0.06,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.868,
    "fifty_two_week_high": 4.01,
    "fifty_two_week_low": 1.6,
    "percent_change_from_200_day_moving_average": -0.23526,
    "percent_change_from_50_day_moving_average": 0.06033,
    "shares_owned": "N/A",
    "short_ratio": 3.45,
    "two_hundred_day_moving_average": 2.59,
    "volume": 100.0,
    "market_cap": 87330000.0,
    "price_to_sales_ttm": 3.88,
    "price_to_book_mrq": 5.48,
    "roa_ttm": -0.024300000000000002,
    "roe_ttm": -0.09939999999999999,
    "shares_outstanding": 44090000.0,
    "pcnt_held_by_insiders": 0.8225,
    "pcnt_held_by_institutions": 0.018000000000000002,
    "pcnt_short_of_float": 0.0137,
    "operating_cash_flow_ttm": -1730000.0,
    "levered_cash_flow_ttm": -1780000.0,
    "book_value_per_share_mrq": 0.37,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ERBA Diagnostics, Inc."
  },
  "ESMC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.12,
    "ebitda": -912172.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.27,
    "fifty_two_week_high": 1.8,
    "fifty_two_week_low": 1.07,
    "percent_change_from_200_day_moving_average": -0.22149999999999997,
    "percent_change_from_50_day_moving_average": -0.15810000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.62,
    "two_hundred_day_moving_average": 1.37,
    "volume": 13359.0,
    "market_cap": 8050000.000000001,
    "price_to_sales_ttm": 0.69,
    "price_to_book_mrq": 2.9,
    "roa_ttm": -0.0803,
    "roe_ttm": -0.2702,
    "shares_outstanding": 7530000.0,
    "pcnt_held_by_insiders": 0.019299999999999998,
    "pcnt_held_by_institutions": 0.09300000000000001,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -1160000.0,
    "levered_cash_flow_ttm": -869840.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Escalon Medical Corp."
  },
  "ESPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.45,
    "earnings_per_share": -2.22,
    "ebitda": -42750000.0,
    "eps_estimate_current_year": -2.4,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 52.23,
    "fifty_two_week_high": 120.96,
    "fifty_two_week_low": 18.0,
    "percent_change_from_200_day_moving_average": -0.5233,
    "percent_change_from_50_day_moving_average": -0.2464,
    "shares_owned": "N/A",
    "short_ratio": 2.55,
    "two_hundred_day_moving_average": 82.57,
    "volume": 677264.0,
    "market_cap": 885160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.14,
    "roa_ttm": -0.1394,
    "roe_ttm": -0.23670000000000002,
    "shares_outstanding": 22490000.0,
    "pcnt_held_by_insiders": 0.7001000000000001,
    "pcnt_held_by_institutions": 0.22899999999999998,
    "pcnt_short_of_float": 0.3578,
    "operating_cash_flow_ttm": -34720000.0,
    "levered_cash_flow_ttm": -19380000.0,
    "book_value_per_share_mrq": 13.59,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Esperion Therapeutics, Inc."
  },
  "ETRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.17,
    "earnings_per_share": -0.371,
    "ebitda": -25790000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.2626,
    "fifty_two_week_high": 2.05,
    "fifty_two_week_low": 0.2,
    "percent_change_from_200_day_moving_average": -0.659649,
    "percent_change_from_50_day_moving_average": -0.036070000000000005,
    "shares_owned": "N/A",
    "short_ratio": 3.38,
    "two_hundred_day_moving_average": 0.7436,
    "volume": 743992.0,
    "market_cap": 26930000.0,
    "price_to_sales_ttm": 350.19,
    "price_to_book_mrq": 13.68,
    "roa_ttm": -1.0058,
    "roe_ttm": -3.2876999999999996,
    "shares_outstanding": 106400000.0,
    "pcnt_held_by_insiders": 0.1986,
    "pcnt_held_by_institutions": 0.315,
    "pcnt_short_of_float": 0.0709,
    "operating_cash_flow_ttm": -20020000.0,
    "levered_cash_flow_ttm": -10100000.0,
    "book_value_per_share_mrq": 0.02,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EnteroMedics Inc."
  },
  "EVAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.077,
    "ebitda": -34370000.0,
    "eps_estimate_current_year": -2.14,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 3.832,
    "fifty_two_week_high": 7.7,
    "fifty_two_week_low": 3.26,
    "percent_change_from_200_day_moving_average": -0.10499599999999999,
    "percent_change_from_50_day_moving_average": -0.015892,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 4.2135,
    "volume": 682.0,
    "market_cap": 75180000.0,
    "price_to_sales_ttm": 3.8,
    "price_to_book_mrq": 1.34,
    "roa_ttm": -0.2766,
    "roe_ttm": -0.5219,
    "shares_outstanding": 19940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0015,
    "operating_cash_flow_ttm": -32570000.0,
    "levered_cash_flow_ttm": -21560000.0,
    "book_value_per_share_mrq": 2.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Lombard Medical, Inc."
  },
  "EVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -15440000.0,
    "eps_estimate_current_year": -0.89,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 8.7,
    "fifty_two_week_high": 13.27,
    "fifty_two_week_low": 7.46,
    "percent_change_from_200_day_moving_average": -0.071,
    "percent_change_from_50_day_moving_average": -0.0178,
    "shares_owned": "N/A",
    "short_ratio": 8.64,
    "two_hundred_day_moving_average": 9.2,
    "volume": 700.0,
    "market_cap": 217070000.0,
    "price_to_sales_ttm": 17.89,
    "price_to_book_mrq": 1.93,
    "roa_ttm": -0.0889,
    "roe_ttm": -0.1496,
    "shares_outstanding": 25390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -8990000.0,
    "levered_cash_flow_ttm": -8700000.0,
    "book_value_per_share_mrq": 4.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Evogene Ltd."
  },
  "EVHC": {
    "p_e_ratio": 39.61,
    "peg_ratio": 1.73,
    "earnings_per_share": 0.99,
    "ebitda": 593270000.0,
    "eps_estimate_current_year": 1.46,
    "eps_estimate_next_quarter": 0.45,
    "fifty_day_moving_average": 42.17,
    "fifty_two_week_high": 45.95,
    "fifty_two_week_low": 30.48,
    "percent_change_from_200_day_moving_average": -0.009000000000000001,
    "percent_change_from_50_day_moving_average": -0.0711,
    "shares_owned": "N/A",
    "short_ratio": 2.84,
    "two_hundred_day_moving_average": 39.53,
    "volume": 2428481.0,
    "market_cap": 7280000000.0,
    "price_to_sales_ttm": 1.53,
    "price_to_book_mrq": 3.99,
    "roa_ttm": 0.055,
    "roe_ttm": 0.106,
    "shares_outstanding": 185740000.0,
    "pcnt_held_by_insiders": 0.0184,
    "pcnt_held_by_institutions": 0.445,
    "pcnt_short_of_float": 0.0273,
    "operating_cash_flow_ttm": 341030000.0,
    "levered_cash_flow_ttm": 246680000.0,
    "book_value_per_share_mrq": 10.15,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Envision Healthcare Holdings, Inc."
  },
  "EVOK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -2.21,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.15,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 3.78,
    "fifty_two_week_high": 8.32,
    "fifty_two_week_low": 2.8,
    "percent_change_from_200_day_moving_average": -0.452,
    "percent_change_from_50_day_moving_average": -0.21960000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.3,
    "two_hundred_day_moving_average": 5.38,
    "volume": 111669.0,
    "market_cap": 18700000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.59,
    "roa_ttm": -0.6037,
    "roe_ttm": -1.3866999999999998,
    "shares_outstanding": 6340000.0,
    "pcnt_held_by_insiders": 0.7432,
    "pcnt_held_by_institutions": 0.08199999999999999,
    "pcnt_short_of_float": 0.02,
    "operating_cash_flow_ttm": -11970000.0,
    "levered_cash_flow_ttm": -6810000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Evoke Pharma, Inc."
  },
  "EXAC": {
    "p_e_ratio": 16.45,
    "peg_ratio": 1.84,
    "earnings_per_share": 1.13,
    "ebitda": 43810000.0,
    "eps_estimate_current_year": 1.18,
    "eps_estimate_next_quarter": 0.38,
    "fifty_day_moving_average": 18.65,
    "fifty_two_week_high": 26.2,
    "fifty_two_week_low": 16.12,
    "percent_change_from_200_day_moving_average": -0.128,
    "percent_change_from_50_day_moving_average": -0.0031,
    "shares_owned": "N/A",
    "short_ratio": 6.65,
    "two_hundred_day_moving_average": 21.32,
    "volume": 73898.0,
    "market_cap": 261290000.00000003,
    "price_to_sales_ttm": 1.07,
    "price_to_book_mrq": 1.19,
    "roa_ttm": 0.0583,
    "roe_ttm": 0.075,
    "shares_outstanding": 14060000.0,
    "pcnt_held_by_insiders": 0.2848,
    "pcnt_held_by_institutions": 0.617,
    "pcnt_short_of_float": 0.042199999999999994,
    "operating_cash_flow_ttm": 25590000.0,
    "levered_cash_flow_ttm": 10160000.0,
    "book_value_per_share_mrq": 15.64,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Exactech Inc."
  },
  "EXAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.44,
    "earnings_per_share": -1.61,
    "ebitda": -134430000.0,
    "eps_estimate_current_year": -1.74,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 21.07,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 17.34,
    "percent_change_from_200_day_moving_average": -0.21600000000000003,
    "percent_change_from_50_day_moving_average": -0.10289999999999999,
    "shares_owned": "N/A",
    "short_ratio": 21.21,
    "two_hundred_day_moving_average": 24.11,
    "volume": 2076988.0,
    "market_cap": 1820000000.0,
    "price_to_sales_ttm": 132.97,
    "price_to_book_mrq": 7.61,
    "roa_ttm": -0.3444,
    "roe_ttm": -0.596,
    "shares_outstanding": 96090000.0,
    "pcnt_held_by_insiders": 0.013000000000000001,
    "pcnt_held_by_institutions": 0.8390000000000001,
    "pcnt_short_of_float": 0.3173,
    "operating_cash_flow_ttm": -117710000.0,
    "levered_cash_flow_ttm": -82250000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Exact Sciences Corporation"
  },
  "EXEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.32,
    "earnings_per_share": -1.02,
    "ebitda": -141760000.0,
    "eps_estimate_current_year": -0.81,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 5.88,
    "fifty_two_week_high": 6.81,
    "fifty_two_week_low": 1.26,
    "percent_change_from_200_day_moving_average": 0.42719999999999997,
    "percent_change_from_50_day_moving_average": 0.0059,
    "shares_owned": "N/A",
    "short_ratio": 7.77,
    "two_hundred_day_moving_average": 4.14,
    "volume": 7652239.0,
    "market_cap": 1330000000.0,
    "price_to_sales_ttm": 45.05,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2606,
    "roe_ttm": "N/A",
    "shares_outstanding": 225430000.0,
    "pcnt_held_by_insiders": 0.0169,
    "pcnt_held_by_institutions": 0.8170000000000001,
    "pcnt_short_of_float": 0.271,
    "operating_cash_flow_ttm": -179900000.0,
    "levered_cash_flow_ttm": -89410000.0,
    "book_value_per_share_mrq": -0.96,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Exelixis, Inc."
  },
  "EYEG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.97,
    "ebitda": -3440000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 4.07,
    "fifty_two_week_high": 27.0,
    "fifty_two_week_low": 2.74,
    "percent_change_from_200_day_moving_average": -0.43310000000000004,
    "percent_change_from_50_day_moving_average": -0.2596,
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 5.31,
    "volume": 23394.0,
    "market_cap": 23040000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 23.05,
    "roa_ttm": -1.6173,
    "roe_ttm": "N/A",
    "shares_outstanding": 7650000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": -3210000.0,
    "levered_cash_flow_ttm": -2740000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Eyegate Pharmaceuticals, Inc."
  },
  "EYES": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.0,
    "ebitda": -20410000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 10.2,
    "fifty_two_week_high": 24.02,
    "fifty_two_week_low": 8.05,
    "percent_change_from_200_day_moving_average": -0.3528,
    "percent_change_from_50_day_moving_average": -0.19219999999999998,
    "shares_owned": "N/A",
    "short_ratio": 10.07,
    "two_hundred_day_moving_average": 12.73,
    "volume": 320387.0,
    "market_cap": 295210000.0,
    "price_to_sales_ttm": 49.56,
    "price_to_book_mrq": 11.44,
    "roa_ttm": -0.5275,
    "roe_ttm": -4.5617,
    "shares_outstanding": 35830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2555,
    "operating_cash_flow_ttm": -16710000.0,
    "levered_cash_flow_ttm": -6780000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Second Sight Medical Products, Inc."
  },
  "FATE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.33,
    "ebitda": -25940000.0,
    "eps_estimate_current_year": -1.27,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 6.67,
    "fifty_two_week_high": 8.78,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": 0.0032,
    "percent_change_from_50_day_moving_average": -0.0571,
    "shares_owned": "N/A",
    "short_ratio": 2.53,
    "two_hundred_day_moving_average": 6.27,
    "volume": 73566.0,
    "market_cap": 180490000.0,
    "price_to_sales_ttm": 597.43,
    "price_to_book_mrq": 3.84,
    "roa_ttm": -0.2605,
    "roe_ttm": -0.6283,
    "shares_outstanding": 28690000.0,
    "pcnt_held_by_insiders": 0.3343,
    "pcnt_held_by_institutions": 0.46799999999999997,
    "pcnt_short_of_float": 0.0239,
    "operating_cash_flow_ttm": -15970000.0,
    "levered_cash_flow_ttm": -12650000.0,
    "book_value_per_share_mrq": 1.79,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fate Therapeutics, Inc."
  },
  "FBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -0.7,
    "ebitda": -28930000.0,
    "eps_estimate_current_year": -0.72,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.85,
    "fifty_two_week_high": 5.35,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.1035,
    "percent_change_from_50_day_moving_average": 0.042300000000000004,
    "shares_owned": "N/A",
    "short_ratio": 19.75,
    "two_hundred_day_moving_average": 3.31,
    "volume": 96010.0,
    "market_cap": 139100000.0,
    "price_to_sales_ttm": 275.38,
    "price_to_book_mrq": 2.46,
    "roa_ttm": -0.2073,
    "roe_ttm": -0.42729999999999996,
    "shares_outstanding": 46830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1114,
    "operating_cash_flow_ttm": -22950000.0,
    "levered_cash_flow_ttm": -12900000.0,
    "book_value_per_share_mrq": 1.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Fortress Biotech, Inc."
  },
  "FCSC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.64,
    "ebitda": -26400000.0,
    "eps_estimate_current_year": -0.68,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 6.0,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 2.28,
    "percent_change_from_200_day_moving_average": -0.0495,
    "percent_change_from_50_day_moving_average": -0.17489999999999997,
    "shares_owned": "N/A",
    "short_ratio": 8.74,
    "two_hundred_day_moving_average": 5.21,
    "volume": 1190952.0,
    "market_cap": 217240000.0,
    "price_to_sales_ttm": 699.82,
    "price_to_book_mrq": 16.14,
    "roa_ttm": -0.3629,
    "roe_ttm": -0.8853,
    "shares_outstanding": 43890000.0,
    "pcnt_held_by_insiders": 0.0067,
    "pcnt_held_by_institutions": 0.6559999999999999,
    "pcnt_short_of_float": 0.1195,
    "operating_cash_flow_ttm": -22800000.0,
    "levered_cash_flow_ttm": -12480000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Fibrocell Science, Inc."
  },
  "FGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.41,
    "ebitda": -65050000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 25.08,
    "fifty_two_week_high": 40.59,
    "fifty_two_week_low": 16.95,
    "percent_change_from_200_day_moving_average": 0.0087,
    "percent_change_from_50_day_moving_average": -0.0161,
    "shares_owned": "N/A",
    "short_ratio": 7.28,
    "two_hundred_day_moving_average": 24.47,
    "volume": 498743.0,
    "market_cap": 1490000000.0,
    "price_to_sales_ttm": 9.67,
    "price_to_book_mrq": 6.33,
    "roa_ttm": -0.0964,
    "roe_ttm": -0.3848,
    "shares_outstanding": 60560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.061900000000000004,
    "operating_cash_flow_ttm": 4030000.0000000005,
    "levered_cash_flow_ttm": -1560000.0,
    "book_value_per_share_mrq": 4.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "FibroGen, Inc."
  },
  "FLDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -1.97,
    "ebitda": -46170000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 11.77,
    "fifty_two_week_high": 46.38,
    "fifty_two_week_low": 9.2,
    "percent_change_from_200_day_moving_average": -0.6474,
    "percent_change_from_50_day_moving_average": -0.21739999999999998,
    "shares_owned": "N/A",
    "short_ratio": 4.78,
    "two_hundred_day_moving_average": 26.12,
    "volume": 478380.0,
    "market_cap": 264450000.0,
    "price_to_sales_ttm": 2.48,
    "price_to_book_mrq": 2.22,
    "roa_ttm": -0.0793,
    "roe_ttm": -0.3789,
    "shares_outstanding": 28710000.0,
    "pcnt_held_by_insiders": 0.07,
    "pcnt_held_by_institutions": 0.973,
    "pcnt_short_of_float": 0.2418,
    "operating_cash_flow_ttm": -30020000.0,
    "levered_cash_flow_ttm": -13430000.0,
    "book_value_per_share_mrq": 4.61,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Fluidigm Corporation"
  },
  "FLKS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.79,
    "ebitda": -20430000.0,
    "eps_estimate_current_year": -1.92,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 13.46,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 10.93,
    "percent_change_from_200_day_moving_average": -0.2867,
    "percent_change_from_50_day_moving_average": -0.0891,
    "shares_owned": "N/A",
    "short_ratio": 17.02,
    "two_hundred_day_moving_average": 17.19,
    "volume": 130616.0,
    "market_cap": 219920000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.86,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 17940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.08529999999999999,
    "operating_cash_flow_ttm": -15120000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Flex Pharma, Inc."
  },
  "FLML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.58,
    "earnings_per_share": -1.08,
    "ebitda": 27610000.0,
    "eps_estimate_current_year": 0.46,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 21.91,
    "fifty_two_week_high": 26.09,
    "fifty_two_week_low": 9.3,
    "percent_change_from_200_day_moving_average": -0.0661,
    "percent_change_from_50_day_moving_average": -0.1555,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 19.81,
    "volume": 250877.0,
    "market_cap": 744680000.0,
    "price_to_sales_ttm": 9.03,
    "price_to_book_mrq": 35.88,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 40250000.0,
    "pcnt_held_by_insiders": 0.1173,
    "pcnt_held_by_institutions": 0.599,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "Flamel Technologies SA"
  },
  "FLXN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.94,
    "ebitda": -36110000.0,
    "eps_estimate_current_year": -2.3,
    "eps_estimate_next_quarter": -0.65,
    "fifty_day_moving_average": 24.03,
    "fifty_two_week_high": 30.37,
    "fifty_two_week_low": 14.5,
    "percent_change_from_200_day_moving_average": -0.1494,
    "percent_change_from_50_day_moving_average": -0.209,
    "shares_owned": "N/A",
    "short_ratio": 6.83,
    "two_hundred_day_moving_average": 22.35,
    "volume": 845849.0,
    "market_cap": 408730000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.0,
    "roa_ttm": -0.2211,
    "roe_ttm": -0.3801,
    "shares_outstanding": 21500000.0,
    "pcnt_held_by_insiders": 0.6836,
    "pcnt_held_by_institutions": 0.31,
    "pcnt_short_of_float": 0.064,
    "operating_cash_flow_ttm": -29920000.0,
    "levered_cash_flow_ttm": -18660000.0,
    "book_value_per_share_mrq": 5.84,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Flexion Therapeutics, Inc."
  },
  "FMI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.57,
    "ebitda": -69110000.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -0.57,
    "fifty_day_moving_average": 21.92,
    "fifty_two_week_high": 54.28,
    "fifty_two_week_low": 18.25,
    "percent_change_from_200_day_moving_average": -0.4257,
    "percent_change_from_50_day_moving_average": -0.09390000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.67,
    "two_hundred_day_moving_average": 34.58,
    "volume": 226958.0,
    "market_cap": 682840000.0,
    "price_to_sales_ttm": 9.53,
    "price_to_book_mrq": 2.52,
    "roa_ttm": -0.2134,
    "roe_ttm": -0.3839,
    "shares_outstanding": 34380000.0,
    "pcnt_held_by_insiders": 0.2659,
    "pcnt_held_by_institutions": 0.521,
    "pcnt_short_of_float": 0.2585,
    "operating_cash_flow_ttm": -67240000.0,
    "levered_cash_flow_ttm": -53880000.0,
    "book_value_per_share_mrq": 8.45,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Foundation Medicine, Inc."
  },
  "FOLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.99,
    "ebitda": -86200000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 15.82,
    "fifty_two_week_high": 18.83,
    "fifty_two_week_low": 5.13,
    "percent_change_from_200_day_moving_average": 0.054400000000000004,
    "percent_change_from_50_day_moving_average": -0.10189999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.49,
    "two_hundred_day_moving_average": 13.48,
    "volume": 3362843.0,
    "market_cap": 1690000000.0,
    "price_to_sales_ttm": 6222.38,
    "price_to_book_mrq": 5.53,
    "roa_ttm": -0.21030000000000001,
    "roe_ttm": -0.4917,
    "shares_outstanding": 118620000.0,
    "pcnt_held_by_insiders": 0.41619999999999996,
    "pcnt_held_by_institutions": 0.512,
    "pcnt_short_of_float": 0.20550000000000002,
    "operating_cash_flow_ttm": -73240000.0,
    "levered_cash_flow_ttm": -43440000.0,
    "book_value_per_share_mrq": 2.78,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Amicus Therapeutics, Inc."
  },
  "FOMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.73,
    "ebitda": -9470000.0,
    "eps_estimate_current_year": -0.71,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 9.86,
    "fifty_two_week_high": 14.0,
    "fifty_two_week_low": 4.75,
    "percent_change_from_200_day_moving_average": -0.22579999999999997,
    "percent_change_from_50_day_moving_average": -0.1672,
    "shares_owned": "N/A",
    "short_ratio": 4.92,
    "two_hundred_day_moving_average": 10.6,
    "volume": 272321.0,
    "market_cap": 250760000.0,
    "price_to_sales_ttm": 69.71,
    "price_to_book_mrq": 2.54,
    "roa_ttm": -0.09699999999999999,
    "roe_ttm": -0.2666,
    "shares_outstanding": 30540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.084,
    "operating_cash_flow_ttm": -7070000.0,
    "levered_cash_flow_ttm": -10200000.0,
    "book_value_per_share_mrq": 3.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Foamix Pharmaceuticals Ltd."
  },
  "FONR": {
    "p_e_ratio": 6.7,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.91,
    "ebitda": 16129999.999999998,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.45,
    "fifty_two_week_high": 14.25,
    "fifty_two_week_low": 9.1,
    "percent_change_from_200_day_moving_average": 0.15289999999999998,
    "percent_change_from_50_day_moving_average": 0.2242,
    "shares_owned": "N/A",
    "short_ratio": 2.58,
    "two_hundred_day_moving_average": 11.09,
    "volume": 94127.0,
    "market_cap": 79020000.0,
    "price_to_sales_ttm": 1.02,
    "price_to_book_mrq": 2.17,
    "roa_ttm": 0.1052,
    "roe_ttm": 0.31920000000000004,
    "shares_outstanding": 6050000.0,
    "pcnt_held_by_insiders": 0.0192,
    "pcnt_held_by_institutions": 0.20800000000000002,
    "pcnt_short_of_float": 0.0075,
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.97,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Fonar Corp."
  },
  "FPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.76,
    "ebitda": -40130000.0,
    "eps_estimate_current_year": -2.54,
    "eps_estimate_next_quarter": -0.66,
    "fifty_day_moving_average": 19.56,
    "fifty_two_week_high": 28.47,
    "fifty_two_week_low": 11.41,
    "percent_change_from_200_day_moving_average": -0.21710000000000002,
    "percent_change_from_50_day_moving_average": -0.10800000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.24,
    "two_hundred_day_moving_average": 22.29,
    "volume": 326495.0,
    "market_cap": 450300000.0,
    "price_to_sales_ttm": 23.44,
    "price_to_book_mrq": 3.42,
    "roa_ttm": -0.1441,
    "roe_ttm": -0.3357,
    "shares_outstanding": 25810000.0,
    "pcnt_held_by_insiders": 0.331,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.1459,
    "operating_cash_flow_ttm": -11400000.0,
    "levered_cash_flow_ttm": -23230000.0,
    "book_value_per_share_mrq": 5.66,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Five Prime Therapeutics, Inc."
  },
  "FVE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -4.42,
    "earnings_per_share": -1.78,
    "ebitda": 17130000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 3.26,
    "fifty_two_week_high": 5.07,
    "fifty_two_week_low": 2.82,
    "percent_change_from_200_day_moving_average": -0.31489999999999996,
    "percent_change_from_50_day_moving_average": -0.124,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 4.17,
    "volume": 372650.0,
    "market_cap": 140270000.0,
    "price_to_sales_ttm": 0.13,
    "price_to_book_mrq": 0.69,
    "roa_ttm": -0.0187,
    "roe_ttm": -0.3098,
    "shares_outstanding": 49050000.0,
    "pcnt_held_by_insiders": 0.1716,
    "pcnt_held_by_institutions": 0.608,
    "pcnt_short_of_float": 0.030899999999999997,
    "operating_cash_flow_ttm": 8510000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": 4.45,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Five Star Quality Care Inc."
  },
  "FWP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.56,
    "earnings_per_share": -1.54,
    "ebitda": -34190000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 26.01,
    "fifty_two_week_high": 43.34,
    "fifty_two_week_low": 15.75,
    "percent_change_from_200_day_moving_average": -0.2837,
    "percent_change_from_50_day_moving_average": -0.1354,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 31.4,
    "volume": 28826.0,
    "market_cap": 1050000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.46,
    "roa_ttm": -0.2052,
    "roe_ttm": -0.22440000000000002,
    "shares_outstanding": 46730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -18030000.0,
    "levered_cash_flow_ttm": -9820000.0,
    "book_value_per_share_mrq": 4.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Forward Pharma A/S"
  },
  "GALE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.3,
    "ebitda": -40740000.0,
    "eps_estimate_current_year": -0.32,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 1.6,
    "fifty_two_week_high": 2.39,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": 0.042199999999999994,
    "percent_change_from_50_day_moving_average": 0.034,
    "shares_owned": "N/A",
    "short_ratio": 15.25,
    "two_hundred_day_moving_average": 1.58,
    "volume": 2013755.0,
    "market_cap": 266829999.99999997,
    "price_to_sales_ttm": 26.59,
    "price_to_book_mrq": 5.9,
    "roa_ttm": -0.28800000000000003,
    "roe_ttm": -1.0383,
    "shares_outstanding": 161720000.0,
    "pcnt_held_by_insiders": 0.0058,
    "pcnt_held_by_institutions": 0.297,
    "pcnt_short_of_float": 0.1462,
    "operating_cash_flow_ttm": -45260000.0,
    "levered_cash_flow_ttm": -22430000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galena Biopharma, Inc."
  },
  "GALT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.78,
    "ebitda": -16550000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 2.15,
    "fifty_two_week_high": 5.88,
    "fifty_two_week_low": 1.68,
    "percent_change_from_200_day_moving_average": -0.23920000000000002,
    "percent_change_from_50_day_moving_average": -0.0115,
    "shares_owned": "N/A",
    "short_ratio": 8.71,
    "two_hundred_day_moving_average": 2.8,
    "volume": 45406.0,
    "market_cap": 48540000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.3378,
    "roe_ttm": -0.5844,
    "shares_outstanding": 22790000.0,
    "pcnt_held_by_insiders": 0.10400000000000001,
    "pcnt_held_by_institutions": 0.19899999999999998,
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -13690000.0,
    "levered_cash_flow_ttm": -7390000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Galectin Therapeutics, Inc."
  },
  "GB": {
    "p_e_ratio": 32.83,
    "peg_ratio": 2.35,
    "earnings_per_share": 1.74,
    "ebitda": 121360000.0,
    "eps_estimate_current_year": 2.65,
    "eps_estimate_next_quarter": 0.81,
    "fifty_day_moving_average": 56.25,
    "fifty_two_week_high": 63.19,
    "fifty_two_week_low": 42.26,
    "percent_change_from_200_day_moving_average": 0.0518,
    "percent_change_from_50_day_moving_average": 0.0151,
    "shares_owned": "N/A",
    "short_ratio": 3.39,
    "two_hundred_day_moving_average": 54.29,
    "volume": 157972.0,
    "market_cap": 1460000000.0,
    "price_to_sales_ttm": 2.2,
    "price_to_book_mrq": 2.32,
    "roa_ttm": 0.056299999999999996,
    "roe_ttm": 0.07429999999999999,
    "shares_outstanding": 25560000.0,
    "pcnt_held_by_insiders": 0.021400000000000002,
    "pcnt_held_by_institutions": 0.938,
    "pcnt_short_of_float": 0.024700000000000003,
    "operating_cash_flow_ttm": 77250000.0,
    "levered_cash_flow_ttm": 48190000.0,
    "book_value_per_share_mrq": 25.12,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Greatbatch, Inc."
  },
  "GBIM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.96,
    "ebitda": -5840000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.55,
    "fifty_two_week_high": 10.95,
    "fifty_two_week_low": 1.43,
    "percent_change_from_200_day_moving_average": -0.4289,
    "percent_change_from_50_day_moving_average": 0.0594,
    "shares_owned": "N/A",
    "short_ratio": 0.35,
    "two_hundred_day_moving_average": 4.73,
    "volume": 18006.0,
    "market_cap": 15530000.0,
    "price_to_sales_ttm": 2.98,
    "price_to_book_mrq": 5.56,
    "roa_ttm": -0.3234,
    "roe_ttm": "N/A",
    "shares_outstanding": 5750000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": -8570000.0,
    "levered_cash_flow_ttm": -12130000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GlobeImmune Inc."
  },
  "GBSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -25.194,
    "ebitda": -14160000.0,
    "eps_estimate_current_year": -9.45,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 0.8814,
    "fifty_two_week_high": 9.08,
    "fifty_two_week_low": 0.045,
    "percent_change_from_200_day_moving_average": -0.968113,
    "percent_change_from_50_day_moving_average": -0.9053749999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.37,
    "two_hundred_day_moving_average": 2.6154,
    "volume": 16694677.0,
    "market_cap": 15900000.0,
    "price_to_sales_ttm": 0.35,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6697,
    "roe_ttm": "N/A",
    "shares_outstanding": 190630000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3893,
    "operating_cash_flow_ttm": -15670000.0,
    "levered_cash_flow_ttm": -12990000.0,
    "book_value_per_share_mrq": -7.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Great Basin Scientific, Inc."
  },
  "GBT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -14.75,
    "ebitda": -22370000.0,
    "eps_estimate_current_year": -5.55,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 47.57,
    "fifty_two_week_low": 43.79,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.97,
    "two_hundred_day_moving_average": 0.0,
    "volume": 130415.0,
    "market_cap": 1250000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 27810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0974,
    "operating_cash_flow_ttm": -21900000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -27.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Global Blood Therapeutics, Inc."
  },
  "GEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.77,
    "earnings_per_share": -4.68,
    "ebitda": 438010000.0,
    "eps_estimate_current_year": 0.37,
    "eps_estimate_next_quarter": 0.09,
    "fifty_day_moving_average": 7.07,
    "fifty_two_week_high": 9.32,
    "fifty_two_week_low": 5.81,
    "percent_change_from_200_day_moving_average": -0.1003,
    "percent_change_from_50_day_moving_average": -0.132,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 6.82,
    "volume": 122045.0,
    "market_cap": 942820000.0,
    "price_to_sales_ttm": 0.2,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 73590000.0,
    "pcnt_held_by_insiders": 0.1808,
    "pcnt_held_by_institutions": 0.184,
    "pcnt_short_of_float": 0.0421,
    "operating_cash_flow_ttm": 63560000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -0.9,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Genesis Healthcare, Inc."
  },
  "GENE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -6820000.0,
    "eps_estimate_current_year": -1.72,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.42,
    "fifty_two_week_high": 11.0,
    "fifty_two_week_low": 1.04,
    "percent_change_from_200_day_moving_average": -0.4143,
    "percent_change_from_50_day_moving_average": -0.1409,
    "shares_owned": "N/A",
    "short_ratio": 3.54,
    "two_hundred_day_moving_average": 3.55,
    "volume": 131579.0,
    "market_cap": 23770000.0,
    "price_to_sales_ttm": 17.42,
    "price_to_book_mrq": 1.81,
    "roa_ttm": -0.4493,
    "roe_ttm": -0.8477,
    "shares_outstanding": 11430000.0,
    "pcnt_held_by_insiders": 0.015,
    "pcnt_held_by_institutions": 0.01,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -6860000.0,
    "levered_cash_flow_ttm": -4450000.0,
    "book_value_per_share_mrq": 1.2,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Genetic Technologies Limited"
  },
  "GERN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.22,
    "earnings_per_share": -0.24,
    "ebitda": -36470000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 3.3,
    "fifty_two_week_high": 4.67,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": -0.2051,
    "percent_change_from_50_day_moving_average": -0.07490000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.53,
    "two_hundred_day_moving_average": 3.84,
    "volume": 4903195.0,
    "market_cap": 482330000.0,
    "price_to_sales_ttm": 460.66,
    "price_to_book_mrq": 4.38,
    "roa_ttm": -0.14800000000000002,
    "roe_ttm": -0.2827,
    "shares_outstanding": 158140000.0,
    "pcnt_held_by_insiders": 0.0087,
    "pcnt_held_by_institutions": 0.526,
    "pcnt_short_of_float": 0.2249,
    "operating_cash_flow_ttm": 9970000.0,
    "levered_cash_flow_ttm": 21980000.0,
    "book_value_per_share_mrq": 0.75,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Geron Corporation"
  },
  "GHDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.15,
    "earnings_per_share": -0.98,
    "ebitda": -25040000.0,
    "eps_estimate_current_year": -0.76,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 25.35,
    "fifty_two_week_high": 37.74,
    "fifty_two_week_low": 21.64,
    "percent_change_from_200_day_moving_average": -0.1985,
    "percent_change_from_50_day_moving_average": -0.1253,
    "shares_owned": "N/A",
    "short_ratio": 11.47,
    "two_hundred_day_moving_average": 27.66,
    "volume": 286421.0,
    "market_cap": 720110000.0,
    "price_to_sales_ttm": 2.81,
    "price_to_book_mrq": 5.18,
    "roa_ttm": -0.1074,
    "roe_ttm": -0.21280000000000002,
    "shares_outstanding": 32479999.999999996,
    "pcnt_held_by_insiders": 0.0785,
    "pcnt_held_by_institutions": 0.912,
    "pcnt_short_of_float": 0.1552,
    "operating_cash_flow_ttm": -10490000.0,
    "levered_cash_flow_ttm": -8300000.000000001,
    "book_value_per_share_mrq": 4.63,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Genomic Health Inc."
  },
  "GI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.27,
    "earnings_per_share": -4.22,
    "ebitda": -42370000.0,
    "eps_estimate_current_year": -2.78,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 15.72,
    "fifty_two_week_high": 19.69,
    "fifty_two_week_low": 12.59,
    "percent_change_from_200_day_moving_average": -0.18989999999999999,
    "percent_change_from_50_day_moving_average": -0.17350000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.28,
    "two_hundred_day_moving_average": 16.03,
    "volume": 151393.0,
    "market_cap": 321230000.0,
    "price_to_sales_ttm": 4.78,
    "price_to_book_mrq": 2.65,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1386,
    "operating_cash_flow_ttm": -40080000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "EndoChoice Holdings, Inc."
  },
  "GKOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.62,
    "ebitda": -9200000.0,
    "eps_estimate_current_year": -1.56,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 30.25,
    "fifty_two_week_high": 33.92,
    "fifty_two_week_low": 24.33,
    "percent_change_from_200_day_moving_average": -0.18489999999999998,
    "percent_change_from_50_day_moving_average": -0.18280000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.62,
    "two_hundred_day_moving_average": 30.33,
    "volume": 193676.0,
    "market_cap": 791450000.0,
    "price_to_sales_ttm": 13.99,
    "price_to_book_mrq": 8.64,
    "roa_ttm": -0.10869999999999999,
    "roe_ttm": -0.8384,
    "shares_outstanding": 32020000.000000004,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0394,
    "operating_cash_flow_ttm": -2350000.0,
    "levered_cash_flow_ttm": 3350000.0,
    "book_value_per_share_mrq": 2.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Glaukos Corporation"
  },
  "GLMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.9,
    "ebitda": -10260000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 8.6,
    "fifty_two_week_high": 13.5,
    "fifty_two_week_low": 4.58,
    "percent_change_from_200_day_moving_average": -0.08470000000000001,
    "percent_change_from_50_day_moving_average": 0.0167,
    "shares_owned": "N/A",
    "short_ratio": 3.98,
    "two_hundred_day_moving_average": 9.55,
    "volume": 17613.0,
    "market_cap": 97020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.55,
    "roa_ttm": -0.1929,
    "roe_ttm": -0.31370000000000003,
    "shares_outstanding": 11100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0063,
    "operating_cash_flow_ttm": -8650000.0,
    "levered_cash_flow_ttm": -5700000.0,
    "book_value_per_share_mrq": 2.47,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Galmed Pharmaceuticals Ltd."
  },
  "GLYC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.57,
    "ebitda": -10650000.0,
    "eps_estimate_current_year": -0.66,
    "eps_estimate_next_quarter": -0.44,
    "fifty_day_moving_average": 7.11,
    "fifty_two_week_high": 9.68,
    "fifty_two_week_low": 6.18,
    "percent_change_from_200_day_moving_average": -0.151,
    "percent_change_from_50_day_moving_average": -0.0636,
    "shares_owned": "N/A",
    "short_ratio": 7.55,
    "two_hundred_day_moving_average": 7.84,
    "volume": 7810.0,
    "market_cap": 126670000.0,
    "price_to_sales_ttm": 6.38,
    "price_to_book_mrq": 2.31,
    "roa_ttm": -0.10439999999999999,
    "roe_ttm": -0.1802,
    "shares_outstanding": 19020000.0,
    "pcnt_held_by_insiders": 0.1186,
    "pcnt_held_by_institutions": 0.742,
    "pcnt_short_of_float": 0.0152,
    "operating_cash_flow_ttm": -25760000.0,
    "levered_cash_flow_ttm": -21380000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "GlycoMimetics, Inc."
  },
  "GMED": {
    "p_e_ratio": 21.25,
    "peg_ratio": 1.84,
    "earnings_per_share": 1.04,
    "ebitda": 174990000.0,
    "eps_estimate_current_year": 1.05,
    "eps_estimate_next_quarter": 0.29,
    "fifty_day_moving_average": 24.75,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 19.0,
    "percent_change_from_200_day_moving_average": -0.12710000000000002,
    "percent_change_from_50_day_moving_average": -0.10710000000000001,
    "shares_owned": "N/A",
    "short_ratio": 15.53,
    "two_hundred_day_moving_average": 25.32,
    "volume": 800751.0,
    "market_cap": 2100000000.0,
    "price_to_sales_ttm": 4.45,
    "price_to_book_mrq": 3.49,
    "roa_ttm": 0.1377,
    "roe_ttm": 0.1697,
    "shares_outstanding": 71190000.0,
    "pcnt_held_by_insiders": 0.0207,
    "pcnt_held_by_institutions": 0.821,
    "pcnt_short_of_float": 0.11230000000000001,
    "operating_cash_flow_ttm": 85420000.0,
    "levered_cash_flow_ttm": 50090000.0,
    "book_value_per_share_mrq": 6.77,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Globus Medical, Inc."
  },
  "GNCA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.21,
    "ebitda": -40990000.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 11.4,
    "fifty_two_week_high": 16.18,
    "fifty_two_week_low": 6.15,
    "percent_change_from_200_day_moving_average": -0.26940000000000003,
    "percent_change_from_50_day_moving_average": -0.2349,
    "shares_owned": "N/A",
    "short_ratio": 4.21,
    "two_hundred_day_moving_average": 11.93,
    "volume": 194191.0,
    "market_cap": 244680000.0,
    "price_to_sales_ttm": 426.46,
    "price_to_book_mrq": 3.82,
    "roa_ttm": -0.37070000000000003,
    "roe_ttm": -0.7879999999999999,
    "shares_outstanding": 28060000.0,
    "pcnt_held_by_insiders": 0.1244,
    "pcnt_held_by_institutions": 0.12300000000000001,
    "pcnt_short_of_float": 0.0642,
    "operating_cash_flow_ttm": -34710000.0,
    "levered_cash_flow_ttm": -21040000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Genocea Biosciences, Inc."
  },
  "GNMK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.31,
    "earnings_per_share": -0.97,
    "ebitda": -37770000.0,
    "eps_estimate_current_year": -1.11,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 9.54,
    "fifty_two_week_high": 14.4,
    "fifty_two_week_low": 7.57,
    "percent_change_from_200_day_moving_average": -0.16699999999999998,
    "percent_change_from_50_day_moving_average": -0.11939999999999999,
    "shares_owned": "N/A",
    "short_ratio": 25.86,
    "two_hundred_day_moving_average": 10.08,
    "volume": 438524.0,
    "market_cap": 356030000.0,
    "price_to_sales_ttm": 12.09,
    "price_to_book_mrq": 6.5,
    "roa_ttm": -0.2686,
    "roe_ttm": -0.5176,
    "shares_outstanding": 42380000.0,
    "pcnt_held_by_insiders": 0.1014,
    "pcnt_held_by_institutions": 1.07,
    "pcnt_short_of_float": 0.2157,
    "operating_cash_flow_ttm": -31910000.0,
    "levered_cash_flow_ttm": -25640000.0,
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "GenMark Diagnostics, Inc."
  },
  "GNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.2,
    "ebitda": -3850000.0,
    "eps_estimate_current_year": -0.4,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 2.44,
    "fifty_two_week_high": 4.67,
    "fifty_two_week_low": 1.61,
    "percent_change_from_200_day_moving_average": -0.0478,
    "percent_change_from_50_day_moving_average": -0.0301,
    "shares_owned": "N/A",
    "short_ratio": 2.68,
    "two_hundred_day_moving_average": 2.49,
    "volume": 10882.0,
    "market_cap": 40930000.0,
    "price_to_sales_ttm": 10.17,
    "price_to_book_mrq": 4.26,
    "roa_ttm": -0.1802,
    "roe_ttm": -0.2829,
    "shares_outstanding": 17270000.0,
    "pcnt_held_by_insiders": 0.1855,
    "pcnt_held_by_institutions": 0.23,
    "pcnt_short_of_float": 0.004,
    "operating_cash_flow_ttm": -3410000.0,
    "levered_cash_flow_ttm": -2740000.0,
    "book_value_per_share_mrq": 0.6,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GenVec, Inc."
  },
  "GTXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.599,
    "ebitda": -20370000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.901,
    "fifty_two_week_high": 1.59,
    "fifty_two_week_low": 0.41,
    "percent_change_from_200_day_moving_average": -0.15693,
    "percent_change_from_50_day_moving_average": -0.0626,
    "shares_owned": "N/A",
    "short_ratio": 23.3,
    "two_hundred_day_moving_average": 1.002,
    "volume": 36754.0,
    "market_cap": 118620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.41869999999999996,
    "roe_ttm": "N/A",
    "shares_outstanding": 140370000.0,
    "pcnt_held_by_insiders": 0.698,
    "pcnt_held_by_institutions": 0.075,
    "pcnt_short_of_float": 0.050300000000000004,
    "operating_cash_flow_ttm": -20630000.0,
    "levered_cash_flow_ttm": 57830000.0,
    "book_value_per_share_mrq": -0.22,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "GTX Inc."
  },
  "GWPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.27,
    "earnings_per_share": -2.5,
    "ebitda": -65940000.0,
    "eps_estimate_current_year": -3.7,
    "eps_estimate_next_quarter": -1.53,
    "fifty_day_moving_average": 106.68,
    "fifty_two_week_high": 133.98,
    "fifty_two_week_low": 58.16,
    "percent_change_from_200_day_moving_average": -0.1026,
    "percent_change_from_50_day_moving_average": -0.07150000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.21,
    "two_hundred_day_moving_average": 110.38,
    "volume": 306201.0,
    "market_cap": 2069999999.9999998,
    "price_to_sales_ttm": 46.4,
    "price_to_book_mrq": 5.5,
    "roa_ttm": -0.11380000000000001,
    "roe_ttm": -0.1549,
    "shares_outstanding": 20890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -53400000.0,
    "levered_cash_flow_ttm": -57140000.0,
    "book_value_per_share_mrq": 18.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "GW Pharmaceuticals plc"
  },
  "HAE": {
    "p_e_ratio": 90.39,
    "peg_ratio": 1.44,
    "earnings_per_share": 0.38,
    "ebitda": 133650000.0,
    "eps_estimate_current_year": 2.02,
    "eps_estimate_next_quarter": 0.62,
    "fifty_day_moving_average": 36.61,
    "fifty_two_week_high": 45.43,
    "fifty_two_week_low": 33.75,
    "percent_change_from_200_day_moving_average": -0.1524,
    "percent_change_from_50_day_moving_average": -0.061799999999999994,
    "shares_owned": "N/A",
    "short_ratio": 10.98,
    "two_hundred_day_moving_average": 40.52,
    "volume": 378531.0,
    "market_cap": 1750000000.0,
    "price_to_sales_ttm": 1.97,
    "price_to_book_mrq": 2.24,
    "roa_ttm": 0.022099999999999998,
    "roe_ttm": 0.0252,
    "shares_outstanding": 50890000.0,
    "pcnt_held_by_insiders": 0.0049,
    "pcnt_held_by_institutions": 1.084,
    "pcnt_short_of_float": 0.056799999999999996,
    "operating_cash_flow_ttm": 122690000.0,
    "levered_cash_flow_ttm": 23680000.0,
    "book_value_per_share_mrq": 15.56,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Haemonetics Corporation"
  },
  "HALO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.31,
    "ebitda": -29620000.0,
    "eps_estimate_current_year": -0.43,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 18.26,
    "fifty_two_week_high": 25.25,
    "fifty_two_week_low": 7.51,
    "percent_change_from_200_day_moving_average": -0.1338,
    "percent_change_from_50_day_moving_average": -0.1225,
    "shares_owned": "N/A",
    "short_ratio": 7.86,
    "two_hundred_day_moving_average": 18.49,
    "volume": 1964433.0,
    "market_cap": 2029999999.9999998,
    "price_to_sales_ttm": 20.7,
    "price_to_book_mrq": 44.12,
    "roa_ttm": -0.1101,
    "roe_ttm": -0.7134,
    "shares_outstanding": 126610000.0,
    "pcnt_held_by_insiders": 0.042300000000000004,
    "pcnt_held_by_institutions": 0.7090000000000001,
    "pcnt_short_of_float": 0.1315,
    "operating_cash_flow_ttm": -19020000.0,
    "levered_cash_flow_ttm": -3670000.0,
    "book_value_per_share_mrq": 0.4,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Halozyme Therapeutics, Inc."
  },
  "HART": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.45,
    "ebitda": -10100000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.0212,
    "fifty_two_week_high": 8.12,
    "fifty_two_week_low": 0.56,
    "percent_change_from_200_day_moving_average": -0.563862,
    "percent_change_from_50_day_moving_average": -0.136996,
    "shares_owned": "N/A",
    "short_ratio": 0.77,
    "two_hundred_day_moving_average": 2.0207,
    "volume": 104404.0,
    "market_cap": 10600000.0,
    "price_to_sales_ttm": 89.07,
    "price_to_book_mrq": 1.32,
    "roa_ttm": -0.5611999999999999,
    "roe_ttm": -1.1467,
    "shares_outstanding": 12020000.0,
    "pcnt_held_by_insiders": 0.1948,
    "pcnt_held_by_institutions": 0.4,
    "pcnt_short_of_float": 0.019799999999999998,
    "operating_cash_flow_ttm": -7890000.0,
    "levered_cash_flow_ttm": -2670000.0,
    "book_value_per_share_mrq": 0.68,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Harvard Apparatus Regenerative Technology, Inc."
  },
  "HBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.06,
    "earnings_per_share": -0.01,
    "ebitda": 6810000.0,
    "eps_estimate_current_year": 0.22,
    "eps_estimate_next_quarter": 0.11,
    "fifty_day_moving_average": 4.42,
    "fifty_two_week_high": 6.84,
    "fifty_two_week_low": 3.98,
    "percent_change_from_200_day_moving_average": -0.2345,
    "percent_change_from_50_day_moving_average": -0.0941,
    "shares_owned": "N/A",
    "short_ratio": 11.84,
    "two_hundred_day_moving_average": 5.23,
    "volume": 140398.0,
    "market_cap": 135700000.0,
    "price_to_sales_ttm": 1.28,
    "price_to_book_mrq": 1.48,
    "roa_ttm": 0.0116,
    "roe_ttm": -0.0045000000000000005,
    "shares_outstanding": 33930000.0,
    "pcnt_held_by_insiders": 0.1724,
    "pcnt_held_by_institutions": 0.532,
    "pcnt_short_of_float": 0.0471,
    "operating_cash_flow_ttm": 884000.0,
    "levered_cash_flow_ttm": -1340000.0,
    "book_value_per_share_mrq": 2.8,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Harvard Bioscience Inc."
  },
  "HEB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.081,
    "ebitda": -17660000.0,
    "eps_estimate_current_year": -0.11,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.174,
    "fifty_two_week_high": 0.4,
    "fifty_two_week_low": 0.14,
    "percent_change_from_200_day_moving_average": -0.197979,
    "percent_change_from_50_day_moving_average": -0.021839,
    "shares_owned": "N/A",
    "short_ratio": 0.05,
    "two_hundred_day_moving_average": 0.2122,
    "volume": 364391.0,
    "market_cap": 42020000.0,
    "price_to_sales_ttm": 251.3,
    "price_to_book_mrq": 1.57,
    "roa_ttm": -0.3603,
    "roe_ttm": -0.6039,
    "shares_outstanding": 246890000.0,
    "pcnt_held_by_insiders": 0.0177,
    "pcnt_held_by_institutions": 0.062,
    "pcnt_short_of_float": 0.0001,
    "operating_cash_flow_ttm": -16950000.0,
    "levered_cash_flow_ttm": -13490000.0,
    "book_value_per_share_mrq": 0.11,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Hemispherx Biopharma, Inc."
  },
  "HGR": {
    "p_e_ratio": 8.86,
    "peg_ratio": 0.95,
    "earnings_per_share": 1.65,
    "ebitda": 156160000.0,
    "eps_estimate_current_year": 1.62,
    "eps_estimate_next_quarter": 0.58,
    "fifty_day_moving_average": 17.62,
    "fifty_two_week_high": 26.79,
    "fifty_two_week_low": 14.42,
    "percent_change_from_200_day_moving_average": -0.3309,
    "percent_change_from_50_day_moving_average": -0.1707,
    "shares_owned": "N/A",
    "short_ratio": 19.24,
    "two_hundred_day_moving_average": 21.83,
    "volume": 327042.0,
    "market_cap": 501700000.0,
    "price_to_sales_ttm": 0.49,
    "price_to_book_mrq": 0.86,
    "roa_ttm": 0.0559,
    "roe_ttm": 0.10289999999999999,
    "shares_outstanding": 34340000.0,
    "pcnt_held_by_insiders": 0.0716,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.0683,
    "operating_cash_flow_ttm": 51130000.0,
    "levered_cash_flow_ttm": -5880000.0,
    "book_value_per_share_mrq": 17.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hanger, Inc."
  },
  "HH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.116,
    "ebitda": -6560000.0,
    "eps_estimate_current_year": 0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.154,
    "fifty_two_week_high": 0.65,
    "fifty_two_week_low": 0.12,
    "percent_change_from_200_day_moving_average": -0.56442,
    "percent_change_from_50_day_moving_average": -0.125,
    "shares_owned": "N/A",
    "short_ratio": 0.1,
    "two_hundred_day_moving_average": 0.31,
    "volume": 136275.0,
    "market_cap": 10460000.0,
    "price_to_sales_ttm": 0.4,
    "price_to_book_mrq": 2.07,
    "roa_ttm": -0.2793,
    "roe_ttm": -0.9661,
    "shares_outstanding": 77500000.0,
    "pcnt_held_by_insiders": 0.071,
    "pcnt_held_by_institutions": 0.529,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": -7350000.0,
    "levered_cash_flow_ttm": 288630.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Hooper Holmes Inc."
  },
  "HIIQ": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.06,
    "earnings_per_share": -0.12,
    "ebitda": 4019999.9999999995,
    "eps_estimate_current_year": 0.15,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 4.72,
    "fifty_two_week_high": 11.5,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": -0.1932,
    "percent_change_from_50_day_moving_average": -0.0034999999999999996,
    "shares_owned": "N/A",
    "short_ratio": 18.62,
    "two_hundred_day_moving_average": 5.83,
    "volume": 36676.0,
    "market_cap": 36370000.0,
    "price_to_sales_ttm": 0.39,
    "price_to_book_mrq": 0.95,
    "roa_ttm": 0.0072,
    "roe_ttm": -0.0095,
    "shares_outstanding": 7740000.0,
    "pcnt_held_by_insiders": 0.054299999999999994,
    "pcnt_held_by_institutions": 0.965,
    "pcnt_short_of_float": 0.21780000000000002,
    "operating_cash_flow_ttm": -969000.0,
    "levered_cash_flow_ttm": 2690000.0,
    "book_value_per_share_mrq": 4.99,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Insurance Innovations, Inc."
  },
  "HLS": {
    "p_e_ratio": 20.91,
    "peg_ratio": 1.57,
    "earnings_per_share": 1.85,
    "ebitda": 621600000.0,
    "eps_estimate_current_year": 2.26,
    "eps_estimate_next_quarter": 0.61,
    "fifty_day_moving_average": 42.48,
    "fifty_two_week_high": 48.37,
    "fifty_two_week_low": 35.84,
    "percent_change_from_200_day_moving_average": -0.1295,
    "percent_change_from_50_day_moving_average": -0.08990000000000001,
    "shares_owned": "N/A",
    "short_ratio": 8.52,
    "two_hundred_day_moving_average": 44.41,
    "volume": 1146448.0,
    "market_cap": 3540000000.0,
    "price_to_sales_ttm": 1.37,
    "price_to_book_mrq": 6.05,
    "roa_ttm": 0.1038,
    "roe_ttm": 0.317,
    "shares_outstanding": 91450000.0,
    "pcnt_held_by_insiders": 0.0254,
    "pcnt_held_by_institutions": 0.9490000000000001,
    "pcnt_short_of_float": 0.0675,
    "operating_cash_flow_ttm": 414700000.0,
    "levered_cash_flow_ttm": 149190000.0,
    "book_value_per_share_mrq": 6.62,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "HEALTHSOUTH Corp."
  },
  "HLTH": {
    "p_e_ratio": 68.47,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.07,
    "ebitda": 24470000.0,
    "eps_estimate_current_year": 0.25,
    "eps_estimate_next_quarter": 0.2,
    "fifty_day_moving_average": 5.13,
    "fifty_two_week_high": 9.34,
    "fifty_two_week_low": 1.07,
    "percent_change_from_200_day_moving_average": -0.1989,
    "percent_change_from_50_day_moving_average": -0.039599999999999996,
    "shares_owned": "N/A",
    "short_ratio": 6.72,
    "two_hundred_day_moving_average": 6.15,
    "volume": 234183.0,
    "market_cap": 349500000.0,
    "price_to_sales_ttm": 2.63,
    "price_to_book_mrq": 4.67,
    "roa_ttm": 0.15130000000000002,
    "roe_ttm": 0.35969999999999996,
    "shares_outstanding": 70890000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 7070000.0,
    "levered_cash_flow_ttm": 3530000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Nobilis Health Corp."
  },
  "HNSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.01,
    "earnings_per_share": -5.31,
    "ebitda": -38580000.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 5.18,
    "fifty_two_week_high": 12.3,
    "fifty_two_week_low": 3.79,
    "percent_change_from_200_day_moving_average": -0.4926,
    "percent_change_from_50_day_moving_average": -0.2253,
    "shares_owned": "N/A",
    "short_ratio": 41.12,
    "two_hundred_day_moving_average": 7.9,
    "volume": 60623.0,
    "market_cap": 75700000.0,
    "price_to_sales_ttm": 4.52,
    "price_to_book_mrq": 3.64,
    "roa_ttm": -0.42369999999999997,
    "roe_ttm": -3.4794,
    "shares_outstanding": 18880000.0,
    "pcnt_held_by_insiders": 0.2722,
    "pcnt_held_by_institutions": 0.336,
    "pcnt_short_of_float": 0.114,
    "operating_cash_flow_ttm": -42350000.0,
    "levered_cash_flow_ttm": -24620000.0,
    "book_value_per_share_mrq": 1.17,
    "next_earnings_announcement_date": "2015-11-05",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Hansen Medical, Inc."
  },
  "HNT": {
    "p_e_ratio": 59.64,
    "peg_ratio": 1.02,
    "earnings_per_share": 1.06,
    "ebitda": 380440000.0,
    "eps_estimate_current_year": 3.32,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 65.92,
    "fifty_two_week_high": 76.67,
    "fifty_two_week_low": 42.61,
    "percent_change_from_200_day_moving_average": 0.0046,
    "percent_change_from_50_day_moving_average": -0.0446,
    "shares_owned": "N/A",
    "short_ratio": 0.95,
    "two_hundred_day_moving_average": 62.69,
    "volume": 694462.0,
    "market_cap": 4870000000.0,
    "price_to_sales_ttm": 0.32,
    "price_to_book_mrq": 2.92,
    "roa_ttm": 0.0425,
    "roe_ttm": 0.04769999999999999,
    "shares_outstanding": 77290000.0,
    "pcnt_held_by_insiders": 0.0203,
    "pcnt_held_by_institutions": 0.239,
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": 1080000000.0,
    "levered_cash_flow_ttm": 212660000.0,
    "book_value_per_share_mrq": 22.15,
    "next_earnings_announcement_date": "2015-11-12",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Health Net, Inc."
  },
  "HRC": {
    "p_e_ratio": 38.72,
    "peg_ratio": 1.93,
    "earnings_per_share": 1.42,
    "ebitda": 274200000.0,
    "eps_estimate_current_year": 2.53,
    "eps_estimate_next_quarter": 0.6,
    "fifty_day_moving_average": 53.6,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 39.58,
    "percent_change_from_200_day_moving_average": 0.048499999999999995,
    "percent_change_from_50_day_moving_average": 0.026600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.99,
    "two_hundred_day_moving_average": 52.48,
    "volume": 745425.0,
    "market_cap": 3120000000.0,
    "price_to_sales_ttm": 1.72,
    "price_to_book_mrq": 4.29,
    "roa_ttm": 0.0672,
    "roe_ttm": 0.10189999999999999,
    "shares_outstanding": 56720000.0,
    "pcnt_held_by_insiders": 0.0202,
    "pcnt_held_by_institutions": 0.8809999999999999,
    "pcnt_short_of_float": 0.0548,
    "operating_cash_flow_ttm": 200500000.0,
    "levered_cash_flow_ttm": 28450000.0,
    "book_value_per_share_mrq": 13.38,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Hill-Rom Holdings, Inc."
  },
  "HRT": {
    "p_e_ratio": 48.22,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.13,
    "ebitda": 1800000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 6.23,
    "fifty_two_week_high": 7.95,
    "fifty_two_week_low": 5.5,
    "percent_change_from_200_day_moving_average": -0.0466,
    "percent_change_from_50_day_moving_average": -0.0014000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.92,
    "two_hundred_day_moving_average": 6.52,
    "volume": 417.0,
    "market_cap": 17330000.0,
    "price_to_sales_ttm": 0.75,
    "price_to_book_mrq": 2.33,
    "roa_ttm": 0.013500000000000002,
    "roe_ttm": 0.0032,
    "shares_outstanding": 2790000.0,
    "pcnt_held_by_insiders": 0.2965,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0064,
    "operating_cash_flow_ttm": 1270000.0,
    "levered_cash_flow_ttm": -594940.0,
    "book_value_per_share_mrq": 2.68,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Arrhythmia Research Technology Inc."
  },
  "HRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.2,
    "earnings_per_share": -2.87,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.8,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 34.87,
    "fifty_two_week_high": 42.25,
    "fifty_two_week_low": 6.51,
    "percent_change_from_200_day_moving_average": 0.2256,
    "percent_change_from_50_day_moving_average": -0.1247,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 24.9,
    "volume": 3565597.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": null,
    "industry": null
  },
  "HSGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.38,
    "ebitda": -35700000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 5.94,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 4.5,
    "percent_change_from_200_day_moving_average": -0.35840000000000005,
    "percent_change_from_50_day_moving_average": -0.2022,
    "shares_owned": "N/A",
    "short_ratio": 3.32,
    "two_hundred_day_moving_average": 7.39,
    "volume": 5181.0,
    "market_cap": 62740000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.42,
    "roa_ttm": -0.6772,
    "roe_ttm": -2.2053,
    "shares_outstanding": 13240000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0091,
    "operating_cash_flow_ttm": -24090000.0,
    "levered_cash_flow_ttm": -24010000.0,
    "book_value_per_share_mrq": 3.32,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Histogenics Corporation"
  },
  "HSKA": {
    "p_e_ratio": 68.39,
    "peg_ratio": 2.65,
    "earnings_per_share": 0.47,
    "ebitda": 9110000.0,
    "eps_estimate_current_year": 0.53,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 33.96,
    "fifty_two_week_high": 35.72,
    "fifty_two_week_low": 11.89,
    "percent_change_from_200_day_moving_average": 0.0713,
    "percent_change_from_50_day_moving_average": -0.051500000000000004,
    "shares_owned": "N/A",
    "short_ratio": 3.09,
    "two_hundred_day_moving_average": 30.07,
    "volume": 61337.0,
    "market_cap": 210430000.0,
    "price_to_sales_ttm": 2.38,
    "price_to_book_mrq": 3.9,
    "roa_ttm": 0.030899999999999997,
    "roe_ttm": 0.041100000000000005,
    "shares_outstanding": 6530000.0,
    "pcnt_held_by_insiders": 0.12539999999999998,
    "pcnt_held_by_institutions": 0.268,
    "pcnt_short_of_float": 0.0334,
    "operating_cash_flow_ttm": 2340000.0,
    "levered_cash_flow_ttm": 6300000.0,
    "book_value_per_share_mrq": 8.67,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Heska Corporation"
  },
  "HTBX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.16,
    "ebitda": -15550000.0,
    "eps_estimate_current_year": -2.36,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 5.0,
    "fifty_two_week_high": 10.9,
    "fifty_two_week_low": 3.0,
    "percent_change_from_200_day_moving_average": -0.18469999999999998,
    "percent_change_from_50_day_moving_average": -0.0009,
    "shares_owned": "N/A",
    "short_ratio": 3.22,
    "two_hundred_day_moving_average": 6.13,
    "volume": 30161.0,
    "market_cap": 42030000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.83,
    "roa_ttm": -0.5015,
    "roe_ttm": -1.02,
    "shares_outstanding": 8410000.0,
    "pcnt_held_by_insiders": 0.4955,
    "pcnt_held_by_institutions": 0.129,
    "pcnt_short_of_float": 0.016,
    "operating_cash_flow_ttm": -13540000.0,
    "levered_cash_flow_ttm": -7680000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Heat Biologics, Inc."
  },
  "HTGM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -18.57,
    "ebitda": -14690000.0,
    "eps_estimate_current_year": -3.08,
    "eps_estimate_next_quarter": -0.82,
    "fifty_day_moving_average": 7.3,
    "fifty_two_week_high": 19.75,
    "fifty_two_week_low": 4.64,
    "percent_change_from_200_day_moving_average": -0.0608,
    "percent_change_from_50_day_moving_average": 0.3884,
    "shares_owned": "N/A",
    "short_ratio": 2.15,
    "two_hundred_day_moving_average": 10.79,
    "volume": 16163.0,
    "market_cap": 69160000.0,
    "price_to_sales_ttm": 19.06,
    "price_to_book_mrq": 2.76,
    "roa_ttm": -0.3488,
    "roe_ttm": -1.7022,
    "shares_outstanding": 6830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0116,
    "operating_cash_flow_ttm": -16550000.0,
    "levered_cash_flow_ttm": -11650000.0,
    "book_value_per_share_mrq": 4.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "HTG Molecular Diagnostics, Inc."
  },
  "HTWR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.53,
    "earnings_per_share": -2.93,
    "ebitda": -6190000.0,
    "eps_estimate_current_year": -2.1,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 74.98,
    "fifty_two_week_high": 95.59,
    "fifty_two_week_low": 53.95,
    "percent_change_from_200_day_moving_average": -0.3039,
    "percent_change_from_50_day_moving_average": -0.2696,
    "shares_owned": "N/A",
    "short_ratio": 9.36,
    "two_hundred_day_moving_average": 78.66,
    "volume": 742318.0,
    "market_cap": 947750000.0,
    "price_to_sales_ttm": 3.62,
    "price_to_book_mrq": 4.97,
    "roa_ttm": -0.020499999999999997,
    "roe_ttm": -0.244,
    "shares_outstanding": 17310000.0,
    "pcnt_held_by_insiders": 0.055099999999999996,
    "pcnt_held_by_institutions": 1.0390000000000001,
    "pcnt_short_of_float": 0.2775,
    "operating_cash_flow_ttm": -7390000.0,
    "levered_cash_flow_ttm": 12720000.0,
    "book_value_per_share_mrq": 12.02,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Heartware International Inc."
  },
  "HWAY": {
    "p_e_ratio": 199.31,
    "peg_ratio": -161.06,
    "earnings_per_share": 0.06,
    "ebitda": 49010000.0,
    "eps_estimate_current_year": 0.11,
    "eps_estimate_next_quarter": 0.05,
    "fifty_day_moving_average": 12.13,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 11.37,
    "percent_change_from_200_day_moving_average": -0.2416,
    "percent_change_from_50_day_moving_average": -0.047,
    "shares_owned": "N/A",
    "short_ratio": 8.34,
    "two_hundred_day_moving_average": 15.24,
    "volume": 651097.0,
    "market_cap": 414220000.0,
    "price_to_sales_ttm": 0.55,
    "price_to_book_mrq": 1.4,
    "roa_ttm": 0.022400000000000003,
    "roe_ttm": 0.0058,
    "shares_outstanding": 35830000.0,
    "pcnt_held_by_insiders": 0.1507,
    "pcnt_held_by_institutions": 1.046,
    "pcnt_short_of_float": 0.0901,
    "operating_cash_flow_ttm": 61770000.0,
    "levered_cash_flow_ttm": 35060000.0,
    "book_value_per_share_mrq": 8.48,
    "next_earnings_announcement_date": "2015-10-29",
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Healthways Inc."
  },
  "HYH": {
    "p_e_ratio": 69.34,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.42,
    "ebitda": 218000000.0,
    "eps_estimate_current_year": 2.02,
    "eps_estimate_next_quarter": 0.52,
    "fifty_day_moving_average": 31.76,
    "fifty_two_week_high": 53.85,
    "fifty_two_week_low": 28.27,
    "percent_change_from_200_day_moving_average": -0.2851,
    "percent_change_from_50_day_moving_average": -0.0765,
    "shares_owned": "N/A",
    "short_ratio": 2.93,
    "two_hundred_day_moving_average": 41.03,
    "volume": 625428.0,
    "market_cap": 1370000000.0,
    "price_to_sales_ttm": 0.86,
    "price_to_book_mrq": 0.92,
    "roa_ttm": 0.036699999999999997,
    "roe_ttm": 0.0111,
    "shares_outstanding": 46610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.069,
    "operating_cash_flow_ttm": 119900000.0,
    "levered_cash_flow_ttm": 132190000.0,
    "book_value_per_share_mrq": 32.67,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Halyard Health, Inc."
  },
  "HZNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.09,
    "earnings_per_share": -0.15,
    "ebitda": 48060000.0,
    "eps_estimate_current_year": 1.36,
    "eps_estimate_next_quarter": 0.42,
    "fifty_day_moving_average": 29.49,
    "fifty_two_week_high": 39.49,
    "fifty_two_week_low": 10.15,
    "percent_change_from_200_day_moving_average": -0.25,
    "percent_change_from_50_day_moving_average": -0.22760000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.92,
    "two_hundred_day_moving_average": 30.38,
    "volume": 6254380.0,
    "market_cap": 3630000000.0,
    "price_to_sales_ttm": 8.14,
    "price_to_book_mrq": 3.0,
    "roa_ttm": 0.0024,
    "roe_ttm": -0.026000000000000002,
    "shares_outstanding": 159210000.0,
    "pcnt_held_by_insiders": 0.3085,
    "pcnt_held_by_institutions": 0.812,
    "pcnt_short_of_float": 0.06849999999999999,
    "operating_cash_flow_ttm": -17610000.0,
    "levered_cash_flow_ttm": 130870000.0,
    "book_value_per_share_mrq": 7.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Horizon Pharma plc"
  },
  "IART": {
    "p_e_ratio": 52.65,
    "peg_ratio": 2.06,
    "earnings_per_share": 1.21,
    "ebitda": 206610000.0,
    "eps_estimate_current_year": 3.07,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 62.3,
    "fifty_two_week_high": 68.46,
    "fifty_two_week_low": 42.09,
    "percent_change_from_200_day_moving_average": 0.06269999999999999,
    "percent_change_from_50_day_moving_average": 0.026000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.04,
    "two_hundred_day_moving_average": 60.15,
    "volume": 292561.0,
    "market_cap": 2330000000.0,
    "price_to_sales_ttm": 2.25,
    "price_to_book_mrq": 3.03,
    "roa_ttm": 0.055999999999999994,
    "roe_ttm": 0.0576,
    "shares_outstanding": 36460000.0,
    "pcnt_held_by_insiders": 0.23070000000000002,
    "pcnt_held_by_institutions": 0.795,
    "pcnt_short_of_float": 0.0677,
    "operating_cash_flow_ttm": 101570000.0,
    "levered_cash_flow_ttm": 79810000.0,
    "book_value_per_share_mrq": 21.5,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Integra LifeSciences Holdings Corporation"
  },
  "IBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.085,
    "ebitda": -5560000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.7174,
    "fifty_two_week_high": 3.48,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.187148,
    "percent_change_from_50_day_moving_average": -0.05928,
    "shares_owned": "N/A",
    "short_ratio": 3.67,
    "two_hundred_day_moving_average": 0.8303,
    "volume": 223391.0,
    "market_cap": 51800000.0,
    "price_to_sales_ttm": 29.12,
    "price_to_book_mrq": 4.78,
    "roa_ttm": -0.3765,
    "roe_ttm": -0.6842,
    "shares_outstanding": 76760000.0,
    "pcnt_held_by_insiders": 0.5233,
    "pcnt_held_by_institutions": 0.022000000000000002,
    "pcnt_short_of_float": 0.049400000000000006,
    "operating_cash_flow_ttm": -4200000.0,
    "levered_cash_flow_ttm": -2670000.0,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "iBio, Inc."
  },
  "ICCC": {
    "p_e_ratio": 28.12,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.22,
    "ebitda": 1740000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.66,
    "fifty_two_week_high": 11.4,
    "fifty_two_week_low": 3.96,
    "percent_change_from_200_day_moving_average": -0.15810000000000002,
    "percent_change_from_50_day_moving_average": -0.18170000000000003,
    "shares_owned": "N/A",
    "short_ratio": 0.05,
    "two_hundred_day_moving_average": 7.45,
    "volume": 10625.0,
    "market_cap": 19160000.0,
    "price_to_sales_ttm": 2.09,
    "price_to_book_mrq": 1.89,
    "roa_ttm": 0.0723,
    "roe_ttm": 0.0751,
    "shares_outstanding": 3060000.0,
    "pcnt_held_by_insiders": 0.2869,
    "pcnt_held_by_institutions": 0.078,
    "pcnt_short_of_float": 0.0006,
    "operating_cash_flow_ttm": 1490000.0,
    "levered_cash_flow_ttm": -1640000.0,
    "book_value_per_share_mrq": 3.26,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmuCell Corp."
  },
  "ICLR": {
    "p_e_ratio": 22.09,
    "peg_ratio": 1.05,
    "earnings_per_share": 3.36,
    "ebitda": 310910000.0,
    "eps_estimate_current_year": 3.93,
    "eps_estimate_next_quarter": 1.08,
    "fifty_day_moving_average": 78.62,
    "fifty_two_week_high": 84.14,
    "fifty_two_week_low": 49.75,
    "percent_change_from_200_day_moving_average": 0.0421,
    "percent_change_from_50_day_moving_average": -0.056299999999999996,
    "shares_owned": "N/A",
    "short_ratio": 3.95,
    "two_hundred_day_moving_average": 71.19,
    "volume": 410512.0,
    "market_cap": 4440000000.0,
    "price_to_sales_ttm": 2.92,
    "price_to_book_mrq": 4.44,
    "roa_ttm": 0.1007,
    "roe_ttm": 0.2078,
    "shares_outstanding": 59870000.0,
    "pcnt_held_by_insiders": 0.08220000000000001,
    "pcnt_held_by_institutions": 0.915,
    "pcnt_short_of_float": 0.04769999999999999,
    "operating_cash_flow_ttm": 275390000.0,
    "levered_cash_flow_ttm": 190900000.0,
    "book_value_per_share_mrq": 17.07,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "ICON Public Limited Company"
  },
  "ICPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.48,
    "earnings_per_share": -7.11,
    "ebitda": -158730000.0,
    "eps_estimate_current_year": -10.45,
    "eps_estimate_next_quarter": -3.77,
    "fifty_day_moving_average": 196.32,
    "fifty_two_week_high": 314.88,
    "fifty_two_week_low": 128.5,
    "percent_change_from_200_day_moving_average": -0.3184,
    "percent_change_from_50_day_moving_average": -0.1349,
    "shares_owned": "N/A",
    "short_ratio": 6.21,
    "two_hundred_day_moving_average": 249.19,
    "volume": 493474.0,
    "market_cap": 4110000000.0000005,
    "price_to_sales_ttm": 1547.16,
    "price_to_book_mrq": 5.27,
    "roa_ttm": -0.1875,
    "roe_ttm": -0.3119,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": 0.4086,
    "pcnt_held_by_institutions": 0.545,
    "pcnt_short_of_float": 0.1913,
    "operating_cash_flow_ttm": -119600000.0,
    "levered_cash_flow_ttm": -70930000.0,
    "book_value_per_share_mrq": 33.76,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intercept Pharmaceuticals, Inc."
  },
  "ICUI": {
    "p_e_ratio": 47.87,
    "peg_ratio": 2.91,
    "earnings_per_share": 2.31,
    "ebitda": 82710000.0,
    "eps_estimate_current_year": 3.62,
    "eps_estimate_next_quarter": 0.83,
    "fifty_day_moving_average": 113.78,
    "fifty_two_week_high": 124.69,
    "fifty_two_week_low": 61.7,
    "percent_change_from_200_day_moving_average": 0.1149,
    "percent_change_from_50_day_moving_average": -0.029500000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.83,
    "two_hundred_day_moving_average": 99.05,
    "volume": 143232.0,
    "market_cap": 1750000000.0,
    "price_to_sales_ttm": 5.53,
    "price_to_book_mrq": 3.29,
    "roa_ttm": 0.0733,
    "roe_ttm": 0.0724,
    "shares_outstanding": 15830000.0,
    "pcnt_held_by_insiders": 0.1195,
    "pcnt_held_by_institutions": 0.917,
    "pcnt_short_of_float": 0.0415,
    "operating_cash_flow_ttm": 57120000.0,
    "levered_cash_flow_ttm": 54510000.0,
    "book_value_per_share_mrq": 34.07,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "ICU Medical, Inc."
  },
  "IDRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.47,
    "ebitda": -46410000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 3.03,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 1.94,
    "percent_change_from_200_day_moving_average": 0.0438,
    "percent_change_from_50_day_moving_average": 0.1723,
    "shares_owned": "N/A",
    "short_ratio": 17.32,
    "two_hundred_day_moving_average": 3.4,
    "volume": 1545619.0,
    "market_cap": 419340000.0,
    "price_to_sales_ttm": 6405.21,
    "price_to_book_mrq": 4.44,
    "roa_ttm": -0.33130000000000004,
    "roe_ttm": -0.5722999999999999,
    "shares_outstanding": 118120000.0,
    "pcnt_held_by_insiders": 0.1818,
    "pcnt_held_by_institutions": 0.318,
    "pcnt_short_of_float": 0.34630000000000005,
    "operating_cash_flow_ttm": -40130000.0,
    "levered_cash_flow_ttm": -24070000.0,
    "book_value_per_share_mrq": 0.87,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Idera Pharmaceuticals, Inc."
  },
  "IDXX": {
    "p_e_ratio": 19.0,
    "peg_ratio": 2.54,
    "earnings_per_share": 3.92,
    "ebitda": 331840000.0,
    "eps_estimate_current_year": 2.11,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 75.23,
    "fifty_two_week_high": 84.25,
    "fifty_two_week_low": 57.56,
    "percent_change_from_200_day_moving_average": 0.0495,
    "percent_change_from_50_day_moving_average": -0.0092,
    "shares_owned": "N/A",
    "short_ratio": 11.37,
    "two_hundred_day_moving_average": 71.02,
    "volume": 358196.0,
    "market_cap": 6980000000.0,
    "price_to_sales_ttm": 4.57,
    "price_to_book_mrq": 836.04,
    "roa_ttm": 0.12140000000000001,
    "roe_ttm": 0.7872,
    "shares_outstanding": 93600000.0,
    "pcnt_held_by_insiders": 0.0111,
    "pcnt_held_by_institutions": 0.991,
    "pcnt_short_of_float": 0.09269999999999999,
    "operating_cash_flow_ttm": 186090000.0,
    "levered_cash_flow_ttm": 122430000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": "2015-10-28",
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "IDEXX Laboratories, Inc."
  },
  "IG": {
    "p_e_ratio": 125.59,
    "peg_ratio": -4.48,
    "earnings_per_share": 0.06,
    "ebitda": 3720000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 8.06,
    "fifty_two_week_high": 12.05,
    "fifty_two_week_low": 4.75,
    "percent_change_from_200_day_moving_average": 0.0003,
    "percent_change_from_50_day_moving_average": -0.0805,
    "shares_owned": "N/A",
    "short_ratio": 22.92,
    "two_hundred_day_moving_average": 7.41,
    "volume": 436814.0,
    "market_cap": 391720000.0,
    "price_to_sales_ttm": 10.34,
    "price_to_book_mrq": 5.54,
    "roa_ttm": 0.018799999999999997,
    "roe_ttm": 0.5173,
    "shares_outstanding": 52860000.0,
    "pcnt_held_by_insiders": 0.5847,
    "pcnt_held_by_institutions": 0.179,
    "pcnt_short_of_float": 0.2865,
    "operating_cash_flow_ttm": -9210000.0,
    "levered_cash_flow_ttm": -8400000.0,
    "book_value_per_share_mrq": 1.41,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "IGI Laboratories, Inc."
  },
  "IMDZ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.79,
    "earnings_per_share": -2.42,
    "ebitda": -39380000.0,
    "eps_estimate_current_year": -2.0,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 16.39,
    "fifty_two_week_high": 40.13,
    "fifty_two_week_low": 12.6,
    "percent_change_from_200_day_moving_average": -0.40840000000000004,
    "percent_change_from_50_day_moving_average": -0.20980000000000001,
    "shares_owned": "N/A",
    "short_ratio": 8.0,
    "two_hundred_day_moving_average": 21.89,
    "volume": 119500.0,
    "market_cap": 260680000.0,
    "price_to_sales_ttm": 32.99,
    "price_to_book_mrq": 2.39,
    "roa_ttm": -0.32270000000000004,
    "roe_ttm": -0.5509000000000001,
    "shares_outstanding": 20130000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.17010000000000003,
    "operating_cash_flow_ttm": -31430000.0,
    "levered_cash_flow_ttm": -17500000.0,
    "book_value_per_share_mrq": 6.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immune Design Corp."
  },
  "IMGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -48940000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 13.47,
    "fifty_two_week_high": 19.43,
    "fifty_two_week_low": 5.34,
    "percent_change_from_200_day_moving_average": -0.1535,
    "percent_change_from_50_day_moving_average": -0.22519999999999998,
    "shares_owned": "N/A",
    "short_ratio": 7.44,
    "two_hundred_day_moving_average": 12.33,
    "volume": 1782593.0,
    "market_cap": 907880000.0,
    "price_to_sales_ttm": 11.39,
    "price_to_book_mrq": 27.65,
    "roa_ttm": -0.1421,
    "roe_ttm": -1.0963,
    "shares_outstanding": 86960000.0,
    "pcnt_held_by_insiders": 0.0039000000000000003,
    "pcnt_held_by_institutions": 0.909,
    "pcnt_short_of_float": 0.1564,
    "operating_cash_flow_ttm": -55290000.0,
    "levered_cash_flow_ttm": -14650000.0,
    "book_value_per_share_mrq": 0.41,
    "next_earnings_announcement_date": "2015-10-23",
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoGen, Inc."
  },
  "IMMU": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -45640000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 2.0,
    "fifty_two_week_high": 5.48,
    "fifty_two_week_low": 1.69,
    "percent_change_from_200_day_moving_average": -0.5046,
    "percent_change_from_50_day_moving_average": -0.1493,
    "shares_owned": "N/A",
    "short_ratio": 13.64,
    "two_hundred_day_moving_average": 3.43,
    "volume": 837649.0,
    "market_cap": 160860000.0,
    "price_to_sales_ttm": 30.3,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.377,
    "roe_ttm": -2.8032,
    "shares_outstanding": 94630000.0,
    "pcnt_held_by_insiders": 0.0725,
    "pcnt_held_by_institutions": 0.434,
    "pcnt_short_of_float": 0.20920000000000002,
    "operating_cash_flow_ttm": -39000000.0,
    "levered_cash_flow_ttm": -22830000.0,
    "book_value_per_share_mrq": -0.04,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Immunomedics Inc."
  },
  "IMMY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.33,
    "earnings_per_share": -1.29,
    "ebitda": -11470000.0,
    "eps_estimate_current_year": -1.44,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 7.45,
    "fifty_two_week_high": 9.24,
    "fifty_two_week_low": 6.65,
    "percent_change_from_200_day_moving_average": -0.1477,
    "percent_change_from_50_day_moving_average": -0.0874,
    "shares_owned": "N/A",
    "short_ratio": 4.03,
    "two_hundred_day_moving_average": 7.98,
    "volume": 19211.0,
    "market_cap": 65239999.99999999,
    "price_to_sales_ttm": 14.6,
    "price_to_book_mrq": 12.53,
    "roa_ttm": -0.4802,
    "roe_ttm": -1.3909,
    "shares_outstanding": 9590000.0,
    "pcnt_held_by_insiders": 0.48619999999999997,
    "pcnt_held_by_institutions": 0.05,
    "pcnt_short_of_float": 0.0126,
    "operating_cash_flow_ttm": -9290000.0,
    "levered_cash_flow_ttm": -4940000.0,
    "book_value_per_share_mrq": 0.55,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Imprimis Pharmaceuticals, Inc."
  },
  "IMNP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.25,
    "ebitda": -16210000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 1.43,
    "fifty_two_week_high": 3.5,
    "fifty_two_week_low": 1.05,
    "percent_change_from_200_day_moving_average": -0.1827,
    "percent_change_from_50_day_moving_average": 0.0259,
    "shares_owned": "N/A",
    "short_ratio": 3.37,
    "two_hundred_day_moving_average": 1.8,
    "volume": 74203.0,
    "market_cap": 40620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.0,
    "roa_ttm": -0.3081,
    "roe_ttm": -2.5201,
    "shares_outstanding": 27630000.0,
    "pcnt_held_by_insiders": 0.4493,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.020499999999999997,
    "operating_cash_flow_ttm": -11820000.0,
    "levered_cash_flow_ttm": -7720000.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Immune Pharmaceuticals, Inc."
  },
  "IMUC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.12,
    "ebitda": -11130000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.43,
    "fifty_two_week_high": 1.03,
    "fifty_two_week_low": 0.35,
    "percent_change_from_200_day_moving_average": -0.0381,
    "percent_change_from_50_day_moving_average": 0.0613,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 0.48,
    "volume": 3289528.0,
    "market_cap": 41520000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.67,
    "roa_ttm": -0.2316,
    "roe_ttm": -0.3172,
    "shares_outstanding": 90250000.0,
    "pcnt_held_by_insiders": 0.038,
    "pcnt_held_by_institutions": 0.071,
    "pcnt_short_of_float": 0.0012,
    "operating_cash_flow_ttm": -11530000.0,
    "levered_cash_flow_ttm": -6840000.0,
    "book_value_per_share_mrq": 0.33,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ImmunoCellular Therapeutics, Ltd."
  },
  "INFI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -1.41,
    "ebitda": -60890000.0,
    "eps_estimate_current_year": -2.77,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 9.03,
    "fifty_two_week_high": 18.25,
    "fifty_two_week_low": 7.56,
    "percent_change_from_200_day_moving_average": -0.2752,
    "percent_change_from_50_day_moving_average": -0.0725,
    "shares_owned": "N/A",
    "short_ratio": 9.14,
    "two_hundred_day_moving_average": 11.56,
    "volume": 1014024.0,
    "market_cap": 412200000.0,
    "price_to_sales_ttm": 2.61,
    "price_to_book_mrq": 5.21,
    "roa_ttm": -0.19260000000000002,
    "roe_ttm": -0.61,
    "shares_outstanding": 49190000.0,
    "pcnt_held_by_insiders": 0.0451,
    "pcnt_held_by_institutions": 1.023,
    "pcnt_short_of_float": 0.146,
    "operating_cash_flow_ttm": 59760000.0,
    "levered_cash_flow_ttm": 21080000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Infinity Pharmaceuticals, Inc."
  },
  "INFU": {
    "p_e_ratio": 27.0,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.1,
    "ebitda": 16219999.999999998,
    "eps_estimate_current_year": 0.24,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.83,
    "fifty_two_week_high": 4.5,
    "fifty_two_week_low": 2.22,
    "percent_change_from_200_day_moving_average": -0.1016,
    "percent_change_from_50_day_moving_average": -0.0453,
    "shares_owned": "N/A",
    "short_ratio": 16.29,
    "two_hundred_day_moving_average": 3.01,
    "volume": 6740.0,
    "market_cap": 60570000.0,
    "price_to_sales_ttm": 0.98,
    "price_to_book_mrq": 1.28,
    "roa_ttm": 0.0692,
    "roe_ttm": 0.049100000000000005,
    "shares_outstanding": 22430000.0,
    "pcnt_held_by_insiders": 0.282,
    "pcnt_held_by_institutions": 0.35600000000000004,
    "pcnt_short_of_float": 0.0215,
    "operating_cash_flow_ttm": 9240000.0,
    "levered_cash_flow_ttm": -1790000.0,
    "book_value_per_share_mrq": 2.12,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "InfuSystem Holdings, Inc."
  },
  "INGN": {
    "p_e_ratio": 120.96,
    "peg_ratio": 4.81,
    "earnings_per_share": 0.41,
    "ebitda": 26260000.0,
    "eps_estimate_current_year": 0.3,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 50.66,
    "fifty_two_week_high": 55.98,
    "fifty_two_week_low": 19.16,
    "percent_change_from_200_day_moving_average": 0.20350000000000001,
    "percent_change_from_50_day_moving_average": -0.0091,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 41.71,
    "volume": 407243.0,
    "market_cap": 976220000.0,
    "price_to_sales_ttm": 7.62,
    "price_to_book_mrq": 8.12,
    "roa_ttm": 0.053099999999999994,
    "roe_ttm": 0.0727,
    "shares_outstanding": 19450000.0,
    "pcnt_held_by_insiders": 0.6748999999999999,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.060899999999999996,
    "operating_cash_flow_ttm": 21290000.0,
    "levered_cash_flow_ttm": -2170000.0,
    "book_value_per_share_mrq": 6.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Inogen, Inc."
  },
  "INNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.86,
    "ebitda": -29480000.0,
    "eps_estimate_current_year": -2.19,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 13.18,
    "fifty_two_week_high": 16.46,
    "fifty_two_week_low": 4.45,
    "percent_change_from_200_day_moving_average": 0.0919,
    "percent_change_from_50_day_moving_average": -0.0134,
    "shares_owned": "N/A",
    "short_ratio": 0.04,
    "two_hundred_day_moving_average": 11.91,
    "volume": 4074.0,
    "market_cap": 285140000.0,
    "price_to_sales_ttm": 86.44,
    "price_to_book_mrq": 13.76,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 21930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -28450000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Innocoll AG"
  },
  "INO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -42090000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 7.25,
    "fifty_two_week_high": 13.04,
    "fifty_two_week_low": 6.19,
    "percent_change_from_200_day_moving_average": -0.19260000000000002,
    "percent_change_from_50_day_moving_average": -0.0942,
    "shares_owned": "N/A",
    "short_ratio": 6.09,
    "two_hundred_day_moving_average": 8.14,
    "volume": 2149180.0,
    "market_cap": 473810000.0,
    "price_to_sales_ttm": 35.05,
    "price_to_book_mrq": 2.85,
    "roa_ttm": -0.1593,
    "roe_ttm": -0.20670000000000002,
    "shares_outstanding": 72120000.0,
    "pcnt_held_by_insiders": 0.0575,
    "pcnt_held_by_institutions": 0.188,
    "pcnt_short_of_float": 0.2523,
    "operating_cash_flow_ttm": -37210000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inovio Pharmaceuticals, Inc."
  },
  "INSM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.91,
    "ebitda": -99520000.0,
    "eps_estimate_current_year": -1.94,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 24.98,
    "fifty_two_week_high": 28.66,
    "fifty_two_week_low": 12.17,
    "percent_change_from_200_day_moving_average": -0.1387,
    "percent_change_from_50_day_moving_average": -0.18539999999999998,
    "shares_owned": "N/A",
    "short_ratio": 11.09,
    "two_hundred_day_moving_average": 23.63,
    "volume": 917593.0,
    "market_cap": 1260000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.83,
    "roa_ttm": -0.2263,
    "roe_ttm": -0.4094,
    "shares_outstanding": 61760000.0,
    "pcnt_held_by_insiders": 0.11810000000000001,
    "pcnt_held_by_institutions": 0.767,
    "pcnt_short_of_float": 0.1162,
    "operating_cash_flow_ttm": -82960000.0,
    "levered_cash_flow_ttm": -59090000.0,
    "book_value_per_share_mrq": 5.92,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Insmed Incorporated"
  },
  "INSY": {
    "p_e_ratio": 59.47,
    "peg_ratio": 1.4,
    "earnings_per_share": 0.49,
    "ebitda": 73910000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 34.52,
    "fifty_two_week_high": 46.17,
    "fifty_two_week_low": 16.5,
    "percent_change_from_200_day_moving_average": -0.13419999999999999,
    "percent_change_from_50_day_moving_average": -0.1577,
    "shares_owned": "N/A",
    "short_ratio": 18.18,
    "two_hundred_day_moving_average": 33.59,
    "volume": 938470.0,
    "market_cap": 2080000000.0,
    "price_to_sales_ttm": 8.38,
    "price_to_book_mrq": 11.22,
    "roa_ttm": 0.2061,
    "roe_ttm": 0.2224,
    "shares_outstanding": 71420000.0,
    "pcnt_held_by_insiders": 0.7088,
    "pcnt_held_by_institutions": 0.287,
    "pcnt_short_of_float": 0.7016,
    "operating_cash_flow_ttm": 60570000.0,
    "levered_cash_flow_ttm": 44240000.0,
    "book_value_per_share_mrq": 2.84,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "INSYS Therapeutics, Inc."
  },
  "IPCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.23,
    "ebitda": -4540000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 2.17,
    "fifty_two_week_high": 3.92,
    "fifty_two_week_low": 1.92,
    "percent_change_from_200_day_moving_average": -0.2705,
    "percent_change_from_50_day_moving_average": -0.0508,
    "shares_owned": "N/A",
    "short_ratio": 8.23,
    "two_hundred_day_moving_average": 2.82,
    "volume": 89295.0,
    "market_cap": 49210000.0,
    "price_to_sales_ttm": 9.47,
    "price_to_book_mrq": 15.92,
    "roa_ttm": -0.34979999999999994,
    "roe_ttm": -1.0552,
    "shares_outstanding": 23890000.0,
    "pcnt_held_by_insiders": 0.009300000000000001,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": 0.0696,
    "operating_cash_flow_ttm": -4130000.0,
    "levered_cash_flow_ttm": -2750000.0,
    "book_value_per_share_mrq": 0.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "IntelliPharmaCeutics International Inc."
  },
  "IPCM": {
    "p_e_ratio": 42.35,
    "peg_ratio": 1.81,
    "earnings_per_share": 1.87,
    "ebitda": 70370000.0,
    "eps_estimate_current_year": 2.19,
    "eps_estimate_next_quarter": 0.59,
    "fifty_day_moving_average": 79.31,
    "fifty_two_week_high": 80.09,
    "fifty_two_week_low": 36.12,
    "percent_change_from_200_day_moving_average": 0.3507,
    "percent_change_from_50_day_moving_average": -0.0013,
    "shares_owned": "N/A",
    "short_ratio": 0.92,
    "two_hundred_day_moving_average": 58.64,
    "volume": 106836.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 1.93,
    "price_to_book_mrq": 3.54,
    "roa_ttm": 0.066,
    "roe_ttm": 0.0908,
    "shares_outstanding": 17420000.0,
    "pcnt_held_by_insiders": 0.0204,
    "pcnt_held_by_institutions": 1.07,
    "pcnt_short_of_float": 0.042199999999999994,
    "operating_cash_flow_ttm": 54210000.0,
    "levered_cash_flow_ttm": 67390000.0,
    "book_value_per_share_mrq": 22.36,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "IPC Healthcare, Inc."
  },
  "IPXL": {
    "p_e_ratio": 381.89,
    "peg_ratio": 1.26,
    "earnings_per_share": 0.11,
    "ebitda": 106210000.0,
    "eps_estimate_current_year": 1.29,
    "eps_estimate_next_quarter": 0.48,
    "fifty_day_moving_average": 43.47,
    "fifty_two_week_high": 52.1,
    "fifty_two_week_low": 23.31,
    "percent_change_from_200_day_moving_average": -0.127,
    "percent_change_from_50_day_moving_average": -0.0689,
    "shares_owned": "N/A",
    "short_ratio": 11.95,
    "two_hundred_day_moving_average": 46.37,
    "volume": 1194119.0,
    "market_cap": 2920000000.0,
    "price_to_sales_ttm": 4.59,
    "price_to_book_mrq": 3.0,
    "roa_ttm": 0.023399999999999997,
    "roe_ttm": 0.0083,
    "shares_outstanding": 72060000.0,
    "pcnt_held_by_insiders": 0.0599,
    "pcnt_held_by_institutions": 0.816,
    "pcnt_short_of_float": 0.1884,
    "operating_cash_flow_ttm": -12190000.0,
    "levered_cash_flow_ttm": -69030000.0,
    "book_value_per_share_mrq": 14.21,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Impax Laboratories Inc."
  },
  "IRIX": {
    "p_e_ratio": 7.92,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.88,
    "ebitda": 1720000.0,
    "eps_estimate_current_year": 0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.01,
    "fifty_two_week_high": 11.28,
    "fifty_two_week_low": 6.41,
    "percent_change_from_200_day_moving_average": -0.1771,
    "percent_change_from_50_day_moving_average": -0.0023,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 8.49,
    "volume": 9905.0,
    "market_cap": 69890000.0,
    "price_to_sales_ttm": 1.68,
    "price_to_book_mrq": 2.1,
    "roa_ttm": 0.0212,
    "roe_ttm": 0.3002,
    "shares_outstanding": 10000000.0,
    "pcnt_held_by_insiders": 0.344,
    "pcnt_held_by_institutions": 0.247,
    "pcnt_short_of_float": 0.0038,
    "operating_cash_flow_ttm": 2980000.0,
    "levered_cash_flow_ttm": 214750.0,
    "book_value_per_share_mrq": 3.32,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRIDEX Corporation"
  },
  "IRMD": {
    "p_e_ratio": 81.03,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.32,
    "ebitda": 5850000.0,
    "eps_estimate_current_year": 0.63,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 25.4,
    "fifty_two_week_high": 28.43,
    "fifty_two_week_low": 6.7,
    "percent_change_from_200_day_moving_average": 0.2782,
    "percent_change_from_50_day_moving_average": 0.0239,
    "shares_owned": "N/A",
    "short_ratio": 4.14,
    "two_hundred_day_moving_average": 20.35,
    "volume": 108893.0,
    "market_cap": 287690000.0,
    "price_to_sales_ttm": 14.0,
    "price_to_book_mrq": 12.11,
    "roa_ttm": 0.18239999999999998,
    "roe_ttm": 0.23260000000000003,
    "shares_outstanding": 11060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0434,
    "operating_cash_flow_ttm": 3080000.0,
    "levered_cash_flow_ttm": 2200000.0,
    "book_value_per_share_mrq": 2.29,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "IRadimed Corporation"
  },
  "IRWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -6.14,
    "earnings_per_share": -1.14,
    "ebitda": -127880000.0,
    "eps_estimate_current_year": -0.87,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 11.18,
    "fifty_two_week_high": 17.11,
    "fifty_two_week_low": 10.0,
    "percent_change_from_200_day_moving_average": -0.2018,
    "percent_change_from_50_day_moving_average": -0.0771,
    "shares_owned": "N/A",
    "short_ratio": 9.81,
    "two_hundred_day_moving_average": 12.93,
    "volume": 1986423.0,
    "market_cap": 1470000000.0,
    "price_to_sales_ttm": 13.79,
    "price_to_book_mrq": 10.98,
    "roa_ttm": -0.17079999999999998,
    "roe_ttm": -1.1405,
    "shares_outstanding": 126680000.0,
    "pcnt_held_by_insiders": 0.0207,
    "pcnt_held_by_institutions": 1.099,
    "pcnt_short_of_float": 0.23170000000000002,
    "operating_cash_flow_ttm": -122800000.0,
    "levered_cash_flow_ttm": -67320000.0,
    "book_value_per_share_mrq": 0.98,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Ironwood Pharmaceuticals, Inc."
  },
  "ISIS": {
    "p_e_ratio": 231.47,
    "peg_ratio": -3.91,
    "earnings_per_share": 0.19,
    "ebitda": 34980000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 50.61,
    "fifty_two_week_high": 77.8,
    "fifty_two_week_low": 35.26,
    "percent_change_from_200_day_moving_average": -0.258,
    "percent_change_from_50_day_moving_average": -0.131,
    "shares_owned": "N/A",
    "short_ratio": 7.25,
    "two_hundred_day_moving_average": 59.27,
    "volume": 2491515.0,
    "market_cap": 5280000000.0,
    "price_to_sales_ttm": 17.65,
    "price_to_book_mrq": 18.32,
    "roa_ttm": 0.0176,
    "roe_ttm": 0.0699,
    "shares_outstanding": 119960000.0,
    "pcnt_held_by_insiders": 0.0079,
    "pcnt_held_by_institutions": 0.888,
    "pcnt_short_of_float": 0.12990000000000002,
    "operating_cash_flow_ttm": 95010000.0,
    "levered_cash_flow_ttm": 76230000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Isis Pharmaceuticals, Inc."
  },
  "ISR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.07,
    "ebitda": -3640000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.02,
    "fifty_day_moving_average": 1.46,
    "fifty_two_week_high": 3.79,
    "fifty_two_week_low": 1.22,
    "percent_change_from_200_day_moving_average": -0.045700000000000005,
    "percent_change_from_50_day_moving_average": 0.0072,
    "shares_owned": "N/A",
    "short_ratio": 12.17,
    "two_hundred_day_moving_average": 1.54,
    "volume": 249625.0,
    "market_cap": 80870000.0,
    "price_to_sales_ttm": 17.43,
    "price_to_book_mrq": 3.78,
    "roa_ttm": -0.1094,
    "roe_ttm": -0.1646,
    "shares_outstanding": 55010000.0,
    "pcnt_held_by_insiders": 0.0125,
    "pcnt_held_by_institutions": 0.04,
    "pcnt_short_of_float": 0.1251,
    "operating_cash_flow_ttm": -3520000.0,
    "levered_cash_flow_ttm": -2230000.0,
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "IsoRay, Inc."
  },
  "ITCI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.1,
    "ebitda": -65830000.0,
    "eps_estimate_current_year": -2.87,
    "eps_estimate_next_quarter": -0.82,
    "fifty_day_moving_average": 32.83,
    "fifty_two_week_high": 60.79,
    "fifty_two_week_low": 13.37,
    "percent_change_from_200_day_moving_average": 0.45530000000000004,
    "percent_change_from_50_day_moving_average": 0.2582,
    "shares_owned": "N/A",
    "short_ratio": 5.09,
    "two_hundred_day_moving_average": 28.39,
    "volume": 1210478.0,
    "market_cap": 1450000000.0,
    "price_to_sales_ttm": 6542.42,
    "price_to_book_mrq": 8.06,
    "roa_ttm": -0.2322,
    "roe_ttm": -0.3823,
    "shares_outstanding": 35060000.0,
    "pcnt_held_by_insiders": 0.3568,
    "pcnt_held_by_institutions": 0.41700000000000004,
    "pcnt_short_of_float": 0.1286,
    "operating_cash_flow_ttm": -57340000.0,
    "levered_cash_flow_ttm": -34950000.0,
    "book_value_per_share_mrq": 5.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intra-Cellular Therapies, Inc."
  },
  "ITEK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.65,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.54,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 13.35,
    "fifty_two_week_high": 19.45,
    "fifty_two_week_low": 4.68,
    "percent_change_from_200_day_moving_average": 0.3469,
    "percent_change_from_50_day_moving_average": -0.17379999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.56,
    "two_hundred_day_moving_average": 8.19,
    "volume": 623968.0,
    "market_cap": 291280000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.5,
    "roa_ttm": -0.21710000000000002,
    "roe_ttm": -0.5315,
    "shares_outstanding": 26410000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1153,
    "operating_cash_flow_ttm": -11880000.0,
    "levered_cash_flow_ttm": -5960000.0,
    "book_value_per_share_mrq": 1.94,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Inotek Pharmaceuticals Corporation"
  },
  "IVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.28,
    "earnings_per_share": -1.25,
    "ebitda": 1350000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 16.23,
    "fifty_two_week_high": 23.59,
    "fifty_two_week_low": 11.65,
    "percent_change_from_200_day_moving_average": -0.2034,
    "percent_change_from_50_day_moving_average": -0.047599999999999996,
    "shares_owned": "N/A",
    "short_ratio": 12.01,
    "two_hundred_day_moving_average": 19.41,
    "volume": 178412.0,
    "market_cap": 502790000.0,
    "price_to_sales_ttm": 0.44,
    "price_to_book_mrq": 1.08,
    "roa_ttm": -0.0147,
    "roe_ttm": -0.09,
    "shares_outstanding": 31440000.0,
    "pcnt_held_by_insiders": 0.0617,
    "pcnt_held_by_institutions": 0.877,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -12600000.0,
    "levered_cash_flow_ttm": 32090000.000000004,
    "book_value_per_share_mrq": 15.18,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Invacare Corporation"
  },
  "IVTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.13,
    "earnings_per_share": -23.3,
    "ebitda": -26220000.0,
    "eps_estimate_current_year": -4.74,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 13.07,
    "fifty_two_week_high": 18.18,
    "fifty_two_week_low": 10.0,
    "percent_change_from_200_day_moving_average": 0.06509999999999999,
    "percent_change_from_50_day_moving_average": 0.0849,
    "shares_owned": "N/A",
    "short_ratio": 3.55,
    "two_hundred_day_moving_average": 13.31,
    "volume": 33924.0,
    "market_cap": 188660000.0,
    "price_to_sales_ttm": 10.91,
    "price_to_book_mrq": 3.11,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0146,
    "operating_cash_flow_ttm": -25260000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 4.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Invuity, Inc."
  },
  "JAGX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -2.78,
    "ebitda": 0.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 3.28,
    "fifty_two_week_high": 7.06,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.2034,
    "percent_change_from_50_day_moving_average": 0.1295,
    "shares_owned": "N/A",
    "short_ratio": 0.67,
    "two_hundred_day_moving_average": 4.64,
    "volume": 2834.0,
    "market_cap": 30060000.0,
    "price_to_sales_ttm": 251.11,
    "price_to_book_mrq": 2.83,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8119999.999999999,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": -10720000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jaguar Animal Health, Inc."
  },
  "JAZZ": {
    "p_e_ratio": 32.74,
    "peg_ratio": 0.77,
    "earnings_per_share": 4.12,
    "ebitda": 668520000.0,
    "eps_estimate_current_year": 9.66,
    "eps_estimate_next_quarter": 2.7,
    "fifty_day_moving_average": 167.36,
    "fifty_two_week_high": 194.73,
    "fifty_two_week_low": 133.23,
    "percent_change_from_200_day_moving_average": -0.2391,
    "percent_change_from_50_day_moving_average": -0.19469999999999998,
    "shares_owned": "N/A",
    "short_ratio": 5.07,
    "two_hundred_day_moving_average": 177.13,
    "volume": 1411921.0,
    "market_cap": 8270000000.0,
    "price_to_sales_ttm": 6.87,
    "price_to_book_mrq": 6.07,
    "roa_ttm": 0.1048,
    "roe_ttm": 0.19519999999999998,
    "shares_outstanding": 61340000.0,
    "pcnt_held_by_insiders": 0.1425,
    "pcnt_held_by_institutions": 0.773,
    "pcnt_short_of_float": 0.057300000000000004,
    "operating_cash_flow_ttm": 499240000.0,
    "levered_cash_flow_ttm": 341520000.0,
    "book_value_per_share_mrq": 23.59,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Jazz Pharmaceuticals Public Limited Company"
  },
  "JNP": {
    "p_e_ratio": 64.81,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.21,
    "ebitda": 4750000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 11.77,
    "fifty_two_week_high": 15.44,
    "fifty_two_week_low": 5.09,
    "percent_change_from_200_day_moving_average": 0.4857,
    "percent_change_from_50_day_moving_average": 0.13419999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.03,
    "two_hundred_day_moving_average": 8.99,
    "volume": 90557.0,
    "market_cap": 144030000.0,
    "price_to_sales_ttm": 3.91,
    "price_to_book_mrq": 3.56,
    "roa_ttm": 0.031200000000000002,
    "roe_ttm": 0.0542,
    "shares_outstanding": 10790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.012,
    "operating_cash_flow_ttm": 6020000.0,
    "levered_cash_flow_ttm": 4650000.0,
    "book_value_per_share_mrq": 3.81,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Juniper Pharmaceuticals, Inc."
  },
  "JUNO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.46,
    "ebitda": -327050000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 39.42,
    "fifty_two_week_high": 69.28,
    "fifty_two_week_low": 33.0,
    "percent_change_from_200_day_moving_average": -0.19190000000000002,
    "percent_change_from_50_day_moving_average": 0.0116,
    "shares_owned": "N/A",
    "short_ratio": 3.47,
    "two_hundred_day_moving_average": 49.35,
    "volume": 2414914.0,
    "market_cap": 4010000000.0,
    "price_to_sales_ttm": 339.65,
    "price_to_book_mrq": 11.44,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 100560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1197,
    "operating_cash_flow_ttm": -129340000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Juno Therapeutics Inc."
  },
  "JYNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -0.83,
    "ebitda": -4210000.0,
    "eps_estimate_current_year": -0.9,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 8.05,
    "fifty_two_week_high": 12.99,
    "fifty_two_week_low": 5.99,
    "percent_change_from_200_day_moving_average": -0.2306,
    "percent_change_from_50_day_moving_average": -0.12869999999999998,
    "shares_owned": "N/A",
    "short_ratio": 11.79,
    "two_hundred_day_moving_average": 9.11,
    "volume": 2790.0,
    "market_cap": 68870000.0,
    "price_to_sales_ttm": 7.19,
    "price_to_book_mrq": 5.79,
    "roa_ttm": -0.17309999999999998,
    "roe_ttm": -1.2201,
    "shares_outstanding": 9830000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0174,
    "operating_cash_flow_ttm": -3250000.0,
    "levered_cash_flow_ttm": -2900000.0,
    "book_value_per_share_mrq": 1.24,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "The Joint Corp."
  },
  "KANG": {
    "p_e_ratio": 28.34,
    "peg_ratio": 0.4,
    "earnings_per_share": 0.51,
    "ebitda": 72030000.0,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 15.58,
    "fifty_two_week_high": 22.67,
    "fifty_two_week_low": 10.2,
    "percent_change_from_200_day_moving_average": -0.1573,
    "percent_change_from_50_day_moving_average": -0.0666,
    "shares_owned": "N/A",
    "short_ratio": 2.51,
    "two_hundred_day_moving_average": 17.25,
    "volume": 406281.0,
    "market_cap": 938560000.0,
    "price_to_sales_ttm": 2.96,
    "price_to_book_mrq": 2.91,
    "roa_ttm": 0.0643,
    "roe_ttm": 0.109,
    "shares_outstanding": 64550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.0,
    "next_earnings_announcement_date": [
      "2015-11-23",
      "2015-11-27"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "iKang Healthcare Group, Inc."
  },
  "KBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -8.11,
    "ebitda": -30190000.0,
    "eps_estimate_current_year": -6.49,
    "eps_estimate_next_quarter": -1.46,
    "fifty_day_moving_average": 2.54,
    "fifty_two_week_high": 17.2,
    "fifty_two_week_low": 1.71,
    "percent_change_from_200_day_moving_average": -0.3958,
    "percent_change_from_50_day_moving_average": -0.1521,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 3.56,
    "volume": 178984.0,
    "market_cap": 8870000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.96,
    "roa_ttm": -0.4409,
    "roe_ttm": -1.29,
    "shares_outstanding": 4120000.0,
    "pcnt_held_by_insiders": 0.1894,
    "pcnt_held_by_institutions": 0.637,
    "pcnt_short_of_float": 0.006500000000000001,
    "operating_cash_flow_ttm": -30110000.0,
    "levered_cash_flow_ttm": -17430000.0,
    "book_value_per_share_mrq": 2.53,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KaloBios Pharmaceuticals, Inc."
  },
  "KERX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -1.34,
    "ebitda": -126330000.0,
    "eps_estimate_current_year": -1.01,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 5.32,
    "fifty_two_week_high": 17.97,
    "fifty_two_week_low": 3.6,
    "percent_change_from_200_day_moving_average": -0.6107,
    "percent_change_from_50_day_moving_average": -0.3181,
    "shares_owned": "N/A",
    "short_ratio": 20.21,
    "two_hundred_day_moving_average": 9.32,
    "volume": 3126704.0,
    "market_cap": 381770000.0,
    "price_to_sales_ttm": 92.73,
    "price_to_book_mrq": 2.84,
    "roa_ttm": -0.4953,
    "roe_ttm": -0.9592,
    "shares_outstanding": 105170000.0,
    "pcnt_held_by_insiders": 0.1707,
    "pcnt_held_by_institutions": 0.679,
    "pcnt_short_of_float": 0.4107,
    "operating_cash_flow_ttm": -127430000.0,
    "levered_cash_flow_ttm": -79490000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Keryx Biopharmaceuticals Inc."
  },
  "KIN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.24,
    "earnings_per_share": -1.34,
    "ebitda": -26470000.0,
    "eps_estimate_current_year": -1.68,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 5.96,
    "fifty_two_week_high": 10.07,
    "fifty_two_week_low": 4.18,
    "percent_change_from_200_day_moving_average": -0.10220000000000001,
    "percent_change_from_50_day_moving_average": 0.0083,
    "shares_owned": "N/A",
    "short_ratio": 4.18,
    "two_hundred_day_moving_average": 6.69,
    "volume": 19813.0,
    "market_cap": 118950000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.36,
    "roa_ttm": -0.1632,
    "roe_ttm": -0.2682,
    "shares_outstanding": 19790000.0,
    "pcnt_held_by_insiders": 0.1117,
    "pcnt_held_by_institutions": 0.379,
    "pcnt_short_of_float": 0.0177,
    "operating_cash_flow_ttm": -22430000.0,
    "levered_cash_flow_ttm": -13110000.0,
    "book_value_per_share_mrq": 4.43,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kindred Biosciences, Inc."
  },
  "KITE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.42,
    "ebitda": -58210000.0,
    "eps_estimate_current_year": -2.05,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 58.62,
    "fifty_two_week_high": 89.21,
    "fifty_two_week_low": 27.01,
    "percent_change_from_200_day_moving_average": -0.059500000000000004,
    "percent_change_from_50_day_moving_average": -0.0274,
    "shares_owned": "N/A",
    "short_ratio": 5.47,
    "two_hundred_day_moving_average": 60.62,
    "volume": 1710405.0,
    "market_cap": 2490000000.0,
    "price_to_sales_ttm": 363.67,
    "price_to_book_mrq": 7.02,
    "roa_ttm": -0.1116,
    "roe_ttm": -0.20190000000000002,
    "shares_outstanding": 43730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.25129999999999997,
    "operating_cash_flow_ttm": 13880000.0,
    "levered_cash_flow_ttm": 7520000.0,
    "book_value_per_share_mrq": 8.63,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Kite Pharma, Inc."
  },
  "KMDA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.43,
    "earnings_per_share": -0.26,
    "ebitda": -3040000.0,
    "eps_estimate_current_year": -0.17,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 3.56,
    "fifty_two_week_high": 5.15,
    "fifty_two_week_low": 3.02,
    "percent_change_from_200_day_moving_average": -0.14279999999999998,
    "percent_change_from_50_day_moving_average": -0.0197,
    "shares_owned": "N/A",
    "short_ratio": 0.74,
    "two_hundred_day_moving_average": 4.07,
    "volume": 3101.0,
    "market_cap": 136230000.0,
    "price_to_sales_ttm": 1.94,
    "price_to_book_mrq": 1.82,
    "roa_ttm": -0.0315,
    "roe_ttm": -0.1201,
    "shares_outstanding": 39030000.0,
    "pcnt_held_by_insiders": 0.1582,
    "pcnt_held_by_institutions": 0.084,
    "pcnt_short_of_float": 0.0005,
    "operating_cash_flow_ttm": -12310000.0,
    "levered_cash_flow_ttm": -10720000.0,
    "book_value_per_share_mrq": 1.93,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Kamada Ltd."
  },
  "KMPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.33,
    "ebitda": -20800000.0,
    "eps_estimate_current_year": -3.33,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 20.44,
    "fifty_two_week_high": 26.15,
    "fifty_two_week_low": 10.9,
    "percent_change_from_200_day_moving_average": 0.2398,
    "percent_change_from_50_day_moving_average": 0.0064,
    "shares_owned": "N/A",
    "short_ratio": 1.17,
    "two_hundred_day_moving_average": 16.59,
    "volume": 54180.0,
    "market_cap": 292680000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 89.59,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 14230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.010700000000000001,
    "operating_cash_flow_ttm": -20110000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.24,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "KemPharm, Inc."
  },
  "KND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.01,
    "earnings_per_share": -2.41,
    "ebitda": 444150000.0,
    "eps_estimate_current_year": 1.37,
    "eps_estimate_next_quarter": 0.39,
    "fifty_day_moving_average": 20.36,
    "fifty_two_week_high": 24.66,
    "fifty_two_week_low": 16.94,
    "percent_change_from_200_day_moving_average": -0.1775,
    "percent_change_from_50_day_moving_average": -0.11900000000000001,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 21.81,
    "volume": 531209.0,
    "market_cap": 1500000000.0,
    "price_to_sales_ttm": 0.26,
    "price_to_book_mrq": 1.04,
    "roa_ttm": 0.034,
    "roe_ttm": -0.0664,
    "shares_outstanding": 83880000.0,
    "pcnt_held_by_insiders": 0.0305,
    "pcnt_held_by_institutions": 0.8079999999999999,
    "pcnt_short_of_float": 0.0528,
    "operating_cash_flow_ttm": 131960000.00000001,
    "levered_cash_flow_ttm": 222620000.0,
    "book_value_per_share_mrq": 17.67,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Kindred Healthcare Inc."
  },
  "KOOL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.37,
    "ebitda": -13350000.0,
    "eps_estimate_current_year": -0.23,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 0.65,
    "fifty_two_week_high": 1.3,
    "fifty_two_week_low": 0.58,
    "percent_change_from_200_day_moving_average": -0.1858,
    "percent_change_from_50_day_moving_average": -0.0175,
    "shares_owned": "N/A",
    "short_ratio": 4.42,
    "two_hundred_day_moving_average": 0.79,
    "volume": 25436.0,
    "market_cap": 25990000.0,
    "price_to_sales_ttm": 1.62,
    "price_to_book_mrq": 0.74,
    "roa_ttm": -0.1617,
    "roe_ttm": -0.3553,
    "shares_outstanding": 40620000.0,
    "pcnt_held_by_insiders": 0.2369,
    "pcnt_held_by_institutions": 0.075,
    "pcnt_short_of_float": 0.0048,
    "operating_cash_flow_ttm": -10650000.0,
    "levered_cash_flow_ttm": -4990000.0,
    "book_value_per_share_mrq": 0.86,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Cesca Therapeutics Inc."
  },
  "KPTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.33,
    "earnings_per_share": -3.06,
    "ebitda": -104320000.0,
    "eps_estimate_current_year": -3.45,
    "eps_estimate_next_quarter": -0.9,
    "fifty_day_moving_average": 14.08,
    "fifty_two_week_high": 49.01,
    "fifty_two_week_low": 11.58,
    "percent_change_from_200_day_moving_average": -0.4825,
    "percent_change_from_50_day_moving_average": -0.105,
    "shares_owned": "N/A",
    "short_ratio": 5.81,
    "two_hundred_day_moving_average": 24.35,
    "volume": 350119.0,
    "market_cap": 449960000.0,
    "price_to_sales_ttm": 2578.49,
    "price_to_book_mrq": 1.94,
    "roa_ttm": -0.32689999999999997,
    "roe_ttm": -0.551,
    "shares_outstanding": 35710000.0,
    "pcnt_held_by_insiders": 0.2562,
    "pcnt_held_by_institutions": 0.195,
    "pcnt_short_of_float": 0.4556,
    "operating_cash_flow_ttm": -77320000.0,
    "levered_cash_flow_ttm": -45060000.0,
    "book_value_per_share_mrq": 6.93,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Karyopharm Therapeutics, Inc."
  },
  "KTWO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.18,
    "earnings_per_share": -1.25,
    "ebitda": -14150000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 21.15,
    "fifty_two_week_high": 26.29,
    "fifty_two_week_low": 12.31,
    "percent_change_from_200_day_moving_average": -0.1795,
    "percent_change_from_50_day_moving_average": -0.1153,
    "shares_owned": "N/A",
    "short_ratio": 4.2,
    "two_hundred_day_moving_average": 22.8,
    "volume": 219522.0,
    "market_cap": 773430000.0,
    "price_to_sales_ttm": 4.19,
    "price_to_book_mrq": 2.94,
    "roa_ttm": -0.0767,
    "roe_ttm": -0.17170000000000002,
    "shares_outstanding": 41340000.0,
    "pcnt_held_by_insiders": 0.0092,
    "pcnt_held_by_institutions": 0.10400000000000001,
    "pcnt_short_of_float": 0.048799999999999996,
    "operating_cash_flow_ttm": -23340000.0,
    "levered_cash_flow_ttm": -12640000.0,
    "book_value_per_share_mrq": 6.93,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "K2M Group Holdings, Inc."
  },
  "KYTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.83,
    "earnings_per_share": -4.77,
    "ebitda": -107530000.0,
    "eps_estimate_current_year": -4.3,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 74.75,
    "fifty_two_week_high": 76.31,
    "fifty_two_week_low": 29.86,
    "percent_change_from_200_day_moving_average": 0.20309999999999997,
    "percent_change_from_50_day_moving_average": 0.0024,
    "shares_owned": "N/A",
    "short_ratio": 3.07,
    "two_hundred_day_moving_average": 62.28,
    "volume": 1344678.0,
    "market_cap": 1970000000.0,
    "price_to_sales_ttm": 6839.21,
    "price_to_book_mrq": 13.43,
    "roa_ttm": -0.4045,
    "roe_ttm": -0.9159999999999999,
    "shares_outstanding": 26300000.0,
    "pcnt_held_by_insiders": 0.3552,
    "pcnt_held_by_institutions": 0.8170000000000001,
    "pcnt_short_of_float": 0.0682,
    "operating_cash_flow_ttm": -77300000.0,
    "levered_cash_flow_ttm": -42620000.0,
    "book_value_per_share_mrq": 5.58,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Kythera Biopharmaceuticals, Inc."
  },
  "LAKE": {
    "p_e_ratio": 8.45,
    "peg_ratio": 1.04,
    "earnings_per_share": 1.73,
    "ebitda": 13650000.0,
    "eps_estimate_current_year": 1.29,
    "eps_estimate_next_quarter": 0.23,
    "fifty_day_moving_average": 10.52,
    "fifty_two_week_high": 29.55,
    "fifty_two_week_low": 6.85,
    "percent_change_from_200_day_moving_average": 0.41840000000000005,
    "percent_change_from_50_day_moving_average": 0.38799999999999996,
    "shares_owned": "N/A",
    "short_ratio": 10.86,
    "two_hundred_day_moving_average": 10.29,
    "volume": 137367.0,
    "market_cap": 105610000.0,
    "price_to_sales_ttm": 0.97,
    "price_to_book_mrq": 1.57,
    "roa_ttm": 0.0862,
    "roe_ttm": 0.231,
    "shares_outstanding": 7230000.0,
    "pcnt_held_by_insiders": 0.1991,
    "pcnt_held_by_institutions": 0.304,
    "pcnt_short_of_float": 0.0664,
    "operating_cash_flow_ttm": -390090.0,
    "levered_cash_flow_ttm": 8240000.0,
    "book_value_per_share_mrq": 9.34,
    "next_earnings_announcement_date": [
      "2015-12-08",
      "2015-12-14"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Lakeland Industries Inc."
  },
  "LBIO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -18910000.0,
    "eps_estimate_current_year": -0.6,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 7.06,
    "fifty_two_week_high": 15.03,
    "fifty_two_week_low": 4.97,
    "percent_change_from_200_day_moving_average": -0.3746,
    "percent_change_from_50_day_moving_average": -0.1258,
    "shares_owned": "N/A",
    "short_ratio": 12.47,
    "two_hundred_day_moving_average": 9.87,
    "volume": 766661.0,
    "market_cap": 291170000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.8,
    "roa_ttm": -0.182,
    "roe_ttm": -0.2968,
    "shares_outstanding": 47190000.0,
    "pcnt_held_by_insiders": 0.728,
    "pcnt_held_by_institutions": 0.134,
    "pcnt_short_of_float": 0.162,
    "operating_cash_flow_ttm": -13000000.0,
    "levered_cash_flow_ttm": -8320000.0,
    "book_value_per_share_mrq": 2.39,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lion Biotechnologies, Inc."
  },
  "LBMH": {
    "p_e_ratio": 17.3,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.15,
    "ebitda": 13720000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.48,
    "fifty_two_week_high": 3.9,
    "fifty_two_week_low": 1.96,
    "percent_change_from_200_day_moving_average": -0.0695,
    "percent_change_from_50_day_moving_average": 0.031,
    "shares_owned": "N/A",
    "short_ratio": 3.17,
    "two_hundred_day_moving_average": 2.75,
    "volume": 60550.0,
    "market_cap": 136840000.0,
    "price_to_sales_ttm": 1.74,
    "price_to_book_mrq": 4.13,
    "roa_ttm": 0.1512,
    "roe_ttm": 0.2402,
    "shares_outstanding": 53460000.0,
    "pcnt_held_by_insiders": 0.5114,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.0132,
    "operating_cash_flow_ttm": 5050000.0,
    "levered_cash_flow_ttm": 19060000.0,
    "book_value_per_share_mrq": 0.63,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Liberator Medical Holdings, Inc."
  },
  "LCI": {
    "p_e_ratio": 12.25,
    "peg_ratio": 0.73,
    "earnings_per_share": 4.04,
    "ebitda": 236070000.0,
    "eps_estimate_current_year": 4.12,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 52.86,
    "fifty_two_week_high": 72.44,
    "fifty_two_week_low": 39.05,
    "percent_change_from_200_day_moving_average": -0.1578,
    "percent_change_from_50_day_moving_average": -0.0638,
    "shares_owned": "N/A",
    "short_ratio": 9.78,
    "two_hundred_day_moving_average": 58.76,
    "volume": 948652.0,
    "market_cap": 1810000000.0,
    "price_to_sales_ttm": 4.71,
    "price_to_book_mrq": 4.11,
    "roa_ttm": 0.3383,
    "roe_ttm": 0.39549999999999996,
    "shares_outstanding": 36480000.0,
    "pcnt_held_by_insiders": 0.2785,
    "pcnt_held_by_institutions": 0.494,
    "pcnt_short_of_float": 0.3614,
    "operating_cash_flow_ttm": 128520000.00000001,
    "levered_cash_flow_ttm": 83580000.0,
    "book_value_per_share_mrq": 12.78,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lannett Company, Inc."
  },
  "LDRH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.78,
    "earnings_per_share": -0.54,
    "ebitda": -10670000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 39.21,
    "fifty_two_week_high": 47.12,
    "fifty_two_week_low": 29.91,
    "percent_change_from_200_day_moving_average": -0.14800000000000002,
    "percent_change_from_50_day_moving_average": -0.12960000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.14,
    "two_hundred_day_moving_average": 40.06,
    "volume": 307229.0,
    "market_cap": 979110000.0,
    "price_to_sales_ttm": 6.41,
    "price_to_book_mrq": 9.59,
    "roa_ttm": -0.0637,
    "roe_ttm": -0.1318,
    "shares_outstanding": 28690000.0,
    "pcnt_held_by_insiders": 0.0922,
    "pcnt_held_by_institutions": 0.423,
    "pcnt_short_of_float": 0.06280000000000001,
    "operating_cash_flow_ttm": -14920000.0,
    "levered_cash_flow_ttm": -17350000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "LDR Holding Corporation"
  },
  "LENS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.46,
    "ebitda": -17870000.0,
    "eps_estimate_current_year": -1.62,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 6.71,
    "fifty_two_week_high": 9.38,
    "fifty_two_week_low": 5.2,
    "percent_change_from_200_day_moving_average": -0.3073,
    "percent_change_from_50_day_moving_average": -0.2206,
    "shares_owned": "N/A",
    "short_ratio": 33.45,
    "two_hundred_day_moving_average": 7.55,
    "volume": 8136.0,
    "market_cap": 69850000.0,
    "price_to_sales_ttm": 409.13,
    "price_to_book_mrq": 2.63,
    "roa_ttm": -0.6774,
    "roe_ttm": -2.8744,
    "shares_outstanding": 13360000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0559,
    "operating_cash_flow_ttm": -11980000.0,
    "levered_cash_flow_ttm": -10880000.0,
    "book_value_per_share_mrq": 2.2,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Presbia PLC"
  },
  "LGND": {
    "p_e_ratio": 59.14,
    "peg_ratio": 0.62,
    "earnings_per_share": 1.55,
    "ebitda": 24680000.0,
    "eps_estimate_current_year": 3.52,
    "eps_estimate_next_quarter": 0.95,
    "fifty_day_moving_average": 93.65,
    "fifty_two_week_high": 112.4,
    "fifty_two_week_low": 41.99,
    "percent_change_from_200_day_moving_average": 0.0137,
    "percent_change_from_50_day_moving_average": -0.020499999999999997,
    "shares_owned": "N/A",
    "short_ratio": 9.22,
    "two_hundred_day_moving_average": 90.49,
    "volume": 507841.0,
    "market_cap": 1820000000.0,
    "price_to_sales_ttm": 27.18,
    "price_to_book_mrq": 27.92,
    "roa_ttm": 0.0682,
    "roe_ttm": 0.4457,
    "shares_outstanding": 19850000.0,
    "pcnt_held_by_insiders": 0.0062,
    "pcnt_held_by_institutions": 0.941,
    "pcnt_short_of_float": 0.25329999999999997,
    "operating_cash_flow_ttm": 31610000.0,
    "levered_cash_flow_ttm": 19930000.0,
    "book_value_per_share_mrq": 3.48,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ligand Pharmaceuticals Incorporated"
  },
  "LHCG": {
    "p_e_ratio": 30.36,
    "peg_ratio": 1.79,
    "earnings_per_share": 1.57,
    "ebitda": 71840000.0,
    "eps_estimate_current_year": 1.8,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 46.75,
    "fifty_two_week_high": 51.83,
    "fifty_two_week_low": 22.37,
    "percent_change_from_200_day_moving_average": 0.23190000000000002,
    "percent_change_from_50_day_moving_average": 0.0203,
    "shares_owned": "N/A",
    "short_ratio": 2.46,
    "two_hundred_day_moving_average": 38.72,
    "volume": 169468.0,
    "market_cap": 856670000.0,
    "price_to_sales_ttm": 1.18,
    "price_to_book_mrq": 2.59,
    "roa_ttm": 0.0756,
    "roe_ttm": 0.1074,
    "shares_outstanding": 17960000.0,
    "pcnt_held_by_insiders": 0.1724,
    "pcnt_held_by_institutions": 0.805,
    "pcnt_short_of_float": 0.0329,
    "operating_cash_flow_ttm": 62810000.0,
    "levered_cash_flow_ttm": 44750000.0,
    "book_value_per_share_mrq": 19.29,
    "next_earnings_announcement_date": "2015-11-04",
    "sector": "Healthcare",
    "industry": "Home Health Care",
    "company_name": "LHC Group, Inc."
  },
  "LIFE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.49,
    "ebitda": -31250000.0,
    "eps_estimate_current_year": 4.19,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 15.83,
    "fifty_two_week_high": 28.29,
    "fifty_two_week_low": 12.05,
    "percent_change_from_200_day_moving_average": -0.2914,
    "percent_change_from_50_day_moving_average": -0.1616,
    "shares_owned": "N/A",
    "short_ratio": 13.9,
    "two_hundred_day_moving_average": 18.73,
    "volume": 298645.0,
    "market_cap": 313690000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.58,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23640000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.9179999999999999,
    "pcnt_short_of_float": 0.062400000000000004,
    "operating_cash_flow_ttm": -29070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 5.89,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "aTyr Pharma Inc."
  },
  "LJPC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -2.12,
    "ebitda": -31190000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 32.84,
    "fifty_two_week_high": 44.99,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": 0.1882,
    "percent_change_from_50_day_moving_average": -0.0748,
    "shares_owned": "N/A",
    "short_ratio": 6.84,
    "two_hundred_day_moving_average": 25.57,
    "volume": 690270.0,
    "market_cap": 552410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 17.8,
    "roa_ttm": -0.9122,
    "roe_ttm": -1.604,
    "shares_outstanding": 18180000.0,
    "pcnt_held_by_insiders": 0.35090000000000005,
    "pcnt_held_by_institutions": 0.172,
    "pcnt_short_of_float": 0.1278,
    "operating_cash_flow_ttm": -19440000.0,
    "levered_cash_flow_ttm": -8930000.0,
    "book_value_per_share_mrq": 1.94,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "La Jolla Pharmaceutical Co."
  },
  "LMAT": {
    "p_e_ratio": 41.01,
    "peg_ratio": 2.94,
    "earnings_per_share": 0.33,
    "ebitda": 13090000.0,
    "eps_estimate_current_year": 0.33,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 13.49,
    "fifty_two_week_high": 14.82,
    "fifty_two_week_low": 6.48,
    "percent_change_from_200_day_moving_average": 0.21969999999999998,
    "percent_change_from_50_day_moving_average": -0.0087,
    "shares_owned": "N/A",
    "short_ratio": 3.1,
    "two_hundred_day_moving_average": 10.96,
    "volume": 172520.0,
    "market_cap": 236900000.0,
    "price_to_sales_ttm": 3.29,
    "price_to_book_mrq": 3.46,
    "roa_ttm": 0.0741,
    "roe_ttm": 0.0866,
    "shares_outstanding": 17720000.0,
    "pcnt_held_by_insiders": 0.3141,
    "pcnt_held_by_institutions": 0.363,
    "pcnt_short_of_float": 0.038599999999999995,
    "operating_cash_flow_ttm": 8880000.0,
    "levered_cash_flow_ttm": 8230000.0,
    "book_value_per_share_mrq": 3.99,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "LeMaitre Vascular, Inc."
  },
  "LMNS": {
    "p_e_ratio": 28.36,
    "peg_ratio": 0.9,
    "earnings_per_share": 0.48,
    "ebitda": 29420000.0,
    "eps_estimate_current_year": 0.62,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 13.86,
    "fifty_two_week_high": 13.97,
    "fifty_two_week_low": 8.45,
    "percent_change_from_200_day_moving_average": 0.0721,
    "percent_change_from_50_day_moving_average": -0.015600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.45,
    "two_hundred_day_moving_average": 12.72,
    "volume": 478430.0,
    "market_cap": 491600000.0,
    "price_to_sales_ttm": 1.68,
    "price_to_book_mrq": 4.8,
    "roa_ttm": 0.0504,
    "roe_ttm": 0.1893,
    "shares_outstanding": 36040000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004699999999999999,
    "operating_cash_flow_ttm": 9800000.0,
    "levered_cash_flow_ttm": 6400000.0,
    "book_value_per_share_mrq": 2.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Lumenis Ltd."
  },
  "LMNX": {
    "p_e_ratio": 19.31,
    "peg_ratio": 1.99,
    "earnings_per_share": 0.91,
    "ebitda": 49570000.0,
    "eps_estimate_current_year": 0.5,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 18.55,
    "fifty_two_week_high": 21.69,
    "fifty_two_week_low": 15.05,
    "percent_change_from_200_day_moving_average": 0.016399999999999998,
    "percent_change_from_50_day_moving_average": -0.0537,
    "shares_owned": "N/A",
    "short_ratio": 14.44,
    "two_hundred_day_moving_average": 17.27,
    "volume": 370799.0,
    "market_cap": 755480000.0,
    "price_to_sales_ttm": 3.29,
    "price_to_book_mrq": 2.24,
    "roa_ttm": 0.0667,
    "roe_ttm": 0.1243,
    "shares_outstanding": 43050000.0,
    "pcnt_held_by_insiders": 0.1343,
    "pcnt_held_by_institutions": 0.6809999999999999,
    "pcnt_short_of_float": 0.1408,
    "operating_cash_flow_ttm": 59080000.0,
    "levered_cash_flow_ttm": 25230000.0,
    "book_value_per_share_mrq": 7.89,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Luminex Corporation"
  },
  "LNTH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.41,
    "earnings_per_share": -1.35,
    "ebitda": 58710000.0,
    "eps_estimate_current_year": 0.29,
    "eps_estimate_next_quarter": 0.03,
    "fifty_day_moving_average": 6.74,
    "fifty_two_week_high": 8.58,
    "fifty_two_week_low": 5.38,
    "percent_change_from_200_day_moving_average": -0.1558,
    "percent_change_from_50_day_moving_average": -0.1464,
    "shares_owned": "N/A",
    "short_ratio": 0.4,
    "two_hundred_day_moving_average": 6.81,
    "volume": 152157.0,
    "market_cap": 177450000.0,
    "price_to_sales_ttm": 0.6,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.0964,
    "roe_ttm": "N/A",
    "shares_outstanding": 30860000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0045000000000000005,
    "operating_cash_flow_ttm": 20360000.0,
    "levered_cash_flow_ttm": 15190000.0,
    "book_value_per_share_mrq": -6.45,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Lantheus Holdings, Inc."
  },
  "LOXO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.88,
    "ebitda": 0.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 20.75,
    "fifty_two_week_high": 23.56,
    "fifty_two_week_low": 9.9,
    "percent_change_from_200_day_moving_average": 0.30469999999999997,
    "percent_change_from_50_day_moving_average": 0.0218,
    "shares_owned": "N/A",
    "short_ratio": 7.69,
    "two_hundred_day_moving_average": 16.25,
    "volume": 69395.0,
    "market_cap": 353770000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.75,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 16690000.000000002,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0701,
    "operating_cash_flow_ttm": -22480000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Loxo Oncology, Inc."
  },
  "LPCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -15320000.0,
    "eps_estimate_current_year": -1.07,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 15.64,
    "fifty_two_week_high": 19.23,
    "fifty_two_week_low": 3.7,
    "percent_change_from_200_day_moving_average": 0.4481,
    "percent_change_from_50_day_moving_average": -0.0698,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 10.05,
    "volume": 246192.0,
    "market_cap": 265459999.99999997,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.52,
    "roa_ttm": -0.2147,
    "roe_ttm": -0.3569,
    "shares_outstanding": 18240000.0,
    "pcnt_held_by_insiders": 0.4877,
    "pcnt_held_by_institutions": 0.003,
    "pcnt_short_of_float": 0.0441,
    "operating_cash_flow_ttm": -13330000.0,
    "levered_cash_flow_ttm": -7590000.0,
    "book_value_per_share_mrq": 2.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Lipocine Inc."
  },
  "LPNT": {
    "p_e_ratio": 25.04,
    "peg_ratio": 2.45,
    "earnings_per_share": 2.91,
    "ebitda": 627500000.0,
    "eps_estimate_current_year": 3.96,
    "eps_estimate_next_quarter": 1.08,
    "fifty_day_moving_average": 79.06,
    "fifty_two_week_high": 88.18,
    "fifty_two_week_low": 62.95,
    "percent_change_from_200_day_moving_average": -0.0663,
    "percent_change_from_50_day_moving_average": -0.0775,
    "shares_owned": "N/A",
    "short_ratio": 3.01,
    "two_hundred_day_moving_average": 78.11,
    "volume": 444834.0,
    "market_cap": 3240000000.0,
    "price_to_sales_ttm": 0.68,
    "price_to_book_mrq": 1.5,
    "roa_ttm": 0.0401,
    "roe_ttm": 0.0639,
    "shares_outstanding": 44410000.0,
    "pcnt_held_by_insiders": 0.023,
    "pcnt_held_by_institutions": 0.99,
    "pcnt_short_of_float": 0.0339,
    "operating_cash_flow_ttm": 603700000.0,
    "levered_cash_flow_ttm": 320940000.0,
    "book_value_per_share_mrq": 50.43,
    "next_earnings_announcement_date": [
      "2015-10-22",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "LifePoint Health, Inc."
  },
  "LPTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.785,
    "ebitda": -16410000.0,
    "eps_estimate_current_year": 2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.229,
    "fifty_two_week_high": 3.8,
    "fifty_two_week_low": 0.18,
    "percent_change_from_200_day_moving_average": -0.8156399999999999,
    "percent_change_from_50_day_moving_average": -0.16210000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.3,
    "two_hundred_day_moving_average": 1.041,
    "volume": 385285.0,
    "market_cap": 5650000.0,
    "price_to_sales_ttm": 1.82,
    "price_to_book_mrq": 0.45,
    "roa_ttm": -0.6156,
    "roe_ttm": -1.157,
    "shares_outstanding": 29400000.0,
    "pcnt_held_by_insiders": 0.2682,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.11720000000000001,
    "operating_cash_flow_ttm": -15520000.0,
    "levered_cash_flow_ttm": -9690000.0,
    "book_value_per_share_mrq": 0.49,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lpath Inc."
  },
  "LXRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.12,
    "earnings_per_share": -1.09,
    "ebitda": -75390000.0,
    "eps_estimate_current_year": -1.29,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 12.15,
    "fifty_two_week_high": 15.79,
    "fifty_two_week_low": 5.6,
    "percent_change_from_200_day_moving_average": 0.25329999999999997,
    "percent_change_from_50_day_moving_average": -0.0799,
    "shares_owned": "N/A",
    "short_ratio": 2.71,
    "two_hundred_day_moving_average": 8.92,
    "volume": 1097420.0,
    "market_cap": 1160000000.0,
    "price_to_sales_ttm": 53.29,
    "price_to_book_mrq": 5.54,
    "roa_ttm": -0.14980000000000002,
    "roe_ttm": -0.5721,
    "shares_outstanding": 103610000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.856,
    "pcnt_short_of_float": 0.294,
    "operating_cash_flow_ttm": -81310000.0,
    "levered_cash_flow_ttm": -62520000.0,
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Lexicon Pharmaceuticals, Inc."
  },
  "MACK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.56,
    "earnings_per_share": -0.89,
    "ebitda": -74360000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": -0.18,
    "fifty_day_moving_average": 10.11,
    "fifty_two_week_high": 13.84,
    "fifty_two_week_low": 7.36,
    "percent_change_from_200_day_moving_average": -0.20679999999999998,
    "percent_change_from_50_day_moving_average": -0.1105,
    "shares_owned": "N/A",
    "short_ratio": 12.0,
    "two_hundred_day_moving_average": 11.33,
    "volume": 2112114.0,
    "market_cap": 1000000000.0,
    "price_to_sales_ttm": 9.34,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.4121,
    "roe_ttm": "N/A",
    "shares_outstanding": 111420000.0,
    "pcnt_held_by_insiders": 0.1217,
    "pcnt_held_by_institutions": 0.536,
    "pcnt_short_of_float": 0.226,
    "operating_cash_flow_ttm": -30250000.0,
    "levered_cash_flow_ttm": -17780000.0,
    "book_value_per_share_mrq": -1.29,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Merrimack Pharmaceuticals, Inc."
  },
  "MASI": {
    "p_e_ratio": 28.48,
    "peg_ratio": 1.78,
    "earnings_per_share": 1.41,
    "ebitda": 122010000.0,
    "eps_estimate_current_year": 1.43,
    "eps_estimate_next_quarter": 0.38,
    "fifty_day_moving_average": 41.61,
    "fifty_two_week_high": 46.0,
    "fifty_two_week_low": 20.48,
    "percent_change_from_200_day_moving_average": 0.0692,
    "percent_change_from_50_day_moving_average": -0.0344,
    "shares_owned": "N/A",
    "short_ratio": 3.75,
    "two_hundred_day_moving_average": 37.58,
    "volume": 505059.0,
    "market_cap": 2049999999.9999998,
    "price_to_sales_ttm": 3.56,
    "price_to_book_mrq": 7.65,
    "roa_ttm": 0.1245,
    "roe_ttm": 0.25329999999999997,
    "shares_outstanding": 50990000.0,
    "pcnt_held_by_insiders": 0.0944,
    "pcnt_held_by_institutions": 0.878,
    "pcnt_short_of_float": 0.04019999999999999,
    "operating_cash_flow_ttm": 84910000.0,
    "levered_cash_flow_ttm": 53620000.0,
    "book_value_per_share_mrq": 5.56,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Masimo Corporation"
  },
  "MCRB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.61,
    "ebitda": -30960000.0,
    "eps_estimate_current_year": -1.69,
    "eps_estimate_next_quarter": -0.39,
    "fifty_day_moving_average": 42.13,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 28.11,
    "percent_change_from_200_day_moving_average": -0.0739,
    "percent_change_from_50_day_moving_average": -0.0897,
    "shares_owned": "N/A",
    "short_ratio": 11.48,
    "two_hundred_day_moving_average": 41.41,
    "volume": 296174.0,
    "market_cap": 1490000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 12.55,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 38960000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1117,
    "operating_cash_flow_ttm": -24850000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.12,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seres Therapeutics, Inc."
  },
  "MCUR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -1.8,
    "ebitda": -26140000.0,
    "eps_estimate_current_year": -1.38,
    "eps_estimate_next_quarter": -0.3,
    "fifty_day_moving_average": 5.89,
    "fifty_two_week_high": 16.1,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": -0.6804000000000001,
    "percent_change_from_50_day_moving_average": -0.4517,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 10.11,
    "volume": 55096.0,
    "market_cap": 53970000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.74,
    "roa_ttm": -0.6509999999999999,
    "roe_ttm": -1.3743,
    "shares_outstanding": 16710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.011699999999999999,
    "operating_cash_flow_ttm": -22050000.0,
    "levered_cash_flow_ttm": -14810000.0,
    "book_value_per_share_mrq": 2.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Macrocure Ltd."
  },
  "MD": {
    "p_e_ratio": 24.1,
    "peg_ratio": 1.71,
    "earnings_per_share": 3.38,
    "ebitda": 589430000.0,
    "eps_estimate_current_year": 3.65,
    "eps_estimate_next_quarter": 1.03,
    "fifty_day_moving_average": 82.24,
    "fifty_two_week_high": 86.09,
    "fifty_two_week_low": 49.82,
    "percent_change_from_200_day_moving_average": 0.0747,
    "percent_change_from_50_day_moving_average": -0.008100000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.86,
    "two_hundred_day_moving_average": 75.9,
    "volume": 729928.0,
    "market_cap": 7660000000.0,
    "price_to_sales_ttm": 2.97,
    "price_to_book_mrq": 3.47,
    "roa_ttm": 0.0898,
    "roe_ttm": 0.14150000000000001,
    "shares_outstanding": 93860000.0,
    "pcnt_held_by_insiders": 0.0199,
    "pcnt_held_by_institutions": 1.022,
    "pcnt_short_of_float": 0.0452,
    "operating_cash_flow_ttm": 430670000.0,
    "levered_cash_flow_ttm": 353260000.0,
    "book_value_per_share_mrq": 24.0,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "MEDNAX, Inc."
  },
  "MDCO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.25,
    "earnings_per_share": -0.98,
    "ebitda": -100810000.0,
    "eps_estimate_current_year": -2.59,
    "eps_estimate_next_quarter": -1.02,
    "fifty_day_moving_average": 36.76,
    "fifty_two_week_high": 43.79,
    "fifty_two_week_low": 19.92,
    "percent_change_from_200_day_moving_average": 0.3018,
    "percent_change_from_50_day_moving_average": 0.1017,
    "shares_owned": "N/A",
    "short_ratio": 6.25,
    "two_hundred_day_moving_average": 31.11,
    "volume": 2038697.0,
    "market_cap": 2740000000.0,
    "price_to_sales_ttm": 4.75,
    "price_to_book_mrq": 2.83,
    "roa_ttm": -0.0425,
    "roe_ttm": -0.0677,
    "shares_outstanding": 67710000.0,
    "pcnt_held_by_insiders": 0.17149999999999999,
    "pcnt_held_by_institutions": 0.865,
    "pcnt_short_of_float": 0.25730000000000003,
    "operating_cash_flow_ttm": -59240000.0,
    "levered_cash_flow_ttm": -64550000.0,
    "book_value_per_share_mrq": 14.75,
    "next_earnings_announcement_date": "2015-10-21",
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "The Medicines Company"
  },
  "MDGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.16,
    "ebitda": -24580000.0,
    "eps_estimate_current_year": -1.3,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 8.12,
    "fifty_two_week_high": 10.25,
    "fifty_two_week_low": 3.68,
    "percent_change_from_200_day_moving_average": 0.08130000000000001,
    "percent_change_from_50_day_moving_average": 0.039,
    "shares_owned": "N/A",
    "short_ratio": 17.25,
    "two_hundred_day_moving_average": 7.81,
    "volume": 192477.0,
    "market_cap": 210410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.59,
    "roa_ttm": -0.7251000000000001,
    "roe_ttm": -1.3978,
    "shares_outstanding": 24930000.0,
    "pcnt_held_by_insiders": 0.25379999999999997,
    "pcnt_held_by_institutions": 0.11900000000000001,
    "pcnt_short_of_float": 0.0886,
    "operating_cash_flow_ttm": -17150000.0,
    "levered_cash_flow_ttm": -7870000.0,
    "book_value_per_share_mrq": 0.84,
    "next_earnings_announcement_date": [
      "2015-10-13",
      "2015-10-19"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medgenics, Inc."
  },
  "MDVN": {
    "p_e_ratio": 25.55,
    "peg_ratio": 0.37,
    "earnings_per_share": 1.63,
    "ebitda": 300730000.0,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.33,
    "fifty_day_moving_average": 47.15,
    "fifty_two_week_high": 70.79,
    "fifty_two_week_low": 40.01,
    "percent_change_from_200_day_moving_average": -0.2698,
    "percent_change_from_50_day_moving_average": -0.1168,
    "shares_owned": "N/A",
    "short_ratio": 2.94,
    "two_hundred_day_moving_average": 57.02,
    "volume": 2851515.0,
    "market_cap": 6800000000.0,
    "price_to_sales_ttm": 9.43,
    "price_to_book_mrq": 13.64,
    "roa_ttm": 0.26039999999999996,
    "roe_ttm": 0.7898000000000001,
    "shares_outstanding": 163390000.0,
    "pcnt_held_by_insiders": 0.0171,
    "pcnt_held_by_institutions": 0.9790000000000001,
    "pcnt_short_of_float": 0.053099999999999994,
    "operating_cash_flow_ttm": 251300000.0,
    "levered_cash_flow_ttm": 173660000.0,
    "book_value_per_share_mrq": 3.3,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Medivation, Inc."
  },
  "MDVX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.56,
    "ebitda": -4600000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.66,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": -0.2939,
    "percent_change_from_50_day_moving_average": -0.042800000000000005,
    "shares_owned": "N/A",
    "short_ratio": 2.76,
    "two_hundred_day_moving_average": 3.61,
    "volume": 137302.0,
    "market_cap": 27600000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.22,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 10820000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0034000000000000002,
    "operating_cash_flow_ttm": -5020000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Medovex Corp."
  },
  "MDWD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -1.06,
    "ebitda": -20780000.0,
    "eps_estimate_current_year": -1.1,
    "eps_estimate_next_quarter": -0.33,
    "fifty_day_moving_average": 7.17,
    "fifty_two_week_high": 9.15,
    "fifty_two_week_low": 4.6,
    "percent_change_from_200_day_moving_average": 0.1322,
    "percent_change_from_50_day_moving_average": 0.0592,
    "shares_owned": "N/A",
    "short_ratio": 5.79,
    "two_hundred_day_moving_average": 6.7,
    "volume": 22982.0,
    "market_cap": 165530000.0,
    "price_to_sales_ttm": 423.74,
    "price_to_book_mrq": 5.06,
    "roa_ttm": -0.18760000000000002,
    "roe_ttm": -0.5166,
    "shares_outstanding": 21810000.0,
    "pcnt_held_by_insiders": 0.0642,
    "pcnt_held_by_institutions": 0.09300000000000001,
    "pcnt_short_of_float": 0.0108,
    "operating_cash_flow_ttm": -18180000.0,
    "levered_cash_flow_ttm": -11840000.0,
    "book_value_per_share_mrq": 1.55,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediWound Ltd."
  },
  "MDXG": {
    "p_e_ratio": 74.07,
    "peg_ratio": 3.65,
    "earnings_per_share": 0.14,
    "ebitda": 20630000.0,
    "eps_estimate_current_year": 0.2,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 9.83,
    "fifty_two_week_high": 13.2,
    "fifty_two_week_low": 6.81,
    "percent_change_from_200_day_moving_average": -0.0405,
    "percent_change_from_50_day_moving_average": 0.0175,
    "shares_owned": "N/A",
    "short_ratio": 11.64,
    "two_hundred_day_moving_average": 10.42,
    "volume": 1338101.0,
    "market_cap": 1090000000.0,
    "price_to_sales_ttm": 7.07,
    "price_to_book_mrq": 12.1,
    "roa_ttm": 0.1143,
    "roe_ttm": 0.20329999999999998,
    "shares_outstanding": 108910000.0,
    "pcnt_held_by_insiders": 0.2182,
    "pcnt_held_by_institutions": 0.33899999999999997,
    "pcnt_short_of_float": 0.1649,
    "operating_cash_flow_ttm": 24380000.0,
    "levered_cash_flow_ttm": 14270000.0,
    "book_value_per_share_mrq": 0.86,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MiMedx Group, Inc."
  },
  "MEIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 21.2,
    "earnings_per_share": -1.16,
    "ebitda": -32710000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 1.77,
    "fifty_two_week_high": 8.33,
    "fifty_two_week_low": 1.47,
    "percent_change_from_200_day_moving_average": -0.2024,
    "percent_change_from_50_day_moving_average": -0.049,
    "shares_owned": "N/A",
    "short_ratio": 2.09,
    "two_hundred_day_moving_average": 2.11,
    "volume": 483649.0,
    "market_cap": 57380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 0.98,
    "roa_ttm": -0.3576,
    "roe_ttm": -0.6228,
    "shares_outstanding": 34160000.0,
    "pcnt_held_by_insiders": 0.2623,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.0687,
    "operating_cash_flow_ttm": -28070000.0,
    "levered_cash_flow_ttm": -15870000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "MEI Pharma, Inc."
  },
  "MELA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -3.71,
    "ebitda": -17800000.0,
    "eps_estimate_current_year": -1.73,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.17,
    "fifty_two_week_high": 4.05,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.2746,
    "percent_change_from_50_day_moving_average": -0.013000000000000001,
    "shares_owned": "N/A",
    "short_ratio": 14.53,
    "two_hundred_day_moving_average": 1.59,
    "volume": 59783.0,
    "market_cap": 11370000.0,
    "price_to_sales_ttm": 9.09,
    "price_to_book_mrq": 0.39,
    "roa_ttm": -0.3615,
    "roe_ttm": -1.2741,
    "shares_outstanding": 9890000.0,
    "pcnt_held_by_insiders": 0.0131,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.1219,
    "operating_cash_flow_ttm": -12320000.0,
    "levered_cash_flow_ttm": -8000000.0,
    "book_value_per_share_mrq": 3.03,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "MELA Sciences, Inc."
  },
  "MGCD": {
    "p_e_ratio": 10.91,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.64,
    "ebitda": 2220000.0,
    "eps_estimate_current_year": 0.06,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.79,
    "fifty_two_week_high": 7.7,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.146,
    "percent_change_from_50_day_moving_average": 0.2003,
    "shares_owned": "N/A",
    "short_ratio": 2.36,
    "two_hundred_day_moving_average": 6.06,
    "volume": 769.0,
    "market_cap": 29610000.0,
    "price_to_sales_ttm": 0.79,
    "price_to_book_mrq": 1.54,
    "roa_ttm": 0.028999999999999998,
    "roe_ttm": 0.1577,
    "shares_outstanding": 4260000.0,
    "pcnt_held_by_insiders": 0.16449999999999998,
    "pcnt_held_by_institutions": 0.20800000000000002,
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -982000.0,
    "levered_cash_flow_ttm": -2990000.0,
    "book_value_per_share_mrq": 4.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "MGC Diagnostics Corporation"
  },
  "MGLN": {
    "p_e_ratio": 25.11,
    "peg_ratio": -1.98,
    "earnings_per_share": 2.27,
    "ebitda": 232660000.0,
    "eps_estimate_current_year": 1.77,
    "eps_estimate_next_quarter": 0.79,
    "fifty_day_moving_average": 57.08,
    "fifty_two_week_high": 73.0,
    "fifty_two_week_low": 52.37,
    "percent_change_from_200_day_moving_average": -0.1206,
    "percent_change_from_50_day_moving_average": -0.0014000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.49,
    "two_hundred_day_moving_average": 64.82,
    "volume": 192116.0,
    "market_cap": 1530000000.0,
    "price_to_sales_ttm": 0.39,
    "price_to_book_mrq": 1.38,
    "roa_ttm": 0.0548,
    "roe_ttm": 0.0487,
    "shares_outstanding": 26900000.0,
    "pcnt_held_by_insiders": 0.0137,
    "pcnt_held_by_institutions": 0.9640000000000001,
    "pcnt_short_of_float": 0.0296,
    "operating_cash_flow_ttm": 186670000.0,
    "levered_cash_flow_ttm": 143050000.0,
    "book_value_per_share_mrq": 42.74,
    "next_earnings_announcement_date": "2015-10-27",
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Magellan Health, Inc."
  },
  "MGNX": {
    "p_e_ratio": 857.14,
    "peg_ratio": 2.02,
    "earnings_per_share": 0.03,
    "ebitda": 3060000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 28.06,
    "fifty_two_week_high": 39.9,
    "fifty_two_week_low": 17.31,
    "percent_change_from_200_day_moving_average": -0.2634,
    "percent_change_from_50_day_moving_average": -0.1447,
    "shares_owned": "N/A",
    "short_ratio": 7.64,
    "two_hundred_day_moving_average": 32.58,
    "volume": 697521.0,
    "market_cap": 820690000.0,
    "price_to_sales_ttm": 8.93,
    "price_to_book_mrq": 3.78,
    "roa_ttm": 0.0024,
    "roe_ttm": 0.0046,
    "shares_outstanding": 34200000.0,
    "pcnt_held_by_insiders": 0.2716,
    "pcnt_held_by_institutions": 0.43700000000000006,
    "pcnt_short_of_float": 0.10869999999999999,
    "operating_cash_flow_ttm": -16370000.000000002,
    "levered_cash_flow_ttm": -6710000.0,
    "book_value_per_share_mrq": 7.03,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MacroGenics, Inc."
  },
  "MLAB": {
    "p_e_ratio": 38.37,
    "peg_ratio": 0.0,
    "earnings_per_share": 2.75,
    "ebitda": 22250000.0,
    "eps_estimate_current_year": 3.72,
    "eps_estimate_next_quarter": 1.01,
    "fifty_day_moving_average": 110.99,
    "fifty_two_week_high": 126.05,
    "fifty_two_week_low": 55.79,
    "percent_change_from_200_day_moving_average": 0.1426,
    "percent_change_from_50_day_moving_average": -0.049400000000000006,
    "shares_owned": "N/A",
    "short_ratio": 9.56,
    "two_hundred_day_moving_average": 92.34,
    "volume": 19865.0,
    "market_cap": 379230000.0,
    "price_to_sales_ttm": 5.4,
    "price_to_book_mrq": 5.16,
    "roa_ttm": 0.0904,
    "roe_ttm": 0.1402,
    "shares_outstanding": 3590000.0,
    "pcnt_held_by_insiders": 0.17989999999999998,
    "pcnt_held_by_institutions": 0.506,
    "pcnt_short_of_float": 0.0432,
    "operating_cash_flow_ttm": 13250000.0,
    "levered_cash_flow_ttm": 11190000.0,
    "book_value_per_share_mrq": 21.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mesa Laboratories Inc."
  },
  "MLSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.19,
    "ebitda": -2550000.0,
    "eps_estimate_current_year": 0.08,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.87,
    "fifty_two_week_high": 4.0,
    "fifty_two_week_low": 1.76,
    "percent_change_from_200_day_moving_average": 0.0063,
    "percent_change_from_50_day_moving_average": 0.053,
    "shares_owned": "N/A",
    "short_ratio": 0.54,
    "two_hundred_day_moving_average": 3.0,
    "volume": 22061.0,
    "market_cap": 64739999.99999999,
    "price_to_sales_ttm": 6.7,
    "price_to_book_mrq": 5.2,
    "roa_ttm": -0.1017,
    "roe_ttm": -0.2981,
    "shares_outstanding": 21440000.0,
    "pcnt_held_by_insiders": 0.4448,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0019,
    "operating_cash_flow_ttm": -2200000.0,
    "levered_cash_flow_ttm": -2840000.0,
    "book_value_per_share_mrq": 0.59,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Milestone Scientific Inc."
  },
  "MMSI": {
    "p_e_ratio": 36.66,
    "peg_ratio": 1.81,
    "earnings_per_share": 0.66,
    "ebitda": 87570000.0,
    "eps_estimate_current_year": 0.9,
    "eps_estimate_next_quarter": 0.23,
    "fifty_day_moving_average": 23.81,
    "fifty_two_week_high": 26.42,
    "fifty_two_week_low": 11.61,
    "percent_change_from_200_day_moving_average": 0.1176,
    "percent_change_from_50_day_moving_average": 0.0131,
    "shares_owned": "N/A",
    "short_ratio": 4.31,
    "two_hundred_day_moving_average": 21.58,
    "volume": 471251.0,
    "market_cap": 1070000000.0000001,
    "price_to_sales_ttm": 2.05,
    "price_to_book_mrq": 2.38,
    "roa_ttm": 0.0425,
    "roe_ttm": 0.0668,
    "shares_outstanding": 44160000.0,
    "pcnt_held_by_insiders": 0.055,
    "pcnt_held_by_institutions": 0.87,
    "pcnt_short_of_float": 0.0478,
    "operating_cash_flow_ttm": 73570000.0,
    "levered_cash_flow_ttm": 22960000.0,
    "book_value_per_share_mrq": 10.26,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Merit Medical Systems, Inc."
  },
  "MNK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.52,
    "earnings_per_share": -0.98,
    "ebitda": 1220000000.0,
    "eps_estimate_current_year": 7.35,
    "eps_estimate_next_quarter": 1.91,
    "fifty_day_moving_average": 86.44,
    "fifty_two_week_high": 134.26,
    "fifty_two_week_low": 67.31,
    "percent_change_from_200_day_moving_average": -0.3998,
    "percent_change_from_50_day_moving_average": -0.2082,
    "shares_owned": "N/A",
    "short_ratio": 3.16,
    "two_hundred_day_moving_average": 114.05,
    "volume": 2480333.0,
    "market_cap": 8029999999.999999,
    "price_to_sales_ttm": 2.33,
    "price_to_book_mrq": 1.55,
    "roa_ttm": 0.0385,
    "roe_ttm": -0.0381,
    "shares_outstanding": 117340000.0,
    "pcnt_held_by_insiders": 0.0017000000000000001,
    "pcnt_held_by_institutions": 0.846,
    "pcnt_short_of_float": 0.0745,
    "operating_cash_flow_ttm": 764500000.0,
    "levered_cash_flow_ttm": 980090000.0,
    "book_value_per_share_mrq": 45.18,
    "next_earnings_announcement_date": [
      "2015-11-17",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Mallinckrodt Public Limited Company"
  },
  "MNKD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.45,
    "earnings_per_share": -0.33,
    "ebitda": -103950000.0,
    "eps_estimate_current_year": -0.29,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 3.76,
    "fifty_two_week_high": 7.88,
    "fifty_two_week_low": 3.2,
    "percent_change_from_200_day_moving_average": -0.3231,
    "percent_change_from_50_day_moving_average": -0.1373,
    "shares_owned": "N/A",
    "short_ratio": 23.55,
    "two_hundred_day_moving_average": 4.79,
    "volume": 3669351.0,
    "market_cap": 1340000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.24230000000000002,
    "roe_ttm": "N/A",
    "shares_outstanding": 414760000.0,
    "pcnt_held_by_insiders": 0.3923,
    "pcnt_held_by_institutions": 0.221,
    "pcnt_short_of_float": 0.494,
    "operating_cash_flow_ttm": 49710000.0,
    "levered_cash_flow_ttm": -10500000.0,
    "book_value_per_share_mrq": -0.29,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MannKind Corp."
  },
  "MNOV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.43,
    "earnings_per_share": -0.38,
    "ebitda": -9180000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.22,
    "fifty_two_week_high": 5.9,
    "fifty_two_week_low": 2.75,
    "percent_change_from_200_day_moving_average": -0.16010000000000002,
    "percent_change_from_50_day_moving_average": -0.043,
    "shares_owned": "N/A",
    "short_ratio": 2.96,
    "two_hundred_day_moving_average": 3.67,
    "volume": 56404.0,
    "market_cap": 92070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.81,
    "roa_ttm": -0.21230000000000002,
    "roe_ttm": -0.4122,
    "shares_outstanding": 29890000.0,
    "pcnt_held_by_insiders": 0.203,
    "pcnt_held_by_institutions": 0.042,
    "pcnt_short_of_float": 0.0134,
    "operating_cash_flow_ttm": -7090000.0,
    "levered_cash_flow_ttm": -3620000.0,
    "book_value_per_share_mrq": 0.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "MediciNova Inc."
  },
  "MNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.26,
    "ebitda": -60880000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.13,
    "fifty_day_moving_average": 19.57,
    "fifty_two_week_high": 25.56,
    "fifty_two_week_low": 9.38,
    "percent_change_from_200_day_moving_average": -0.1436,
    "percent_change_from_50_day_moving_average": -0.1384,
    "shares_owned": "N/A",
    "short_ratio": 10.14,
    "two_hundred_day_moving_average": 19.69,
    "volume": 893114.0,
    "market_cap": 1160000000.0,
    "price_to_sales_ttm": 14.09,
    "price_to_book_mrq": 2.84,
    "roa_ttm": -0.1195,
    "roe_ttm": -0.2155,
    "shares_outstanding": 68810000.0,
    "pcnt_held_by_insiders": 0.2144,
    "pcnt_held_by_institutions": 0.735,
    "pcnt_short_of_float": 0.1578,
    "operating_cash_flow_ttm": -70580000.0,
    "levered_cash_flow_ttm": -45940000.0,
    "book_value_per_share_mrq": 6.14,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Momenta Pharmaceuticals Inc."
  },
  "MOH": {
    "p_e_ratio": 30.86,
    "peg_ratio": 0.91,
    "earnings_per_share": 2.33,
    "ebitda": 415940000.0,
    "eps_estimate_current_year": 2.6,
    "eps_estimate_next_quarter": 0.64,
    "fifty_day_moving_average": 76.67,
    "fifty_two_week_high": 82.37,
    "fifty_two_week_low": 40.79,
    "percent_change_from_200_day_moving_average": 0.0288,
    "percent_change_from_50_day_moving_average": -0.062400000000000004,
    "shares_owned": "N/A",
    "short_ratio": 8.11,
    "two_hundred_day_moving_average": 69.87,
    "volume": 1036679.0,
    "market_cap": 4030000000.0000005,
    "price_to_sales_ttm": 0.37,
    "price_to_book_mrq": 2.93,
    "roa_ttm": 0.0455,
    "roe_ttm": 0.0984,
    "shares_outstanding": 56060000.0,
    "pcnt_held_by_insiders": 0.34020000000000006,
    "pcnt_held_by_institutions": 0.7709999999999999,
    "pcnt_short_of_float": 0.2475,
    "operating_cash_flow_ttm": 1470000000.0,
    "levered_cash_flow_ttm": 608370000.0,
    "book_value_per_share_mrq": 26.1,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Molina Healthcare, Inc."
  },
  "MR": {
    "p_e_ratio": 16.46,
    "peg_ratio": 15.05,
    "earnings_per_share": 1.44,
    "ebitda": 230490000.0,
    "eps_estimate_current_year": 1.49,
    "eps_estimate_next_quarter": 0.36,
    "fifty_day_moving_average": 24.84,
    "fifty_two_week_high": 33.83,
    "fifty_two_week_low": 23.11,
    "percent_change_from_200_day_moving_average": -0.1355,
    "percent_change_from_50_day_moving_average": -0.045899999999999996,
    "shares_owned": "N/A",
    "short_ratio": 10.02,
    "two_hundred_day_moving_average": 27.41,
    "volume": 369889.0,
    "market_cap": 2790000000.0,
    "price_to_sales_ttm": 2.11,
    "price_to_book_mrq": 1.72,
    "roa_ttm": 0.0467,
    "roe_ttm": 0.1091,
    "shares_outstanding": 117830000.0,
    "pcnt_held_by_insiders": 0.019299999999999998,
    "pcnt_held_by_institutions": 1.167,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 325270000.0,
    "levered_cash_flow_ttm": -179140000.0,
    "book_value_per_share_mrq": 13.87,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mindray Medical International Limited"
  },
  "MRNS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.38,
    "ebitda": -18070000.0,
    "eps_estimate_current_year": -1.82,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 14.11,
    "fifty_two_week_high": 20.72,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.0506,
    "percent_change_from_50_day_moving_average": -0.139,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 11.56,
    "volume": 44387.0,
    "market_cap": 173690000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.18,
    "roa_ttm": -0.4472,
    "roe_ttm": -1.0216,
    "shares_outstanding": 14300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0102,
    "operating_cash_flow_ttm": -14250000.0,
    "levered_cash_flow_ttm": -8520000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Marinus Pharmaceuticals, Inc."
  },
  "MRTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.17,
    "ebitda": -48310000.0,
    "eps_estimate_current_year": -3.47,
    "eps_estimate_next_quarter": -0.89,
    "fifty_day_moving_average": 29.87,
    "fifty_two_week_high": 52.0,
    "fifty_two_week_low": 13.69,
    "percent_change_from_200_day_moving_average": 0.0864,
    "percent_change_from_50_day_moving_average": 0.0732,
    "shares_owned": "N/A",
    "short_ratio": 5.31,
    "two_hundred_day_moving_average": 29.51,
    "volume": 403059.0,
    "market_cap": 596250000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.5,
    "roa_ttm": -0.5435,
    "roe_ttm": -1.5582,
    "shares_outstanding": 18600000.0,
    "pcnt_held_by_insiders": 0.0023,
    "pcnt_held_by_institutions": 0.6940000000000001,
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -37020000.0,
    "levered_cash_flow_ttm": -58630000.0,
    "book_value_per_share_mrq": 3.35,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mirati Therapeutics, Inc."
  },
  "MSLI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.04,
    "ebitda": 18480000.0,
    "eps_estimate_current_year": 0.05,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 1.72,
    "fifty_two_week_high": 2.85,
    "fifty_two_week_low": 1.15,
    "percent_change_from_200_day_moving_average": -0.344,
    "percent_change_from_50_day_moving_average": -0.1516,
    "shares_owned": "N/A",
    "short_ratio": 29.89,
    "two_hundred_day_moving_average": 2.23,
    "volume": 82781.0,
    "market_cap": 149360000.0,
    "price_to_sales_ttm": 5.11,
    "price_to_book_mrq": 1.2,
    "roa_ttm": 0.0095,
    "roe_ttm": -0.0311,
    "shares_outstanding": 102300000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.002,
    "operating_cash_flow_ttm": 15730000.0,
    "levered_cash_flow_ttm": -106590000.0,
    "book_value_per_share_mrq": 1.22,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Merus Labs International Inc."
  },
  "MSON": {
    "p_e_ratio": 16.672,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.693,
    "ebitda": -274785.0,
    "eps_estimate_current_year": 0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 10.479,
    "fifty_two_week_high": 14.9,
    "fifty_two_week_low": 8.2,
    "percent_change_from_200_day_moving_average": 0.034769999999999995,
    "percent_change_from_50_day_moving_average": 0.10253999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.85,
    "two_hundred_day_moving_average": 11.166,
    "volume": 16147.0,
    "market_cap": 89480000.0,
    "price_to_sales_ttm": 4.17,
    "price_to_book_mrq": 3.9,
    "roa_ttm": -0.0466,
    "roe_ttm": 0.2645,
    "shares_outstanding": 7740000.0,
    "pcnt_held_by_insiders": 0.2263,
    "pcnt_held_by_institutions": 0.128,
    "pcnt_short_of_float": 0.0036,
    "operating_cash_flow_ttm": 2390000.0,
    "levered_cash_flow_ttm": -2730000.0,
    "book_value_per_share_mrq": 3.07,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Misonix, Inc."
  },
  "MSTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.237,
    "ebitda": -33950000.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.4494,
    "fifty_two_week_high": 0.63,
    "fifty_two_week_low": 0.38,
    "percent_change_from_200_day_moving_average": -0.06631999999999999,
    "percent_change_from_50_day_moving_average": 0.001493,
    "shares_owned": "N/A",
    "short_ratio": 5.09,
    "two_hundred_day_moving_average": 0.4821,
    "volume": 334542.0,
    "market_cap": 73820000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.75,
    "roa_ttm": -0.3667,
    "roe_ttm": -0.7535,
    "shares_outstanding": 164000000.0,
    "pcnt_held_by_insiders": 0.037200000000000004,
    "pcnt_held_by_institutions": 0.196,
    "pcnt_short_of_float": 0.0304,
    "operating_cash_flow_ttm": -27260000.0,
    "levered_cash_flow_ttm": -13710000.0,
    "book_value_per_share_mrq": 0.26,
    "next_earnings_announcement_date": [
      "2015-10-29",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Mast Therapeutics, Inc."
  },
  "MTD": {
    "p_e_ratio": 23.44,
    "peg_ratio": 1.93,
    "earnings_per_share": 11.99,
    "ebitda": 528890000.0,
    "eps_estimate_current_year": 12.82,
    "eps_estimate_next_quarter": 4.62,
    "fifty_day_moving_average": 302.47,
    "fifty_two_week_high": 350.11,
    "fifty_two_week_low": 228.3,
    "percent_change_from_200_day_moving_average": -0.1307,
    "percent_change_from_50_day_moving_average": -0.0707,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 323.34,
    "volume": 237197.0,
    "market_cap": 7790000000.0,
    "price_to_sales_ttm": 3.16,
    "price_to_book_mrq": 11.82,
    "roa_ttm": 0.14400000000000002,
    "roe_ttm": 0.444,
    "shares_outstanding": 27700000.0,
    "pcnt_held_by_insiders": 0.0217,
    "pcnt_held_by_institutions": 0.95,
    "pcnt_short_of_float": 0.0535,
    "operating_cash_flow_ttm": 431720000.0,
    "levered_cash_flow_ttm": 327170000.0,
    "book_value_per_share_mrq": 23.62,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Mettler-Toledo International Inc."
  },
  "MYOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.83,
    "ebitda": -6000000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.21,
    "fifty_two_week_high": 14.96,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.2748,
    "percent_change_from_50_day_moving_average": 0.2217,
    "shares_owned": "N/A",
    "short_ratio": 5.57,
    "two_hundred_day_moving_average": 3.72,
    "volume": 32781.0,
    "market_cap": 8960000.0,
    "price_to_sales_ttm": 40.25,
    "price_to_book_mrq": 1.45,
    "roa_ttm": -0.5067,
    "roe_ttm": -0.8519,
    "shares_outstanding": 3320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0172,
    "operating_cash_flow_ttm": -3960000.0,
    "levered_cash_flow_ttm": -2380000.0,
    "book_value_per_share_mrq": 1.73,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "MYOS Corporation"
  },
  "MZOR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.81,
    "earnings_per_share": -0.7,
    "ebitda": -13850000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 12.27,
    "fifty_two_week_high": 15.04,
    "fifty_two_week_low": 9.63,
    "percent_change_from_200_day_moving_average": -0.0796,
    "percent_change_from_50_day_moving_average": -0.0414,
    "shares_owned": "N/A",
    "short_ratio": 23.91,
    "two_hundred_day_moving_average": 12.78,
    "volume": 15068.0,
    "market_cap": 248630000.0,
    "price_to_sales_ttm": 10.84,
    "price_to_book_mrq": 5.34,
    "roa_ttm": -0.145,
    "roe_ttm": -0.2726,
    "shares_outstanding": 21140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -10540000.0,
    "levered_cash_flow_ttm": -5080000.0,
    "book_value_per_share_mrq": 2.3,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Mazor Robotics Ltd."
  },
  "NAII": {
    "p_e_ratio": 12.94,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.49,
    "ebitda": 8000000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.95,
    "fifty_two_week_high": 6.7,
    "fifty_two_week_low": 5.0,
    "percent_change_from_200_day_moving_average": 0.1074,
    "percent_change_from_50_day_moving_average": 0.0647,
    "shares_owned": "N/A",
    "short_ratio": 4.07,
    "two_hundred_day_moving_average": 5.73,
    "volume": 14053.0,
    "market_cap": 42570000.0,
    "price_to_sales_ttm": 0.52,
    "price_to_book_mrq": 0.94,
    "roa_ttm": 0.06559999999999999,
    "roe_ttm": 0.0775,
    "shares_outstanding": 6710000.0,
    "pcnt_held_by_insiders": 0.5049,
    "pcnt_held_by_institutions": 0.113,
    "pcnt_short_of_float": 0.0024,
    "operating_cash_flow_ttm": 2680000.0,
    "levered_cash_flow_ttm": 421120.0,
    "book_value_per_share_mrq": 6.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "Natural Alternatives International Inc."
  },
  "NATR": {
    "p_e_ratio": 42.33,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.28,
    "ebitda": 20580000.0,
    "eps_estimate_current_year": 0.8,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 12.28,
    "fifty_two_week_high": 15.76,
    "fifty_two_week_low": 11.3,
    "percent_change_from_200_day_moving_average": -0.0839,
    "percent_change_from_50_day_moving_average": -0.0519,
    "shares_owned": "N/A",
    "short_ratio": 14.59,
    "two_hundred_day_moving_average": 12.71,
    "volume": 25098.0,
    "market_cap": 217570000.0,
    "price_to_sales_ttm": 0.65,
    "price_to_book_mrq": 1.71,
    "roa_ttm": 0.0507,
    "roe_ttm": 0.09960000000000001,
    "shares_outstanding": 18690000.0,
    "pcnt_held_by_insiders": 0.1674,
    "pcnt_held_by_institutions": 0.617,
    "pcnt_short_of_float": 0.0232,
    "operating_cash_flow_ttm": 9170000.0,
    "levered_cash_flow_ttm": -10500000.0,
    "book_value_per_share_mrq": 6.96,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Nature's Sunshine Products Inc."
  },
  "NAVB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.2,
    "ebitda": -20360000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 1.98,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 0.97,
    "percent_change_from_200_day_moving_average": 0.3458,
    "percent_change_from_50_day_moving_average": 0.1261,
    "shares_owned": "N/A",
    "short_ratio": 63.27,
    "two_hundred_day_moving_average": 1.66,
    "volume": 1675921.0,
    "market_cap": 336060000.0,
    "price_to_sales_ttm": 38.24,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5713,
    "roe_ttm": "N/A",
    "shares_outstanding": 150700000.0,
    "pcnt_held_by_insiders": 0.10830000000000001,
    "pcnt_held_by_institutions": 0.272,
    "pcnt_short_of_float": 0.21109999999999998,
    "operating_cash_flow_ttm": -22330000.0,
    "levered_cash_flow_ttm": -13750000.0,
    "book_value_per_share_mrq": -0.3,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Navidea Biopharmaceuticals, Inc"
  },
  "NBIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 6.04,
    "earnings_per_share": -0.76,
    "ebitda": -64000000.0,
    "eps_estimate_current_year": -0.83,
    "eps_estimate_next_quarter": -0.27,
    "fifty_day_moving_average": 47.95,
    "fifty_two_week_high": 56.97,
    "fifty_two_week_low": 15.2,
    "percent_change_from_200_day_moving_average": -0.0953,
    "percent_change_from_50_day_moving_average": -0.15,
    "shares_owned": "N/A",
    "short_ratio": 7.1,
    "two_hundred_day_moving_average": 45.05,
    "volume": 1454557.0,
    "market_cap": 3500000000.0,
    "price_to_sales_ttm": 200.08,
    "price_to_book_mrq": 8.46,
    "roa_ttm": -0.10400000000000001,
    "roe_ttm": -0.17190000000000003,
    "shares_outstanding": 85870000.0,
    "pcnt_held_by_insiders": 0.0115,
    "pcnt_held_by_institutions": 0.9359999999999999,
    "pcnt_short_of_float": 0.0816,
    "operating_cash_flow_ttm": -31630000.0,
    "levered_cash_flow_ttm": -24040000.0,
    "book_value_per_share_mrq": 5.45,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neurocrine Biosciences Inc."
  },
  "NBY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.33,
    "ebitda": -18360000.0,
    "eps_estimate_current_year": -0.27,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 0.43,
    "fifty_two_week_high": 1.05,
    "fifty_two_week_low": 0.22,
    "percent_change_from_200_day_moving_average": -0.49770000000000003,
    "percent_change_from_50_day_moving_average": -0.28190000000000004,
    "shares_owned": "N/A",
    "short_ratio": 7.48,
    "two_hundred_day_moving_average": 0.62,
    "volume": 721099.0,
    "market_cap": 23190000.0,
    "price_to_sales_ttm": 12.13,
    "price_to_book_mrq": 5.37,
    "roa_ttm": -0.9781,
    "roe_ttm": -2.5792,
    "shares_outstanding": 74810000.0,
    "pcnt_held_by_insiders": 0.22760000000000002,
    "pcnt_held_by_institutions": 0.042,
    "pcnt_short_of_float": 0.0403,
    "operating_cash_flow_ttm": -16820000.0,
    "levered_cash_flow_ttm": -10550000.0,
    "book_value_per_share_mrq": 0.07,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NovaBay Pharmaceuticals, Inc."
  },
  "NDRM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.01,
    "ebitda": -15220000.0,
    "eps_estimate_current_year": -1.35,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 22.82,
    "fifty_two_week_high": 26.5,
    "fifty_two_week_low": 5.67,
    "percent_change_from_200_day_moving_average": 0.2193,
    "percent_change_from_50_day_moving_average": -0.1048,
    "shares_owned": "N/A",
    "short_ratio": 1.82,
    "two_hundred_day_moving_average": 16.76,
    "volume": 243270.0,
    "market_cap": 427620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.79,
    "roa_ttm": -0.4789,
    "roe_ttm": -2.5408,
    "shares_outstanding": 20930000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0767,
    "operating_cash_flow_ttm": -11980000.0,
    "levered_cash_flow_ttm": -4760000.0,
    "book_value_per_share_mrq": 2.01,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NeuroDerm Ltd."
  },
  "NEO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.01,
    "ebitda": 7640000.0,
    "eps_estimate_current_year": 0.0,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 6.31,
    "fifty_two_week_high": 7.22,
    "fifty_two_week_low": 3.33,
    "percent_change_from_200_day_moving_average": 0.096,
    "percent_change_from_50_day_moving_average": -0.0318,
    "shares_owned": "N/A",
    "short_ratio": 9.04,
    "two_hundred_day_moving_average": 5.57,
    "volume": 385069.0,
    "market_cap": 369720000.0,
    "price_to_sales_ttm": 4.26,
    "price_to_book_mrq": 6.69,
    "roa_ttm": 0.0106,
    "roe_ttm": -0.0043,
    "shares_outstanding": 60510000.0,
    "pcnt_held_by_insiders": 0.42460000000000003,
    "pcnt_held_by_institutions": 0.34299999999999997,
    "pcnt_short_of_float": 0.0499,
    "operating_cash_flow_ttm": 6050000.0,
    "levered_cash_flow_ttm": 2720000.0,
    "book_value_per_share_mrq": 1.01,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Neogenomics Inc."
  },
  "NEOG": {
    "p_e_ratio": 53.65,
    "peg_ratio": 2.7,
    "earnings_per_share": 0.91,
    "ebitda": 65370000.00000001,
    "eps_estimate_current_year": 1.07,
    "eps_estimate_next_quarter": 0.26,
    "fifty_day_moving_average": 52.86,
    "fifty_two_week_high": 62.7,
    "fifty_two_week_low": 38.74,
    "percent_change_from_200_day_moving_average": -0.0127,
    "percent_change_from_50_day_moving_average": -0.0764,
    "shares_owned": "N/A",
    "short_ratio": 8.92,
    "two_hundred_day_moving_average": 49.45,
    "volume": 408756.0,
    "market_cap": 1820000000.0,
    "price_to_sales_ttm": 6.24,
    "price_to_book_mrq": 4.95,
    "roa_ttm": 0.09,
    "roe_ttm": 0.10220000000000001,
    "shares_outstanding": 37370000.0,
    "pcnt_held_by_insiders": 0.0451,
    "pcnt_held_by_institutions": 0.825,
    "pcnt_short_of_float": 0.0583,
    "operating_cash_flow_ttm": 43790000.0,
    "levered_cash_flow_ttm": 34390000.0,
    "book_value_per_share_mrq": 9.79,
    "next_earnings_announcement_date": [
      "2015-12-16",
      "2015-12-21"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Neogen Corp."
  },
  "NEOS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -29.65,
    "ebitda": -17820000.0,
    "eps_estimate_current_year": -7.25,
    "eps_estimate_next_quarter": -0.7,
    "fifty_day_moving_average": 22.76,
    "fifty_two_week_high": 28.99,
    "fifty_two_week_low": 17.1,
    "percent_change_from_200_day_moving_average": -0.1346,
    "percent_change_from_50_day_moving_average": -0.1558,
    "shares_owned": "N/A",
    "short_ratio": 0.34,
    "two_hundred_day_moving_average": 22.2,
    "volume": 103789.0,
    "market_cap": 304220000.0,
    "price_to_sales_ttm": 131.84,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15840000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0029,
    "operating_cash_flow_ttm": -21180000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -104.81,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Neos Therapeutics, Inc."
  },
  "NEOT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.12,
    "earnings_per_share": -2.72,
    "ebitda": -20930000.0,
    "eps_estimate_current_year": -3.47,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 12.08,
    "fifty_two_week_high": 15.05,
    "fifty_two_week_low": 5.92,
    "percent_change_from_200_day_moving_average": 0.0161,
    "percent_change_from_50_day_moving_average": -0.213,
    "shares_owned": "N/A",
    "short_ratio": 2.0,
    "two_hundred_day_moving_average": 9.36,
    "volume": 292200.0,
    "market_cap": 130310000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.3,
    "roa_ttm": -0.3436,
    "roe_ttm": -0.8270000000000001,
    "shares_outstanding": 13700000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0154,
    "operating_cash_flow_ttm": -17480000.0,
    "levered_cash_flow_ttm": -9710000.0,
    "book_value_per_share_mrq": 3.62,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Neothetics, Inc."
  },
  "NEPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.28,
    "ebitda": -26560000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 1.31,
    "fifty_two_week_high": 2.2,
    "fifty_two_week_low": 1.1,
    "percent_change_from_200_day_moving_average": -0.1999,
    "percent_change_from_50_day_moving_average": -0.1153,
    "shares_owned": "N/A",
    "short_ratio": 27.68,
    "two_hundred_day_moving_average": 1.45,
    "volume": 268600.0,
    "market_cap": 87420000.0,
    "price_to_sales_ttm": 8.31,
    "price_to_book_mrq": 2.27,
    "roa_ttm": -0.2122,
    "roe_ttm": -0.37270000000000003,
    "shares_outstanding": 75370000.0,
    "pcnt_held_by_insiders": 0.1522,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.0002,
    "operating_cash_flow_ttm": -20230000.0,
    "levered_cash_flow_ttm": -19690000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neptune Technologies & Bioressources, Inc."
  },
  "NERV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.35,
    "ebitda": -46770000.0,
    "eps_estimate_current_year": -1.34,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 5.72,
    "fifty_two_week_high": 10.0,
    "fifty_two_week_low": 4.08,
    "percent_change_from_200_day_moving_average": 0.0147,
    "percent_change_from_50_day_moving_average": -0.0172,
    "shares_owned": "N/A",
    "short_ratio": 5.31,
    "two_hundred_day_moving_average": 5.54,
    "volume": 4978.0,
    "market_cap": 138930000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.11,
    "roa_ttm": -0.3973,
    "roe_ttm": -0.9692000000000001,
    "shares_outstanding": 24720000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0092,
    "operating_cash_flow_ttm": -44120000.0,
    "levered_cash_flow_ttm": -40310000.0,
    "book_value_per_share_mrq": 2.77,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Minerva Neurosciences, Inc."
  },
  "NHC": {
    "p_e_ratio": 19.91,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.12,
    "ebitda": 106550000.0,
    "eps_estimate_current_year": 2.54,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 61.96,
    "fifty_two_week_high": 66.5,
    "fifty_two_week_low": 54.33,
    "percent_change_from_200_day_moving_average": -0.0173,
    "percent_change_from_50_day_moving_average": 0.0023,
    "shares_owned": "N/A",
    "short_ratio": 15.39,
    "two_hundred_day_moving_average": 63.19,
    "volume": 12514.0,
    "market_cap": 885040000.0,
    "price_to_sales_ttm": 1.0,
    "price_to_book_mrq": 1.56,
    "roa_ttm": 0.0416,
    "roe_ttm": 0.0729,
    "shares_outstanding": 14250000.0,
    "pcnt_held_by_insiders": 0.34450000000000003,
    "pcnt_held_by_institutions": 0.349,
    "pcnt_short_of_float": 0.027000000000000003,
    "operating_cash_flow_ttm": 88880000.0,
    "levered_cash_flow_ttm": 36870000.0,
    "book_value_per_share_mrq": 40.22,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "National Healthcare Corp."
  },
  "NK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 10.91,
    "earnings_per_share": -3.24,
    "ebitda": -118630000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 20.52,
    "fifty_two_week_high": 38.48,
    "fifty_two_week_low": 15.34,
    "percent_change_from_200_day_moving_average": -0.2847,
    "percent_change_from_50_day_moving_average": -0.21530000000000002,
    "shares_owned": "N/A",
    "short_ratio": 2.12,
    "two_hundred_day_moving_average": 22.51,
    "volume": 304596.0,
    "market_cap": 1310000000.0,
    "price_to_sales_ttm": 3118.97,
    "price_to_book_mrq": 9.35,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 81140000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.052000000000000005,
    "operating_cash_flow_ttm": -13300000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NantKwest, Inc."
  },
  "NKTR": {
    "p_e_ratio": 254.26,
    "peg_ratio": 3.03,
    "earnings_per_share": 0.05,
    "ebitda": 54650000.0,
    "eps_estimate_current_year": -0.59,
    "eps_estimate_next_quarter": -0.16,
    "fifty_day_moving_average": 11.56,
    "fifty_two_week_high": 17.53,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": 0.0195,
    "percent_change_from_50_day_moving_average": 0.0334,
    "shares_owned": "N/A",
    "short_ratio": 16.1,
    "two_hundred_day_moving_average": 11.72,
    "volume": 1704302.0,
    "market_cap": 1580000000.0,
    "price_to_sales_ttm": 6.09,
    "price_to_book_mrq": 49.06,
    "roa_ttm": 0.0567,
    "roe_ttm": "N/A",
    "shares_outstanding": 132370000.0,
    "pcnt_held_by_insiders": 0.0036,
    "pcnt_held_by_institutions": 0.907,
    "pcnt_short_of_float": 0.2458,
    "operating_cash_flow_ttm": -54570000.0,
    "levered_cash_flow_ttm": -10680000.0,
    "book_value_per_share_mrq": 0.27,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nektar Therapeutics"
  },
  "NLNK": {
    "p_e_ratio": 12.74,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.78,
    "ebitda": 134120000.0,
    "eps_estimate_current_year": -1.55,
    "eps_estimate_next_quarter": -0.8,
    "fifty_day_moving_average": 48.78,
    "fifty_two_week_high": 58.73,
    "fifty_two_week_low": 17.32,
    "percent_change_from_200_day_moving_average": -0.011699999999999999,
    "percent_change_from_50_day_moving_average": -0.0129,
    "shares_owned": "N/A",
    "short_ratio": 8.48,
    "two_hundred_day_moving_average": 48.72,
    "volume": 585535.0,
    "market_cap": 1380000000.0,
    "price_to_sales_ttm": 6.88,
    "price_to_book_mrq": 6.65,
    "roa_ttm": 0.5065999999999999,
    "roe_ttm": 0.7934,
    "shares_outstanding": 28760000.0,
    "pcnt_held_by_insiders": 0.2904,
    "pcnt_held_by_institutions": 0.511,
    "pcnt_short_of_float": 0.2205,
    "operating_cash_flow_ttm": 113460000.0,
    "levered_cash_flow_ttm": 73830000.0,
    "book_value_per_share_mrq": 7.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NewLink Genetics Corporation"
  },
  "NNVC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.09,
    "ebitda": -6910000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.18,
    "fifty_two_week_high": 3.99,
    "fifty_two_week_low": 0.89,
    "percent_change_from_200_day_moving_average": -0.2469,
    "percent_change_from_50_day_moving_average": 0.10220000000000001,
    "shares_owned": "N/A",
    "short_ratio": 5.6,
    "two_hundred_day_moving_average": 1.73,
    "volume": 118478.0,
    "market_cap": 74410000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.23,
    "roa_ttm": -0.1024,
    "roe_ttm": -0.0797,
    "shares_outstanding": 57240000.0,
    "pcnt_held_by_insiders": 0.2446,
    "pcnt_held_by_institutions": 0.081,
    "pcnt_short_of_float": 0.0213,
    "operating_cash_flow_ttm": -6210000.0,
    "levered_cash_flow_ttm": -10840000.0,
    "book_value_per_share_mrq": 0.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "NanoViricides, Inc."
  },
  "NRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.39,
    "ebitda": -20930000.0,
    "eps_estimate_current_year": -2.56,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 4.01,
    "fifty_two_week_high": 17.98,
    "fifty_two_week_low": 3.4,
    "percent_change_from_200_day_moving_average": -0.42340000000000005,
    "percent_change_from_50_day_moving_average": -0.1027,
    "shares_owned": "N/A",
    "short_ratio": 4.12,
    "two_hundred_day_moving_average": 6.24,
    "volume": 43792.0,
    "market_cap": 37720000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.0,
    "roa_ttm": -0.5118,
    "roe_ttm": -1.1561,
    "shares_outstanding": 10480000.0,
    "pcnt_held_by_insiders": 0.5586,
    "pcnt_held_by_institutions": 0.264,
    "pcnt_short_of_float": 0.0434,
    "operating_cash_flow_ttm": -17680000.0,
    "levered_cash_flow_ttm": -9610000.0,
    "book_value_per_share_mrq": 0.94,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "NephroGenex, Inc."
  },
  "NSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -7.66,
    "ebitda": -31230000.0,
    "eps_estimate_current_year": -5.19,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 2.4,
    "fifty_two_week_high": 25.4,
    "fifty_two_week_low": 1.82,
    "percent_change_from_200_day_moving_average": -0.4692,
    "percent_change_from_50_day_moving_average": -0.23600000000000002,
    "shares_owned": "N/A",
    "short_ratio": 3.65,
    "two_hundred_day_moving_average": 3.45,
    "volume": 154497.0,
    "market_cap": 13510000.0,
    "price_to_sales_ttm": 0.83,
    "price_to_book_mrq": 0.68,
    "roa_ttm": -0.4648,
    "roe_ttm": -1.4477000000000002,
    "shares_outstanding": 7380000.0,
    "pcnt_held_by_insiders": 0.2043,
    "pcnt_held_by_institutions": 0.373,
    "pcnt_short_of_float": 0.03,
    "operating_cash_flow_ttm": -30060000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Nanosphere, Inc."
  },
  "NSPR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.41,
    "ebitda": -18720000.0,
    "eps_estimate_current_year": -0.26,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.2,
    "fifty_two_week_high": 2.23,
    "fifty_two_week_low": 0.16,
    "percent_change_from_200_day_moving_average": -0.2441,
    "percent_change_from_50_day_moving_average": -0.0404,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 0.25,
    "volume": 557753.0,
    "market_cap": 14790000.0,
    "price_to_sales_ttm": 6.1,
    "price_to_book_mrq": 5.82,
    "roa_ttm": -0.8628,
    "roe_ttm": "N/A",
    "shares_outstanding": 77860000.0,
    "pcnt_held_by_insiders": 0.1961,
    "pcnt_held_by_institutions": 0.295,
    "pcnt_short_of_float": 0.0028000000000000004,
    "operating_cash_flow_ttm": -18050000.0,
    "levered_cash_flow_ttm": -10750000.0,
    "book_value_per_share_mrq": 0.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "InspireMD, Inc."
  },
  "NSTG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.82,
    "ebitda": -46220000.0,
    "eps_estimate_current_year": -1.96,
    "eps_estimate_next_quarter": -0.4,
    "fifty_day_moving_average": 15.69,
    "fifty_two_week_high": 19.81,
    "fifty_two_week_low": 7.8,
    "percent_change_from_200_day_moving_average": 0.1272,
    "percent_change_from_50_day_moving_average": 0.0147,
    "shares_owned": "N/A",
    "short_ratio": 11.42,
    "two_hundred_day_moving_average": 14.12,
    "volume": 74453.0,
    "market_cap": 308640000.0,
    "price_to_sales_ttm": 6.45,
    "price_to_book_mrq": 9.99,
    "roa_ttm": -0.30870000000000003,
    "roe_ttm": -1.0384,
    "shares_outstanding": 19390000.0,
    "pcnt_held_by_insiders": 0.4426,
    "pcnt_held_by_institutions": 0.46299999999999997,
    "pcnt_short_of_float": 0.1199,
    "operating_cash_flow_ttm": -48650000.0,
    "levered_cash_flow_ttm": -34920000.0,
    "book_value_per_share_mrq": 1.75,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "NanoString Technologies, Inc."
  },
  "NTRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.78,
    "ebitda": -6780000.0,
    "eps_estimate_current_year": -2.17,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 15.3,
    "fifty_two_week_high": 23.24,
    "fifty_two_week_low": 12.61,
    "percent_change_from_200_day_moving_average": -0.2457,
    "percent_change_from_50_day_moving_average": -0.1543,
    "shares_owned": "N/A",
    "short_ratio": 7.22,
    "two_hundred_day_moving_average": 17.16,
    "volume": 164876.0,
    "market_cap": 633820000.0,
    "price_to_sales_ttm": 3.59,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 48980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0646,
    "operating_cash_flow_ttm": 111000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -27.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Natera, Inc."
  },
  "NURO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.25,
    "earnings_per_share": -1.34,
    "ebitda": -10830000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.9071,
    "fifty_two_week_high": 2.05,
    "fifty_two_week_low": 0.71,
    "percent_change_from_200_day_moving_average": -0.217379,
    "percent_change_from_50_day_moving_average": -0.042488,
    "shares_owned": "N/A",
    "short_ratio": 1.18,
    "two_hundred_day_moving_average": 1.1099,
    "volume": 150073.0,
    "market_cap": 11970000.0,
    "price_to_sales_ttm": 1.85,
    "price_to_book_mrq": 0.85,
    "roa_ttm": -0.43829999999999997,
    "roe_ttm": -0.7951,
    "shares_outstanding": 13790000.0,
    "pcnt_held_by_insiders": 0.1155,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.07730000000000001,
    "operating_cash_flow_ttm": -10420000.0,
    "levered_cash_flow_ttm": -6980000.0,
    "book_value_per_share_mrq": 1.06,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "NeuroMetrix Inc."
  },
  "NUVA": {
    "p_e_ratio": 54.11,
    "peg_ratio": 3.04,
    "earnings_per_share": 0.96,
    "ebitda": 150120000.0,
    "eps_estimate_current_year": 1.19,
    "eps_estimate_next_quarter": 0.32,
    "fifty_day_moving_average": 53.03,
    "fifty_two_week_high": 56.61,
    "fifty_two_week_low": 33.33,
    "percent_change_from_200_day_moving_average": 0.06,
    "percent_change_from_50_day_moving_average": -0.0235,
    "shares_owned": "N/A",
    "short_ratio": 5.21,
    "two_hundred_day_moving_average": 48.85,
    "volume": 866363.0,
    "market_cap": 2530000000.0,
    "price_to_sales_ttm": 3.33,
    "price_to_book_mrq": 3.93,
    "roa_ttm": 0.0466,
    "roe_ttm": 0.0717,
    "shares_outstanding": 48940000.0,
    "pcnt_held_by_insiders": 0.0154,
    "pcnt_held_by_institutions": 0.99,
    "pcnt_short_of_float": 0.057999999999999996,
    "operating_cash_flow_ttm": 102420000.0,
    "levered_cash_flow_ttm": -59190000.0,
    "book_value_per_share_mrq": 13.67,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "NuVasive, Inc."
  },
  "NVAX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.39,
    "ebitda": -90230000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 11.09,
    "fifty_two_week_high": 15.01,
    "fifty_two_week_low": 3.92,
    "percent_change_from_200_day_moving_average": -0.1328,
    "percent_change_from_50_day_moving_average": -0.2218,
    "shares_owned": "N/A",
    "short_ratio": 4.3,
    "two_hundred_day_moving_average": 9.95,
    "volume": 8055227.0,
    "market_cap": 2320000000.0,
    "price_to_sales_ttm": 63.61,
    "price_to_book_mrq": 6.37,
    "roa_ttm": -0.16390000000000002,
    "roe_ttm": -0.2877,
    "shares_outstanding": 269180000.0,
    "pcnt_held_by_insiders": 0.0452,
    "pcnt_held_by_institutions": 0.527,
    "pcnt_short_of_float": 0.1137,
    "operating_cash_flow_ttm": -78450000.0,
    "levered_cash_flow_ttm": -54960000.0,
    "book_value_per_share_mrq": 1.44,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Novavax, Inc."
  },
  "NVCN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.34,
    "ebitda": -20140000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.5,
    "fifty_two_week_high": 10.12,
    "fifty_two_week_low": 3.66,
    "percent_change_from_200_day_moving_average": -0.21789999999999998,
    "percent_change_from_50_day_moving_average": 0.0018,
    "shares_owned": "N/A",
    "short_ratio": 1.27,
    "two_hundred_day_moving_average": 7.05,
    "volume": 124270.0,
    "market_cap": 366700000.0,
    "price_to_sales_ttm": 36.57,
    "price_to_book_mrq": 5.29,
    "roa_ttm": -0.2584,
    "roe_ttm": -0.42579999999999996,
    "shares_outstanding": 66550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -13130000.0,
    "levered_cash_flow_ttm": -7510000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Neovasc Inc."
  },
  "NVDQ": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.5,
    "earnings_per_share": -0.68,
    "ebitda": -30030000.0,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 11.71,
    "fifty_two_week_high": 18.24,
    "fifty_two_week_low": 9.4,
    "percent_change_from_200_day_moving_average": -0.0955,
    "percent_change_from_50_day_moving_average": -0.054299999999999994,
    "shares_owned": "N/A",
    "short_ratio": 24.62,
    "two_hundred_day_moving_average": 12.24,
    "volume": 343447.0,
    "market_cap": 622080000.0,
    "price_to_sales_ttm": 13.51,
    "price_to_book_mrq": 4.26,
    "roa_ttm": -0.1159,
    "roe_ttm": -0.1936,
    "shares_outstanding": 56200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -30150000.0,
    "levered_cash_flow_ttm": -25460000.0,
    "book_value_per_share_mrq": 2.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Novadaq Technologies Inc."
  },
  "NVET": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.27,
    "ebitda": -15830000.0,
    "eps_estimate_current_year": -2.04,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 4.72,
    "fifty_two_week_high": 11.3,
    "fifty_two_week_low": 3.54,
    "percent_change_from_200_day_moving_average": -0.34299999999999997,
    "percent_change_from_50_day_moving_average": -0.1439,
    "shares_owned": "N/A",
    "short_ratio": 2.37,
    "two_hundred_day_moving_average": 6.15,
    "volume": 34827.0,
    "market_cap": 46260000.0,
    "price_to_sales_ttm": 1923.77,
    "price_to_book_mrq": 0.89,
    "roa_ttm": -0.2213,
    "roe_ttm": -0.3023,
    "shares_outstanding": 11450000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0039000000000000003,
    "operating_cash_flow_ttm": -10850000.0,
    "levered_cash_flow_ttm": -9090000.0,
    "book_value_per_share_mrq": 4.7,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nexvet Biopharma Public Limited Company"
  },
  "NVGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.52,
    "ebitda": -5290000.0,
    "eps_estimate_current_year": -0.01,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.74,
    "fifty_two_week_high": 9.5,
    "fifty_two_week_low": 1.51,
    "percent_change_from_200_day_moving_average": -0.4068,
    "percent_change_from_50_day_moving_average": -0.0467,
    "shares_owned": "N/A",
    "short_ratio": 0.41,
    "two_hundred_day_moving_average": 4.4,
    "volume": 51991.0,
    "market_cap": 44170000.0,
    "price_to_sales_ttm": 38.42,
    "price_to_book_mrq": 1.47,
    "roa_ttm": -0.19820000000000002,
    "roe_ttm": -0.31920000000000004,
    "shares_outstanding": 16920000.0,
    "pcnt_held_by_insiders": 0.0479,
    "pcnt_held_by_institutions": 0.006,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -4080000.0,
    "levered_cash_flow_ttm": -2480000.0,
    "book_value_per_share_mrq": 1.88,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Novogen Limited"
  },
  "NVIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.43,
    "ebitda": -19190000.0,
    "eps_estimate_current_year": -0.63,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 10.67,
    "fifty_two_week_high": 19.68,
    "fifty_two_week_low": 2.94,
    "percent_change_from_200_day_moving_average": -0.2916,
    "percent_change_from_50_day_moving_average": -0.08449999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.52,
    "two_hundred_day_moving_average": 13.79,
    "volume": 253636.0,
    "market_cap": 263829999.99999997,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 18.6,
    "roa_ttm": -0.4885,
    "roe_ttm": -2.4459999999999997,
    "shares_outstanding": 27000000.0,
    "pcnt_held_by_insiders": 0.26940000000000003,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.10439999999999999,
    "operating_cash_flow_ttm": -14590000.0,
    "levered_cash_flow_ttm": -5740000.0,
    "book_value_per_share_mrq": 0.57,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "InVivo Therapeutics Holdings Corp."
  },
  "NVLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -7.28,
    "ebitda": -16239999.999999998,
    "eps_estimate_current_year": 2.92,
    "eps_estimate_next_quarter": -0.46,
    "fifty_day_moving_average": 16.18,
    "fifty_two_week_high": 20.43,
    "fifty_two_week_low": 13.22,
    "percent_change_from_200_day_moving_average": -0.16390000000000002,
    "percent_change_from_50_day_moving_average": -0.1545,
    "shares_owned": "N/A",
    "short_ratio": 0.72,
    "two_hundred_day_moving_average": 16.36,
    "volume": 83274.0,
    "market_cap": 211380000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.28,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 15450000.0,
    "pcnt_held_by_insiders": 0.006500000000000001,
    "pcnt_held_by_institutions": 1.032,
    "pcnt_short_of_float": 0.0042,
    "operating_cash_flow_ttm": -14370000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 6.16,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Nivalis Therapeutics, Inc."
  },
  "NVRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": -358.8,
    "earnings_per_share": -3.03,
    "ebitda": -44930000.0,
    "eps_estimate_current_year": -2.77,
    "eps_estimate_next_quarter": -0.68,
    "fifty_day_moving_average": 47.03,
    "fifty_two_week_high": 65.5,
    "fifty_two_week_low": 23.13,
    "percent_change_from_200_day_moving_average": -0.0091,
    "percent_change_from_50_day_moving_average": 0.042300000000000004,
    "shares_owned": "N/A",
    "short_ratio": 5.67,
    "two_hundred_day_moving_average": 49.47,
    "volume": 422129.0,
    "market_cap": 1370000000.0,
    "price_to_sales_ttm": 35.89,
    "price_to_book_mrq": 5.4,
    "roa_ttm": -0.1566,
    "roe_ttm": -0.3164,
    "shares_outstanding": 27880000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1646,
    "operating_cash_flow_ttm": -56680000.0,
    "levered_cash_flow_ttm": -36260000.0,
    "book_value_per_share_mrq": 9.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nevro Corp."
  },
  "NVTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.58,
    "ebitda": -66900000.00000001,
    "eps_estimate_current_year": -3.11,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 9.73,
    "fifty_two_week_high": 22.35,
    "fifty_two_week_low": 8.0,
    "percent_change_from_200_day_moving_average": -0.3636,
    "percent_change_from_50_day_moving_average": -0.1432,
    "shares_owned": "N/A",
    "short_ratio": 4.97,
    "two_hundred_day_moving_average": 13.1,
    "volume": 311596.0,
    "market_cap": 265320000.0,
    "price_to_sales_ttm": 70.19,
    "price_to_book_mrq": 1.62,
    "roa_ttm": -0.3851,
    "roe_ttm": -0.6655,
    "shares_outstanding": 31810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.077,
    "operating_cash_flow_ttm": -62240000.0,
    "levered_cash_flow_ttm": -42660000.0,
    "book_value_per_share_mrq": 5.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Invitae Corporation"
  },
  "NWBO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.6,
    "ebitda": -113700000.0,
    "eps_estimate_current_year": -1.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.28,
    "fifty_two_week_high": 12.55,
    "fifty_two_week_low": 3.79,
    "percent_change_from_200_day_moving_average": -0.2541,
    "percent_change_from_50_day_moving_average": -0.1917,
    "shares_owned": "N/A",
    "short_ratio": 12.3,
    "two_hundred_day_moving_average": 8.97,
    "volume": 622371.0,
    "market_cap": 522950000.00000006,
    "price_to_sales_ttm": 281.39,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.8503,
    "roe_ttm": "N/A",
    "shares_outstanding": 78170000.0,
    "pcnt_held_by_insiders": 0.4694,
    "pcnt_held_by_institutions": 0.155,
    "pcnt_short_of_float": 0.2797,
    "operating_cash_flow_ttm": -71760000.0,
    "levered_cash_flow_ttm": -2240000.0,
    "book_value_per_share_mrq": -0.98,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Northwest Biotherapeutics, Inc."
  },
  "NXTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.68,
    "earnings_per_share": -0.36,
    "ebitda": -5110000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 17.24,
    "fifty_two_week_high": 19.63,
    "fifty_two_week_low": 12.71,
    "percent_change_from_200_day_moving_average": 0.026000000000000002,
    "percent_change_from_50_day_moving_average": -0.013999999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.17,
    "two_hundred_day_moving_average": 16.57,
    "volume": 900488.0,
    "market_cap": 1080000000.0,
    "price_to_sales_ttm": 3.46,
    "price_to_book_mrq": 5.82,
    "roa_ttm": -0.0436,
    "roe_ttm": -0.1229,
    "shares_outstanding": 63450000.0,
    "pcnt_held_by_insiders": 0.1208,
    "pcnt_held_by_institutions": 0.912,
    "pcnt_short_of_float": 0.062,
    "operating_cash_flow_ttm": -8440000.0,
    "levered_cash_flow_ttm": 9810000.0,
    "book_value_per_share_mrq": 2.95,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Nxstage Medical, Inc."
  },
  "NYMX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.63,
    "ebitda": -22940000.0,
    "eps_estimate_current_year": -0.2,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.67,
    "fifty_two_week_high": 5.55,
    "fifty_two_week_low": 0.33,
    "percent_change_from_200_day_moving_average": 1.406,
    "percent_change_from_50_day_moving_average": 0.5182,
    "shares_owned": "N/A",
    "short_ratio": 2.52,
    "two_hundred_day_moving_average": 1.68,
    "volume": 1167599.0,
    "market_cap": 150610000.0,
    "price_to_sales_ttm": 36.78,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "-1,382.64%",
    "roe_ttm": "N/A",
    "shares_outstanding": 37190000.0,
    "pcnt_held_by_insiders": 0.5221,
    "pcnt_held_by_institutions": 0.038,
    "pcnt_short_of_float": 0.0593,
    "operating_cash_flow_ttm": -4040000.0,
    "levered_cash_flow_ttm": 5690000.0,
    "book_value_per_share_mrq": -0.06,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Nymox Pharmaceutical Corporation"
  },
  "OCAT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.73,
    "ebitda": -24300000.0,
    "eps_estimate_current_year": -0.61,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 4.09,
    "fifty_two_week_high": 9.45,
    "fifty_two_week_low": 3.06,
    "percent_change_from_200_day_moving_average": -0.2827,
    "percent_change_from_50_day_moving_average": -0.0348,
    "shares_owned": "N/A",
    "short_ratio": 4.8,
    "two_hundred_day_moving_average": 5.51,
    "volume": 570426.0,
    "market_cap": 166790000.0,
    "price_to_sales_ttm": 1123.33,
    "price_to_book_mrq": 10.94,
    "roa_ttm": -0.7889,
    "roe_ttm": -4.8003,
    "shares_outstanding": 42230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0691,
    "operating_cash_flow_ttm": -24570000.0,
    "levered_cash_flow_ttm": -38440000.0,
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocata Therapeutics, Inc."
  },
  "OCLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.92,
    "ebitda": -7200000.0,
    "eps_estimate_current_year": -0.45,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.19,
    "fifty_two_week_high": 2.35,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": 0.2138,
    "percent_change_from_50_day_moving_average": 0.1616,
    "shares_owned": "N/A",
    "short_ratio": 3.09,
    "two_hundred_day_moving_average": 1.14,
    "volume": 348694.0,
    "market_cap": 22640000.0,
    "price_to_sales_ttm": 1.6,
    "price_to_book_mrq": 1.94,
    "roa_ttm": -0.2734,
    "roe_ttm": -0.8534999999999999,
    "shares_outstanding": 16410000.0,
    "pcnt_held_by_insiders": 0.0815,
    "pcnt_held_by_institutions": 0.107,
    "pcnt_short_of_float": 0.08689999999999999,
    "operating_cash_flow_ttm": -7930000.0,
    "levered_cash_flow_ttm": -6520000.0,
    "book_value_per_share_mrq": 0.71,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Oculus Innovative Sciences, Inc."
  },
  "OCRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.27,
    "ebitda": -24940000.0,
    "eps_estimate_current_year": -1.43,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 3.75,
    "fifty_two_week_high": 8.1,
    "fifty_two_week_low": 3.3,
    "percent_change_from_200_day_moving_average": -0.06280000000000001,
    "percent_change_from_50_day_moving_average": -0.0134,
    "shares_owned": "N/A",
    "short_ratio": 2.04,
    "two_hundred_day_moving_average": 3.95,
    "volume": 44612.0,
    "market_cap": 73570000.0,
    "price_to_sales_ttm": 228.93,
    "price_to_book_mrq": 1.95,
    "roa_ttm": -0.38079999999999997,
    "roe_ttm": -0.6589,
    "shares_outstanding": 19880000.0,
    "pcnt_held_by_insiders": 0.26890000000000003,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.0106,
    "operating_cash_flow_ttm": -20050000.0,
    "levered_cash_flow_ttm": -11480000.0,
    "book_value_per_share_mrq": 1.99,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocera Therapeutics, Inc."
  },
  "OCUL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.64,
    "ebitda": -30410000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 17.93,
    "fifty_two_week_high": 44.19,
    "fifty_two_week_low": 13.0,
    "percent_change_from_200_day_moving_average": -0.3791,
    "percent_change_from_50_day_moving_average": -0.1396,
    "shares_owned": "N/A",
    "short_ratio": 5.53,
    "two_hundred_day_moving_average": 24.85,
    "volume": 246605.0,
    "market_cap": 381420000.0,
    "price_to_sales_ttm": 287.34,
    "price_to_book_mrq": 4.04,
    "roa_ttm": -0.2531,
    "roe_ttm": -0.5716,
    "shares_outstanding": 24720000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1295,
    "operating_cash_flow_ttm": -27370000.0,
    "levered_cash_flow_ttm": -15870000.0,
    "book_value_per_share_mrq": 4.42,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ocular Therapeutix, Inc."
  },
  "OFIX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.86,
    "earnings_per_share": -0.54,
    "ebitda": 18830000.0,
    "eps_estimate_current_year": 0.69,
    "eps_estimate_next_quarter": 0.22,
    "fifty_day_moving_average": 37.24,
    "fifty_two_week_high": 42.1,
    "fifty_two_week_low": 26.96,
    "percent_change_from_200_day_moving_average": -0.015,
    "percent_change_from_50_day_moving_average": -0.08199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 5.88,
    "two_hundred_day_moving_average": 34.71,
    "volume": 121737.0,
    "market_cap": 644500000.0,
    "price_to_sales_ttm": 1.72,
    "price_to_book_mrq": 2.27,
    "roa_ttm": 0.013999999999999999,
    "roe_ttm": -0.028900000000000002,
    "shares_outstanding": 18850000.0,
    "pcnt_held_by_insiders": 0.0336,
    "pcnt_held_by_institutions": 0.875,
    "pcnt_short_of_float": 0.0374,
    "operating_cash_flow_ttm": 42040000.0,
    "levered_cash_flow_ttm": 78030000.0,
    "book_value_per_share_mrq": 15.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Orthofix International N.V."
  },
  "OGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.27,
    "ebitda": -9850000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.5,
    "fifty_two_week_high": 3.87,
    "fifty_two_week_low": 0.66,
    "percent_change_from_200_day_moving_average": 0.4432,
    "percent_change_from_50_day_moving_average": -0.0882,
    "shares_owned": "N/A",
    "short_ratio": 0.85,
    "two_hundred_day_moving_average": 1.58,
    "volume": 161909.0,
    "market_cap": 83170000.0,
    "price_to_sales_ttm": 92.32,
    "price_to_book_mrq": 30.59,
    "roa_ttm": -0.5615,
    "roe_ttm": -1.2625,
    "shares_outstanding": 36480000.0,
    "pcnt_held_by_insiders": 0.3296,
    "pcnt_held_by_institutions": 0.414,
    "pcnt_short_of_float": 0.0398,
    "operating_cash_flow_ttm": -4510000.0,
    "levered_cash_flow_ttm": -6170000.0,
    "book_value_per_share_mrq": 0.09,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oragenics Inc."
  },
  "OGXI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.95,
    "ebitda": -24530000.0,
    "eps_estimate_current_year": -1.0,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 2.74,
    "fifty_two_week_high": 4.1,
    "fifty_two_week_low": 1.38,
    "percent_change_from_200_day_moving_average": 0.0004,
    "percent_change_from_50_day_moving_average": -0.0964,
    "shares_owned": "N/A",
    "short_ratio": 2.05,
    "two_hundred_day_moving_average": 2.48,
    "volume": 816081.0,
    "market_cap": 73880000.0,
    "price_to_sales_ttm": 5.09,
    "price_to_book_mrq": 2.35,
    "roa_ttm": -0.2737,
    "roe_ttm": -0.7726999999999999,
    "shares_outstanding": 29790000.0,
    "pcnt_held_by_insiders": 0.1058,
    "pcnt_held_by_institutions": 0.26899999999999996,
    "pcnt_short_of_float": 0.0861,
    "operating_cash_flow_ttm": -2490000.0,
    "levered_cash_flow_ttm": 9820000.0,
    "book_value_per_share_mrq": 1.15,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoGenex Pharmaceuticals, Inc."
  },
  "OHRP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -0.53,
    "ebitda": -15900000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.83,
    "fifty_two_week_high": 12.31,
    "fifty_two_week_low": 2.02,
    "percent_change_from_200_day_moving_average": -0.1201,
    "percent_change_from_50_day_moving_average": 0.0591,
    "shares_owned": "N/A",
    "short_ratio": 3.46,
    "two_hundred_day_moving_average": 3.41,
    "volume": 421730.0,
    "market_cap": 90990000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.12,
    "roa_ttm": -0.2516,
    "roe_ttm": -0.38659999999999994,
    "shares_outstanding": 30330000.0,
    "pcnt_held_by_insiders": 0.4111,
    "pcnt_held_by_institutions": 0.134,
    "pcnt_short_of_float": 0.13720000000000002,
    "operating_cash_flow_ttm": -10060000.0,
    "levered_cash_flow_ttm": -12250000.0,
    "book_value_per_share_mrq": 1.5,
    "next_earnings_announcement_date": [
      "2015-12-21",
      "2015-12-28"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ohr Pharmaceutical, Inc."
  },
  "OMED": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.9,
    "ebitda": -55770000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 19.45,
    "fifty_two_week_high": 29.83,
    "fifty_two_week_low": 14.6,
    "percent_change_from_200_day_moving_average": -0.35719999999999996,
    "percent_change_from_50_day_moving_average": -0.2389,
    "shares_owned": "N/A",
    "short_ratio": 16.24,
    "two_hundred_day_moving_average": 23.02,
    "volume": 533981.0,
    "market_cap": 444920000.0,
    "price_to_sales_ttm": 11.72,
    "price_to_book_mrq": 10.6,
    "roa_ttm": -0.1452,
    "roe_ttm": -0.818,
    "shares_outstanding": 30060000.0,
    "pcnt_held_by_insiders": 0.7356999999999999,
    "pcnt_held_by_institutions": 0.21100000000000002,
    "pcnt_short_of_float": 0.1177,
    "operating_cash_flow_ttm": -66370000.00000001,
    "levered_cash_flow_ttm": -38530000.0,
    "book_value_per_share_mrq": 1.54,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoMed Pharmaceuticals, Inc."
  },
  "OMER": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -2.09,
    "ebitda": -70740000.0,
    "eps_estimate_current_year": -1.83,
    "eps_estimate_next_quarter": -0.42,
    "fifty_day_moving_average": 14.86,
    "fifty_two_week_high": 30.23,
    "fifty_two_week_low": 11.18,
    "percent_change_from_200_day_moving_average": -0.3889,
    "percent_change_from_50_day_moving_average": -0.20579999999999998,
    "shares_owned": "N/A",
    "short_ratio": 3.74,
    "two_hundred_day_moving_average": 19.31,
    "volume": 800413.0,
    "market_cap": 447050000.0,
    "price_to_sales_ttm": 118.55,
    "price_to_book_mrq": 59.43,
    "roa_ttm": -0.8909,
    "roe_ttm": "N/A",
    "shares_outstanding": 37890000.0,
    "pcnt_held_by_insiders": 0.06849999999999999,
    "pcnt_held_by_institutions": 0.408,
    "pcnt_short_of_float": 0.2838,
    "operating_cash_flow_ttm": -65650000.00000001,
    "levered_cash_flow_ttm": -38480000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Omeros Corporation"
  },
  "ONCE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.09,
    "ebitda": -38200000.0,
    "eps_estimate_current_year": -2.08,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 46.01,
    "fifty_two_week_high": 79.5,
    "fifty_two_week_low": 36.96,
    "percent_change_from_200_day_moving_average": -0.2386,
    "percent_change_from_50_day_moving_average": 0.0015,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 60.52,
    "volume": 750484.0,
    "market_cap": 1130000000.0,
    "price_to_sales_ttm": 300.63,
    "price_to_book_mrq": 6.11,
    "roa_ttm": -0.1535,
    "roe_ttm": -0.29059999999999997,
    "shares_outstanding": 24560000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2147,
    "operating_cash_flow_ttm": -4950000.0,
    "levered_cash_flow_ttm": -23520000.0,
    "book_value_per_share_mrq": 8.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spark Therapeutics, Inc."
  },
  "ONCS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.5,
    "ebitda": -17410000.0,
    "eps_estimate_current_year": -1.26,
    "eps_estimate_next_quarter": -0.51,
    "fifty_day_moving_average": 5.95,
    "fifty_two_week_high": 13.2,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": 0.08039999999999999,
    "percent_change_from_50_day_moving_average": 0.1317,
    "shares_owned": "N/A",
    "short_ratio": 0.2,
    "two_hundred_day_moving_average": 6.23,
    "volume": 136694.0,
    "market_cap": 99760000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.23,
    "roa_ttm": -0.4267,
    "roe_ttm": -0.7225,
    "shares_outstanding": 14820000.0,
    "pcnt_held_by_insiders": 0.1709,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -15140000.0,
    "levered_cash_flow_ttm": -9340000.0,
    "book_value_per_share_mrq": 2.1,
    "next_earnings_announcement_date": [
      "2015-10-08",
      "2015-10-12"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OncoSec Medical Incorporated"
  },
  "ONCY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.12,
    "ebitda": -11910000.0,
    "eps_estimate_current_year": -0.18,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.55,
    "fifty_two_week_high": 1.4,
    "fifty_two_week_low": 0.4,
    "percent_change_from_200_day_moving_average": -0.196,
    "percent_change_from_50_day_moving_average": -0.0604,
    "shares_owned": "N/A",
    "short_ratio": 4.39,
    "two_hundred_day_moving_average": 0.65,
    "volume": 383013.0,
    "market_cap": 61350000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.73,
    "roa_ttm": -0.37549999999999994,
    "roe_ttm": -0.6801999999999999,
    "shares_outstanding": 117980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0089,
    "operating_cash_flow_ttm": -11830000.0,
    "levered_cash_flow_ttm": -7660000.0,
    "book_value_per_share_mrq": 0.19,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Oncolytics Biotech Inc."
  },
  "ONTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.28,
    "ebitda": -49260000.0,
    "eps_estimate_current_year": -1.63,
    "eps_estimate_next_quarter": -0.34,
    "fifty_day_moving_average": 1.61,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 1.35,
    "percent_change_from_200_day_moving_average": -0.33649999999999997,
    "percent_change_from_50_day_moving_average": -0.0658,
    "shares_owned": "N/A",
    "short_ratio": 0.35,
    "two_hundred_day_moving_average": 2.26,
    "volume": 119394.0,
    "market_cap": 32689999.999999996,
    "price_to_sales_ttm": 69.36,
    "price_to_book_mrq": 8.6,
    "roa_ttm": -0.6053999999999999,
    "roe_ttm": -1.8552000000000002,
    "shares_outstanding": 21790000.0,
    "pcnt_held_by_insiders": 0.6256,
    "pcnt_held_by_institutions": 0.135,
    "pcnt_short_of_float": 0.0277,
    "operating_cash_flow_ttm": -45790000.0,
    "levered_cash_flow_ttm": -26820000.0,
    "book_value_per_share_mrq": 0.17,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Onconova Therapeutics, Inc."
  },
  "ONTY": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.58,
    "ebitda": -51230000.0,
    "eps_estimate_current_year": -0.38,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.31,
    "fifty_two_week_high": 4.69,
    "fifty_two_week_low": 1.41,
    "percent_change_from_200_day_moving_average": 0.0684,
    "percent_change_from_50_day_moving_average": -0.0697,
    "shares_owned": "N/A",
    "short_ratio": 6.11,
    "two_hundred_day_moving_average": 2.88,
    "volume": 1344757.0,
    "market_cap": 292320000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.46,
    "roa_ttm": -0.3739,
    "roe_ttm": -0.6931,
    "shares_outstanding": 94910000.0,
    "pcnt_held_by_insiders": 0.0794,
    "pcnt_held_by_institutions": 0.562,
    "pcnt_short_of_float": 0.08779999999999999,
    "operating_cash_flow_ttm": -50200000.0,
    "levered_cash_flow_ttm": -28630000.0,
    "book_value_per_share_mrq": 1.01,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oncothyreon Inc"
  },
  "ONVO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.4,
    "ebitda": -31830000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 2.87,
    "fifty_two_week_high": 7.68,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": -0.16,
    "percent_change_from_50_day_moving_average": 0.1603,
    "shares_owned": "N/A",
    "short_ratio": 13.44,
    "two_hundred_day_moving_average": 3.96,
    "volume": 1243675.0,
    "market_cap": 307780000.0,
    "price_to_sales_ttm": 438.37,
    "price_to_book_mrq": 4.0,
    "roa_ttm": -0.29410000000000003,
    "roe_ttm": -0.4978,
    "shares_outstanding": 92430000.0,
    "pcnt_held_by_insiders": 0.10769999999999999,
    "pcnt_held_by_institutions": 0.19699999999999998,
    "pcnt_short_of_float": 0.3099,
    "operating_cash_flow_ttm": -22530000.0,
    "levered_cash_flow_ttm": -12540000.0,
    "book_value_per_share_mrq": 0.92,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Organovo Holdings, Inc."
  },
  "OPGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.74,
    "ebitda": -8050000.000000001,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.63,
    "fifty_two_week_high": 5.44,
    "fifty_two_week_low": 2.21,
    "percent_change_from_200_day_moving_average": -0.1198,
    "percent_change_from_50_day_moving_average": 0.15789999999999998,
    "shares_owned": "N/A",
    "short_ratio": 0.84,
    "two_hundred_day_moving_average": 3.47,
    "volume": 5002.0,
    "market_cap": 38240000.0,
    "price_to_sales_ttm": 13.9,
    "price_to_book_mrq": 3.77,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0037,
    "operating_cash_flow_ttm": -7360000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "OpGen, Inc."
  },
  "OPHT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.58,
    "ebitda": -51850000.0,
    "eps_estimate_current_year": -3.15,
    "eps_estimate_next_quarter": -1.14,
    "fifty_day_moving_average": 47.17,
    "fifty_two_week_high": 72.51,
    "fifty_two_week_low": 36.46,
    "percent_change_from_200_day_moving_average": -0.24109999999999998,
    "percent_change_from_50_day_moving_average": -0.1698,
    "shares_owned": "N/A",
    "short_ratio": 5.5,
    "two_hundred_day_moving_average": 51.6,
    "volume": 853393.0,
    "market_cap": 1360000000.0,
    "price_to_sales_ttm": 17.26,
    "price_to_book_mrq": 12.8,
    "roa_ttm": -0.069,
    "roe_ttm": -0.3923,
    "shares_outstanding": 34740000.0,
    "pcnt_held_by_insiders": 0.6469,
    "pcnt_held_by_institutions": 0.23800000000000002,
    "pcnt_short_of_float": 0.1272,
    "operating_cash_flow_ttm": -49530000.0,
    "levered_cash_flow_ttm": -34170000.0,
    "book_value_per_share_mrq": 3.28,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ophthotech Corporation"
  },
  "OPK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -94770000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 11.27,
    "fifty_two_week_high": 19.2,
    "fifty_two_week_low": 8.02,
    "percent_change_from_200_day_moving_average": -0.3747,
    "percent_change_from_50_day_moving_average": -0.19440000000000002,
    "shares_owned": "N/A",
    "short_ratio": 8.59,
    "two_hundred_day_moving_average": 14.52,
    "volume": 11396219.0,
    "market_cap": 4910000000.0,
    "price_to_sales_ttm": 38.72,
    "price_to_book_mrq": 5.46,
    "roa_ttm": -0.0481,
    "roe_ttm": -0.3044,
    "shares_outstanding": 540420000.0,
    "pcnt_held_by_insiders": 0.5118,
    "pcnt_held_by_institutions": 0.185,
    "pcnt_short_of_float": 0.804,
    "operating_cash_flow_ttm": 158900000.0,
    "levered_cash_flow_ttm": 53660000.0,
    "book_value_per_share_mrq": 1.8,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opko Health, Inc."
  },
  "OPXA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -13730000.0,
    "eps_estimate_current_year": -0.3,
    "eps_estimate_next_quarter": -0.08,
    "fifty_day_moving_average": 0.418,
    "fifty_two_week_high": 1.08,
    "fifty_two_week_low": 0.3,
    "percent_change_from_200_day_moving_average": -0.0124,
    "percent_change_from_50_day_moving_average": 0.10212,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 0.467,
    "volume": 145094.0,
    "market_cap": 24610000.0,
    "price_to_sales_ttm": 14.91,
    "price_to_book_mrq": 1.94,
    "roa_ttm": -0.4556,
    "roe_ttm": -1.0519,
    "shares_outstanding": 53390000.0,
    "pcnt_held_by_insiders": 0.09970000000000001,
    "pcnt_held_by_institutions": 0.049,
    "pcnt_short_of_float": 0.0166,
    "operating_cash_flow_ttm": -10600000.0,
    "levered_cash_flow_ttm": -5120000.0,
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Opexa Therapeutics, Inc."
  },
  "OREX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.04,
    "earnings_per_share": -0.22,
    "ebitda": -20570000.0,
    "eps_estimate_current_year": -0.67,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 2.85,
    "fifty_two_week_high": 9.37,
    "fifty_two_week_low": 1.97,
    "percent_change_from_200_day_moving_average": -0.5879,
    "percent_change_from_50_day_moving_average": -0.2713,
    "shares_owned": "N/A",
    "short_ratio": 13.52,
    "two_hundred_day_moving_average": 5.05,
    "volume": 4816267.0,
    "market_cap": 260820000.0,
    "price_to_sales_ttm": 4.43,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0782,
    "roe_ttm": "N/A",
    "shares_outstanding": 125390000.0,
    "pcnt_held_by_insiders": 0.09050000000000001,
    "pcnt_held_by_institutions": 0.7959999999999999,
    "pcnt_short_of_float": 0.32380000000000003,
    "operating_cash_flow_ttm": 36510000.0,
    "levered_cash_flow_ttm": 7040000.0,
    "book_value_per_share_mrq": -0.03,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Orexigen Therapeutics, Inc."
  },
  "ORMP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.64,
    "ebitda": -6850000.0,
    "eps_estimate_current_year": -0.72,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.93,
    "fifty_two_week_high": 9.84,
    "fifty_two_week_low": 3.71,
    "percent_change_from_200_day_moving_average": 0.0304,
    "percent_change_from_50_day_moving_average": 0.1159,
    "shares_owned": "N/A",
    "short_ratio": 13.53,
    "two_hundred_day_moving_average": 6.42,
    "volume": 94685.0,
    "market_cap": 76470000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.4,
    "roa_ttm": -0.19210000000000002,
    "roe_ttm": -0.3116,
    "shares_outstanding": 11550000.0,
    "pcnt_held_by_insiders": 0.2372,
    "pcnt_held_by_institutions": 0.13,
    "pcnt_short_of_float": 0.08070000000000001,
    "operating_cash_flow_ttm": -4720000.0,
    "levered_cash_flow_ttm": -2130000.0,
    "book_value_per_share_mrq": 1.97,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Oramed Pharmaceuticals Inc."
  },
  "ORPN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.88,
    "ebitda": -12370000.0,
    "eps_estimate_current_year": -1.13,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 5.73,
    "fifty_two_week_high": 8.85,
    "fifty_two_week_low": 4.5,
    "percent_change_from_200_day_moving_average": -0.06860000000000001,
    "percent_change_from_50_day_moving_average": 0.0046,
    "shares_owned": "N/A",
    "short_ratio": 0.96,
    "two_hundred_day_moving_average": 6.18,
    "volume": 29121.0,
    "market_cap": 81960000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.39,
    "roa_ttm": -0.4927,
    "roe_ttm": -0.8467,
    "shares_outstanding": 14230000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004699999999999999,
    "operating_cash_flow_ttm": -9580000.0,
    "levered_cash_flow_ttm": -5040000.0,
    "book_value_per_share_mrq": 1.77,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio Blast Pharma Ltd."
  },
  "OSIR": {
    "p_e_ratio": 159.65,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.11,
    "ebitda": 7020000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.08,
    "fifty_day_moving_average": 18.41,
    "fifty_two_week_high": 23.67,
    "fifty_two_week_low": 11.87,
    "percent_change_from_200_day_moving_average": -0.020499999999999997,
    "percent_change_from_50_day_moving_average": -0.0202,
    "shares_owned": "N/A",
    "short_ratio": 14.1,
    "two_hundred_day_moving_average": 18.42,
    "volume": 222727.0,
    "market_cap": 621290000.0,
    "price_to_sales_ttm": 8.1,
    "price_to_book_mrq": 7.4,
    "roa_ttm": 0.038900000000000004,
    "roe_ttm": 0.051100000000000007,
    "shares_outstanding": 34440000.0,
    "pcnt_held_by_insiders": 0.5297,
    "pcnt_held_by_institutions": 0.266,
    "pcnt_short_of_float": 0.18230000000000002,
    "operating_cash_flow_ttm": 5960000.0,
    "levered_cash_flow_ttm": -8750000.0,
    "book_value_per_share_mrq": 2.58,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Osiris Therapeutics, Inc."
  },
  "OSUR": {
    "p_e_ratio": 504.0,
    "peg_ratio": 6.59,
    "earnings_per_share": 0.01,
    "ebitda": 6800000.0,
    "eps_estimate_current_year": 0.04,
    "eps_estimate_next_quarter": 0.01,
    "fifty_day_moving_average": 5.31,
    "fifty_two_week_high": 10.93,
    "fifty_two_week_low": 4.42,
    "percent_change_from_200_day_moving_average": -0.1398,
    "percent_change_from_50_day_moving_average": -0.051500000000000004,
    "shares_owned": "N/A",
    "short_ratio": 3.23,
    "two_hundred_day_moving_average": 5.86,
    "volume": 1123222.0,
    "market_cap": 284670000.0,
    "price_to_sales_ttm": 2.7,
    "price_to_book_mrq": 1.93,
    "roa_ttm": 0.0026,
    "roe_ttm": 0.0036,
    "shares_outstanding": 56480000.0,
    "pcnt_held_by_insiders": 0.0292,
    "pcnt_held_by_institutions": 0.7909999999999999,
    "pcnt_short_of_float": 0.0455,
    "operating_cash_flow_ttm": 14500000.0,
    "levered_cash_flow_ttm": 12790000.0,
    "book_value_per_share_mrq": 2.83,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "OraSure Technologies, Inc."
  },
  "OTIC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.33,
    "earnings_per_share": -2.36,
    "ebitda": -43770000.0,
    "eps_estimate_current_year": -2.87,
    "eps_estimate_next_quarter": -0.92,
    "fifty_day_moving_average": 23.27,
    "fifty_two_week_high": 41.99,
    "fifty_two_week_low": 19.86,
    "percent_change_from_200_day_moving_average": -0.2109,
    "percent_change_from_50_day_moving_average": -0.07629999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.82,
    "two_hundred_day_moving_average": 27.24,
    "volume": 252003.0,
    "market_cap": 520299999.99999994,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.72,
    "roa_ttm": -0.1894,
    "roe_ttm": -0.33270000000000005,
    "shares_outstanding": 24200000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1419,
    "operating_cash_flow_ttm": -40980000.0,
    "levered_cash_flow_ttm": -25830000.0,
    "book_value_per_share_mrq": 8.79,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Otonomy, Inc."
  },
  "OVAS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.62,
    "ebitda": -63960000.0,
    "eps_estimate_current_year": -2.55,
    "eps_estimate_next_quarter": -0.61,
    "fifty_day_moving_average": 19.95,
    "fifty_two_week_high": 55.69,
    "fifty_two_week_low": 13.25,
    "percent_change_from_200_day_moving_average": -0.4414,
    "percent_change_from_50_day_moving_average": -0.1744,
    "shares_owned": "N/A",
    "short_ratio": 12.97,
    "two_hundred_day_moving_average": 29.48,
    "volume": 574708.0,
    "market_cap": 449080000.0,
    "price_to_sales_ttm": 10936.7,
    "price_to_book_mrq": 3.14,
    "roa_ttm": -0.32299999999999995,
    "roe_ttm": -0.5650999999999999,
    "shares_outstanding": 27270000.0,
    "pcnt_held_by_insiders": 0.29760000000000003,
    "pcnt_held_by_institutions": 0.581,
    "pcnt_short_of_float": 0.49079999999999996,
    "operating_cash_flow_ttm": -45500000.0,
    "levered_cash_flow_ttm": -24210000.0,
    "book_value_per_share_mrq": 5.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OvaScience, Inc."
  },
  "OXFD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.37,
    "ebitda": -23920000.0,
    "eps_estimate_current_year": -1.17,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 13.73,
    "fifty_two_week_high": 15.61,
    "fifty_two_week_low": 10.01,
    "percent_change_from_200_day_moving_average": -0.056100000000000004,
    "percent_change_from_50_day_moving_average": -0.0649,
    "shares_owned": "N/A",
    "short_ratio": 11.64,
    "two_hundred_day_moving_average": 13.6,
    "volume": 21855.0,
    "market_cap": 289310000.0,
    "price_to_sales_ttm": 5.85,
    "price_to_book_mrq": 3.06,
    "roa_ttm": -0.16140000000000002,
    "roe_ttm": -0.3009,
    "shares_outstanding": 22530000.0,
    "pcnt_held_by_insiders": 0.1099,
    "pcnt_held_by_institutions": 0.595,
    "pcnt_short_of_float": 0.0315,
    "operating_cash_flow_ttm": -23220000.0,
    "levered_cash_flow_ttm": -16940000.0,
    "book_value_per_share_mrq": 4.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Oxford Immunotec Global PLC"
  },
  "OXGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.55,
    "ebitda": -12140000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 1.27,
    "fifty_two_week_high": 2.53,
    "fifty_two_week_low": 1.01,
    "percent_change_from_200_day_moving_average": -0.146,
    "percent_change_from_50_day_moving_average": -0.0509,
    "shares_owned": "N/A",
    "short_ratio": 6.07,
    "two_hundred_day_moving_average": 1.42,
    "volume": 584351.0,
    "market_cap": 32119999.999999996,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.05,
    "roa_ttm": -0.2164,
    "roe_ttm": -0.3617,
    "shares_outstanding": 26540000.0,
    "pcnt_held_by_insiders": 0.20379999999999998,
    "pcnt_held_by_institutions": 0.057,
    "pcnt_short_of_float": 0.04650000000000001,
    "operating_cash_flow_ttm": -12340000.0,
    "levered_cash_flow_ttm": -7820000.0,
    "book_value_per_share_mrq": 1.22,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "OXiGENE, Inc."
  },
  "PACB": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.82,
    "ebitda": -53240000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 4.6,
    "fifty_two_week_high": 8.78,
    "fifty_two_week_low": 3.95,
    "percent_change_from_200_day_moving_average": -0.2612,
    "percent_change_from_50_day_moving_average": -0.131,
    "shares_owned": "N/A",
    "short_ratio": 23.76,
    "two_hundred_day_moving_average": 5.41,
    "volume": 1184452.0,
    "market_cap": 299870000.0,
    "price_to_sales_ttm": 4.0,
    "price_to_book_mrq": 9.47,
    "roa_ttm": -0.3166,
    "roe_ttm": -1.2977,
    "shares_outstanding": 74970000.0,
    "pcnt_held_by_insiders": 0.18969999999999998,
    "pcnt_held_by_institutions": 0.5429999999999999,
    "pcnt_short_of_float": 0.318,
    "operating_cash_flow_ttm": -53000000.0,
    "levered_cash_flow_ttm": -14690000.0,
    "book_value_per_share_mrq": 0.45,
    "next_earnings_announcement_date": [
      "2015-10-12",
      "2015-10-22"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pacific Biosciences of California, Inc."
  },
  "PAHC": {
    "p_e_ratio": 21.39,
    "peg_ratio": 1.46,
    "earnings_per_share": 1.51,
    "ebitda": 107110000.0,
    "eps_estimate_current_year": 1.7,
    "eps_estimate_next_quarter": 0.41,
    "fifty_day_moving_average": 35.84,
    "fifty_two_week_high": 40.54,
    "fifty_two_week_low": 21.01,
    "percent_change_from_200_day_moving_average": -0.092,
    "percent_change_from_50_day_moving_average": -0.09880000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.95,
    "two_hundred_day_moving_average": 35.57,
    "volume": 202596.0,
    "market_cap": 1260000000.0,
    "price_to_sales_ttm": 1.78,
    "price_to_book_mrq": 45.0,
    "roa_ttm": 0.11449999999999999,
    "roe_ttm": 2.6925,
    "shares_outstanding": 17950000.0,
    "pcnt_held_by_insiders": 0.3583,
    "pcnt_held_by_institutions": 0.264,
    "pcnt_short_of_float": 0.0388,
    "operating_cash_flow_ttm": 68700000.0,
    "levered_cash_flow_ttm": 50690000.0,
    "book_value_per_share_mrq": 0.76,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Phibro Animal Health Corporation"
  },
  "PARN": {
    "p_e_ratio": 11.17,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.32,
    "ebitda": -6160000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 4.1,
    "fifty_two_week_high": 6.38,
    "fifty_two_week_low": 3.29,
    "percent_change_from_200_day_moving_average": -0.2016,
    "percent_change_from_50_day_moving_average": -0.1425,
    "shares_owned": "N/A",
    "short_ratio": 1.0,
    "two_hundred_day_moving_average": 4.41,
    "volume": 7646.0,
    "market_cap": 46760000.0,
    "price_to_sales_ttm": 8.59,
    "price_to_book_mrq": 2.35,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 13280000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.001,
    "operating_cash_flow_ttm": -4080000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Parnell Pharmaceuticals Holdings Ltd."
  },
  "PBMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -9190000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.21,
    "fifty_two_week_high": 6.48,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": 0.12029999999999999,
    "percent_change_from_50_day_moving_average": 0.14980000000000002,
    "shares_owned": "N/A",
    "short_ratio": 0.38,
    "two_hundred_day_moving_average": 1.24,
    "volume": 2308182.0,
    "market_cap": 91470000.0,
    "price_to_sales_ttm": 82.86,
    "price_to_book_mrq": 3.97,
    "roa_ttm": -0.3179,
    "roe_ttm": -1.36,
    "shares_outstanding": 65810000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -5600000.0,
    "levered_cash_flow_ttm": -4760000.0,
    "book_value_per_share_mrq": 0.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prima Biomed Ltd."
  },
  "PBYI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.35,
    "earnings_per_share": -6.46,
    "ebitda": -200350000.0,
    "eps_estimate_current_year": -7.28,
    "eps_estimate_next_quarter": -1.81,
    "fifty_day_moving_average": 92.75,
    "fifty_two_week_high": 255.43,
    "fifty_two_week_low": 79.01,
    "percent_change_from_200_day_moving_average": -0.45289999999999997,
    "percent_change_from_50_day_moving_average": -0.1158,
    "shares_owned": "N/A",
    "short_ratio": 7.06,
    "two_hundred_day_moving_average": 149.91,
    "volume": 456474.0,
    "market_cap": 2650000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 10.37,
    "roa_ttm": -0.5042,
    "roe_ttm": -0.9075,
    "shares_outstanding": 32310000.000000004,
    "pcnt_held_by_insiders": 0.18239999999999998,
    "pcnt_held_by_institutions": 0.8640000000000001,
    "pcnt_short_of_float": 0.20829999999999999,
    "operating_cash_flow_ttm": -127350000.0,
    "levered_cash_flow_ttm": -53550000.0,
    "book_value_per_share_mrq": 8.53,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Puma Biotechnology, Inc."
  },
  "PCRX": {
    "p_e_ratio": 445.05,
    "peg_ratio": 0.8,
    "earnings_per_share": 0.11,
    "ebitda": 22580000.0,
    "eps_estimate_current_year": 0.83,
    "eps_estimate_next_quarter": 0.24,
    "fifty_day_moving_average": 60.33,
    "fifty_two_week_high": 121.95,
    "fifty_two_week_low": 45.76,
    "percent_change_from_200_day_moving_average": -0.35009999999999997,
    "percent_change_from_50_day_moving_average": -0.2107,
    "shares_owned": "N/A",
    "short_ratio": 7.54,
    "two_hundred_day_moving_average": 73.27,
    "volume": 2171533.0,
    "market_cap": 1750000000.0,
    "price_to_sales_ttm": 8.15,
    "price_to_book_mrq": 9.65,
    "roa_ttm": 0.023399999999999997,
    "roe_ttm": 0.023700000000000002,
    "shares_outstanding": 36650000.0,
    "pcnt_held_by_insiders": 0.07150000000000001,
    "pcnt_held_by_institutions": 1.0270000000000001,
    "pcnt_short_of_float": 0.1745,
    "operating_cash_flow_ttm": 31130000.0,
    "levered_cash_flow_ttm": -4240000.0,
    "book_value_per_share_mrq": 5.33,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-31"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Pacira Pharmaceuticals, Inc."
  },
  "PDEX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.088,
    "ebitda": -324000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.3631,
    "fifty_two_week_high": 3.07,
    "fifty_two_week_low": 1.99,
    "percent_change_from_200_day_moving_average": 0.139933,
    "percent_change_from_50_day_moving_average": 0.087494,
    "shares_owned": "N/A",
    "short_ratio": 0.7,
    "two_hundred_day_moving_average": 2.2544,
    "volume": 12081.0,
    "market_cap": 10640000.0,
    "price_to_sales_ttm": 0.77,
    "price_to_book_mrq": 1.22,
    "roa_ttm": -0.04650000000000001,
    "roe_ttm": -0.0454,
    "shares_outstanding": 4139999.9999999995,
    "pcnt_held_by_insiders": 0.4263,
    "pcnt_held_by_institutions": 0.017,
    "pcnt_short_of_float": 0.0017000000000000001,
    "operating_cash_flow_ttm": -775000.0,
    "levered_cash_flow_ttm": -742500.0,
    "book_value_per_share_mrq": 2.05,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Pro-Dex Inc."
  },
  "PDLI": {
    "p_e_ratio": 2.76,
    "peg_ratio": 0.17,
    "earnings_per_share": 1.89,
    "ebitda": 450670000.0,
    "eps_estimate_current_year": 2.26,
    "eps_estimate_next_quarter": 0.68,
    "fifty_day_moving_average": 5.51,
    "fifty_two_week_high": 8.6,
    "fifty_two_week_low": 4.58,
    "percent_change_from_200_day_moving_average": -0.1771,
    "percent_change_from_50_day_moving_average": -0.0527,
    "shares_owned": "N/A",
    "short_ratio": 15.63,
    "two_hundred_day_moving_average": 6.34,
    "volume": 3082677.0,
    "market_cap": 857010000.0,
    "price_to_sales_ttm": 1.79,
    "price_to_book_mrq": 1.69,
    "roa_ttm": 0.302,
    "roe_ttm": 0.777,
    "shares_outstanding": 164180000.0,
    "pcnt_held_by_insiders": 0.10490000000000001,
    "pcnt_held_by_institutions": 0.8909999999999999,
    "pcnt_short_of_float": 0.3059,
    "operating_cash_flow_ttm": 302030000.0,
    "levered_cash_flow_ttm": 209980000.0,
    "book_value_per_share_mrq": 3.22,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PDL BioPharma, Inc."
  },
  "PETS": {
    "p_e_ratio": 18.24,
    "peg_ratio": 3.36,
    "earnings_per_share": 0.91,
    "ebitda": 31270000.0,
    "eps_estimate_current_year": 0.99,
    "eps_estimate_next_quarter": 0.25,
    "fifty_day_moving_average": 16.54,
    "fifty_two_week_high": 18.42,
    "fifty_two_week_low": 12.07,
    "percent_change_from_200_day_moving_average": -0.005699999999999999,
    "percent_change_from_50_day_moving_average": 0.0038,
    "shares_owned": "N/A",
    "short_ratio": 31.99,
    "two_hundred_day_moving_average": 16.69,
    "volume": 245264.0,
    "market_cap": 337490000.0,
    "price_to_sales_ttm": 1.44,
    "price_to_book_mrq": 4.24,
    "roa_ttm": 0.213,
    "roe_ttm": 0.24309999999999998,
    "shares_outstanding": 20330000.0,
    "pcnt_held_by_insiders": 0.045899999999999996,
    "pcnt_held_by_institutions": 0.6970000000000001,
    "pcnt_short_of_float": 0.3056,
    "operating_cash_flow_ttm": 28600000.0,
    "levered_cash_flow_ttm": 26230000.0,
    "book_value_per_share_mrq": 3.88,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Drug Delivery",
    "company_name": "PetMed Express, Inc."
  },
  "PETX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.85,
    "earnings_per_share": -1.13,
    "ebitda": -43760000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": -0.41,
    "fifty_day_moving_average": 17.52,
    "fifty_two_week_high": 20.63,
    "fifty_two_week_low": 9.2,
    "percent_change_from_200_day_moving_average": -0.3379,
    "percent_change_from_50_day_moving_average": -0.3911,
    "shares_owned": "N/A",
    "short_ratio": 8.46,
    "two_hundred_day_moving_average": 16.11,
    "volume": 2950400.0,
    "market_cap": 373080000.0,
    "price_to_sales_ttm": 903.28,
    "price_to_book_mrq": 3.64,
    "roa_ttm": -0.1523,
    "roe_ttm": -0.2285,
    "shares_outstanding": 34960000.0,
    "pcnt_held_by_insiders": 0.1673,
    "pcnt_held_by_institutions": 0.7390000000000001,
    "pcnt_short_of_float": 0.1137,
    "operating_cash_flow_ttm": -34050000.0,
    "levered_cash_flow_ttm": -23790000.0,
    "book_value_per_share_mrq": 4.81,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Aratana Therapeutics, Inc."
  },
  "PFNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.88,
    "ebitda": -16980000.0,
    "eps_estimate_current_year": -1.52,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 20.15,
    "fifty_two_week_high": 24.41,
    "fifty_two_week_low": 6.27,
    "percent_change_from_200_day_moving_average": -0.1039,
    "percent_change_from_50_day_moving_average": -0.1892,
    "shares_owned": "N/A",
    "short_ratio": 5.27,
    "two_hundred_day_moving_average": 18.23,
    "volume": 106432.0,
    "market_cap": 378970000.0,
    "price_to_sales_ttm": 46.84,
    "price_to_book_mrq": 4.94,
    "roa_ttm": -0.1258,
    "roe_ttm": -0.35590000000000005,
    "shares_outstanding": 23190000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.069,
    "operating_cash_flow_ttm": 31900000.0,
    "levered_cash_flow_ttm": -7290000.0,
    "book_value_per_share_mrq": 3.72,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pfenex Inc."
  },
  "PGND": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.42,
    "earnings_per_share": -0.86,
    "ebitda": 27600000.0,
    "eps_estimate_current_year": 0.89,
    "eps_estimate_next_quarter": 0.22,
    "fifty_day_moving_average": 31.83,
    "fifty_two_week_high": 35.09,
    "fifty_two_week_low": 25.0,
    "percent_change_from_200_day_moving_average": 0.0513,
    "percent_change_from_50_day_moving_average": -0.028900000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.5,
    "two_hundred_day_moving_average": 29.4,
    "volume": 191577.0,
    "market_cap": 1630000000.0,
    "price_to_sales_ttm": 5.47,
    "price_to_book_mrq": 3.03,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 52600000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0298,
    "operating_cash_flow_ttm": 65170000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 10.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Long-Term Care Facilities",
    "company_name": "Press Ganey Holdings, Inc."
  },
  "PGNX": {
    "p_e_ratio": 179.44,
    "peg_ratio": -0.08,
    "earnings_per_share": 0.04,
    "ebitda": -537000.0,
    "eps_estimate_current_year": -0.56,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 7.49,
    "fifty_two_week_high": 11.15,
    "fifty_two_week_low": 4.26,
    "percent_change_from_200_day_moving_average": -0.052300000000000006,
    "percent_change_from_50_day_moving_average": -0.1376,
    "shares_owned": "N/A",
    "short_ratio": 10.54,
    "two_hundred_day_moving_average": 6.82,
    "volume": 986159.0,
    "market_cap": 450160000.0,
    "price_to_sales_ttm": 11.14,
    "price_to_book_mrq": 4.58,
    "roa_ttm": -0.0049,
    "roe_ttm": 0.027999999999999997,
    "shares_outstanding": 69680000.0,
    "pcnt_held_by_insiders": 0.1535,
    "pcnt_held_by_institutions": 0.669,
    "pcnt_short_of_float": 0.26839999999999997,
    "operating_cash_flow_ttm": 11810000.0,
    "levered_cash_flow_ttm": 4110000.0000000005,
    "book_value_per_share_mrq": 1.51,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Progenics Pharmaceuticals, Inc."
  },
  "PHMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -5.961,
    "ebitda": -18590000.0,
    "eps_estimate_current_year": -0.73,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 0.8414,
    "fifty_two_week_high": 6.8,
    "fifty_two_week_low": 0.43,
    "percent_change_from_200_day_moving_average": -0.605587,
    "percent_change_from_50_day_moving_average": -0.32745399999999997,
    "shares_owned": "N/A",
    "short_ratio": 37.38,
    "two_hundred_day_moving_average": 1.4348,
    "volume": 103448.0,
    "market_cap": 12490000.0,
    "price_to_sales_ttm": 0.11,
    "price_to_book_mrq": 0.32,
    "roa_ttm": -0.0859,
    "roe_ttm": -0.6372,
    "shares_outstanding": 22080000.0,
    "pcnt_held_by_insiders": 0.4033,
    "pcnt_held_by_institutions": 0.489,
    "pcnt_short_of_float": 0.1841,
    "operating_cash_flow_ttm": 47000.0,
    "levered_cash_flow_ttm": 11550000.0,
    "book_value_per_share_mrq": 2.04,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "PhotoMedex, Inc."
  },
  "PIP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.13,
    "ebitda": -5180000.0,
    "eps_estimate_current_year": -0.1,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.49,
    "fifty_two_week_high": 2.1,
    "fifty_two_week_low": 1.36,
    "percent_change_from_200_day_moving_average": -0.15960000000000002,
    "percent_change_from_50_day_moving_average": -0.0726,
    "shares_owned": "N/A",
    "short_ratio": 21.38,
    "two_hundred_day_moving_average": 1.64,
    "volume": 46417.0,
    "market_cap": 88630000.0,
    "price_to_sales_ttm": 8.23,
    "price_to_book_mrq": 4.91,
    "roa_ttm": -0.17600000000000002,
    "roe_ttm": -0.5572,
    "shares_outstanding": 64220000.0,
    "pcnt_held_by_insiders": 0.025099999999999997,
    "pcnt_held_by_institutions": 0.107,
    "pcnt_short_of_float": 0.039,
    "operating_cash_flow_ttm": -5710000.0,
    "levered_cash_flow_ttm": -1300000.0,
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PharmAthene, Inc."
  },
  "PIRS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.59,
    "ebitda": -10660000.0,
    "eps_estimate_current_year": -0.5,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 2.82,
    "fifty_two_week_high": 4.4,
    "fifty_two_week_low": 2.3,
    "percent_change_from_200_day_moving_average": -0.201,
    "percent_change_from_50_day_moving_average": -0.1478,
    "shares_owned": "N/A",
    "short_ratio": 0.21,
    "two_hundred_day_moving_average": 3.0,
    "volume": 306649.0,
    "market_cap": 95360000.0,
    "price_to_sales_ttm": 27.05,
    "price_to_book_mrq": 6.6,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 39730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0025,
    "operating_cash_flow_ttm": -8340000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.38,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pieris Pharmaceuticals, Inc."
  },
  "PKI": {
    "p_e_ratio": 31.77,
    "peg_ratio": 2.26,
    "earnings_per_share": 1.44,
    "ebitda": 350060000.0,
    "eps_estimate_current_year": 2.58,
    "eps_estimate_next_quarter": 0.89,
    "fifty_day_moving_average": 48.36,
    "fifty_two_week_high": 54.45,
    "fifty_two_week_low": 38.96,
    "percent_change_from_200_day_moving_average": -0.0999,
    "percent_change_from_50_day_moving_average": -0.053899999999999997,
    "shares_owned": "N/A",
    "short_ratio": 3.23,
    "two_hundred_day_moving_average": 50.83,
    "volume": 993040.0,
    "market_cap": 5190000000.0,
    "price_to_sales_ttm": 2.32,
    "price_to_book_mrq": 2.45,
    "roa_ttm": 0.0366,
    "roe_ttm": 0.0783,
    "shares_outstanding": 113380000.0,
    "pcnt_held_by_insiders": 0.0097,
    "pcnt_held_by_institutions": 0.9520000000000001,
    "pcnt_short_of_float": 0.0275,
    "operating_cash_flow_ttm": 260620000.0,
    "levered_cash_flow_ttm": 221280000.0,
    "book_value_per_share_mrq": 18.71,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PerkinElmer Inc."
  },
  "PLX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.18,
    "earnings_per_share": -0.29,
    "ebitda": -19870000.0,
    "eps_estimate_current_year": -0.31,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 1.48,
    "fifty_two_week_high": 3.0,
    "fifty_two_week_low": 1.33,
    "percent_change_from_200_day_moving_average": -0.23170000000000002,
    "percent_change_from_50_day_moving_average": -0.0447,
    "shares_owned": "N/A",
    "short_ratio": 27.73,
    "two_hundred_day_moving_average": 1.84,
    "volume": 16555.0,
    "market_cap": 132210000.00000001,
    "price_to_sales_ttm": 8.73,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.17379999999999998,
    "roe_ttm": "N/A",
    "shares_outstanding": 93770000.0,
    "pcnt_held_by_insiders": 0.0635,
    "pcnt_held_by_institutions": 0.312,
    "pcnt_short_of_float": 0.0318,
    "operating_cash_flow_ttm": -26190000.0,
    "levered_cash_flow_ttm": -13340000.0,
    "book_value_per_share_mrq": -0.7,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Protalix BioTherapeutics, Inc."
  },
  "PMD": {
    "p_e_ratio": 26.75,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.39,
    "ebitda": 4050000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 11.06,
    "fifty_two_week_high": 17.83,
    "fifty_two_week_low": 9.82,
    "percent_change_from_200_day_moving_average": -0.244,
    "percent_change_from_50_day_moving_average": -0.0467,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 13.94,
    "volume": 3883.0,
    "market_cap": 57150000.0,
    "price_to_sales_ttm": 2.05,
    "price_to_book_mrq": 4.8,
    "roa_ttm": 0.0827,
    "roe_ttm": 0.1724,
    "shares_outstanding": 5420000.0,
    "pcnt_held_by_insiders": 0.0684,
    "pcnt_held_by_institutions": 0.509,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 6030000.0,
    "levered_cash_flow_ttm": 1430000.0,
    "book_value_per_share_mrq": 2.22,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Psychemedics Corp."
  },
  "PODD": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.12,
    "earnings_per_share": -0.77,
    "ebitda": 3210000.0,
    "eps_estimate_current_year": -0.99,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 29.79,
    "fifty_two_week_high": 47.97,
    "fifty_two_week_low": 24.95,
    "percent_change_from_200_day_moving_average": -0.10279999999999999,
    "percent_change_from_50_day_moving_average": -0.08289999999999999,
    "shares_owned": "N/A",
    "short_ratio": 8.2,
    "two_hundred_day_moving_average": 30.45,
    "volume": 438404.0,
    "market_cap": 1550000000.0,
    "price_to_sales_ttm": 5.76,
    "price_to_book_mrq": 23.31,
    "roa_ttm": -0.02,
    "roe_ttm": -0.5874,
    "shares_outstanding": 56900000.0,
    "pcnt_held_by_insiders": 0.0085,
    "pcnt_held_by_institutions": 1.1520000000000001,
    "pcnt_short_of_float": 0.0898,
    "operating_cash_flow_ttm": 6730000.0,
    "levered_cash_flow_ttm": 10550000.0,
    "book_value_per_share_mrq": 1.23,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Insulet Corporation"
  },
  "POZN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -3.93,
    "earnings_per_share": -0.08,
    "ebitda": 8369999.999999999,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 9.03,
    "fifty_two_week_high": 12.69,
    "fifty_two_week_low": 6.38,
    "percent_change_from_200_day_moving_average": -0.1419,
    "percent_change_from_50_day_moving_average": -0.1524,
    "shares_owned": "N/A",
    "short_ratio": 4.2,
    "two_hundred_day_moving_average": 8.91,
    "volume": 693443.0,
    "market_cap": 248020000.0,
    "price_to_sales_ttm": 10.05,
    "price_to_book_mrq": 7.71,
    "roa_ttm": 0.12269999999999999,
    "roe_ttm": -0.0794,
    "shares_outstanding": 32420000.0,
    "pcnt_held_by_insiders": 0.1757,
    "pcnt_held_by_institutions": 0.523,
    "pcnt_short_of_float": 0.0984,
    "operating_cash_flow_ttm": 2630000.0,
    "levered_cash_flow_ttm": 11970000.0,
    "book_value_per_share_mrq": 1.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "POZEN Inc."
  },
  "PPHM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.29,
    "ebitda": -50080000.0,
    "eps_estimate_current_year": -0.34,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 1.15,
    "fifty_two_week_high": 1.75,
    "fifty_two_week_low": 1.0,
    "percent_change_from_200_day_moving_average": -0.2335,
    "percent_change_from_50_day_moving_average": -0.1274,
    "shares_owned": "N/A",
    "short_ratio": 7.74,
    "two_hundred_day_moving_average": 1.3,
    "volume": 1861802.0,
    "market_cap": 202120000.0,
    "price_to_sales_ttm": 6.92,
    "price_to_book_mrq": 3.84,
    "roa_ttm": -0.3555,
    "roe_ttm": -0.8419,
    "shares_outstanding": 202120000.0,
    "pcnt_held_by_insiders": 0.0501,
    "pcnt_held_by_institutions": 0.17,
    "pcnt_short_of_float": 0.0454,
    "operating_cash_flow_ttm": -40610000.0,
    "levered_cash_flow_ttm": -24230000.0,
    "book_value_per_share_mrq": 0.28,
    "next_earnings_announcement_date": [
      "2015-12-08",
      "2015-12-14"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Peregrine Pharmaceuticals, Inc."
  },
  "PRAH": {
    "p_e_ratio": 279.73,
    "peg_ratio": 1.14,
    "earnings_per_share": 0.15,
    "ebitda": 186820000.0,
    "eps_estimate_current_year": 1.81,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 40.61,
    "fifty_two_week_high": 46.35,
    "fifty_two_week_low": 19.1,
    "percent_change_from_200_day_moving_average": 0.179,
    "percent_change_from_50_day_moving_average": 0.0194,
    "shares_owned": "N/A",
    "short_ratio": 12.34,
    "two_hundred_day_moving_average": 35.11,
    "volume": 466541.0,
    "market_cap": 2490000000.0,
    "price_to_sales_ttm": 1.96,
    "price_to_book_mrq": 3.69,
    "roa_ttm": 0.0274,
    "roe_ttm": 0.0138,
    "shares_outstanding": 60170000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1182,
    "operating_cash_flow_ttm": 55960000.0,
    "levered_cash_flow_ttm": 47970000.0,
    "book_value_per_share_mrq": 11.56,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PRA Health Sciences, Inc."
  },
  "PRAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.08,
    "ebitda": -7660000.0,
    "eps_estimate_current_year": -0.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.983,
    "fifty_two_week_high": 2.29,
    "fifty_two_week_low": 0.8,
    "percent_change_from_200_day_moving_average": -0.23146999999999998,
    "percent_change_from_50_day_moving_average": -0.09372,
    "shares_owned": "N/A",
    "short_ratio": 7.03,
    "two_hundred_day_moving_average": 1.159,
    "volume": 313088.0,
    "market_cap": 47570000.0,
    "price_to_sales_ttm": 11.21,
    "price_to_book_mrq": 1.85,
    "roa_ttm": -0.16010000000000002,
    "roe_ttm": -0.1533,
    "shares_outstanding": 53390000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -7810000.0,
    "levered_cash_flow_ttm": -4960000.0,
    "book_value_per_share_mrq": 0.53,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Prana Biotechnology Limited"
  },
  "PRPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.42,
    "ebitda": -2950000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.55,
    "fifty_two_week_high": 1.75,
    "fifty_two_week_low": 1.21,
    "percent_change_from_200_day_moving_average": 0.13019999999999998,
    "percent_change_from_50_day_moving_average": 0.022799999999999997,
    "shares_owned": "N/A",
    "short_ratio": 0.26,
    "two_hundred_day_moving_average": 1.41,
    "volume": 14778.0,
    "market_cap": 25970000.0,
    "price_to_sales_ttm": 1.1,
    "price_to_book_mrq": 2.92,
    "roa_ttm": -0.128,
    "roe_ttm": -0.6225,
    "shares_outstanding": 16329999.999999998,
    "pcnt_held_by_insiders": 0.41009999999999996,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.003,
    "operating_cash_flow_ttm": -3450000.0,
    "levered_cash_flow_ttm": -2880000.0,
    "book_value_per_share_mrq": 0.51,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "ProPhase Labs, Inc."
  },
  "PRQR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.79,
    "ebitda": -25240000.0,
    "eps_estimate_current_year": -0.92,
    "eps_estimate_next_quarter": -0.28,
    "fifty_day_moving_average": 16.8,
    "fifty_two_week_high": 27.6,
    "fifty_two_week_low": 11.0,
    "percent_change_from_200_day_moving_average": -0.08449999999999999,
    "percent_change_from_50_day_moving_average": 0.0118,
    "shares_owned": "N/A",
    "short_ratio": 8.84,
    "two_hundred_day_moving_average": 18.57,
    "volume": 274289.0,
    "market_cap": 396750000.0,
    "price_to_sales_ttm": 293.31,
    "price_to_book_mrq": 4.03,
    "roa_ttm": -0.19149999999999998,
    "roe_ttm": -0.20350000000000001,
    "shares_outstanding": 23340000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0187,
    "operating_cash_flow_ttm": -22770000.0,
    "levered_cash_flow_ttm": -16020000.0,
    "book_value_per_share_mrq": 4.84,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ProQR Therapeutics N.V."
  },
  "PRSC": {
    "p_e_ratio": 44.7,
    "peg_ratio": 1.61,
    "earnings_per_share": 1.03,
    "ebitda": 110720000.0,
    "eps_estimate_current_year": 1.95,
    "eps_estimate_next_quarter": 0.34,
    "fifty_day_moving_average": 46.12,
    "fifty_two_week_high": 55.99,
    "fifty_two_week_low": 34.03,
    "percent_change_from_200_day_moving_average": -0.0177,
    "percent_change_from_50_day_moving_average": 0.0014000000000000002,
    "shares_owned": "N/A",
    "short_ratio": 6.57,
    "two_hundred_day_moving_average": 47.01,
    "volume": 108651.0,
    "market_cap": 741330000.0,
    "price_to_sales_ttm": 0.41,
    "price_to_book_mrq": 3.12,
    "roa_ttm": 0.0414,
    "roe_ttm": 0.08109999999999999,
    "shares_outstanding": 16050000.0,
    "pcnt_held_by_insiders": 0.0106,
    "pcnt_held_by_institutions": 0.866,
    "pcnt_short_of_float": 0.0452,
    "operating_cash_flow_ttm": 60520000.0,
    "levered_cash_flow_ttm": 41420000.0,
    "book_value_per_share_mrq": 15.14,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "Providence Service Corp."
  },
  "PRSN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.131,
    "ebitda": -12220000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.493,
    "fifty_two_week_high": 7.6,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.82596,
    "percent_change_from_50_day_moving_average": -0.19902,
    "shares_owned": "N/A",
    "short_ratio": 0.27,
    "two_hundred_day_moving_average": 2.27,
    "volume": 278258.0,
    "market_cap": 3860000.0,
    "price_to_sales_ttm": 0.69,
    "price_to_book_mrq": 1.06,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9770000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0134,
    "operating_cash_flow_ttm": -10160000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.44,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Perseon Corporation"
  },
  "PRTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.18,
    "earnings_per_share": -2.12,
    "ebitda": -58530000.0,
    "eps_estimate_current_year": -2.59,
    "eps_estimate_next_quarter": -0.78,
    "fifty_day_moving_average": 58.16,
    "fifty_two_week_high": 70.52,
    "fifty_two_week_low": 17.0,
    "percent_change_from_200_day_moving_average": 0.08220000000000001,
    "percent_change_from_50_day_moving_average": -0.121,
    "shares_owned": "N/A",
    "short_ratio": 5.99,
    "two_hundred_day_moving_average": 47.24,
    "volume": 437649.0,
    "market_cap": 1600000000.0,
    "price_to_sales_ttm": 409.0,
    "price_to_book_mrq": 4.52,
    "roa_ttm": -0.1026,
    "roe_ttm": -0.1723,
    "shares_outstanding": 31380000.0,
    "pcnt_held_by_insiders": 0.0463,
    "pcnt_held_by_institutions": 0.8320000000000001,
    "pcnt_short_of_float": 0.1557,
    "operating_cash_flow_ttm": -50650000.0,
    "levered_cash_flow_ttm": -28090000.0,
    "book_value_per_share_mrq": 12.6,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Prothena Corporation plc"
  },
  "PRTK": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -4.09,
    "ebitda": -29420000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": -0.99,
    "fifty_day_moving_average": 24.66,
    "fifty_two_week_high": 39.8,
    "fifty_two_week_low": 16.0,
    "percent_change_from_200_day_moving_average": -0.1625,
    "percent_change_from_50_day_moving_average": -0.0761,
    "shares_owned": "N/A",
    "short_ratio": 9.07,
    "two_hundred_day_moving_average": 27.2,
    "volume": 84578.0,
    "market_cap": 400050000.0,
    "price_to_sales_ttm": 113.4,
    "price_to_book_mrq": 3.22,
    "roa_ttm": -0.2336,
    "roe_ttm": -0.6496999999999999,
    "shares_outstanding": 17560000.0,
    "pcnt_held_by_insiders": 0.2086,
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1307,
    "operating_cash_flow_ttm": -29990000.0,
    "levered_cash_flow_ttm": -17350000.0,
    "book_value_per_share_mrq": 8.03,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Paratek Pharmaceuticals, Inc."
  },
  "PRTO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.94,
    "ebitda": -12710000.0,
    "eps_estimate_current_year": -1.28,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 14.16,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 8.57,
    "percent_change_from_200_day_moving_average": -0.0947,
    "percent_change_from_50_day_moving_average": -0.0371,
    "shares_owned": "N/A",
    "short_ratio": 13.31,
    "two_hundred_day_moving_average": 15.06,
    "volume": 22781.0,
    "market_cap": 224330000.0,
    "price_to_sales_ttm": 81.51,
    "price_to_book_mrq": 3.26,
    "roa_ttm": -0.1535,
    "roe_ttm": -0.16010000000000002,
    "shares_outstanding": 16460000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0546,
    "operating_cash_flow_ttm": -14230000.0,
    "levered_cash_flow_ttm": -10470000.0,
    "book_value_per_share_mrq": 4.48,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Proteon Therapeutics Inc"
  },
  "PRXL": {
    "p_e_ratio": 24.53,
    "peg_ratio": 1.31,
    "earnings_per_share": 2.65,
    "ebitda": 297220000.0,
    "eps_estimate_current_year": 3.22,
    "eps_estimate_next_quarter": 0.75,
    "fifty_day_moving_average": 68.23,
    "fifty_two_week_high": 76.17,
    "fifty_two_week_low": 52.19,
    "percent_change_from_200_day_moving_average": -0.0373,
    "percent_change_from_50_day_moving_average": -0.0471,
    "shares_owned": "N/A",
    "short_ratio": 5.43,
    "two_hundred_day_moving_average": 67.53,
    "volume": 737582.0,
    "market_cap": 3600000000.0,
    "price_to_sales_ttm": 1.85,
    "price_to_book_mrq": 5.59,
    "roa_ttm": 0.0717,
    "roe_ttm": 0.2379,
    "shares_outstanding": 55340000.0,
    "pcnt_held_by_insiders": 0.0206,
    "pcnt_held_by_institutions": 0.9890000000000001,
    "pcnt_short_of_float": 0.0967,
    "operating_cash_flow_ttm": 157840000.0,
    "levered_cash_flow_ttm": 77510000.0,
    "book_value_per_share_mrq": 12.04,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "PAREXEL International Corporation"
  },
  "PSDV": {
    "p_e_ratio": 16.71,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.21,
    "ebitda": 7300000.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 3.86,
    "fifty_two_week_high": 4.68,
    "fifty_two_week_low": 3.23,
    "percent_change_from_200_day_moving_average": -0.1204,
    "percent_change_from_50_day_moving_average": -0.08990000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.2,
    "two_hundred_day_moving_average": 3.99,
    "volume": 70013.0,
    "market_cap": 103260000.0,
    "price_to_sales_ttm": 4.0,
    "price_to_book_mrq": 4.55,
    "roa_ttm": 0.1458,
    "roe_ttm": 0.33149999999999996,
    "shares_outstanding": 29420000.0,
    "pcnt_held_by_insiders": 0.16760000000000003,
    "pcnt_held_by_institutions": 0.251,
    "pcnt_short_of_float": 0.022099999999999998,
    "operating_cash_flow_ttm": 10300000.0,
    "levered_cash_flow_ttm": 7680000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "pSivida Corp."
  },
  "PSTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.35,
    "ebitda": -23190000.0,
    "eps_estimate_current_year": -0.37,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 2.04,
    "fifty_two_week_high": 3.78,
    "fifty_two_week_low": 1.84,
    "percent_change_from_200_day_moving_average": -0.2267,
    "percent_change_from_50_day_moving_average": -0.0447,
    "shares_owned": "N/A",
    "short_ratio": 4.29,
    "two_hundred_day_moving_average": 2.52,
    "volume": 64971.0,
    "market_cap": 154260000.0,
    "price_to_sales_ttm": 417.45,
    "price_to_book_mrq": 2.71,
    "roa_ttm": -0.22210000000000002,
    "roe_ttm": -0.4104,
    "shares_outstanding": 79110000.0,
    "pcnt_held_by_insiders": 0.0861,
    "pcnt_held_by_institutions": 0.015,
    "pcnt_short_of_float": 0.008199999999999999,
    "operating_cash_flow_ttm": -20600000.0,
    "levered_cash_flow_ttm": -8450000.0,
    "book_value_per_share_mrq": 0.74,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pluristem Therapeutics, Inc."
  },
  "PTCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.87,
    "earnings_per_share": -3.82,
    "ebitda": -134130000.0,
    "eps_estimate_current_year": -4.61,
    "eps_estimate_next_quarter": -1.17,
    "fifty_day_moving_average": 37.35,
    "fifty_two_week_high": 78.72,
    "fifty_two_week_low": 28.5,
    "percent_change_from_200_day_moving_average": -0.4486,
    "percent_change_from_50_day_moving_average": -0.2157,
    "shares_owned": "N/A",
    "short_ratio": 6.45,
    "two_hundred_day_moving_average": 53.12,
    "volume": 1097936.0,
    "market_cap": 1000000000.0,
    "price_to_sales_ttm": 37.91,
    "price_to_book_mrq": 4.36,
    "roa_ttm": -0.3337,
    "roe_ttm": -0.5539999999999999,
    "shares_outstanding": 34270000.0,
    "pcnt_held_by_insiders": 0.3993,
    "pcnt_held_by_institutions": 0.62,
    "pcnt_short_of_float": 0.19079999999999997,
    "operating_cash_flow_ttm": -91270000.0,
    "levered_cash_flow_ttm": -52930000.0,
    "book_value_per_share_mrq": 7.34,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "PTC Therapeutics, Inc."
  },
  "PTIE": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.26,
    "ebitda": -11670000.0,
    "eps_estimate_current_year": -0.35,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.84,
    "fifty_two_week_high": 4.27,
    "fifty_two_week_low": 1.53,
    "percent_change_from_200_day_moving_average": 0.020499999999999997,
    "percent_change_from_50_day_moving_average": 0.0364,
    "shares_owned": "N/A",
    "short_ratio": 6.34,
    "two_hundred_day_moving_average": 1.87,
    "volume": 98675.0,
    "market_cap": 87390000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.49,
    "roa_ttm": -0.17579999999999998,
    "roe_ttm": -0.2927,
    "shares_outstanding": 45760000.0,
    "pcnt_held_by_insiders": 0.265,
    "pcnt_held_by_institutions": 0.504,
    "pcnt_short_of_float": 0.023,
    "operating_cash_flow_ttm": -7330000.0,
    "levered_cash_flow_ttm": -3190000.0,
    "book_value_per_share_mrq": 0.79,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pain Therapeutics Inc."
  },
  "PTLA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.77,
    "ebitda": -178940000.0,
    "eps_estimate_current_year": -4.58,
    "eps_estimate_next_quarter": -1.36,
    "fifty_day_moving_average": 48.06,
    "fifty_two_week_high": 57.96,
    "fifty_two_week_low": 24.75,
    "percent_change_from_200_day_moving_average": -0.0006,
    "percent_change_from_50_day_moving_average": -0.0891,
    "shares_owned": "N/A",
    "short_ratio": 8.73,
    "two_hundred_day_moving_average": 43.81,
    "volume": 627859.0,
    "market_cap": 2300000000.0,
    "price_to_sales_ttm": 263.01,
    "price_to_book_mrq": 6.83,
    "roa_ttm": -0.3063,
    "roe_ttm": -0.5912,
    "shares_outstanding": 52560000.0,
    "pcnt_held_by_insiders": 0.1821,
    "pcnt_held_by_institutions": 0.79,
    "pcnt_short_of_float": 0.1094,
    "operating_cash_flow_ttm": -163390000.0,
    "levered_cash_flow_ttm": -96940000.0,
    "book_value_per_share_mrq": 7.02,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Portola Pharmaceuticals, Inc."
  },
  "PTN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.309,
    "ebitda": -17170000.0,
    "eps_estimate_current_year": -0.32,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.902,
    "fifty_two_week_high": 1.58,
    "fifty_two_week_low": 0.59,
    "percent_change_from_200_day_moving_average": -0.14827,
    "percent_change_from_50_day_moving_average": -0.09949,
    "shares_owned": "N/A",
    "short_ratio": 1.15,
    "two_hundred_day_moving_average": 0.953,
    "volume": 388570.0,
    "market_cap": 55240000.0,
    "price_to_sales_ttm": 4.57,
    "price_to_book_mrq": 4.07,
    "roa_ttm": -0.5141,
    "roe_ttm": -1.6065,
    "shares_outstanding": 68030000.0,
    "pcnt_held_by_insiders": 0.0178,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.0697,
    "operating_cash_flow_ttm": -13360000.0,
    "levered_cash_flow_ttm": -7110000.0,
    "book_value_per_share_mrq": 0.21,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Palatin Technologies Inc."
  },
  "PTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -13.72,
    "earnings_per_share": -1.8,
    "ebitda": 37900000.0,
    "eps_estimate_current_year": -0.07,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 4.49,
    "fifty_two_week_high": 12.88,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.4885,
    "percent_change_from_50_day_moving_average": -0.26039999999999996,
    "shares_owned": "N/A",
    "short_ratio": 5.58,
    "two_hundred_day_moving_average": 6.49,
    "volume": 1667704.0,
    "market_cap": 202650000.0,
    "price_to_sales_ttm": 1.33,
    "price_to_book_mrq": 1.8,
    "roa_ttm": -0.045599999999999995,
    "roe_ttm": -0.6859999999999999,
    "shares_outstanding": 61040000.0,
    "pcnt_held_by_insiders": 0.3538,
    "pcnt_held_by_institutions": 0.447,
    "pcnt_short_of_float": 0.226,
    "operating_cash_flow_ttm": 9170000.0,
    "levered_cash_flow_ttm": 36840000.0,
    "book_value_per_share_mrq": 2.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Pernix Therapeutics Holdings, Inc."
  },
  "PULM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.35,
    "ebitda": -11110000.0,
    "eps_estimate_current_year": -4.13,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 5.62,
    "fifty_two_week_high": 14.55,
    "fifty_two_week_low": 4.3,
    "percent_change_from_200_day_moving_average": -0.42100000000000004,
    "percent_change_from_50_day_moving_average": -0.1484,
    "shares_owned": "N/A",
    "short_ratio": 0.43,
    "two_hundred_day_moving_average": 8.27,
    "volume": 2694.0,
    "market_cap": 69530000.0,
    "price_to_sales_ttm": 120.77,
    "price_to_book_mrq": 1.92,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 14520000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0032,
    "operating_cash_flow_ttm": -10470000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Pulmatrix, Inc."
  },
  "PVCT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.066,
    "ebitda": -16800000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.5096,
    "fifty_two_week_high": 1.1,
    "fifty_two_week_low": 0.34,
    "percent_change_from_200_day_moving_average": -0.137303,
    "percent_change_from_50_day_moving_average": 0.157509,
    "shares_owned": "N/A",
    "short_ratio": 4.63,
    "two_hundred_day_moving_average": 0.6838,
    "volume": 359863.0,
    "market_cap": 120700000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.19,
    "roa_ttm": -0.4097,
    "roe_ttm": -0.4779,
    "shares_outstanding": 204610000.0,
    "pcnt_held_by_insiders": 0.0726,
    "pcnt_held_by_institutions": 0.001,
    "pcnt_short_of_float": 0.0074,
    "operating_cash_flow_ttm": -15800000.0,
    "levered_cash_flow_ttm": -10120000.0,
    "book_value_per_share_mrq": 0.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Provectus Biopharmaceuticals, Inc."
  },
  "Q": {
    "p_e_ratio": 26.67,
    "peg_ratio": 1.93,
    "earnings_per_share": 2.75,
    "ebitda": 750690000.0,
    "eps_estimate_current_year": 3.16,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 74.85,
    "fifty_two_week_high": 80.45,
    "fifty_two_week_low": 51.09,
    "percent_change_from_200_day_moving_average": 0.0305,
    "percent_change_from_50_day_moving_average": -0.0199,
    "shares_owned": "N/A",
    "short_ratio": 2.55,
    "two_hundred_day_moving_average": 71.19,
    "volume": 893528.0,
    "market_cap": 9000000000.0,
    "price_to_sales_ttm": 2.18,
    "price_to_book_mrq": "N/A",
    "roa_ttm": 0.1243,
    "roe_ttm": "N/A",
    "shares_outstanding": 122710000.0,
    "pcnt_held_by_insiders": 0.1572,
    "pcnt_held_by_institutions": 0.8590000000000001,
    "pcnt_short_of_float": 0.045700000000000005,
    "operating_cash_flow_ttm": 379490000.0,
    "levered_cash_flow_ttm": 220290000.0,
    "book_value_per_share_mrq": -5.72,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Quintiles Transnational Holdings Inc."
  },
  "QDEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -8.58,
    "earnings_per_share": -0.11,
    "ebitda": 30400000.0,
    "eps_estimate_current_year": -0.12,
    "eps_estimate_next_quarter": 0.16,
    "fifty_day_moving_average": 20.7,
    "fifty_two_week_high": 29.38,
    "fifty_two_week_low": 18.23,
    "percent_change_from_200_day_moving_average": -0.1353,
    "percent_change_from_50_day_moving_average": -0.045700000000000005,
    "shares_owned": "N/A",
    "short_ratio": 25.67,
    "two_hundred_day_moving_average": 22.84,
    "volume": 358707.0,
    "market_cap": 662160000.0,
    "price_to_sales_ttm": 3.39,
    "price_to_book_mrq": 2.96,
    "roa_ttm": 0.009399999999999999,
    "roe_ttm": -0.016,
    "shares_outstanding": 33530000.0,
    "pcnt_held_by_insiders": 0.26890000000000003,
    "pcnt_held_by_institutions": 0.836,
    "pcnt_short_of_float": 0.2536,
    "operating_cash_flow_ttm": 41660000.0,
    "levered_cash_flow_ttm": 35840000.0,
    "book_value_per_share_mrq": 6.79,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Quidel Corp."
  },
  "QLTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.36,
    "earnings_per_share": -0.11,
    "ebitda": -24830000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 3.48,
    "fifty_two_week_high": 4.86,
    "fifty_two_week_low": 3.22,
    "percent_change_from_200_day_moving_average": -0.11470000000000001,
    "percent_change_from_50_day_moving_average": -0.0339,
    "shares_owned": "N/A",
    "short_ratio": 3.31,
    "two_hundred_day_moving_average": 3.8,
    "volume": 117854.0,
    "market_cap": 177510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.22,
    "roa_ttm": -0.10490000000000001,
    "roe_ttm": -0.0385,
    "shares_outstanding": 52830000.0,
    "pcnt_held_by_insiders": 0.4533,
    "pcnt_held_by_institutions": 0.508,
    "pcnt_short_of_float": 0.0111,
    "operating_cash_flow_ttm": 2009999.9999999998,
    "levered_cash_flow_ttm": -4370000.0,
    "book_value_per_share_mrq": 2.8,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "QLT Inc."
  },
  "QTNT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.21,
    "ebitda": -34390000.0,
    "eps_estimate_current_year": -3.0,
    "eps_estimate_next_quarter": -0.76,
    "fifty_day_moving_average": 15.59,
    "fifty_two_week_high": 19.95,
    "fifty_two_week_low": 9.02,
    "percent_change_from_200_day_moving_average": -0.1348,
    "percent_change_from_50_day_moving_average": -0.1341,
    "shares_owned": "N/A",
    "short_ratio": 4.16,
    "two_hundred_day_moving_average": 15.6,
    "volume": 22564.0,
    "market_cap": 229900000.0,
    "price_to_sales_ttm": 11.01,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3389,
    "roe_ttm": -8.8625,
    "shares_outstanding": 17030000.0,
    "pcnt_held_by_insiders": 0.0519,
    "pcnt_held_by_institutions": 0.095,
    "pcnt_short_of_float": 0.006999999999999999,
    "operating_cash_flow_ttm": -32780000.0,
    "levered_cash_flow_ttm": -16770000.0,
    "book_value_per_share_mrq": -0.49,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Quotient Limited"
  },
  "QURE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.06,
    "ebitda": -51390000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.66,
    "fifty_day_moving_average": 26.55,
    "fifty_two_week_high": 36.38,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": -0.1041,
    "percent_change_from_50_day_moving_average": -0.0771,
    "shares_owned": "N/A",
    "short_ratio": 3.04,
    "two_hundred_day_moving_average": 27.35,
    "volume": 455163.0,
    "market_cap": 525039999.99999994,
    "price_to_sales_ttm": 104.23,
    "price_to_book_mrq": 4.61,
    "roa_ttm": -0.1856,
    "roe_ttm": -0.5991,
    "shares_outstanding": 21430000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0721,
    "operating_cash_flow_ttm": 13010000.0,
    "levered_cash_flow_ttm": -31230000.0,
    "book_value_per_share_mrq": 5.75,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "uniQure N.V."
  },
  "RARE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.51,
    "ebitda": -83550000.0,
    "eps_estimate_current_year": -3.29,
    "eps_estimate_next_quarter": -0.91,
    "fifty_day_moving_average": 113.39,
    "fifty_two_week_high": 137.05,
    "fifty_two_week_low": 38.01,
    "percent_change_from_200_day_moving_average": 0.022000000000000002,
    "percent_change_from_50_day_moving_average": -0.17,
    "shares_owned": "N/A",
    "short_ratio": 4.74,
    "two_hundred_day_moving_average": 92.08,
    "volume": 607465.0,
    "market_cap": 3640000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 11.49,
    "roa_ttm": -0.2087,
    "roe_ttm": -0.3546,
    "shares_outstanding": 38680000.0,
    "pcnt_held_by_insiders": 0.0002,
    "pcnt_held_by_institutions": 0.441,
    "pcnt_short_of_float": 0.1001,
    "operating_cash_flow_ttm": -58420000.0,
    "levered_cash_flow_ttm": -34150000.0,
    "book_value_per_share_mrq": 8.85,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ultragenyx Pharmaceutical Inc."
  },
  "RCPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.17,
    "ebitda": -15990000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.0,
    "fifty_two_week_high": 9.25,
    "fifty_two_week_low": 0.76,
    "percent_change_from_200_day_moving_average": -0.4632,
    "percent_change_from_50_day_moving_average": 0.0083,
    "shares_owned": "N/A",
    "short_ratio": 5.14,
    "two_hundred_day_moving_average": 1.88,
    "volume": 74644.0,
    "market_cap": 10980000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.4606999999999999,
    "roe_ttm": "N/A",
    "shares_outstanding": 10870000.0,
    "pcnt_held_by_insiders": 0.2325,
    "pcnt_held_by_institutions": 0.152,
    "pcnt_short_of_float": 0.1069,
    "operating_cash_flow_ttm": -10970000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": -0.62,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rock Creek Pharmaceuticals, Inc."
  },
  "RDHL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -20440000.0,
    "eps_estimate_current_year": -2.37,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 13.68,
    "fifty_two_week_high": 22.22,
    "fifty_two_week_low": 6.89,
    "percent_change_from_200_day_moving_average": -0.1295,
    "percent_change_from_50_day_moving_average": -0.0315,
    "shares_owned": "N/A",
    "short_ratio": 2.56,
    "two_hundred_day_moving_average": 15.22,
    "volume": 51563.0,
    "market_cap": 131740000.00000001,
    "price_to_sales_ttm": 20354.74,
    "price_to_book_mrq": 5.15,
    "roa_ttm": -0.3475,
    "roe_ttm": -0.6787000000000001,
    "shares_outstanding": 9940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -17790000.0,
    "levered_cash_flow_ttm": -11930000.0,
    "book_value_per_share_mrq": 2.78,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "RedHill Biopharma Ltd."
  },
  "RDNT": {
    "p_e_ratio": 34.57,
    "peg_ratio": 2.01,
    "earnings_per_share": 0.16,
    "ebitda": 100640000.0,
    "eps_estimate_current_year": 0.31,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 6.41,
    "fifty_two_week_high": 10.35,
    "fifty_two_week_low": 5.62,
    "percent_change_from_200_day_moving_average": -0.2148,
    "percent_change_from_50_day_moving_average": -0.1159,
    "shares_owned": "N/A",
    "short_ratio": 4.0,
    "two_hundred_day_moving_average": 7.22,
    "volume": 230075.0,
    "market_cap": 252120000.0,
    "price_to_sales_ttm": 0.35,
    "price_to_book_mrq": 26.17,
    "roa_ttm": 0.0351,
    "roe_ttm": 1.6743000000000001,
    "shares_outstanding": 44470000.0,
    "pcnt_held_by_insiders": 0.4048,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.0378,
    "operating_cash_flow_ttm": 69280000.0,
    "levered_cash_flow_ttm": -30890000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "RadNet, Inc."
  },
  "RDUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -11.72,
    "earnings_per_share": -2.2,
    "ebitda": -72320000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 66.31,
    "fifty_two_week_high": 84.64,
    "fifty_two_week_low": 16.55,
    "percent_change_from_200_day_moving_average": 0.1963,
    "percent_change_from_50_day_moving_average": 0.0213,
    "shares_owned": "N/A",
    "short_ratio": 4.21,
    "two_hundred_day_moving_average": 56.61,
    "volume": 1373069.0,
    "market_cap": 2900000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 14.17,
    "roa_ttm": -0.2927,
    "roe_ttm": -0.6618999999999999,
    "shares_outstanding": 42790000.0,
    "pcnt_held_by_insiders": 0.374,
    "pcnt_held_by_institutions": 0.363,
    "pcnt_short_of_float": 0.14,
    "operating_cash_flow_ttm": -68270000.0,
    "levered_cash_flow_ttm": -43760000.0,
    "book_value_per_share_mrq": 4.96,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Radius Health, Inc."
  },
  "REPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.97,
    "ebitda": -7230000.0,
    "eps_estimate_current_year": -1.55,
    "eps_estimate_next_quarter": -0.78,
    "fifty_day_moving_average": 14.35,
    "fifty_two_week_high": 18.3,
    "fifty_two_week_low": 2.36,
    "percent_change_from_200_day_moving_average": 0.0673,
    "percent_change_from_50_day_moving_average": -0.12179999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.54,
    "two_hundred_day_moving_average": 11.81,
    "volume": 108197.0,
    "market_cap": 116190000.0,
    "price_to_sales_ttm": 7.29,
    "price_to_book_mrq": 7.85,
    "roa_ttm": -0.07200000000000001,
    "roe_ttm": -0.6577,
    "shares_outstanding": 9220000.0,
    "pcnt_held_by_insiders": 0.4113,
    "pcnt_held_by_institutions": 0.27899999999999997,
    "pcnt_short_of_float": 0.0613,
    "operating_cash_flow_ttm": -6450000.0,
    "levered_cash_flow_ttm": -26110000.0,
    "book_value_per_share_mrq": 1.88,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Recro Pharma, Inc."
  },
  "RGEN": {
    "p_e_ratio": 152.57,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.22,
    "ebitda": 20040000.0,
    "eps_estimate_current_year": 0.35,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 35.04,
    "fifty_two_week_high": 42.48,
    "fifty_two_week_low": 18.57,
    "percent_change_from_200_day_moving_average": -0.054299999999999994,
    "percent_change_from_50_day_moving_average": -0.0334,
    "shares_owned": "N/A",
    "short_ratio": 8.82,
    "two_hundred_day_moving_average": 35.82,
    "volume": 426724.0,
    "market_cap": 1110000000.0,
    "price_to_sales_ttm": 16.4,
    "price_to_book_mrq": 10.26,
    "roa_ttm": 0.0731,
    "roe_ttm": 0.06509999999999999,
    "shares_outstanding": 32909999.999999996,
    "pcnt_held_by_insiders": 0.062,
    "pcnt_held_by_institutions": 0.8540000000000001,
    "pcnt_short_of_float": 0.09949999999999999,
    "operating_cash_flow_ttm": 13190000.0,
    "levered_cash_flow_ttm": 11400000.0,
    "book_value_per_share_mrq": 3.59,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repligen Corporation"
  },
  "RGLS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.17,
    "earnings_per_share": -1.41,
    "ebitda": -49060000.0,
    "eps_estimate_current_year": -1.35,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 8.03,
    "fifty_two_week_high": 25.6,
    "fifty_two_week_low": 6.23,
    "percent_change_from_200_day_moving_average": -0.3791,
    "percent_change_from_50_day_moving_average": -0.0797,
    "shares_owned": "N/A",
    "short_ratio": 11.17,
    "two_hundred_day_moving_average": 11.9,
    "volume": 383667.0,
    "market_cap": 383690000.0,
    "price_to_sales_ttm": 31.26,
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.2396,
    "roe_ttm": -0.6286,
    "shares_outstanding": 51920000.0,
    "pcnt_held_by_insiders": 0.7401000000000001,
    "pcnt_held_by_institutions": 0.32899999999999996,
    "pcnt_short_of_float": 0.3615,
    "operating_cash_flow_ttm": -41470000.0,
    "levered_cash_flow_ttm": -15090000.0,
    "book_value_per_share_mrq": 2.57,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Regulus Therapeutics Inc."
  },
  "RGNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -5.92,
    "ebitda": 0.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 26.99,
    "fifty_two_week_low": 24.16,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 0.0,
    "volume": 141966.0,
    "market_cap": 614910000.0,
    "price_to_sales_ttm": 19.98,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 24610000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": -13090000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -10.45,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Regenxbio Inc."
  },
  "RIGL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.86,
    "ebitda": -73730000.0,
    "eps_estimate_current_year": -0.71,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 2.97,
    "fifty_two_week_high": 5.2,
    "fifty_two_week_low": 1.56,
    "percent_change_from_200_day_moving_average": -0.2002,
    "percent_change_from_50_day_moving_average": -0.07629999999999999,
    "shares_owned": "N/A",
    "short_ratio": 6.2,
    "two_hundred_day_moving_average": 3.43,
    "volume": 646397.0,
    "market_cap": 242500000.0,
    "price_to_sales_ttm": 16.84,
    "price_to_book_mrq": 2.6,
    "roa_ttm": -0.2858,
    "roe_ttm": -0.5644,
    "shares_outstanding": 88500000.0,
    "pcnt_held_by_insiders": 0.0049,
    "pcnt_held_by_institutions": 0.9129999999999999,
    "pcnt_short_of_float": 0.0408,
    "operating_cash_flow_ttm": -33540000.0,
    "levered_cash_flow_ttm": -12340000.0,
    "book_value_per_share_mrq": 1.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Rigel Pharmaceuticals, Inc."
  },
  "RLYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.08,
    "earnings_per_share": -3.14,
    "ebitda": -106710000.0,
    "eps_estimate_current_year": -4.21,
    "eps_estimate_next_quarter": -1.56,
    "fifty_day_moving_average": 24.02,
    "fifty_two_week_high": 42.26,
    "fifty_two_week_low": 17.6,
    "percent_change_from_200_day_moving_average": -0.3627,
    "percent_change_from_50_day_moving_average": -0.1506,
    "shares_owned": "N/A",
    "short_ratio": 5.16,
    "two_hundred_day_moving_average": 32.01,
    "volume": 838455.0,
    "market_cap": 848370000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.19,
    "roa_ttm": -0.2903,
    "roe_ttm": -0.5596,
    "shares_outstanding": 41590000.0,
    "pcnt_held_by_insiders": 0.5737,
    "pcnt_held_by_institutions": 0.253,
    "pcnt_short_of_float": 0.1213,
    "operating_cash_flow_ttm": -88730000.0,
    "levered_cash_flow_ttm": -45580000.0,
    "book_value_per_share_mrq": 6.58,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Relypsa, Inc."
  },
  "RMD": {
    "p_e_ratio": 20.45,
    "peg_ratio": 2.08,
    "earnings_per_share": 2.47,
    "ebitda": 482290000.0,
    "eps_estimate_current_year": 2.65,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 52.22,
    "fifty_two_week_high": 75.33,
    "fifty_two_week_low": 45.74,
    "percent_change_from_200_day_moving_average": -0.1578,
    "percent_change_from_50_day_moving_average": -0.0326,
    "shares_owned": "N/A",
    "short_ratio": 12.32,
    "two_hundred_day_moving_average": 59.98,
    "volume": 917427.0,
    "market_cap": 7100000000.0,
    "price_to_sales_ttm": 4.33,
    "price_to_book_mrq": 4.58,
    "roa_ttm": 0.11259999999999999,
    "roe_ttm": 0.21100000000000002,
    "shares_outstanding": 140520000.0,
    "pcnt_held_by_insiders": 0.0113,
    "pcnt_held_by_institutions": 0.568,
    "pcnt_short_of_float": 0.0799,
    "operating_cash_flow_ttm": 383180000.0,
    "levered_cash_flow_ttm": 222390000.0,
    "book_value_per_share_mrq": 11.3,
    "next_earnings_announcement_date": "2015-10-22",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ResMed Inc."
  },
  "RMTI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.43,
    "earnings_per_share": -0.36,
    "ebitda": -13720000.0,
    "eps_estimate_current_year": -0.08,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 11.59,
    "fifty_two_week_high": 18.9,
    "fifty_two_week_low": 8.1,
    "percent_change_from_200_day_moving_average": -0.2949,
    "percent_change_from_50_day_moving_average": -0.2544,
    "shares_owned": "N/A",
    "short_ratio": 12.39,
    "two_hundred_day_moving_average": 12.25,
    "volume": 1159287.0,
    "market_cap": 433930000.0,
    "price_to_sales_ttm": 8.65,
    "price_to_book_mrq": 7.21,
    "roa_ttm": -0.1557,
    "roe_ttm": -0.5344,
    "shares_outstanding": 50220000.0,
    "pcnt_held_by_insiders": 0.1855,
    "pcnt_held_by_institutions": 0.28,
    "pcnt_short_of_float": 0.22190000000000001,
    "operating_cash_flow_ttm": 8170000.0,
    "levered_cash_flow_ttm": -2620000.0,
    "book_value_per_share_mrq": 1.31,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Rockwell Medical, Inc."
  },
  "RNN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.06,
    "ebitda": -16210000.0,
    "eps_estimate_current_year": -0.09,
    "eps_estimate_next_quarter": -0.03,
    "fifty_day_moving_average": 0.56,
    "fifty_two_week_high": 0.96,
    "fifty_two_week_low": 0.5,
    "percent_change_from_200_day_moving_average": -0.0608,
    "percent_change_from_50_day_moving_average": 0.0876,
    "shares_owned": "N/A",
    "short_ratio": 13.77,
    "two_hundred_day_moving_average": 0.65,
    "volume": 680152.0,
    "market_cap": 110230000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.04,
    "roa_ttm": -0.3046,
    "roe_ttm": -0.44920000000000004,
    "shares_outstanding": 180700000.0,
    "pcnt_held_by_insiders": 0.1705,
    "pcnt_held_by_institutions": 0.069,
    "pcnt_short_of_float": 0.0229,
    "operating_cash_flow_ttm": -13960000.0,
    "levered_cash_flow_ttm": -7880000.0,
    "book_value_per_share_mrq": 0.12,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Rexahn Pharmaceuticals, Inc."
  },
  "ROKA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.04,
    "earnings_per_share": -1.79,
    "ebitda": -28070000.0,
    "eps_estimate_current_year": -2.1,
    "eps_estimate_next_quarter": -0.53,
    "fifty_day_moving_average": 2.63,
    "fifty_two_week_high": 11.19,
    "fifty_two_week_low": 2.01,
    "percent_change_from_200_day_moving_average": -0.2925,
    "percent_change_from_50_day_moving_average": -0.19260000000000002,
    "shares_owned": "N/A",
    "short_ratio": 5.17,
    "two_hundred_day_moving_average": 3.0,
    "volume": 94553.0,
    "market_cap": 38250000.0,
    "price_to_sales_ttm": 7.45,
    "price_to_book_mrq": 0.7,
    "roa_ttm": -0.30579999999999996,
    "roe_ttm": -0.731,
    "shares_outstanding": 18040000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.016200000000000003,
    "operating_cash_flow_ttm": -25670000.0,
    "levered_cash_flow_ttm": -26510000.0,
    "book_value_per_share_mrq": 3.45,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Roka Bioscience, Inc."
  },
  "ROSG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.29,
    "ebitda": -13950000.0,
    "eps_estimate_current_year": -1.37,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.64,
    "fifty_two_week_high": 5.55,
    "fifty_two_week_low": 2.07,
    "percent_change_from_200_day_moving_average": -0.121,
    "percent_change_from_50_day_moving_average": 0.0638,
    "shares_owned": "N/A",
    "short_ratio": 5.43,
    "two_hundred_day_moving_average": 3.2,
    "volume": 90754.0,
    "market_cap": 33049999.999999996,
    "price_to_sales_ttm": 25.7,
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.4128,
    "roe_ttm": -0.7506999999999999,
    "shares_outstanding": 11760000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.081,
    "pcnt_short_of_float": 0.0373,
    "operating_cash_flow_ttm": -13600000.0,
    "levered_cash_flow_ttm": -7960000.0,
    "book_value_per_share_mrq": 1.28,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Rosetta Genomics, Ltd."
  },
  "RPRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.31,
    "earnings_per_share": -1.3,
    "ebitda": -31280000.0,
    "eps_estimate_current_year": -1.29,
    "eps_estimate_next_quarter": -0.32,
    "fifty_day_moving_average": 7.79,
    "fifty_two_week_high": 11.21,
    "fifty_two_week_low": 5.92,
    "percent_change_from_200_day_moving_average": 0.048,
    "percent_change_from_50_day_moving_average": 0.0591,
    "shares_owned": "N/A",
    "short_ratio": 6.55,
    "two_hundred_day_moving_average": 7.87,
    "volume": 327098.0,
    "market_cap": 200320000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.21,
    "roa_ttm": -0.40409999999999996,
    "roe_ttm": -0.6962999999999999,
    "shares_outstanding": 24280000.0,
    "pcnt_held_by_insiders": 0.0363,
    "pcnt_held_by_institutions": 0.924,
    "pcnt_short_of_float": 0.0978,
    "operating_cash_flow_ttm": -28600000.0,
    "levered_cash_flow_ttm": -16870000.0,
    "book_value_per_share_mrq": 1.23,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Repros Therapeutics Inc."
  },
  "RPTP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.85,
    "ebitda": -42370000.0,
    "eps_estimate_current_year": -0.79,
    "eps_estimate_next_quarter": -0.19,
    "fifty_day_moving_average": 11.08,
    "fifty_two_week_high": 16.28,
    "fifty_two_week_low": 5.56,
    "percent_change_from_200_day_moving_average": -0.5167,
    "percent_change_from_50_day_moving_average": -0.4646,
    "shares_owned": "N/A",
    "short_ratio": 10.8,
    "two_hundred_day_moving_average": 12.27,
    "volume": 2205343.0,
    "market_cap": 481400000.0,
    "price_to_sales_ttm": 6.17,
    "price_to_book_mrq": 4.32,
    "roa_ttm": -0.1557,
    "roe_ttm": -0.8443999999999999,
    "shares_outstanding": 81180000.0,
    "pcnt_held_by_insiders": 0.0716,
    "pcnt_held_by_institutions": 0.493,
    "pcnt_short_of_float": 0.18100000000000002,
    "operating_cash_flow_ttm": -42900000.0,
    "levered_cash_flow_ttm": -30020000.0,
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Raptor Pharmaceuticals Corp."
  },
  "RTIX": {
    "p_e_ratio": 48.63,
    "peg_ratio": 1.94,
    "earnings_per_share": 0.12,
    "ebitda": 37770000.0,
    "eps_estimate_current_year": 0.21,
    "eps_estimate_next_quarter": 0.07,
    "fifty_day_moving_average": 6.3,
    "fifty_two_week_high": 7.48,
    "fifty_two_week_low": 3.5,
    "percent_change_from_200_day_moving_average": -0.079,
    "percent_change_from_50_day_moving_average": -0.0967,
    "shares_owned": "N/A",
    "short_ratio": 6.23,
    "two_hundred_day_moving_average": 6.18,
    "volume": 273935.0,
    "market_cap": 327850000.0,
    "price_to_sales_ttm": 1.29,
    "price_to_book_mrq": 2.04,
    "roa_ttm": 0.036000000000000004,
    "roe_ttm": 0.044199999999999996,
    "shares_outstanding": 57620000.0,
    "pcnt_held_by_insiders": 0.1056,
    "pcnt_held_by_institutions": 0.654,
    "pcnt_short_of_float": 0.0471,
    "operating_cash_flow_ttm": 14300000.0,
    "levered_cash_flow_ttm": 7310000.0,
    "book_value_per_share_mrq": 3.03,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "RTI Surgical Inc."
  },
  "RTRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.84,
    "earnings_per_share": -1.16,
    "ebitda": -39870000.0,
    "eps_estimate_current_year": 0.76,
    "eps_estimate_next_quarter": 0.17,
    "fifty_day_moving_average": 27.63,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 7.85,
    "percent_change_from_200_day_moving_average": -0.21239999999999998,
    "percent_change_from_50_day_moving_average": -0.2107,
    "shares_owned": "N/A",
    "short_ratio": 7.45,
    "two_hundred_day_moving_average": 27.69,
    "volume": 983509.0,
    "market_cap": 779620000.0,
    "price_to_sales_ttm": 13.07,
    "price_to_book_mrq": 5.43,
    "roa_ttm": -0.1057,
    "roe_ttm": -0.43310000000000004,
    "shares_outstanding": 35750000.0,
    "pcnt_held_by_insiders": 0.4459,
    "pcnt_held_by_institutions": 0.325,
    "pcnt_short_of_float": 0.1285,
    "operating_cash_flow_ttm": -24030000.0,
    "levered_cash_flow_ttm": -26040000.0,
    "book_value_per_share_mrq": 4.3,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Retrophin, Inc."
  },
  "RTTR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -12.45,
    "ebitda": -5100000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.14,
    "fifty_two_week_high": 5.5,
    "fifty_two_week_low": 2.5,
    "percent_change_from_200_day_moving_average": -0.25670000000000004,
    "percent_change_from_50_day_moving_average": -0.146,
    "shares_owned": "N/A",
    "short_ratio": 0.06,
    "two_hundred_day_moving_average": 3.61,
    "volume": 63860.0,
    "market_cap": 20880000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.3,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 7790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0013,
    "operating_cash_flow_ttm": -1470000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 2.23,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ritter Pharmaceuticals, Inc."
  },
  "RVNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.57,
    "ebitda": -57330000.0,
    "eps_estimate_current_year": -3.55,
    "eps_estimate_next_quarter": -1.15,
    "fifty_day_moving_average": 29.8,
    "fifty_two_week_high": 35.72,
    "fifty_two_week_low": 14.02,
    "percent_change_from_200_day_moving_average": -0.0024,
    "percent_change_from_50_day_moving_average": -0.09369999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.74,
    "two_hundred_day_moving_average": 27.07,
    "volume": 292439.0,
    "market_cap": 646900000.0,
    "price_to_sales_ttm": 2260.88,
    "price_to_book_mrq": 4.56,
    "roa_ttm": -0.1883,
    "roe_ttm": -0.3478,
    "shares_outstanding": 23950000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3406,
    "operating_cash_flow_ttm": -47330000.0,
    "levered_cash_flow_ttm": -31490000.0,
    "book_value_per_share_mrq": 6.22,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Revance Therapeutics, Inc."
  },
  "RVP": {
    "p_e_ratio": 21.03,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.17,
    "ebitda": -645645.0,
    "eps_estimate_current_year": -0.46,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.82,
    "fifty_two_week_high": 5.7,
    "fifty_two_week_low": 2.78,
    "percent_change_from_200_day_moving_average": -0.0665,
    "percent_change_from_50_day_moving_average": -0.040999999999999995,
    "shares_owned": "N/A",
    "short_ratio": 1.23,
    "two_hundred_day_moving_average": 3.92,
    "volume": 24927.0,
    "market_cap": 101980000.0,
    "price_to_sales_ttm": 3.15,
    "price_to_book_mrq": 3.44,
    "roa_ttm": -0.0225,
    "roe_ttm": 0.20850000000000002,
    "shares_outstanding": 27860000.0,
    "pcnt_held_by_insiders": 0.6542,
    "pcnt_held_by_institutions": 0.051,
    "pcnt_short_of_float": 0.0021,
    "operating_cash_flow_ttm": -1870000.0,
    "levered_cash_flow_ttm": -9700000.0,
    "book_value_per_share_mrq": 1.11,
    "next_earnings_announcement_date": [
      "2015-11-16",
      "2015-11-20"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Retractable Technologies, Inc."
  },
  "RWLK": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.5,
    "ebitda": -23850000.0,
    "eps_estimate_current_year": -1.93,
    "eps_estimate_next_quarter": -0.52,
    "fifty_day_moving_average": 8.92,
    "fifty_two_week_high": 35.55,
    "fifty_two_week_low": 7.31,
    "percent_change_from_200_day_moving_average": -0.2783,
    "percent_change_from_50_day_moving_average": -0.10339999999999999,
    "shares_owned": "N/A",
    "short_ratio": 7.78,
    "two_hundred_day_moving_average": 11.09,
    "volume": 20671.0,
    "market_cap": 95830000.0,
    "price_to_sales_ttm": 24.36,
    "price_to_book_mrq": 3.08,
    "roa_ttm": -0.6754000000000001,
    "roe_ttm": -1.3030000000000002,
    "shares_outstanding": 11980000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0929,
    "operating_cash_flow_ttm": -20050000.0,
    "levered_cash_flow_ttm": -10310000.0,
    "book_value_per_share_mrq": 2.77,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ReWalk Robotics Ltd."
  },
  "RXDX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.13,
    "ebitda": -64700000.0,
    "eps_estimate_current_year": -2.69,
    "eps_estimate_next_quarter": -0.65,
    "fifty_day_moving_average": 14.46,
    "fifty_two_week_high": 19.4,
    "fifty_two_week_low": 6.25,
    "percent_change_from_200_day_moving_average": 0.049,
    "percent_change_from_50_day_moving_average": -0.0709,
    "shares_owned": "N/A",
    "short_ratio": 5.74,
    "two_hundred_day_moving_average": 12.8,
    "volume": 283463.0,
    "market_cap": 397510000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.1,
    "roa_ttm": -0.2989,
    "roe_ttm": -0.5838,
    "shares_outstanding": 29600000.0,
    "pcnt_held_by_insiders": 0.2275,
    "pcnt_held_by_institutions": 0.496,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": -44920000.0,
    "levered_cash_flow_ttm": -37210000.0,
    "book_value_per_share_mrq": 4.9,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Ignyta, Inc."
  },
  "RXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.411,
    "ebitda": -9540000.0,
    "eps_estimate_current_year": -0.22,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 0.414,
    "fifty_two_week_high": 2.3,
    "fifty_two_week_low": 0.342,
    "percent_change_from_200_day_moving_average": -0.2865,
    "percent_change_from_50_day_moving_average": -0.03167,
    "shares_owned": "N/A",
    "short_ratio": 6.02,
    "two_hundred_day_moving_average": 0.562,
    "volume": 1306584.0,
    "market_cap": 26040000.0,
    "price_to_sales_ttm": 455.66,
    "price_to_book_mrq": 2.22,
    "roa_ttm": -0.4375,
    "roe_ttm": -0.7813,
    "shares_outstanding": 64950000.0,
    "pcnt_held_by_insiders": 0.3389,
    "pcnt_held_by_institutions": 0.12,
    "pcnt_short_of_float": 0.1435,
    "operating_cash_flow_ttm": -7130000.0,
    "levered_cash_flow_ttm": -3790000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "RXi Pharmaceuticals Corporation"
  },
  "SAGE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.88,
    "ebitda": -63710000.0,
    "eps_estimate_current_year": -3.24,
    "eps_estimate_next_quarter": -0.87,
    "fifty_day_moving_average": 56.07,
    "fifty_two_week_high": 89.04,
    "fifty_two_week_low": 28.97,
    "percent_change_from_200_day_moving_average": -0.2298,
    "percent_change_from_50_day_moving_average": -0.1514,
    "shares_owned": "N/A",
    "short_ratio": 5.36,
    "two_hundred_day_moving_average": 61.78,
    "volume": 701810.0,
    "market_cap": 1370000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 6.98,
    "roa_ttm": -0.2846,
    "roe_ttm": -0.4807,
    "shares_outstanding": 28820000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.2834,
    "operating_cash_flow_ttm": -49200000.0,
    "levered_cash_flow_ttm": -24990000.0,
    "book_value_per_share_mrq": 7.6,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sage Therapeutics, Inc."
  },
  "SCAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.48,
    "earnings_per_share": "N/A",
    "ebitda": 0.0,
    "eps_estimate_current_year": 2.03,
    "eps_estimate_next_quarter": 0.7,
    "fifty_day_moving_average": 37.18,
    "fifty_two_week_high": 40.99,
    "fifty_two_week_low": 26.55,
    "percent_change_from_200_day_moving_average": -0.015700000000000002,
    "percent_change_from_50_day_moving_average": -0.0085,
    "shares_owned": "N/A",
    "short_ratio": 0.0,
    "two_hundred_day_moving_average": 37.46,
    "volume": 272869.0,
    "market_cap": null,
    "price_to_sales_ttm": null,
    "price_to_book_mrq": null,
    "roa_ttm": null,
    "roe_ttm": null,
    "shares_outstanding": null,
    "pcnt_held_by_insiders": null,
    "pcnt_held_by_institutions": null,
    "pcnt_short_of_float": null,
    "operating_cash_flow_ttm": null,
    "levered_cash_flow_ttm": null,
    "book_value_per_share_mrq": null,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": null,
    "industry": null
  },
  "SCLN": {
    "p_e_ratio": 22.06,
    "peg_ratio": 1.67,
    "earnings_per_share": 0.31,
    "ebitda": 28050000.0,
    "eps_estimate_current_year": 0.33,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 7.87,
    "fifty_two_week_high": 11.71,
    "fifty_two_week_low": 6.59,
    "percent_change_from_200_day_moving_average": -0.22769999999999999,
    "percent_change_from_50_day_moving_average": -0.1311,
    "shares_owned": "N/A",
    "short_ratio": 7.56,
    "two_hundred_day_moving_average": 8.86,
    "volume": 300148.0,
    "market_cap": 343710000.0,
    "price_to_sales_ttm": 2.48,
    "price_to_book_mrq": 2.27,
    "roa_ttm": 0.0908,
    "roe_ttm": 0.1041,
    "shares_outstanding": 50250000.0,
    "pcnt_held_by_insiders": 0.1333,
    "pcnt_held_by_institutions": 0.516,
    "pcnt_short_of_float": 0.08199999999999999,
    "operating_cash_flow_ttm": 33830000.0,
    "levered_cash_flow_ttm": 32520000.000000004,
    "book_value_per_share_mrq": 3.2,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "SciClone Pharmaceuticals, Inc."
  },
  "SCMP": {
    "p_e_ratio": 35.52,
    "peg_ratio": 2.86,
    "earnings_per_share": 0.59,
    "ebitda": 48140000.0,
    "eps_estimate_current_year": 0.74,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 25.38,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 6.23,
    "percent_change_from_200_day_moving_average": 0.052300000000000006,
    "percent_change_from_50_day_moving_average": -0.1783,
    "shares_owned": "N/A",
    "short_ratio": 3.25,
    "two_hundred_day_moving_average": 19.81,
    "volume": 1838140.0,
    "market_cap": 931060000.0,
    "price_to_sales_ttm": 8.15,
    "price_to_book_mrq": 10.03,
    "roa_ttm": 0.19649999999999998,
    "roe_ttm": 0.3038,
    "shares_outstanding": 44660000.0,
    "pcnt_held_by_insiders": 0.6481,
    "pcnt_held_by_institutions": 0.243,
    "pcnt_short_of_float": 0.23420000000000002,
    "operating_cash_flow_ttm": 41870000.0,
    "levered_cash_flow_ttm": 72820000.0,
    "book_value_per_share_mrq": 2.39,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Sucampo Pharmaceuticals, Inc."
  },
  "SCYX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.38,
    "ebitda": -17160000.0,
    "eps_estimate_current_year": -2.69,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 7.07,
    "fifty_two_week_high": 15.0,
    "fifty_two_week_low": 5.7,
    "percent_change_from_200_day_moving_average": -0.17170000000000002,
    "percent_change_from_50_day_moving_average": -0.0115,
    "shares_owned": "N/A",
    "short_ratio": 3.69,
    "two_hundred_day_moving_average": 8.44,
    "volume": 5481.0,
    "market_cap": 97190000.0,
    "price_to_sales_ttm": 5.04,
    "price_to_book_mrq": 1.69,
    "roa_ttm": -0.2059,
    "roe_ttm": -0.37549999999999994,
    "shares_outstanding": 13900000.0,
    "pcnt_held_by_insiders": 0.6431,
    "pcnt_held_by_institutions": 0.013999999999999999,
    "pcnt_short_of_float": 0.0111,
    "operating_cash_flow_ttm": -18220000.0,
    "levered_cash_flow_ttm": -11290000.0,
    "book_value_per_share_mrq": 4.08,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SCYNEXIS, Inc."
  },
  "SEM": {
    "p_e_ratio": 12.11,
    "peg_ratio": 1.01,
    "earnings_per_share": 0.95,
    "ebitda": 366960000.0,
    "eps_estimate_current_year": 0.93,
    "eps_estimate_next_quarter": 0.19,
    "fifty_day_moving_average": 12.8,
    "fifty_two_week_high": 17.2,
    "fifty_two_week_low": 11.41,
    "percent_change_from_200_day_moving_average": -0.2192,
    "percent_change_from_50_day_moving_average": -0.10310000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.74,
    "two_hundred_day_moving_average": 14.7,
    "volume": 567145.0,
    "market_cap": 1510000000.0,
    "price_to_sales_ttm": 0.49,
    "price_to_book_mrq": 1.91,
    "roa_ttm": 0.050499999999999996,
    "roe_ttm": 0.1426,
    "shares_outstanding": 131380000.0,
    "pcnt_held_by_insiders": 0.4144,
    "pcnt_held_by_institutions": 0.703,
    "pcnt_short_of_float": 0.1025,
    "operating_cash_flow_ttm": 203530000.0,
    "levered_cash_flow_ttm": 4480000.0,
    "book_value_per_share_mrq": 6.14,
    "next_earnings_announcement_date": "2015-10-29",
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Select Medical Holdings Corporation"
  },
  "SGEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.91,
    "earnings_per_share": -0.9,
    "ebitda": -99030000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.2,
    "fifty_day_moving_average": 43.31,
    "fifty_two_week_high": 52.33,
    "fifty_two_week_low": 30.05,
    "percent_change_from_200_day_moving_average": -0.0771,
    "percent_change_from_50_day_moving_average": -0.0917,
    "shares_owned": "N/A",
    "short_ratio": 19.46,
    "two_hundred_day_moving_average": 42.63,
    "volume": 1430894.0,
    "market_cap": 5390000000.0,
    "price_to_sales_ttm": 17.41,
    "price_to_book_mrq": 29.99,
    "roa_ttm": -0.1605,
    "roe_ttm": -0.5497,
    "shares_outstanding": 137010000.0,
    "pcnt_held_by_insiders": 0.1827,
    "pcnt_held_by_institutions": 0.8759999999999999,
    "pcnt_short_of_float": 0.2741,
    "operating_cash_flow_ttm": -106260000.0,
    "levered_cash_flow_ttm": -33189999.999999996,
    "book_value_per_share_mrq": 1.43,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Seattle Genetics, Inc."
  },
  "SGMO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.43,
    "ebitda": -29590000.0,
    "eps_estimate_current_year": -0.82,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 7.48,
    "fifty_two_week_high": 19.25,
    "fifty_two_week_low": 6.04,
    "percent_change_from_200_day_moving_average": -0.4379,
    "percent_change_from_50_day_moving_average": -0.14730000000000001,
    "shares_owned": "N/A",
    "short_ratio": 9.99,
    "two_hundred_day_moving_average": 11.35,
    "volume": 1527462.0,
    "market_cap": 445710000.0,
    "price_to_sales_ttm": 9.64,
    "price_to_book_mrq": 2.37,
    "roa_ttm": -0.0788,
    "roe_ttm": -0.14150000000000001,
    "shares_outstanding": 69860000.0,
    "pcnt_held_by_insiders": 0.0308,
    "pcnt_held_by_institutions": 0.772,
    "pcnt_short_of_float": 0.1673,
    "operating_cash_flow_ttm": -18900000.0,
    "levered_cash_flow_ttm": -2660000.0,
    "book_value_per_share_mrq": 2.86,
    "next_earnings_announcement_date": [
      "2015-10-20",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sangamo Biosciences Inc."
  },
  "SGNL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.67,
    "ebitda": -8930000.0,
    "eps_estimate_current_year": -1.5,
    "eps_estimate_next_quarter": -0.37,
    "fifty_day_moving_average": 1.43,
    "fifty_two_week_high": 5.8,
    "fifty_two_week_low": 1.12,
    "percent_change_from_200_day_moving_average": -0.3421,
    "percent_change_from_50_day_moving_average": -0.184,
    "shares_owned": "N/A",
    "short_ratio": 2.08,
    "two_hundred_day_moving_average": 1.78,
    "volume": 844670.0,
    "market_cap": 9210000.0,
    "price_to_sales_ttm": 3.12,
    "price_to_book_mrq": 0.95,
    "roa_ttm": -0.4783,
    "roe_ttm": -0.9369,
    "shares_outstanding": 7870000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0667,
    "operating_cash_flow_ttm": -5120000.0,
    "levered_cash_flow_ttm": -2520000.0,
    "book_value_per_share_mrq": 1.4,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "Signal Genetics, Inc."
  },
  "SGNT": {
    "p_e_ratio": 18.35,
    "peg_ratio": -19.73,
    "earnings_per_share": 0.91,
    "ebitda": 26900000.0,
    "eps_estimate_current_year": -0.04,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 19.39,
    "fifty_two_week_high": 33.6,
    "fifty_two_week_low": 16.37,
    "percent_change_from_200_day_moving_average": -0.28550000000000003,
    "percent_change_from_50_day_moving_average": -0.1388,
    "shares_owned": "N/A",
    "short_ratio": 6.55,
    "two_hundred_day_moving_average": 23.37,
    "volume": 455152.0,
    "market_cap": 545920000.0,
    "price_to_sales_ttm": 1.79,
    "price_to_book_mrq": 1.98,
    "roa_ttm": 0.0288,
    "roe_ttm": 0.1124,
    "shares_outstanding": 32689999.999999996,
    "pcnt_held_by_insiders": 0.514,
    "pcnt_held_by_institutions": 0.593,
    "pcnt_short_of_float": 0.18109999999999998,
    "operating_cash_flow_ttm": 1870000.0,
    "levered_cash_flow_ttm": -16379999.999999998,
    "book_value_per_share_mrq": 8.54,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sagent Pharmaceuticals, Inc."
  },
  "SGYP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.182,
    "ebitda": -100640000.0,
    "eps_estimate_current_year": -1.16,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 7.159,
    "fifty_two_week_high": 10.15,
    "fifty_two_week_low": 2.45,
    "percent_change_from_200_day_moving_average": -0.02305,
    "percent_change_from_50_day_moving_average": -0.17375,
    "shares_owned": "N/A",
    "short_ratio": 8.2,
    "two_hundred_day_moving_average": 6.055,
    "volume": 3704984.0,
    "market_cap": 665240000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5686,
    "roe_ttm": "-1,404.92%",
    "shares_outstanding": 112470000.0,
    "pcnt_held_by_insiders": 0.09539999999999998,
    "pcnt_held_by_institutions": 0.287,
    "pcnt_short_of_float": 0.2242,
    "operating_cash_flow_ttm": -98590000.0,
    "levered_cash_flow_ttm": -56310000.0,
    "book_value_per_share_mrq": -0.21,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Synergy Pharmaceuticals, Inc."
  },
  "SIEN": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.42,
    "earnings_per_share": -1.11,
    "ebitda": -7550000.0,
    "eps_estimate_current_year": -1.15,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 22.38,
    "fifty_two_week_high": 26.67,
    "fifty_two_week_low": 9.38,
    "percent_change_from_200_day_moving_average": -0.531,
    "percent_change_from_50_day_moving_average": -0.5490999999999999,
    "shares_owned": "N/A",
    "short_ratio": 3.46,
    "two_hundred_day_moving_average": 21.51,
    "volume": 2195432.0,
    "market_cap": 181040000.0,
    "price_to_sales_ttm": 2.94,
    "price_to_book_mrq": 1.6,
    "roa_ttm": -0.049699999999999994,
    "roe_ttm": -0.19469999999999998,
    "shares_outstanding": 17940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0298,
    "operating_cash_flow_ttm": -8330000.0,
    "levered_cash_flow_ttm": -5680000.0,
    "book_value_per_share_mrq": 6.05,
    "next_earnings_announcement_date": [
      "2015-11-18",
      "2015-11-23"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Sientra, Inc."
  },
  "SIRO": {
    "p_e_ratio": 30.04,
    "peg_ratio": 2.18,
    "earnings_per_share": 3.26,
    "ebitda": 280200000.0,
    "eps_estimate_current_year": 3.97,
    "eps_estimate_next_quarter": 1.05,
    "fifty_day_moving_average": 97.87,
    "fifty_two_week_high": 105.37,
    "fifty_two_week_low": 74.38,
    "percent_change_from_200_day_moving_average": 0.0127,
    "percent_change_from_50_day_moving_average": 0.0006,
    "shares_owned": "N/A",
    "short_ratio": 6.51,
    "two_hundred_day_moving_average": 96.71,
    "volume": 577862.0,
    "market_cap": 5470000000.0,
    "price_to_sales_ttm": 4.8,
    "price_to_book_mrq": 4.29,
    "roa_ttm": 0.0823,
    "roe_ttm": 0.1432,
    "shares_outstanding": 55900000.0,
    "pcnt_held_by_insiders": 0.002,
    "pcnt_held_by_institutions": 1.095,
    "pcnt_short_of_float": 0.049800000000000004,
    "operating_cash_flow_ttm": 249400000.0,
    "levered_cash_flow_ttm": 147640000.0,
    "book_value_per_share_mrq": 22.99,
    "next_earnings_announcement_date": [
      "2015-11-19",
      "2015-11-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sirona Dental Systems Inc."
  },
  "SKBI": {
    "p_e_ratio": 0.8,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.37,
    "ebitda": 14480000.0,
    "eps_estimate_current_year": 2.25,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.22,
    "fifty_two_week_high": 4.97,
    "fifty_two_week_low": 1.03,
    "percent_change_from_200_day_moving_average": -0.5942000000000001,
    "percent_change_from_50_day_moving_average": -0.09939999999999999,
    "shares_owned": "N/A",
    "short_ratio": 1.83,
    "two_hundred_day_moving_average": 2.71,
    "volume": 4971.0,
    "market_cap": 9570000.0,
    "price_to_sales_ttm": 0.2,
    "price_to_book_mrq": 0.08,
    "roa_ttm": 0.051100000000000007,
    "roe_ttm": 0.09609999999999999,
    "shares_outstanding": 8700000.0,
    "pcnt_held_by_insiders": 0.469,
    "pcnt_held_by_institutions": 0.046,
    "pcnt_short_of_float": 0.005,
    "operating_cash_flow_ttm": 18910000.0,
    "levered_cash_flow_ttm": -1920000.0,
    "book_value_per_share_mrq": 14.41,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Skystar Bio Pharmaceutical Company"
  },
  "SKLN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.581,
    "ebitda": -4130000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 3.8418,
    "fifty_two_week_high": 7.15,
    "fifty_two_week_low": 2.0,
    "percent_change_from_200_day_moving_average": -0.131627,
    "percent_change_from_50_day_moving_average": -0.11625500000000001,
    "shares_owned": "N/A",
    "short_ratio": 3.66,
    "two_hundred_day_moving_average": 3.9098,
    "volume": 7263.0,
    "market_cap": 11250000.0,
    "price_to_sales_ttm": 11.8,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -3.0585000000000004,
    "roe_ttm": "N/A",
    "shares_outstanding": 3310000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0131,
    "operating_cash_flow_ttm": -1640000.0,
    "levered_cash_flow_ttm": 429360.0,
    "book_value_per_share_mrq": -1.86,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Skyline Medical Inc."
  },
  "SMLR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.12,
    "ebitda": -4970000.0,
    "eps_estimate_current_year": -0.78,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.91,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.81,
    "percent_change_from_200_day_moving_average": -0.2403,
    "percent_change_from_50_day_moving_average": -0.1072,
    "shares_owned": "N/A",
    "short_ratio": 2.07,
    "two_hundred_day_moving_average": 3.42,
    "volume": 8300.0,
    "market_cap": 12960000.0,
    "price_to_sales_ttm": 2.96,
    "price_to_book_mrq": 7.77,
    "roa_ttm": -0.4878,
    "roe_ttm": -1.4143999999999999,
    "shares_outstanding": 4980000.0,
    "pcnt_held_by_insiders": 0.4363,
    "pcnt_held_by_institutions": 0.138,
    "pcnt_short_of_float": 0.005699999999999999,
    "operating_cash_flow_ttm": -4350000.0,
    "levered_cash_flow_ttm": -4940000.0,
    "book_value_per_share_mrq": 0.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Semler Scientific Inc"
  },
  "SNSS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.02,
    "earnings_per_share": -0.59,
    "ebitda": -43820000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 1.16,
    "fifty_two_week_high": 7.78,
    "fifty_two_week_low": 0.84,
    "percent_change_from_200_day_moving_average": -0.5103,
    "percent_change_from_50_day_moving_average": -0.07490000000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.65,
    "two_hundred_day_moving_average": 2.19,
    "volume": 770430.0,
    "market_cap": 80750000.0,
    "price_to_sales_ttm": 24.23,
    "price_to_book_mrq": 4.87,
    "roa_ttm": -0.5457,
    "roe_ttm": -2.1033,
    "shares_outstanding": 75470000.0,
    "pcnt_held_by_insiders": 0.1815,
    "pcnt_held_by_institutions": 0.821,
    "pcnt_short_of_float": 0.0556,
    "operating_cash_flow_ttm": -41360000.0,
    "levered_cash_flow_ttm": -36190000.0,
    "book_value_per_share_mrq": 0.23,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sunesis Pharmaceuticals, Inc."
  },
  "SNTA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.71,
    "ebitda": -78510000.0,
    "eps_estimate_current_year": -0.65,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 2.02,
    "fifty_two_week_high": 3.44,
    "fifty_two_week_low": 1.75,
    "percent_change_from_200_day_moving_average": -0.1839,
    "percent_change_from_50_day_moving_average": -0.091,
    "shares_owned": "N/A",
    "short_ratio": 10.51,
    "two_hundred_day_moving_average": 2.25,
    "volume": 1384824.0,
    "market_cap": 251050000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.91,
    "roa_ttm": -0.4551,
    "roe_ttm": -1.1306,
    "shares_outstanding": 136440000.0,
    "pcnt_held_by_insiders": 0.3763,
    "pcnt_held_by_institutions": 0.213,
    "pcnt_short_of_float": 0.11220000000000001,
    "operating_cash_flow_ttm": -74290000.0,
    "levered_cash_flow_ttm": -44180000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synta Pharmaceuticals Corp."
  },
  "SPAN": {
    "p_e_ratio": 15.4,
    "peg_ratio": 0.0,
    "earnings_per_share": 1.12,
    "ebitda": 5530000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.95,
    "fifty_two_week_high": 21.62,
    "fifty_two_week_low": 16.44,
    "percent_change_from_200_day_moving_average": -0.0684,
    "percent_change_from_50_day_moving_average": -0.0388,
    "shares_owned": "N/A",
    "short_ratio": 0.24,
    "two_hundred_day_moving_average": 18.52,
    "volume": 2616.0,
    "market_cap": 51550000.0,
    "price_to_sales_ttm": 0.88,
    "price_to_book_mrq": 1.83,
    "roa_ttm": 0.0754,
    "roe_ttm": 0.1131,
    "shares_outstanding": 2990000.0,
    "pcnt_held_by_insiders": 0.2827,
    "pcnt_held_by_institutions": 0.354,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": 4600000.0,
    "levered_cash_flow_ttm": 3330000.0,
    "book_value_per_share_mrq": 9.55,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Span-America Medical Systems Inc."
  },
  "SPHS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.279,
    "ebitda": -20840000.0,
    "eps_estimate_current_year": -0.95,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.8994,
    "fifty_two_week_high": 3.25,
    "fifty_two_week_low": 0.42,
    "percent_change_from_200_day_moving_average": 0.068628,
    "percent_change_from_50_day_moving_average": -0.016153999999999998,
    "shares_owned": "N/A",
    "short_ratio": 1.36,
    "two_hundred_day_moving_average": 0.8281,
    "volume": 176678.0,
    "market_cap": 14910000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.14,
    "roa_ttm": -0.4803,
    "roe_ttm": -1.258,
    "shares_outstanding": 16840000.0,
    "pcnt_held_by_insiders": 0.08449999999999999,
    "pcnt_held_by_institutions": 0.40700000000000003,
    "pcnt_short_of_float": 0.0155,
    "operating_cash_flow_ttm": -22280000.0,
    "levered_cash_flow_ttm": -14350000.0,
    "book_value_per_share_mrq": 0.42,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Sophiris Bio, Inc."
  },
  "SPNC": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.95,
    "earnings_per_share": -1.54,
    "ebitda": -8510000.0,
    "eps_estimate_current_year": -1.02,
    "eps_estimate_next_quarter": -0.25,
    "fifty_day_moving_average": 15.79,
    "fifty_two_week_high": 37.04,
    "fifty_two_week_low": 12.4,
    "percent_change_from_200_day_moving_average": -0.48969999999999997,
    "percent_change_from_50_day_moving_average": -0.2073,
    "shares_owned": "N/A",
    "short_ratio": 7.32,
    "two_hundred_day_moving_average": 24.54,
    "volume": 859958.0,
    "market_cap": 532080000.00000006,
    "price_to_sales_ttm": 2.42,
    "price_to_book_mrq": 4.21,
    "roa_ttm": -0.0435,
    "roe_ttm": -0.40369999999999995,
    "shares_outstanding": 42500000.0,
    "pcnt_held_by_insiders": 0.1075,
    "pcnt_held_by_institutions": 0.938,
    "pcnt_short_of_float": 0.1567,
    "operating_cash_flow_ttm": -43520000.0,
    "levered_cash_flow_ttm": 8830000.0,
    "book_value_per_share_mrq": 3.21,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "The Spectranetics Corporation"
  },
  "SPNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -3.7,
    "ebitda": -4260000.0,
    "eps_estimate_current_year": -3.64,
    "eps_estimate_next_quarter": -0.56,
    "fifty_day_moving_average": 16.25,
    "fifty_two_week_high": 26.0,
    "fifty_two_week_low": 13.56,
    "percent_change_from_200_day_moving_average": -0.005699999999999999,
    "percent_change_from_50_day_moving_average": 0.0462,
    "shares_owned": "N/A",
    "short_ratio": 2.09,
    "two_hundred_day_moving_average": 17.1,
    "volume": 161425.0,
    "market_cap": 188940000.0,
    "price_to_sales_ttm": 1.49,
    "price_to_book_mrq": 1.46,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11110000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": -25820000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 12.36,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "SeaSpine Holdings Corporation"
  },
  "SPPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.65,
    "ebitda": -12890000.0,
    "eps_estimate_current_year": -0.89,
    "eps_estimate_next_quarter": -0.23,
    "fifty_day_moving_average": 6.92,
    "fifty_two_week_high": 8.34,
    "fifty_two_week_low": 5.45,
    "percent_change_from_200_day_moving_average": 0.0004,
    "percent_change_from_50_day_moving_average": -0.0449,
    "shares_owned": "N/A",
    "short_ratio": 13.61,
    "two_hundred_day_moving_average": 6.61,
    "volume": 1892282.0,
    "market_cap": 444930000.0,
    "price_to_sales_ttm": 2.5,
    "price_to_book_mrq": 1.96,
    "roa_ttm": -0.0541,
    "roe_ttm": -0.1698,
    "shares_outstanding": 67310000.0,
    "pcnt_held_by_insiders": 0.1193,
    "pcnt_held_by_institutions": 0.687,
    "pcnt_short_of_float": 0.3851,
    "operating_cash_flow_ttm": 33690000.0,
    "levered_cash_flow_ttm": 32560000.000000004,
    "book_value_per_share_mrq": 3.58,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Spectrum Pharmaceuticals, Inc."
  },
  "SQNM": {
    "p_e_ratio": 12.95,
    "peg_ratio": -0.4,
    "earnings_per_share": 0.15,
    "ebitda": 4920000.0,
    "eps_estimate_current_year": -0.24,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 2.14,
    "fifty_two_week_high": 4.8,
    "fifty_two_week_low": 1.82,
    "percent_change_from_200_day_moving_average": -0.3998,
    "percent_change_from_50_day_moving_average": -0.09910000000000001,
    "shares_owned": "N/A",
    "short_ratio": 13.23,
    "two_hundred_day_moving_average": 3.22,
    "volume": 2673503.0,
    "market_cap": 228670000.0,
    "price_to_sales_ttm": 1.7,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0311,
    "roe_ttm": "N/A",
    "shares_outstanding": 118480000.0,
    "pcnt_held_by_insiders": 0.0636,
    "pcnt_held_by_institutions": 0.43,
    "pcnt_short_of_float": 0.1535,
    "operating_cash_flow_ttm": -18250000.0,
    "levered_cash_flow_ttm": 23830000.0,
    "book_value_per_share_mrq": -0.18,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sequenom Inc."
  },
  "SRDX": {
    "p_e_ratio": 23.73,
    "peg_ratio": 1.81,
    "earnings_per_share": 0.96,
    "ebitda": 23000000.0,
    "eps_estimate_current_year": 0.97,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 23.34,
    "fifty_two_week_high": 27.68,
    "fifty_two_week_low": 18.0,
    "percent_change_from_200_day_moving_average": -0.0705,
    "percent_change_from_50_day_moving_average": -0.024,
    "shares_owned": "N/A",
    "short_ratio": 16.83,
    "two_hundred_day_moving_average": 24.51,
    "volume": 164663.0,
    "market_cap": 294590000.0,
    "price_to_sales_ttm": 4.91,
    "price_to_book_mrq": 3.3,
    "roa_ttm": 0.12869999999999998,
    "roe_ttm": 0.1414,
    "shares_outstanding": 12930000.0,
    "pcnt_held_by_insiders": 0.0118,
    "pcnt_held_by_institutions": 0.857,
    "pcnt_short_of_float": 0.1093,
    "operating_cash_flow_ttm": 17990000.0,
    "levered_cash_flow_ttm": 15170000.0,
    "book_value_per_share_mrq": 6.89,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "SurModics, Inc."
  },
  "SRNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.15,
    "ebitda": -34540000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 13.41,
    "fifty_two_week_high": 26.8,
    "fifty_two_week_low": 3.1,
    "percent_change_from_200_day_moving_average": -0.3527,
    "percent_change_from_50_day_moving_average": -0.3073,
    "shares_owned": "N/A",
    "short_ratio": 2.47,
    "two_hundred_day_moving_average": 14.35,
    "volume": 638496.0,
    "market_cap": 350810000.0,
    "price_to_sales_ttm": 90.83,
    "price_to_book_mrq": 4.05,
    "roa_ttm": -0.1932,
    "roe_ttm": -0.44310000000000005,
    "shares_outstanding": 37760000.0,
    "pcnt_held_by_insiders": 0.3342,
    "pcnt_held_by_institutions": 0.228,
    "pcnt_short_of_float": 0.0706,
    "operating_cash_flow_ttm": -20800000.0,
    "levered_cash_flow_ttm": -17620000.0,
    "book_value_per_share_mrq": 2.51,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sorrento Therapeutics, Inc."
  },
  "SRPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 40.0,
    "earnings_per_share": -4.29,
    "ebitda": -168290000.0,
    "eps_estimate_current_year": -4.86,
    "eps_estimate_next_quarter": -1.16,
    "fifty_day_moving_average": 35.71,
    "fifty_two_week_high": 41.47,
    "fifty_two_week_low": 11.33,
    "percent_change_from_200_day_moving_average": 0.41859999999999997,
    "percent_change_from_50_day_moving_average": 0.015600000000000001,
    "shares_owned": "N/A",
    "short_ratio": 7.9,
    "two_hundred_day_moving_average": 25.57,
    "volume": 1585206.0,
    "market_cap": 1510000000.0,
    "price_to_sales_ttm": 1486.21,
    "price_to_book_mrq": 9.76,
    "roa_ttm": -0.38020000000000004,
    "roe_ttm": -0.7609999999999999,
    "shares_outstanding": 41510000.0,
    "pcnt_held_by_insiders": 0.131,
    "pcnt_held_by_institutions": 0.654,
    "pcnt_short_of_float": 0.2928,
    "operating_cash_flow_ttm": -132650000.0,
    "levered_cash_flow_ttm": -86780000.0,
    "book_value_per_share_mrq": 3.98,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sarepta Therapeutics, Inc."
  },
  "SSH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.51,
    "ebitda": -25790000.0,
    "eps_estimate_current_year": -1.51,
    "eps_estimate_next_quarter": -0.38,
    "fifty_day_moving_average": 2.78,
    "fifty_two_week_high": 6.9,
    "fifty_two_week_low": 1.99,
    "percent_change_from_200_day_moving_average": -0.3131,
    "percent_change_from_50_day_moving_average": -0.0925,
    "shares_owned": "N/A",
    "short_ratio": 13.43,
    "two_hundred_day_moving_average": 3.67,
    "volume": 111299.0,
    "market_cap": 46200000.0,
    "price_to_sales_ttm": 157.85,
    "price_to_book_mrq": 1.9,
    "roa_ttm": -0.4167,
    "roe_ttm": -0.8085,
    "shares_outstanding": 18330000.0,
    "pcnt_held_by_insiders": 0.1875,
    "pcnt_held_by_institutions": 0.20600000000000002,
    "pcnt_short_of_float": 0.0623,
    "operating_cash_flow_ttm": -23530000.0,
    "levered_cash_flow_ttm": -13380000.0,
    "book_value_per_share_mrq": 1.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Sunshine Heart Inc."
  },
  "SSRG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.94,
    "ebitda": 7320000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 8.63,
    "fifty_two_week_high": 9.21,
    "fifty_two_week_low": 6.42,
    "percent_change_from_200_day_moving_average": 0.005600000000000001,
    "percent_change_from_50_day_moving_average": -0.0315,
    "shares_owned": "N/A",
    "short_ratio": 1.24,
    "two_hundred_day_moving_average": 8.31,
    "volume": 23415.0,
    "market_cap": 86310000.0,
    "price_to_sales_ttm": 1.05,
    "price_to_book_mrq": 0.61,
    "roa_ttm": 0.0033,
    "roe_ttm": -0.1882,
    "shares_outstanding": 10320000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0077,
    "operating_cash_flow_ttm": -2110000.0,
    "levered_cash_flow_ttm": -2580000.0,
    "book_value_per_share_mrq": 13.53,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Symmetry Surgical Inc."
  },
  "SSY": {
    "p_e_ratio": 10.44,
    "peg_ratio": 0.0,
    "earnings_per_share": 0.16,
    "ebitda": 4680000.0,
    "eps_estimate_current_year": "nan",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.72,
    "fifty_two_week_high": 2.01,
    "fifty_two_week_low": 1.12,
    "percent_change_from_200_day_moving_average": 0.0451,
    "percent_change_from_50_day_moving_average": -0.0365,
    "shares_owned": "N/A",
    "short_ratio": 0.16,
    "two_hundred_day_moving_average": 1.59,
    "volume": 40041.0,
    "market_cap": 15680000.0,
    "price_to_sales_ttm": 0.15,
    "price_to_book_mrq": 0.48,
    "roa_ttm": 0.0152,
    "roe_ttm": 0.0054,
    "shares_outstanding": 9440000.0,
    "pcnt_held_by_insiders": 0.5939,
    "pcnt_held_by_institutions": 0.07400000000000001,
    "pcnt_short_of_float": 0.0003,
    "operating_cash_flow_ttm": 1870000.0,
    "levered_cash_flow_ttm": 1130000.0,
    "book_value_per_share_mrq": 3.55,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "SunLink Health Systems Inc."
  },
  "STAA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.07,
    "earnings_per_share": -0.24,
    "ebitda": -6190000.0,
    "eps_estimate_current_year": -0.16,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 7.72,
    "fifty_two_week_high": 11.64,
    "fifty_two_week_low": 4.84,
    "percent_change_from_200_day_moving_average": -0.171,
    "percent_change_from_50_day_moving_average": -0.07490000000000001,
    "shares_owned": "N/A",
    "short_ratio": 22.77,
    "two_hundred_day_moving_average": 8.61,
    "volume": 311035.0,
    "market_cap": 284200000.0,
    "price_to_sales_ttm": 4.06,
    "price_to_book_mrq": 7.36,
    "roa_ttm": -0.0858,
    "roe_ttm": -0.225,
    "shares_outstanding": 39800000.0,
    "pcnt_held_by_insiders": 0.0184,
    "pcnt_held_by_institutions": 0.7959999999999999,
    "pcnt_short_of_float": 0.132,
    "operating_cash_flow_ttm": -5290000.0,
    "levered_cash_flow_ttm": -3140000.0,
    "book_value_per_share_mrq": 1.0,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "STAAR Surgical Company"
  },
  "STDY": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.03,
    "earnings_per_share": -2.23,
    "ebitda": -21220000.0,
    "eps_estimate_current_year": -2.51,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 4.0233,
    "fifty_two_week_high": 11.14,
    "fifty_two_week_low": 3.14,
    "percent_change_from_200_day_moving_average": -0.453502,
    "percent_change_from_50_day_moving_average": -0.11868600000000001,
    "shares_owned": "N/A",
    "short_ratio": 2.0,
    "two_hundred_day_moving_average": 6.4882,
    "volume": 9053.0,
    "market_cap": 48160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.21,
    "roa_ttm": -0.41859999999999997,
    "roe_ttm": -0.8447,
    "shares_outstanding": 13580000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0085,
    "operating_cash_flow_ttm": -18750000.0,
    "levered_cash_flow_ttm": -10420000.0,
    "book_value_per_share_mrq": 2.99,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "SteadyMed Ltd."
  },
  "STE": {
    "p_e_ratio": 30.1,
    "peg_ratio": 1.94,
    "earnings_per_share": 2.24,
    "ebitda": 354560000.0,
    "eps_estimate_current_year": 3.25,
    "eps_estimate_next_quarter": 0.86,
    "fifty_day_moving_average": 65.16,
    "fifty_two_week_high": 71.39,
    "fifty_two_week_low": 52.29,
    "percent_change_from_200_day_moving_average": 0.0072,
    "percent_change_from_50_day_moving_average": 0.0344,
    "shares_owned": "N/A",
    "short_ratio": 13.83,
    "two_hundred_day_moving_average": 66.92,
    "volume": 5465734.0,
    "market_cap": 4030000000.0000005,
    "price_to_sales_ttm": 2.18,
    "price_to_book_mrq": 3.71,
    "roa_ttm": 0.0787,
    "roe_ttm": 0.1245,
    "shares_outstanding": 59840000.0,
    "pcnt_held_by_insiders": 0.0089,
    "pcnt_held_by_institutions": 0.9570000000000001,
    "pcnt_short_of_float": 0.11320000000000001,
    "operating_cash_flow_ttm": 240840000.0,
    "levered_cash_flow_ttm": 181980000.0,
    "book_value_per_share_mrq": 18.34,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Steris Corp."
  },
  "STEM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.411,
    "ebitda": -33159999.999999996,
    "eps_estimate_current_year": -0.39,
    "eps_estimate_next_quarter": -0.09,
    "fifty_day_moving_average": 0.464,
    "fifty_two_week_high": 1.39,
    "fifty_two_week_low": 0.31,
    "percent_change_from_200_day_moving_average": -0.28157499999999996,
    "percent_change_from_50_day_moving_average": 0.016810000000000002,
    "shares_owned": "N/A",
    "short_ratio": 4.05,
    "two_hundred_day_moving_average": 0.6567,
    "volume": 525383.0,
    "market_cap": 51200000.0,
    "price_to_sales_ttm": 52.43,
    "price_to_book_mrq": 3.48,
    "roa_ttm": -0.657,
    "roe_ttm": -4.8031,
    "shares_outstanding": 108520000.0,
    "pcnt_held_by_insiders": 0.2377,
    "pcnt_held_by_institutions": 0.09,
    "pcnt_short_of_float": 0.0256,
    "operating_cash_flow_ttm": -29560000.0,
    "levered_cash_flow_ttm": -16440000.000000002,
    "book_value_per_share_mrq": 0.14,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "StemCells Inc."
  },
  "STML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.11,
    "ebitda": -31690000.0,
    "eps_estimate_current_year": -2.22,
    "eps_estimate_next_quarter": -0.58,
    "fifty_day_moving_average": 9.72,
    "fifty_two_week_high": 18.94,
    "fifty_two_week_low": 8.31,
    "percent_change_from_200_day_moving_average": -0.25730000000000003,
    "percent_change_from_50_day_moving_average": -0.0322,
    "shares_owned": "N/A",
    "short_ratio": 5.97,
    "two_hundred_day_moving_average": 12.67,
    "volume": 87455.0,
    "market_cap": 169140000.0,
    "price_to_sales_ttm": 422.03,
    "price_to_book_mrq": 1.75,
    "roa_ttm": -0.21760000000000002,
    "roe_ttm": -0.369,
    "shares_outstanding": 17970000.0,
    "pcnt_held_by_insiders": 0.1938,
    "pcnt_held_by_institutions": 0.6629999999999999,
    "pcnt_short_of_float": 0.0351,
    "operating_cash_flow_ttm": -24810000.0,
    "levered_cash_flow_ttm": -13550000.0,
    "book_value_per_share_mrq": 5.98,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Stemline Therapeutics, Inc."
  },
  "STXS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.18,
    "ebitda": -3390000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 1.04,
    "fifty_two_week_high": 2.97,
    "fifty_two_week_low": 0.65,
    "percent_change_from_200_day_moving_average": -0.3739,
    "percent_change_from_50_day_moving_average": -0.0512,
    "shares_owned": "N/A",
    "short_ratio": 0.8,
    "two_hundred_day_moving_average": 1.58,
    "volume": 156797.0,
    "market_cap": 20860000.0,
    "price_to_sales_ttm": 0.6,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.1059,
    "roe_ttm": "N/A",
    "shares_outstanding": 21070000.0,
    "pcnt_held_by_insiders": 0.1576,
    "pcnt_held_by_institutions": 0.17300000000000001,
    "pcnt_short_of_float": 0.027999999999999997,
    "operating_cash_flow_ttm": -7840000.0,
    "levered_cash_flow_ttm": -9090000.0,
    "book_value_per_share_mrq": -0.75,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Stereotaxis Inc."
  },
  "SUPN": {
    "p_e_ratio": 28.08,
    "peg_ratio": 2.17,
    "earnings_per_share": 0.59,
    "ebitda": 41300000.0,
    "eps_estimate_current_year": 0.12,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 18.48,
    "fifty_two_week_high": 23.3,
    "fifty_two_week_low": 7.31,
    "percent_change_from_200_day_moving_average": 0.042300000000000004,
    "percent_change_from_50_day_moving_average": -0.1033,
    "shares_owned": "N/A",
    "short_ratio": 4.54,
    "two_hundred_day_moving_average": 15.9,
    "volume": 883942.0,
    "market_cap": 802760000.0,
    "price_to_sales_ttm": 6.02,
    "price_to_book_mrq": 8.62,
    "roa_ttm": 0.2034,
    "roe_ttm": 0.5177,
    "shares_outstanding": 48450000.0,
    "pcnt_held_by_insiders": 0.1653,
    "pcnt_held_by_institutions": 0.767,
    "pcnt_short_of_float": 0.11320000000000001,
    "operating_cash_flow_ttm": 48950000.0,
    "levered_cash_flow_ttm": 34100000.0,
    "book_value_per_share_mrq": 2.11,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Supernus Pharmaceuticals, Inc."
  },
  "SURG": {
    "p_e_ratio": 38.65,
    "peg_ratio": 2.58,
    "earnings_per_share": 0.17,
    "ebitda": 10110000.0,
    "eps_estimate_current_year": 0.17,
    "eps_estimate_next_quarter": 0.06,
    "fifty_day_moving_average": 5.47,
    "fifty_two_week_high": 6.7,
    "fifty_two_week_low": 3.18,
    "percent_change_from_200_day_moving_average": 0.3118,
    "percent_change_from_50_day_moving_average": 0.2016,
    "shares_owned": "N/A",
    "short_ratio": 0.83,
    "two_hundred_day_moving_average": 5.01,
    "volume": 166941.0,
    "market_cap": 168150000.0,
    "price_to_sales_ttm": 2.32,
    "price_to_book_mrq": 2.5,
    "roa_ttm": 0.0521,
    "roe_ttm": 0.0674,
    "shares_outstanding": 25590000.0,
    "pcnt_held_by_insiders": 0.1039,
    "pcnt_held_by_institutions": 0.418,
    "pcnt_short_of_float": 0.0016,
    "operating_cash_flow_ttm": 11080000.0,
    "levered_cash_flow_ttm": 10570000.0,
    "book_value_per_share_mrq": 2.63,
    "next_earnings_announcement_date": [
      "2015-10-12",
      "2015-10-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Synergetics USA, Inc."
  },
  "SVA": {
    "p_e_ratio": 252.5,
    "peg_ratio": -8.62,
    "earnings_per_share": 0.02,
    "ebitda": 11700000.0,
    "eps_estimate_current_year": -0.05,
    "eps_estimate_next_quarter": -0.06,
    "fifty_day_moving_average": 5.36,
    "fifty_two_week_high": 6.0,
    "fifty_two_week_low": 4.51,
    "percent_change_from_200_day_moving_average": -0.0395,
    "percent_change_from_50_day_moving_average": -0.057699999999999994,
    "shares_owned": "N/A",
    "short_ratio": 8.47,
    "two_hundred_day_moving_average": 5.26,
    "volume": 130669.0,
    "market_cap": 281840000.0,
    "price_to_sales_ttm": 4.38,
    "price_to_book_mrq": 2.24,
    "roa_ttm": 0.0129,
    "roe_ttm": 0.0202,
    "shares_outstanding": 55810000.0,
    "pcnt_held_by_insiders": 0.099,
    "pcnt_held_by_institutions": 0.267,
    "pcnt_short_of_float": 0.0273,
    "operating_cash_flow_ttm": -5010000.0,
    "levered_cash_flow_ttm": -11950000.0,
    "book_value_per_share_mrq": 2.28,
    "next_earnings_announcement_date": [
      "2015-11-13",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Sinovac Biotech Ltd."
  },
  "SYN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.54,
    "ebitda": -29920000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.58,
    "fifty_two_week_high": 4.32,
    "fifty_two_week_low": 1.34,
    "percent_change_from_200_day_moving_average": 0.14529999999999998,
    "percent_change_from_50_day_moving_average": 0.1378,
    "shares_owned": "N/A",
    "short_ratio": 3.1,
    "two_hundred_day_moving_average": 2.56,
    "volume": 1673159.0,
    "market_cap": 259350000.00000003,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": "N/A",
    "roa_ttm": -1.7721,
    "roe_ttm": "N/A",
    "shares_outstanding": 88520000.0,
    "pcnt_held_by_insiders": 0.0379,
    "pcnt_held_by_institutions": 0.354,
    "pcnt_short_of_float": 0.09179999999999999,
    "operating_cash_flow_ttm": -22020000.0,
    "levered_cash_flow_ttm": 2600000.0,
    "book_value_per_share_mrq": -0.19,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Synthetic Biologics Inc."
  },
  "TARO": {
    "p_e_ratio": 11.96,
    "peg_ratio": 0.81,
    "earnings_per_share": 12.64,
    "ebitda": 625560000.0,
    "eps_estimate_current_year": 11.92,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 139.06,
    "fifty_two_week_high": 173.0,
    "fifty_two_week_low": 124.35,
    "percent_change_from_200_day_moving_average": 0.0663,
    "percent_change_from_50_day_moving_average": 0.0874,
    "shares_owned": "N/A",
    "short_ratio": 0.24,
    "two_hundred_day_moving_average": 141.81,
    "volume": 113675.0,
    "market_cap": 6480000000.0,
    "price_to_sales_ttm": 6.96,
    "price_to_book_mrq": 4.33,
    "roa_ttm": 0.24309999999999998,
    "roe_ttm": 0.4152,
    "shares_outstanding": 42830000.0,
    "pcnt_held_by_insiders": 0.6887000000000001,
    "pcnt_held_by_institutions": 0.12300000000000001,
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": 439320000.0,
    "levered_cash_flow_ttm": 253700000.0,
    "book_value_per_share_mrq": 35.59,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Taro Pharmaceutical Industries Ltd."
  },
  "TBPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.26,
    "earnings_per_share": -6.43,
    "ebitda": -196420000.0,
    "eps_estimate_current_year": -5.47,
    "eps_estimate_next_quarter": -1.35,
    "fifty_day_moving_average": 13.22,
    "fifty_two_week_high": 24.26,
    "fifty_two_week_low": 11.36,
    "percent_change_from_200_day_moving_average": -0.15289999999999998,
    "percent_change_from_50_day_moving_average": -0.0596,
    "shares_owned": "N/A",
    "short_ratio": 15.41,
    "two_hundred_day_moving_average": 14.67,
    "volume": 284014.0,
    "market_cap": 421860000.0,
    "price_to_sales_ttm": 12.92,
    "price_to_book_mrq": 1.77,
    "roa_ttm": -0.3452,
    "roe_ttm": -0.6503,
    "shares_outstanding": 33940000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1732,
    "operating_cash_flow_ttm": -182040000.0,
    "levered_cash_flow_ttm": -101720000.0,
    "book_value_per_share_mrq": 7.59,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-10"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Biopharma, Inc."
  },
  "TBRA": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -10.65,
    "ebitda": -26770000.0,
    "eps_estimate_current_year": -15.03,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 13.07,
    "fifty_two_week_high": 24.31,
    "fifty_two_week_low": 7.2,
    "percent_change_from_200_day_moving_average": -0.1358,
    "percent_change_from_50_day_moving_average": -0.0604,
    "shares_owned": "N/A",
    "short_ratio": 1.92,
    "two_hundred_day_moving_average": 14.21,
    "volume": 28020.0,
    "market_cap": 214160000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.98,
    "roa_ttm": -0.31329999999999997,
    "roe_ttm": -2.2641,
    "shares_outstanding": 17440000.0,
    "pcnt_held_by_insiders": 0.6657,
    "pcnt_held_by_institutions": 0.175,
    "pcnt_short_of_float": 0.0242,
    "operating_cash_flow_ttm": -29580000.0,
    "levered_cash_flow_ttm": -21380000.0,
    "book_value_per_share_mrq": 3.3,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tobira Therapeutics, Inc."
  },
  "TCON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.98,
    "ebitda": -10320000.0,
    "eps_estimate_current_year": -1.75,
    "eps_estimate_next_quarter": -0.62,
    "fifty_day_moving_average": 11.47,
    "fifty_two_week_high": 21.0,
    "fifty_two_week_low": 9.02,
    "percent_change_from_200_day_moving_average": -0.1352,
    "percent_change_from_50_day_moving_average": -0.0843,
    "shares_owned": "N/A",
    "short_ratio": 2.63,
    "two_hundred_day_moving_average": 12.14,
    "volume": 266881.0,
    "market_cap": 127090000.0,
    "price_to_sales_ttm": 19.49,
    "price_to_book_mrq": 3.12,
    "roa_ttm": -0.16260000000000002,
    "roe_ttm": -0.5279,
    "shares_outstanding": 12100000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0226,
    "operating_cash_flow_ttm": -12820000.0,
    "levered_cash_flow_ttm": -5450000.0,
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TRACON Pharmaceuticals, Inc."
  },
  "TEAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -0.86,
    "ebitda": -25740000.0,
    "eps_estimate_current_year": -0.96,
    "eps_estimate_next_quarter": -0.24,
    "fifty_day_moving_average": 2.44,
    "fifty_two_week_high": 3.71,
    "fifty_two_week_low": 1.5,
    "percent_change_from_200_day_moving_average": -0.2089,
    "percent_change_from_50_day_moving_average": -0.22920000000000001,
    "shares_owned": "N/A",
    "short_ratio": 12.15,
    "two_hundred_day_moving_average": 2.38,
    "volume": 170560.0,
    "market_cap": 63380000.0,
    "price_to_sales_ttm": 2.89,
    "price_to_book_mrq": 6.12,
    "roa_ttm": -0.5091,
    "roe_ttm": -1.272,
    "shares_outstanding": 33710000.0,
    "pcnt_held_by_insiders": 0.1377,
    "pcnt_held_by_institutions": 0.695,
    "pcnt_short_of_float": 0.08039999999999999,
    "operating_cash_flow_ttm": -22730000.0,
    "levered_cash_flow_ttm": -14050000.0,
    "book_value_per_share_mrq": 0.31,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TearLab Corporation"
  },
  "TECH": {
    "p_e_ratio": 31.43,
    "peg_ratio": 2.16,
    "earnings_per_share": 2.89,
    "ebitda": 186230000.0,
    "eps_estimate_current_year": 3.56,
    "eps_estimate_next_quarter": 0.85,
    "fifty_day_moving_average": 98.07,
    "fifty_two_week_high": 114.56,
    "fifty_two_week_low": 86.01,
    "percent_change_from_200_day_moving_average": -0.0929,
    "percent_change_from_50_day_moving_average": -0.0739,
    "shares_owned": "N/A",
    "short_ratio": 7.21,
    "two_hundred_day_moving_average": 100.13,
    "volume": 231355.0,
    "market_cap": 3380000000.0,
    "price_to_sales_ttm": 7.71,
    "price_to_book_mrq": 4.11,
    "roa_ttm": 0.10289999999999999,
    "roe_ttm": 0.13119999999999998,
    "shares_outstanding": 37180000.0,
    "pcnt_held_by_insiders": 0.0053,
    "pcnt_held_by_institutions": 0.961,
    "pcnt_short_of_float": 0.0487,
    "operating_cash_flow_ttm": 139360000.0,
    "levered_cash_flow_ttm": 105380000.0,
    "book_value_per_share_mrq": 22.8,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Bio-Techne Corp."
  },
  "TENX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -14120000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 3.52,
    "fifty_two_week_high": 4.76,
    "fifty_two_week_low": 2.88,
    "percent_change_from_200_day_moving_average": -0.0279,
    "percent_change_from_50_day_moving_average": -0.0256,
    "shares_owned": "N/A",
    "short_ratio": 28.49,
    "two_hundred_day_moving_average": 3.53,
    "volume": 17578.0,
    "market_cap": 96450000.0,
    "price_to_sales_ttm": 2031.08,
    "price_to_book_mrq": 1.49,
    "roa_ttm": -0.1047,
    "roe_ttm": -0.2007,
    "shares_outstanding": 28120000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0394,
    "operating_cash_flow_ttm": -11610000.0,
    "levered_cash_flow_ttm": -6430000.0,
    "book_value_per_share_mrq": 2.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tenax Therapeutics, Inc."
  },
  "TFX": {
    "p_e_ratio": 32.55,
    "peg_ratio": 1.91,
    "earnings_per_share": 3.99,
    "ebitda": 409950000.0,
    "eps_estimate_current_year": 6.22,
    "eps_estimate_next_quarter": 1.94,
    "fifty_day_moving_average": 132.49,
    "fifty_two_week_high": 140.5,
    "fifty_two_week_low": 101.95,
    "percent_change_from_200_day_moving_average": 0.0046,
    "percent_change_from_50_day_moving_average": -0.019299999999999998,
    "shares_owned": "N/A",
    "short_ratio": 12.08,
    "two_hundred_day_moving_average": 129.33,
    "volume": 415609.0,
    "market_cap": 5400000000.0,
    "price_to_sales_ttm": 3.02,
    "price_to_book_mrq": 2.84,
    "roa_ttm": 0.0479,
    "roe_ttm": 0.0983,
    "shares_outstanding": 41600000.0,
    "pcnt_held_by_insiders": 0.0031,
    "pcnt_held_by_institutions": 0.924,
    "pcnt_short_of_float": 0.0643,
    "operating_cash_flow_ttm": 276160000.0,
    "levered_cash_flow_ttm": 196350000.0,
    "book_value_per_share_mrq": 46.11,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Teleflex Incorporated"
  },
  "TGTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.7,
    "ebitda": -67870000.0,
    "eps_estimate_current_year": -1.44,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 13.23,
    "fifty_two_week_high": 20.0,
    "fifty_two_week_low": 9.16,
    "percent_change_from_200_day_moving_average": -0.2963,
    "percent_change_from_50_day_moving_average": -0.1678,
    "shares_owned": "N/A",
    "short_ratio": 11.69,
    "two_hundred_day_moving_average": 15.65,
    "volume": 853498.0,
    "market_cap": 578550000.0,
    "price_to_sales_ttm": 4040.79,
    "price_to_book_mrq": 5.45,
    "roa_ttm": -0.47159999999999996,
    "roe_ttm": -0.8231999999999999,
    "shares_outstanding": 52550000.0,
    "pcnt_held_by_insiders": 0.43799999999999994,
    "pcnt_held_by_institutions": 0.263,
    "pcnt_short_of_float": 0.2097,
    "operating_cash_flow_ttm": -44290000.0,
    "levered_cash_flow_ttm": -19120000.0,
    "book_value_per_share_mrq": 2.19,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TG Therapeutics, Inc."
  },
  "THC": {
    "p_e_ratio": 72.76,
    "peg_ratio": 0.89,
    "earnings_per_share": 0.56,
    "ebitda": 2190000000.0,
    "eps_estimate_current_year": 2.17,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 48.2,
    "fifty_two_week_high": 61.01,
    "fifty_two_week_low": 40.14,
    "percent_change_from_200_day_moving_average": -0.21239999999999998,
    "percent_change_from_50_day_moving_average": -0.1591,
    "shares_owned": "N/A",
    "short_ratio": 3.92,
    "two_hundred_day_moving_average": 51.46,
    "volume": 2576443.0,
    "market_cap": 4040000000.0,
    "price_to_sales_ttm": 0.24,
    "price_to_book_mrq": 5.25,
    "roa_ttm": 0.0421,
    "roe_ttm": 0.0787,
    "shares_outstanding": 99560000.0,
    "pcnt_held_by_insiders": 0.012199999999999999,
    "pcnt_held_by_institutions": 1.025,
    "pcnt_short_of_float": 0.0902,
    "operating_cash_flow_ttm": 793000000.0,
    "levered_cash_flow_ttm": -498750000.0,
    "book_value_per_share_mrq": 8.09,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "Tenet Healthcare Corp."
  },
  "THLD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.53,
    "ebitda": -32650000.0,
    "eps_estimate_current_year": -0.53,
    "eps_estimate_next_quarter": -0.11,
    "fifty_day_moving_average": 4.42,
    "fifty_two_week_high": 5.28,
    "fifty_two_week_low": 2.58,
    "percent_change_from_200_day_moving_average": 0.045,
    "percent_change_from_50_day_moving_average": -0.0115,
    "shares_owned": "N/A",
    "short_ratio": 7.54,
    "two_hundred_day_moving_average": 4.18,
    "volume": 1261236.0,
    "market_cap": 311730000.0,
    "price_to_sales_ttm": 22.77,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.2669,
    "roe_ttm": "N/A",
    "shares_outstanding": 71330000.0,
    "pcnt_held_by_insiders": 0.1736,
    "pcnt_held_by_institutions": 0.508,
    "pcnt_short_of_float": 0.08289999999999999,
    "operating_cash_flow_ttm": -40990000.0,
    "levered_cash_flow_ttm": -13850000.0,
    "book_value_per_share_mrq": -0.37,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Threshold Pharmaceuticals Inc."
  },
  "THOR": {
    "p_e_ratio": 89.63,
    "peg_ratio": 4.39,
    "earnings_per_share": 0.7,
    "ebitda": 70480000.0,
    "eps_estimate_current_year": 1.34,
    "eps_estimate_next_quarter": 0.37,
    "fifty_day_moving_average": 62.96,
    "fifty_two_week_high": 63.51,
    "fifty_two_week_low": 25.04,
    "percent_change_from_200_day_moving_average": 0.259,
    "percent_change_from_50_day_moving_average": 0.0023,
    "shares_owned": "N/A",
    "short_ratio": 1.23,
    "two_hundred_day_moving_average": 50.12,
    "volume": 717514.0,
    "market_cap": 3460000000.0,
    "price_to_sales_ttm": 7.16,
    "price_to_book_mrq": 5.09,
    "roa_ttm": 0.043,
    "roe_ttm": 0.0571,
    "shares_outstanding": 54790000.0,
    "pcnt_held_by_insiders": 0.005600000000000001,
    "pcnt_held_by_institutions": 0.903,
    "pcnt_short_of_float": 0.0424,
    "operating_cash_flow_ttm": 105660000.0,
    "levered_cash_flow_ttm": 80510000.0,
    "book_value_per_share_mrq": 12.43,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Thoratec Corp."
  },
  "THRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.36,
    "earnings_per_share": -0.49,
    "ebitda": -4210000.0,
    "eps_estimate_current_year": -0.14,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 12.49,
    "fifty_two_week_high": 21.16,
    "fifty_two_week_low": 7.53,
    "percent_change_from_200_day_moving_average": -0.5136,
    "percent_change_from_50_day_moving_average": -0.3851,
    "shares_owned": "N/A",
    "short_ratio": 46.24,
    "two_hundred_day_moving_average": 15.79,
    "volume": 1936191.0,
    "market_cap": 899550000.0,
    "price_to_sales_ttm": 38.63,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.0042,
    "roe_ttm": "N/A",
    "shares_outstanding": 117130000.0,
    "pcnt_held_by_insiders": 0.3126,
    "pcnt_held_by_institutions": 0.8079999999999999,
    "pcnt_short_of_float": 0.8108,
    "operating_cash_flow_ttm": -25120000.0,
    "levered_cash_flow_ttm": -76030000.0,
    "book_value_per_share_mrq": -2.51,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Theravance Inc."
  },
  "TKAI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.0,
    "ebitda": -34940000.0,
    "eps_estimate_current_year": -2.03,
    "eps_estimate_next_quarter": -0.54,
    "fifty_day_moving_average": 12.43,
    "fifty_two_week_high": 17.87,
    "fifty_two_week_low": 9.67,
    "percent_change_from_200_day_moving_average": -0.0765,
    "percent_change_from_50_day_moving_average": -0.0718,
    "shares_owned": "N/A",
    "short_ratio": 28.39,
    "two_hundred_day_moving_average": 12.5,
    "volume": 309806.0,
    "market_cap": 260200000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.49,
    "roa_ttm": -0.3944,
    "roe_ttm": -0.6794,
    "shares_outstanding": 22550000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.3135,
    "operating_cash_flow_ttm": -33030000.0,
    "levered_cash_flow_ttm": -21030000.0,
    "book_value_per_share_mrq": 3.68,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tokai Pharmaceuticals, Inc."
  },
  "TLOG": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.03,
    "ebitda": -37320000.0,
    "eps_estimate_current_year": -1.98,
    "eps_estimate_next_quarter": -0.49,
    "fifty_day_moving_average": 2.28,
    "fifty_two_week_high": 6.3,
    "fifty_two_week_low": 0.72,
    "percent_change_from_200_day_moving_average": -0.3222,
    "percent_change_from_50_day_moving_average": -0.1235,
    "shares_owned": "N/A",
    "short_ratio": 12.12,
    "two_hundred_day_moving_average": 2.95,
    "volume": 172039.0,
    "market_cap": 46670000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.31,
    "roa_ttm": -0.20620000000000002,
    "roe_ttm": -1.3722,
    "shares_outstanding": 23330000.0,
    "pcnt_held_by_insiders": 0.4286,
    "pcnt_held_by_institutions": 0.29,
    "pcnt_short_of_float": 0.0575,
    "operating_cash_flow_ttm": -37170000.0,
    "levered_cash_flow_ttm": -20490000.0,
    "book_value_per_share_mrq": 0.61,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "TetraLogic Pharmaceuticals Corporation"
  },
  "TNDM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.27,
    "earnings_per_share": -3.09,
    "ebitda": -70700000.0,
    "eps_estimate_current_year": -2.83,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 11.91,
    "fifty_two_week_high": 17.98,
    "fifty_two_week_low": 10.04,
    "percent_change_from_200_day_moving_average": -0.165,
    "percent_change_from_50_day_moving_average": -0.1424,
    "shares_owned": "N/A",
    "short_ratio": 18.92,
    "two_hundred_day_moving_average": 12.23,
    "volume": 324313.0,
    "market_cap": 306450000.0,
    "price_to_sales_ttm": 5.7,
    "price_to_book_mrq": 3.86,
    "roa_ttm": -0.3482,
    "roe_ttm": -0.9236,
    "shares_outstanding": 30010000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.22519999999999998,
    "operating_cash_flow_ttm": -61300000.0,
    "levered_cash_flow_ttm": -34830000.0,
    "book_value_per_share_mrq": 2.92,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Tandem Diabetes Care, Inc."
  },
  "TNXP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.96,
    "ebitda": -37850000.0,
    "eps_estimate_current_year": -2.68,
    "eps_estimate_next_quarter": -0.63,
    "fifty_day_moving_average": 7.02,
    "fifty_two_week_high": 10.72,
    "fifty_two_week_low": 5.33,
    "percent_change_from_200_day_moving_average": -0.1553,
    "percent_change_from_50_day_moving_average": -0.1184,
    "shares_owned": "N/A",
    "short_ratio": 4.43,
    "two_hundred_day_moving_average": 7.33,
    "volume": 111036.0,
    "market_cap": 116370000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.26,
    "roa_ttm": -0.4938,
    "roe_ttm": -0.8515,
    "shares_outstanding": 18800000.0,
    "pcnt_held_by_insiders": 0.129,
    "pcnt_held_by_institutions": 0.294,
    "pcnt_short_of_float": 0.056600000000000004,
    "operating_cash_flow_ttm": -31370000.0,
    "levered_cash_flow_ttm": -17650000.0,
    "book_value_per_share_mrq": 2.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Tonix Pharmaceuticals Holding Corp"
  },
  "TPI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.14,
    "ebitda": 3120000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 0.27,
    "fifty_two_week_high": 0.78,
    "fifty_two_week_low": 0.21,
    "percent_change_from_200_day_moving_average": -0.41259999999999997,
    "percent_change_from_50_day_moving_average": -0.1418,
    "shares_owned": "N/A",
    "short_ratio": 0.71,
    "two_hundred_day_moving_average": 0.39,
    "volume": 9200.0,
    "market_cap": 6770000.0,
    "price_to_sales_ttm": 0.25,
    "price_to_book_mrq": 0.08,
    "roa_ttm": -0.0124,
    "roe_ttm": -0.041100000000000005,
    "shares_outstanding": 29430000.0,
    "pcnt_held_by_insiders": 0.2967,
    "pcnt_held_by_institutions": 0.106,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -1250000.0,
    "levered_cash_flow_ttm": -10240000.0,
    "book_value_per_share_mrq": 3.25,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "Tianyin Pharmaceutical Co., Inc."
  },
  "TRIB": {
    "p_e_ratio": 20.71,
    "peg_ratio": 1.44,
    "earnings_per_share": 0.6,
    "ebitda": 18660000.0,
    "eps_estimate_current_year": 0.48,
    "eps_estimate_next_quarter": 0.11,
    "fifty_day_moving_average": 15.04,
    "fifty_two_week_high": 20.24,
    "fifty_two_week_low": 12.39,
    "percent_change_from_200_day_moving_average": -0.2687,
    "percent_change_from_50_day_moving_average": -0.171,
    "shares_owned": "N/A",
    "short_ratio": 21.56,
    "two_hundred_day_moving_average": 17.05,
    "volume": 157245.0,
    "market_cap": 289240000.0,
    "price_to_sales_ttm": 2.92,
    "price_to_book_mrq": 1.46,
    "roa_ttm": 0.029900000000000003,
    "roe_ttm": 0.0757,
    "shares_outstanding": 23200000.0,
    "pcnt_held_by_insiders": 0.050300000000000004,
    "pcnt_held_by_institutions": 0.58,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": 16810000.0,
    "levered_cash_flow_ttm": -17650000.0,
    "book_value_per_share_mrq": 8.84,
    "next_earnings_announcement_date": [
      "2015-10-21",
      "2015-10-26"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Trinity Biotech plc"
  },
  "TRIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.08,
    "earnings_per_share": -2.9,
    "ebitda": -50500000.0,
    "eps_estimate_current_year": -2.88,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 5.08,
    "fifty_two_week_high": 16.62,
    "fifty_two_week_low": 3.98,
    "percent_change_from_200_day_moving_average": -0.15990000000000001,
    "percent_change_from_50_day_moving_average": 0.1075,
    "shares_owned": "N/A",
    "short_ratio": 12.69,
    "two_hundred_day_moving_average": 6.7,
    "volume": 18170.0,
    "market_cap": 115530000.0,
    "price_to_sales_ttm": 3.1,
    "price_to_book_mrq": 8.44,
    "roa_ttm": -0.31,
    "roe_ttm": -1.4978,
    "shares_outstanding": 20520000.0,
    "pcnt_held_by_insiders": 0.3243,
    "pcnt_held_by_institutions": 0.40399999999999997,
    "pcnt_short_of_float": 0.0443,
    "operating_cash_flow_ttm": -53750000.0,
    "levered_cash_flow_ttm": -33070000.0,
    "book_value_per_share_mrq": 0.62,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TriVascular Technologies, Inc."
  },
  "TRNX": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.81,
    "earnings_per_share": -0.57,
    "ebitda": 27200000.0,
    "eps_estimate_current_year": -0.44,
    "eps_estimate_next_quarter": -0.07,
    "fifty_day_moving_average": 23.46,
    "fifty_two_week_high": 28.53,
    "fifty_two_week_low": 21.43,
    "percent_change_from_200_day_moving_average": -0.0818,
    "percent_change_from_50_day_moving_average": -0.0121,
    "shares_owned": "N/A",
    "short_ratio": 12.84,
    "two_hundred_day_moving_average": 25.24,
    "volume": 284265.0,
    "market_cap": 1140000000.0,
    "price_to_sales_ttm": 3.46,
    "price_to_book_mrq": 2.62,
    "roa_ttm": -0.0128,
    "roe_ttm": -0.0588,
    "shares_outstanding": 49270000.0,
    "pcnt_held_by_insiders": 0.04769999999999999,
    "pcnt_held_by_institutions": 0.935,
    "pcnt_short_of_float": 0.0575,
    "operating_cash_flow_ttm": 2510000.0,
    "levered_cash_flow_ttm": 6650000.0,
    "book_value_per_share_mrq": 9.13,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Tornier N.V."
  },
  "TROV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.32,
    "ebitda": -19650000.0,
    "eps_estimate_current_year": -0.65,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 6.18,
    "fifty_two_week_high": 13.58,
    "fifty_two_week_low": 4.0,
    "percent_change_from_200_day_moving_average": -0.2943,
    "percent_change_from_50_day_moving_average": -0.038599999999999995,
    "shares_owned": "N/A",
    "short_ratio": 4.57,
    "two_hundred_day_moving_average": 8.42,
    "volume": 582304.0,
    "market_cap": 175960000.0,
    "price_to_sales_ttm": 671.3,
    "price_to_book_mrq": 9.02,
    "roa_ttm": -0.3119,
    "roe_ttm": -1.5467,
    "shares_outstanding": 29620000.0,
    "pcnt_held_by_insiders": 0.1167,
    "pcnt_held_by_institutions": 0.22,
    "pcnt_short_of_float": 0.1649,
    "operating_cash_flow_ttm": -17450000.0,
    "levered_cash_flow_ttm": -10040000.0,
    "book_value_per_share_mrq": 0.73,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "TrovaGene, Inc."
  },
  "TRVN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.57,
    "ebitda": -53160000.0,
    "eps_estimate_current_year": -1.33,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 8.84,
    "fifty_two_week_high": 13.57,
    "fifty_two_week_low": 3.8,
    "percent_change_from_200_day_moving_average": 0.5713,
    "percent_change_from_50_day_moving_average": 0.2829,
    "shares_owned": "N/A",
    "short_ratio": 3.25,
    "two_hundred_day_moving_average": 7.22,
    "volume": 1276082.0,
    "market_cap": 550670000.0,
    "price_to_sales_ttm": 214.45,
    "price_to_book_mrq": 5.65,
    "roa_ttm": -0.34619999999999995,
    "roe_ttm": -0.6204,
    "shares_outstanding": 48560000.0,
    "pcnt_held_by_insiders": 0.5299,
    "pcnt_held_by_institutions": 0.429,
    "pcnt_short_of_float": 0.054299999999999994,
    "operating_cash_flow_ttm": -40280000.0,
    "levered_cash_flow_ttm": -21420000.0,
    "book_value_per_share_mrq": 2.2,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Trevena, Inc."
  },
  "TRXC": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.61,
    "ebitda": -36490000.0,
    "eps_estimate_current_year": -0.52,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.68,
    "fifty_two_week_high": 4.87,
    "fifty_two_week_low": 1.4,
    "percent_change_from_200_day_moving_average": -0.19920000000000002,
    "percent_change_from_50_day_moving_average": -0.0526,
    "shares_owned": "N/A",
    "short_ratio": 5.92,
    "two_hundred_day_moving_average": 3.17,
    "volume": 451553.0,
    "market_cap": 254260000.0,
    "price_to_sales_ttm": 1227.17,
    "price_to_book_mrq": 1.49,
    "roa_ttm": -0.14679999999999999,
    "roe_ttm": -0.2626,
    "shares_outstanding": 100100000.0,
    "pcnt_held_by_insiders": 0.5964,
    "pcnt_held_by_institutions": 0.145,
    "pcnt_short_of_float": 0.1208,
    "operating_cash_flow_ttm": -35990000.0,
    "levered_cash_flow_ttm": -23200000.0,
    "book_value_per_share_mrq": 1.9,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "TransEnterix, Inc."
  },
  "TSRO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 2.54,
    "earnings_per_share": -5.17,
    "ebitda": -173480000.0,
    "eps_estimate_current_year": -6.01,
    "eps_estimate_next_quarter": -1.67,
    "fifty_day_moving_average": 52.07,
    "fifty_two_week_high": 66.95,
    "fifty_two_week_low": 23.0,
    "percent_change_from_200_day_moving_average": -0.1304,
    "percent_change_from_50_day_moving_average": -0.0547,
    "shares_owned": "N/A",
    "short_ratio": 14.84,
    "two_hundred_day_moving_average": 56.6,
    "volume": 734627.0,
    "market_cap": 1970000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 9.76,
    "roa_ttm": -0.41840000000000005,
    "roe_ttm": -1.1206,
    "shares_outstanding": 40030000.0,
    "pcnt_held_by_insiders": 0.1649,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.3346,
    "operating_cash_flow_ttm": -146830000.0,
    "levered_cash_flow_ttm": -90860000.0,
    "book_value_per_share_mrq": 5.19,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Tesaro, Inc."
  },
  "TTHI": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.06,
    "ebitda": -40720000.0,
    "eps_estimate_current_year": -1.47,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.11,
    "fifty_two_week_high": 9.3,
    "fifty_two_week_low": 1.77,
    "percent_change_from_200_day_moving_average": -0.5836,
    "percent_change_from_50_day_moving_average": -0.0395,
    "shares_owned": "N/A",
    "short_ratio": 2.06,
    "two_hundred_day_moving_average": 4.88,
    "volume": 164335.0,
    "market_cap": 78720000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.91,
    "roa_ttm": -0.5770000000000001,
    "roe_ttm": -1.0715000000000001,
    "shares_outstanding": 38780000.0,
    "pcnt_held_by_insiders": 0.419,
    "pcnt_held_by_institutions": 0.405,
    "pcnt_short_of_float": 0.0148,
    "operating_cash_flow_ttm": -36000000.0,
    "levered_cash_flow_ttm": -21270000.0,
    "book_value_per_share_mrq": 0.71,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Transition Therapeutics Inc."
  },
  "TTOO": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.19,
    "ebitda": -36310000.0,
    "eps_estimate_current_year": -2.26,
    "eps_estimate_next_quarter": -0.6,
    "fifty_day_moving_average": 12.1,
    "fifty_two_week_high": 24.04,
    "fifty_two_week_low": 10.0,
    "percent_change_from_200_day_moving_average": -0.3428,
    "percent_change_from_50_day_moving_average": -0.1578,
    "shares_owned": "N/A",
    "short_ratio": 6.31,
    "two_hundred_day_moving_average": 15.51,
    "volume": 154261.0,
    "market_cap": 207250000.0,
    "price_to_sales_ttm": 256.15,
    "price_to_book_mrq": 6.56,
    "roa_ttm": -0.5566,
    "roe_ttm": -1.7265000000000001,
    "shares_outstanding": 20340000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0688,
    "operating_cash_flow_ttm": -33380000.000000004,
    "levered_cash_flow_ttm": -25180000.0,
    "book_value_per_share_mrq": 1.68,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "T2 Biosystems, Inc."
  },
  "TTPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.01,
    "earnings_per_share": -2.65,
    "ebitda": -81040000.0,
    "eps_estimate_current_year": -2.64,
    "eps_estimate_next_quarter": -0.59,
    "fifty_day_moving_average": 30.49,
    "fifty_two_week_high": 52.9,
    "fifty_two_week_low": 8.31,
    "percent_change_from_200_day_moving_average": -0.772,
    "percent_change_from_50_day_moving_average": -0.7061,
    "shares_owned": "N/A",
    "short_ratio": 5.87,
    "two_hundred_day_moving_average": 39.29,
    "volume": 1955469.0,
    "market_cap": 326330000.0,
    "price_to_sales_ttm": 30.04,
    "price_to_book_mrq": 1.5,
    "roa_ttm": -0.30879999999999996,
    "roe_ttm": -0.5596,
    "shares_outstanding": 36420000.0,
    "pcnt_held_by_insiders": 0.2796,
    "pcnt_held_by_institutions": 0.514,
    "pcnt_short_of_float": 0.1119,
    "operating_cash_flow_ttm": -72380000.0,
    "levered_cash_flow_ttm": -42330000.0,
    "book_value_per_share_mrq": 6.43,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Tetraphase Pharmaceuticals, Inc."
  },
  "TXMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.51,
    "ebitda": -82290000.0,
    "eps_estimate_current_year": -0.49,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 6.57,
    "fifty_two_week_high": 8.83,
    "fifty_two_week_low": 3.44,
    "percent_change_from_200_day_moving_average": -0.09230000000000001,
    "percent_change_from_50_day_moving_average": -0.037200000000000004,
    "shares_owned": "N/A",
    "short_ratio": 14.81,
    "two_hundred_day_moving_average": 6.97,
    "volume": 1458822.0,
    "market_cap": 1120000000.0,
    "price_to_sales_ttm": 71.43,
    "price_to_book_mrq": 19.64,
    "roa_ttm": -0.8569,
    "roe_ttm": -1.6371,
    "shares_outstanding": 177500000.0,
    "pcnt_held_by_insiders": 0.4401,
    "pcnt_held_by_institutions": 0.519,
    "pcnt_short_of_float": 0.2194,
    "operating_cash_flow_ttm": -70740000.0,
    "levered_cash_flow_ttm": -41350000.0,
    "book_value_per_share_mrq": 0.36,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "TherapeuticsMD, Inc."
  },
  "UAM": {
    "p_e_ratio": "N/A",
    "peg_ratio": 1.1,
    "earnings_per_share": -0.24,
    "ebitda": -7430000.0,
    "eps_estimate_current_year": 0.15,
    "eps_estimate_next_quarter": 0.04,
    "fifty_day_moving_average": 7.27,
    "fifty_two_week_high": 11.16,
    "fifty_two_week_low": 6.73,
    "percent_change_from_200_day_moving_average": -0.2336,
    "percent_change_from_50_day_moving_average": -0.0089,
    "shares_owned": "N/A",
    "short_ratio": 4.85,
    "two_hundred_day_moving_average": 9.41,
    "volume": 219485.0,
    "market_cap": 582260000.0,
    "price_to_sales_ttm": 0.31,
    "price_to_book_mrq": 0.98,
    "roa_ttm": -0.0058,
    "roe_ttm": -0.018600000000000002,
    "shares_outstanding": 80760000.0,
    "pcnt_held_by_insiders": 0.4576,
    "pcnt_held_by_institutions": 0.42200000000000004,
    "pcnt_short_of_float": 0.0276,
    "operating_cash_flow_ttm": -1590000.0,
    "levered_cash_flow_ttm": 47540000.0,
    "book_value_per_share_mrq": 7.53,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "Universal American Corp"
  },
  "UNIS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.8084,
    "ebitda": -75510000.0,
    "eps_estimate_current_year": -0.43,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 1.2486,
    "fifty_two_week_high": 4.9,
    "fifty_two_week_low": 0.9,
    "percent_change_from_200_day_moving_average": -0.631497,
    "percent_change_from_50_day_moving_average": -0.278214,
    "shares_owned": "N/A",
    "short_ratio": 19.19,
    "two_hundred_day_moving_average": 2.4456,
    "volume": 1219981.0,
    "market_cap": 109460000.0,
    "price_to_sales_ttm": 9.22,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.5716,
    "roe_ttm": "N/A",
    "shares_outstanding": 121460000.0,
    "pcnt_held_by_insiders": 0.0895,
    "pcnt_held_by_institutions": 0.47600000000000003,
    "pcnt_short_of_float": 0.2192,
    "operating_cash_flow_ttm": -55200000.0,
    "levered_cash_flow_ttm": -46990000.0,
    "book_value_per_share_mrq": -0.15,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Unilife Corporation"
  },
  "USMD": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.92,
    "ebitda": -2830000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 7.51,
    "fifty_two_week_high": 18.0,
    "fifty_two_week_low": 6.5,
    "percent_change_from_200_day_moving_average": -0.19899999999999998,
    "percent_change_from_50_day_moving_average": -0.0348,
    "shares_owned": "N/A",
    "short_ratio": 0.81,
    "two_hundred_day_moving_average": 9.05,
    "volume": 773.0,
    "market_cap": 75200000.0,
    "price_to_sales_ttm": 0.26,
    "price_to_book_mrq": 0.6,
    "roa_ttm": -0.026699999999999998,
    "roe_ttm": -0.1304,
    "shares_outstanding": 10370000.0,
    "pcnt_held_by_insiders": 0.8708,
    "pcnt_held_by_institutions": 0.004,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": 12910000.0,
    "levered_cash_flow_ttm": 535250.0,
    "book_value_per_share_mrq": 13.27,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Hospitals",
    "company_name": "USMD Holdings, Inc."
  },
  "USNA": {
    "p_e_ratio": 20.71,
    "peg_ratio": 1.96,
    "earnings_per_share": 6.56,
    "ebitda": 139480000.0,
    "eps_estimate_current_year": 7.18,
    "eps_estimate_next_quarter": 1.99,
    "fifty_day_moving_average": 147.2,
    "fifty_two_week_high": 176.88,
    "fifty_two_week_low": 71.03,
    "percent_change_from_200_day_moving_average": 0.038,
    "percent_change_from_50_day_moving_average": -0.077,
    "shares_owned": "N/A",
    "short_ratio": 5.13,
    "two_hundred_day_moving_average": 130.9,
    "volume": 101002.0,
    "market_cap": 1740000000.0,
    "price_to_sales_ttm": 2.06,
    "price_to_book_mrq": 6.32,
    "roa_ttm": 0.21359999999999998,
    "roe_ttm": 0.3189,
    "shares_outstanding": 12810000.0,
    "pcnt_held_by_insiders": 0.5437,
    "pcnt_held_by_institutions": 0.591,
    "pcnt_short_of_float": 0.1441,
    "operating_cash_flow_ttm": 120100000.0,
    "levered_cash_flow_ttm": 91060000.0,
    "book_value_per_share_mrq": 22.22,
    "next_earnings_announcement_date": "2015-11-03",
    "sector": "Healthcare",
    "industry": "Drug Related Products",
    "company_name": "USANA Health Sciences Inc."
  },
  "USPH": {
    "p_e_ratio": 26.7,
    "peg_ratio": 1.89,
    "earnings_per_share": 1.65,
    "ebitda": 52550000.0,
    "eps_estimate_current_year": 1.78,
    "eps_estimate_next_quarter": 0.47,
    "fifty_day_moving_average": 47.49,
    "fifty_two_week_high": 56.37,
    "fifty_two_week_low": 34.0,
    "percent_change_from_200_day_moving_average": -0.1124,
    "percent_change_from_50_day_moving_average": -0.0735,
    "shares_owned": "N/A",
    "short_ratio": 7.09,
    "two_hundred_day_moving_average": 49.57,
    "volume": 79158.0,
    "market_cap": 546530000.0,
    "price_to_sales_ttm": 1.8,
    "price_to_book_mrq": 3.64,
    "roa_ttm": 0.1104,
    "roe_ttm": 0.1673,
    "shares_outstanding": 12420000.0,
    "pcnt_held_by_insiders": 0.047599999999999996,
    "pcnt_held_by_institutions": 0.887,
    "pcnt_short_of_float": 0.039900000000000005,
    "operating_cash_flow_ttm": 43380000.0,
    "levered_cash_flow_ttm": 28310000.0,
    "book_value_per_share_mrq": 12.5,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Specialized Health Services",
    "company_name": "US Physical Therapy Inc."
  },
  "UTHR": {
    "p_e_ratio": 42.03,
    "peg_ratio": 1.08,
    "earnings_per_share": 3.27,
    "ebitda": 336970000.0,
    "eps_estimate_current_year": 6.97,
    "eps_estimate_next_quarter": 2.55,
    "fifty_day_moving_average": 155.31,
    "fifty_two_week_high": 190.29,
    "fifty_two_week_low": 118.47,
    "percent_change_from_200_day_moving_average": -0.1968,
    "percent_change_from_50_day_moving_average": -0.11539999999999999,
    "shares_owned": "N/A",
    "short_ratio": 11.65,
    "two_hundred_day_moving_average": 171.05,
    "volume": 698022.0,
    "market_cap": 6260000000.0,
    "price_to_sales_ttm": 4.76,
    "price_to_book_mrq": 6.2,
    "roa_ttm": 0.1027,
    "roe_ttm": 0.1565,
    "shares_outstanding": 45540000.0,
    "pcnt_held_by_insiders": 0.0127,
    "pcnt_held_by_institutions": 1.129,
    "pcnt_short_of_float": 0.1679,
    "operating_cash_flow_ttm": 449080000.0,
    "levered_cash_flow_ttm": 877230000.0,
    "book_value_per_share_mrq": 22.77,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Other",
    "company_name": "United Therapeutics Corporation"
  },
  "UTMD": {
    "p_e_ratio": 17.29,
    "peg_ratio": 0.0,
    "earnings_per_share": 3.03,
    "ebitda": 19450000.0,
    "eps_estimate_current_year": 2.81,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 52.67,
    "fifty_two_week_high": 63.98,
    "fifty_two_week_low": 47.33,
    "percent_change_from_200_day_moving_average": -0.0652,
    "percent_change_from_50_day_moving_average": -0.0072,
    "shares_owned": "N/A",
    "short_ratio": 12.2,
    "two_hundred_day_moving_average": 55.94,
    "volume": 7581.0,
    "market_cap": 196520000.0,
    "price_to_sales_ttm": 4.85,
    "price_to_book_mrq": 2.94,
    "roa_ttm": 0.1235,
    "roe_ttm": 0.17129999999999998,
    "shares_outstanding": 3760000.0,
    "pcnt_held_by_insiders": 0.17579999999999998,
    "pcnt_held_by_institutions": 0.5589999999999999,
    "pcnt_short_of_float": 0.030699999999999998,
    "operating_cash_flow_ttm": 15360000.0,
    "levered_cash_flow_ttm": 14170000.0,
    "book_value_per_share_mrq": 18.15,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Utah Medical Products Inc."
  },
  "VAR": {
    "p_e_ratio": 18.26,
    "peg_ratio": 2.19,
    "earnings_per_share": 4.12,
    "ebitda": 658730000.0,
    "eps_estimate_current_year": 4.38,
    "eps_estimate_next_quarter": 1.02,
    "fifty_day_moving_average": 81.31,
    "fifty_two_week_high": 96.67,
    "fifty_two_week_low": 74.74,
    "percent_change_from_200_day_moving_average": -0.1386,
    "percent_change_from_50_day_moving_average": -0.07429999999999999,
    "shares_owned": "N/A",
    "short_ratio": 8.83,
    "two_hundred_day_moving_average": 87.38,
    "volume": 867373.0,
    "market_cap": 7430000000.0,
    "price_to_sales_ttm": 2.42,
    "price_to_book_mrq": 4.36,
    "roa_ttm": 0.1057,
    "roe_ttm": 0.2422,
    "shares_outstanding": 98720000.0,
    "pcnt_held_by_insiders": 0.0027,
    "pcnt_held_by_institutions": 0.937,
    "pcnt_short_of_float": 0.0725,
    "operating_cash_flow_ttm": 509560000.0,
    "levered_cash_flow_ttm": 420620000.0,
    "book_value_per_share_mrq": 17.37,
    "next_earnings_announcement_date": "2015-10-28",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Varian Medical Systems, Inc."
  },
  "VASC": {
    "p_e_ratio": 49.06,
    "peg_ratio": 1.72,
    "earnings_per_share": 0.71,
    "ebitda": 29740000.0,
    "eps_estimate_current_year": 1.03,
    "eps_estimate_next_quarter": 0.28,
    "fifty_day_moving_average": 35.88,
    "fifty_two_week_high": 40.33,
    "fifty_two_week_low": 22.92,
    "percent_change_from_200_day_moving_average": 0.0311,
    "percent_change_from_50_day_moving_average": -0.0294,
    "shares_owned": "N/A",
    "short_ratio": 6.65,
    "two_hundred_day_moving_average": 33.78,
    "volume": 106745.0,
    "market_cap": 603330000.0,
    "price_to_sales_ttm": 4.53,
    "price_to_book_mrq": 5.13,
    "roa_ttm": 0.1197,
    "roe_ttm": 0.1127,
    "shares_outstanding": 17320000.0,
    "pcnt_held_by_insiders": 0.08130000000000001,
    "pcnt_held_by_institutions": 0.59,
    "pcnt_short_of_float": 0.0461,
    "operating_cash_flow_ttm": 18300000.0,
    "levered_cash_flow_ttm": 932870.0,
    "book_value_per_share_mrq": 6.95,
    "next_earnings_announcement_date": "2015-10-20",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Vascular Solutions Inc."
  },
  "VBIV": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.84,
    "ebitda": -14770000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 2.68,
    "fifty_two_week_high": 3.97,
    "fifty_two_week_low": 1.9,
    "percent_change_from_200_day_moving_average": 0.0757,
    "percent_change_from_50_day_moving_average": 0.0819,
    "shares_owned": "N/A",
    "short_ratio": 4.01,
    "two_hundred_day_moving_average": 2.7,
    "volume": 6236.0,
    "market_cap": 66790000.00000001,
    "price_to_sales_ttm": 229.86,
    "price_to_book_mrq": 9.93,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 23030000.0,
    "pcnt_held_by_insiders": 0.2792,
    "pcnt_held_by_institutions": 0.013000000000000001,
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": -10310000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.29,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VBI Vaccines Inc"
  },
  "VBLT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.97,
    "ebitda": -14240000.0,
    "eps_estimate_current_year": -0.69,
    "eps_estimate_next_quarter": -0.21,
    "fifty_day_moving_average": 5.94,
    "fifty_two_week_high": 17.02,
    "fifty_two_week_low": 3.09,
    "percent_change_from_200_day_moving_average": 0.7461,
    "percent_change_from_50_day_moving_average": 0.6573,
    "shares_owned": "N/A",
    "short_ratio": 2.32,
    "two_hundred_day_moving_average": 5.64,
    "volume": 2688742.0,
    "market_cap": 196120000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.44,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 19910000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.028399999999999998,
    "operating_cash_flow_ttm": -12720000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 1.49,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "Vascular Biogenics Ltd."
  },
  "VCEL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.11,
    "ebitda": -16030000.000000002,
    "eps_estimate_current_year": -0.8,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 3.19,
    "fifty_two_week_high": 4.35,
    "fifty_two_week_low": 2.6,
    "percent_change_from_200_day_moving_average": -0.1705,
    "percent_change_from_50_day_moving_average": -0.1139,
    "shares_owned": "N/A",
    "short_ratio": 3.33,
    "two_hundred_day_moving_average": 3.41,
    "volume": 72178.0,
    "market_cap": 67320000.0,
    "price_to_sales_ttm": 1.42,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.3522,
    "roe_ttm": -0.9871,
    "shares_outstanding": 23790000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0059,
    "operating_cash_flow_ttm": -23260000.0,
    "levered_cash_flow_ttm": -20160000.0,
    "book_value_per_share_mrq": -0.34,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vericel Corporation"
  },
  "VCYT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.41,
    "ebitda": -31050000.0,
    "eps_estimate_current_year": -1.32,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 8.79,
    "fifty_two_week_high": 12.47,
    "fifty_two_week_low": 6.01,
    "percent_change_from_200_day_moving_average": -0.2623,
    "percent_change_from_50_day_moving_average": -0.2004,
    "shares_owned": "N/A",
    "short_ratio": 20.04,
    "two_hundred_day_moving_average": 9.53,
    "volume": 91154.0,
    "market_cap": 194480000.0,
    "price_to_sales_ttm": 4.58,
    "price_to_book_mrq": 3.17,
    "roa_ttm": -0.2704,
    "roe_ttm": -0.5956,
    "shares_outstanding": 27660000.0,
    "pcnt_held_by_insiders": 0.5095000000000001,
    "pcnt_held_by_institutions": 0.397,
    "pcnt_short_of_float": 0.1366,
    "operating_cash_flow_ttm": -35300000.0,
    "levered_cash_flow_ttm": -23790000.0,
    "book_value_per_share_mrq": 2.36,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Veracyte, Inc."
  },
  "VICL": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.171,
    "ebitda": -14060000.0,
    "eps_estimate_current_year": -0.15,
    "eps_estimate_next_quarter": -0.04,
    "fifty_day_moving_average": 0.5877,
    "fifty_two_week_high": 1.55,
    "fifty_two_week_low": 0.44,
    "percent_change_from_200_day_moving_average": -0.431314,
    "percent_change_from_50_day_moving_average": -0.200121,
    "shares_owned": "N/A",
    "short_ratio": 2.74,
    "two_hundred_day_moving_average": 0.8266,
    "volume": 196384.0,
    "market_cap": 42990000.0,
    "price_to_sales_ttm": 2.63,
    "price_to_book_mrq": 0.97,
    "roa_ttm": -0.1686,
    "roe_ttm": -0.2998,
    "shares_outstanding": 91460000.0,
    "pcnt_held_by_insiders": 0.1375,
    "pcnt_held_by_institutions": 0.33299999999999996,
    "pcnt_short_of_float": 0.0059,
    "operating_cash_flow_ttm": -10300000.0,
    "levered_cash_flow_ttm": -5450000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vical Incorporated"
  },
  "VIVO": {
    "p_e_ratio": 20.35,
    "peg_ratio": 1.3,
    "earnings_per_share": 0.84,
    "ebitda": 60040000.0,
    "eps_estimate_current_year": 0.86,
    "eps_estimate_next_quarter": 0.21,
    "fifty_day_moving_average": 18.11,
    "fifty_two_week_high": 20.28,
    "fifty_two_week_low": 15.56,
    "percent_change_from_200_day_moving_average": -0.0794,
    "percent_change_from_50_day_moving_average": -0.0565,
    "shares_owned": "N/A",
    "short_ratio": 24.07,
    "two_hundred_day_moving_average": 18.56,
    "volume": 295522.0,
    "market_cap": 712900000.0,
    "price_to_sales_ttm": 3.72,
    "price_to_book_mrq": 4.38,
    "roa_ttm": 0.1912,
    "roe_ttm": 0.2165,
    "shares_outstanding": 41710000.0,
    "pcnt_held_by_insiders": 0.0204,
    "pcnt_held_by_institutions": 0.932,
    "pcnt_short_of_float": 0.1348,
    "operating_cash_flow_ttm": 45850000.0,
    "levered_cash_flow_ttm": 37960000.0,
    "book_value_per_share_mrq": 3.93,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Meridian Bioscience, Inc."
  },
  "VKTX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.34,
    "ebitda": 0.0,
    "eps_estimate_current_year": -2.5,
    "eps_estimate_next_quarter": -0.31,
    "fifty_day_moving_average": 6.31,
    "fifty_two_week_high": 10.23,
    "fifty_two_week_low": 5.14,
    "percent_change_from_200_day_moving_average": -0.184,
    "percent_change_from_50_day_moving_average": -0.0669,
    "shares_owned": "N/A",
    "short_ratio": 0.59,
    "two_hundred_day_moving_average": 7.22,
    "volume": 23067.0,
    "market_cap": 57620000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 3.13,
    "roa_ttm": -0.23629999999999998,
    "roe_ttm": "N/A",
    "shares_outstanding": 9780000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0028000000000000004,
    "operating_cash_flow_ttm": -3080000.0,
    "levered_cash_flow_ttm": -22190000.0,
    "book_value_per_share_mrq": 1.78,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Viking Therapeutics, Inc."
  },
  "VNDA": {
    "p_e_ratio": 9.67,
    "peg_ratio": -1.19,
    "earnings_per_share": 1.29,
    "ebitda": -15830000.0,
    "eps_estimate_current_year": -0.7,
    "eps_estimate_next_quarter": -0.22,
    "fifty_day_moving_average": 12.41,
    "fifty_two_week_high": 15.51,
    "fifty_two_week_low": 8.34,
    "percent_change_from_200_day_moving_average": 0.10490000000000001,
    "percent_change_from_50_day_moving_average": 0.0074,
    "shares_owned": "N/A",
    "short_ratio": 14.62,
    "two_hundred_day_moving_average": 11.31,
    "volume": 908797.0,
    "market_cap": 528570000.00000006,
    "price_to_sales_ttm": 7.09,
    "price_to_book_mrq": 3.78,
    "roa_ttm": -0.0989,
    "roe_ttm": 0.6995,
    "shares_outstanding": 42290000.0,
    "pcnt_held_by_insiders": 0.17920000000000003,
    "pcnt_held_by_institutions": 0.9670000000000001,
    "pcnt_short_of_float": 0.25739999999999996,
    "operating_cash_flow_ttm": -3330000.0,
    "levered_cash_flow_ttm": -14120000.0,
    "book_value_per_share_mrq": 3.54,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vanda Pharmaceuticals, Inc."
  },
  "VNRX": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.69,
    "ebitda": -7850000.0,
    "eps_estimate_current_year": -0.51,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 3.92,
    "fifty_two_week_high": 5.3,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": 0.2611,
    "percent_change_from_50_day_moving_average": 0.2384,
    "shares_owned": "N/A",
    "short_ratio": 1.61,
    "two_hundred_day_moving_average": 3.85,
    "volume": 38312.0,
    "market_cap": 87590000.0,
    "price_to_sales_ttm": 5740.77,
    "price_to_book_mrq": 9.0,
    "roa_ttm": -0.6966,
    "roe_ttm": -2.4134,
    "shares_outstanding": 18060000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0014000000000000002,
    "operating_cash_flow_ttm": -5990000.0,
    "levered_cash_flow_ttm": -5790000.0,
    "book_value_per_share_mrq": 0.52,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "VolitionRX Ltd"
  },
  "VRML": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.47,
    "ebitda": -17330000.0,
    "eps_estimate_current_year": -0.41,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 2.0,
    "fifty_two_week_high": 2.5,
    "fifty_two_week_low": 1.2,
    "percent_change_from_200_day_moving_average": 0.0183,
    "percent_change_from_50_day_moving_average": 0.0063,
    "shares_owned": "N/A",
    "short_ratio": 27.57,
    "two_hundred_day_moving_average": 1.97,
    "volume": 13299.0,
    "market_cap": 104450000.0,
    "price_to_sales_ttm": 30.61,
    "price_to_book_mrq": 9.13,
    "roa_ttm": -0.6112,
    "roe_ttm": -1.3836000000000002,
    "shares_outstanding": 51960000.0,
    "pcnt_held_by_insiders": 0.1184,
    "pcnt_held_by_institutions": 0.231,
    "pcnt_short_of_float": 0.0621,
    "operating_cash_flow_ttm": -19020000.0,
    "levered_cash_flow_ttm": -11420000.0,
    "book_value_per_share_mrq": 0.22,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Diagnostic Substances",
    "company_name": "Vermillion, Inc."
  },
  "VSAR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.83,
    "ebitda": -69210000.0,
    "eps_estimate_current_year": -2.9,
    "eps_estimate_next_quarter": -0.69,
    "fifty_day_moving_average": 13.71,
    "fifty_two_week_high": 23.99,
    "fifty_two_week_low": 9.97,
    "percent_change_from_200_day_moving_average": -0.3134,
    "percent_change_from_50_day_moving_average": -0.1602,
    "shares_owned": "N/A",
    "short_ratio": 9.55,
    "two_hundred_day_moving_average": 16.76,
    "volume": 277659.0,
    "market_cap": 337840000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.78,
    "roa_ttm": -0.2075,
    "roe_ttm": -0.3508,
    "shares_outstanding": 29350000.0,
    "pcnt_held_by_insiders": 0.294,
    "pcnt_held_by_institutions": 0.08900000000000001,
    "pcnt_short_of_float": 0.1333,
    "operating_cash_flow_ttm": -58380000.0,
    "levered_cash_flow_ttm": -30840000.0,
    "book_value_per_share_mrq": 7.24,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Versartis, Inc."
  },
  "VSCP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.11,
    "ebitda": -2780000.0,
    "eps_estimate_current_year": -0.85,
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 2.19,
    "fifty_two_week_high": 4.69,
    "fifty_two_week_low": 1.91,
    "percent_change_from_200_day_moving_average": -0.2645,
    "percent_change_from_50_day_moving_average": -0.11960000000000001,
    "shares_owned": "N/A",
    "short_ratio": 0.54,
    "two_hundred_day_moving_average": 2.62,
    "volume": 4918.0,
    "market_cap": 5780000.0,
    "price_to_sales_ttm": 0.6,
    "price_to_book_mrq": 1.7,
    "roa_ttm": -0.2526,
    "roe_ttm": -0.5916,
    "shares_outstanding": 2990000.0,
    "pcnt_held_by_insiders": 0.3271,
    "pcnt_held_by_institutions": 0.065,
    "pcnt_short_of_float": 0.0007000000000000001,
    "operating_cash_flow_ttm": -3400000.0,
    "levered_cash_flow_ttm": -2560000.0,
    "book_value_per_share_mrq": 1.25,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "VirtualScopics Inc."
  },
  "VSTM": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.93,
    "earnings_per_share": -1.9,
    "ebitda": -57430000.0,
    "eps_estimate_current_year": -1.76,
    "eps_estimate_next_quarter": -0.45,
    "fifty_day_moving_average": 6.47,
    "fifty_two_week_high": 12.35,
    "fifty_two_week_low": 4.35,
    "percent_change_from_200_day_moving_average": -0.3046,
    "percent_change_from_50_day_moving_average": -0.1231,
    "shares_owned": "N/A",
    "short_ratio": 8.01,
    "two_hundred_day_moving_average": 8.15,
    "volume": 600898.0,
    "market_cap": 209210000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.71,
    "roa_ttm": -0.2988,
    "roe_ttm": -0.5154,
    "shares_outstanding": 36900000.0,
    "pcnt_held_by_insiders": 0.2052,
    "pcnt_held_by_institutions": 0.597,
    "pcnt_short_of_float": 0.12369999999999999,
    "operating_cash_flow_ttm": -42650000.0,
    "levered_cash_flow_ttm": -24710000.0,
    "book_value_per_share_mrq": 3.4,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Verastem, Inc."
  },
  "VTAE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.83,
    "ebitda": -27950000.0,
    "eps_estimate_current_year": -1.89,
    "eps_estimate_next_quarter": -0.5,
    "fifty_day_moving_average": 10.57,
    "fifty_two_week_high": 23.35,
    "fifty_two_week_low": 5.41,
    "percent_change_from_200_day_moving_average": 0.1911,
    "percent_change_from_50_day_moving_average": 0.35619999999999996,
    "shares_owned": "N/A",
    "short_ratio": 11.13,
    "two_hundred_day_moving_average": 12.03,
    "volume": 608116.0,
    "market_cap": 313130000.0,
    "price_to_sales_ttm": 54.47,
    "price_to_book_mrq": 4.74,
    "roa_ttm": -0.3382,
    "roe_ttm": -0.6652,
    "shares_outstanding": 21850000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0842,
    "operating_cash_flow_ttm": -22630000.0,
    "levered_cash_flow_ttm": -12900000.0,
    "book_value_per_share_mrq": 3.5,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vitae Pharmaceuticals, Inc."
  },
  "VTL": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.14,
    "earnings_per_share": -2.42,
    "ebitda": -55560000.0,
    "eps_estimate_current_year": -2.37,
    "eps_estimate_next_quarter": -0.55,
    "fifty_day_moving_average": 7.74,
    "fifty_two_week_high": 29.67,
    "fifty_two_week_low": 2.81,
    "percent_change_from_200_day_moving_average": -0.7726000000000001,
    "percent_change_from_50_day_moving_average": -0.4315,
    "shares_owned": "N/A",
    "short_ratio": 2.36,
    "two_hundred_day_moving_average": 19.35,
    "volume": 813041.0,
    "market_cap": 105670000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 1.63,
    "roa_ttm": -0.4008,
    "roe_ttm": -0.7126,
    "shares_outstanding": 24020000.0,
    "pcnt_held_by_insiders": 0.0141,
    "pcnt_held_by_institutions": 0.07200000000000001,
    "pcnt_short_of_float": 0.1643,
    "operating_cash_flow_ttm": -50210000.0,
    "levered_cash_flow_ttm": -31860000.0,
    "book_value_per_share_mrq": 2.9,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Vital Therapies, Inc."
  },
  "VTVT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -6.57,
    "ebitda": -29140000.0,
    "eps_estimate_current_year": -4.91,
    "eps_estimate_next_quarter": -1.24,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 6.8,
    "fifty_two_week_low": 6.27,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 1.22,
    "two_hundred_day_moving_average": 0.0,
    "volume": 100192.0,
    "market_cap": 58970000.0,
    "price_to_sales_ttm": 41.55,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 9160000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.028300000000000002,
    "operating_cash_flow_ttm": -30690000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -115.39,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "vTv Therapeutics Inc."
  },
  "VVUS": {
    "p_e_ratio": "N/A",
    "peg_ratio": -2.09,
    "earnings_per_share": -1.02,
    "ebitda": -40440000.0,
    "eps_estimate_current_year": -0.97,
    "eps_estimate_next_quarter": -0.14,
    "fifty_day_moving_average": 1.31,
    "fifty_two_week_high": 4.11,
    "fifty_two_week_low": 0.94,
    "percent_change_from_200_day_moving_average": -0.2606,
    "percent_change_from_50_day_moving_average": 0.1888,
    "shares_owned": "N/A",
    "short_ratio": 16.58,
    "two_hundred_day_moving_average": 2.11,
    "volume": 2421688.0,
    "market_cap": 162300000.0,
    "price_to_sales_ttm": 1.52,
    "price_to_book_mrq": 8.14,
    "roa_ttm": -0.0735,
    "roe_ttm": -1.5212999999999999,
    "shares_outstanding": 104040000.0,
    "pcnt_held_by_insiders": 0.11,
    "pcnt_held_by_institutions": 0.7170000000000001,
    "pcnt_short_of_float": 0.3582,
    "operating_cash_flow_ttm": -40730000.0,
    "levered_cash_flow_ttm": 17640000.0,
    "book_value_per_share_mrq": 0.2,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "VIVUS Inc."
  },
  "VWR": {
    "p_e_ratio": 14.53,
    "peg_ratio": 1.48,
    "earnings_per_share": 1.77,
    "ebitda": 455800000.0,
    "eps_estimate_current_year": 1.47,
    "eps_estimate_next_quarter": 0.42,
    "fifty_day_moving_average": 26.29,
    "fifty_two_week_high": 28.83,
    "fifty_two_week_low": 20.6,
    "percent_change_from_200_day_moving_average": -0.024700000000000003,
    "percent_change_from_50_day_moving_average": -0.0233,
    "shares_owned": "N/A",
    "short_ratio": 10.65,
    "two_hundred_day_moving_average": 26.33,
    "volume": 323847.0,
    "market_cap": 3370000000.0,
    "price_to_sales_ttm": 0.8,
    "price_to_book_mrq": 2.64,
    "roa_ttm": 0.0409,
    "roe_ttm": 0.156,
    "shares_outstanding": 131360000.00000001,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.1267,
    "operating_cash_flow_ttm": 219700000.0,
    "levered_cash_flow_ttm": 219410000.0,
    "book_value_per_share_mrq": 9.95,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "VWR Corporation"
  },
  "WAT": {
    "p_e_ratio": 21.15,
    "peg_ratio": 2.21,
    "earnings_per_share": 5.54,
    "ebitda": 675470000.0,
    "eps_estimate_current_year": 5.85,
    "eps_estimate_next_quarter": 1.94,
    "fifty_day_moving_average": 124.07,
    "fifty_two_week_high": 137.39,
    "fifty_two_week_low": 93.56,
    "percent_change_from_200_day_moving_average": -0.0828,
    "percent_change_from_50_day_moving_average": -0.0557,
    "shares_owned": "N/A",
    "short_ratio": 6.15,
    "two_hundred_day_moving_average": 127.74,
    "volume": 523519.0,
    "market_cap": 9640000000.0,
    "price_to_sales_ttm": 4.81,
    "price_to_book_mrq": 5.05,
    "roa_ttm": 0.09300000000000001,
    "roe_ttm": 0.24710000000000001,
    "shares_outstanding": 82270000.0,
    "pcnt_held_by_insiders": 0.0415,
    "pcnt_held_by_institutions": 0.955,
    "pcnt_short_of_float": 0.0466,
    "operating_cash_flow_ttm": 557110000.0,
    "levered_cash_flow_ttm": 337100000.0,
    "book_value_per_share_mrq": 23.49,
    "next_earnings_announcement_date": [
      "2015-10-19",
      "2015-10-23"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "Waters Corporation"
  },
  "WCG": {
    "p_e_ratio": 41.05,
    "peg_ratio": 1.7,
    "earnings_per_share": 2.17,
    "ebitda": 407800000.0,
    "eps_estimate_current_year": 3.45,
    "eps_estimate_next_quarter": 0.66,
    "fifty_day_moving_average": 90.77,
    "fifty_two_week_high": 98.79,
    "fifty_two_week_low": 55.43,
    "percent_change_from_200_day_moving_average": 0.0278,
    "percent_change_from_50_day_moving_average": -0.0178,
    "shares_owned": "N/A",
    "short_ratio": 5.14,
    "two_hundred_day_moving_average": 86.74,
    "volume": 541961.0,
    "market_cap": 3930000000.0,
    "price_to_sales_ttm": 0.3,
    "price_to_book_mrq": 2.45,
    "roa_ttm": 0.0508,
    "roe_ttm": 0.059699999999999996,
    "shares_outstanding": 44070000.0,
    "pcnt_held_by_insiders": 0.004699999999999999,
    "pcnt_held_by_institutions": 0.965,
    "pcnt_short_of_float": 0.0625,
    "operating_cash_flow_ttm": 471200000.0,
    "levered_cash_flow_ttm": -283770000.0,
    "book_value_per_share_mrq": 37.87,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Health Care Plans",
    "company_name": "WellCare Health Plans, Inc."
  },
  "WGBS": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.97,
    "ebitda": -14140000.0,
    "eps_estimate_current_year": -2.71,
    "eps_estimate_next_quarter": -1.68,
    "fifty_day_moving_average": 1.47,
    "fifty_two_week_high": 5.89,
    "fifty_two_week_low": 0.97,
    "percent_change_from_200_day_moving_average": -0.5558,
    "percent_change_from_50_day_moving_average": -0.0493,
    "shares_owned": "N/A",
    "short_ratio": 1.1,
    "two_hundred_day_moving_average": 3.15,
    "volume": 1352717.0,
    "market_cap": 7990000.0,
    "price_to_sales_ttm": 1.81,
    "price_to_book_mrq": 1.74,
    "roa_ttm": -0.8238,
    "roe_ttm": -3.6513999999999998,
    "shares_outstanding": 5710000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0171,
    "operating_cash_flow_ttm": -12330000.0,
    "levered_cash_flow_ttm": -6580000.0,
    "book_value_per_share_mrq": 1.02,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "WaferGen Bio-systems, Inc."
  },
  "WMGI": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.95,
    "earnings_per_share": -5.27,
    "ebitda": -55910000.0,
    "eps_estimate_current_year": -1.74,
    "eps_estimate_next_quarter": -0.29,
    "fifty_day_moving_average": 24.35,
    "fifty_two_week_high": 32.65,
    "fifty_two_week_low": 22.17,
    "percent_change_from_200_day_moving_average": -0.0708,
    "percent_change_from_50_day_moving_average": -0.0144,
    "shares_owned": "N/A",
    "short_ratio": 16.94,
    "two_hundred_day_moving_average": 25.83,
    "volume": 1276835.0,
    "market_cap": 1220000000.0,
    "price_to_sales_ttm": 4.08,
    "price_to_book_mrq": 5.98,
    "roa_ttm": -0.049800000000000004,
    "roe_ttm": -0.7356,
    "shares_outstanding": 50930000.0,
    "pcnt_held_by_insiders": 0.0158,
    "pcnt_held_by_institutions": 1.034,
    "pcnt_short_of_float": 0.15109999999999998,
    "operating_cash_flow_ttm": -115410000.0,
    "levered_cash_flow_ttm": -1330000.0,
    "book_value_per_share_mrq": 4.14,
    "next_earnings_announcement_date": "2015-11-04",
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Wright Medical Group Inc."
  },
  "WST": {
    "p_e_ratio": 32.93,
    "peg_ratio": 2.35,
    "earnings_per_share": 1.69,
    "ebitda": 263000000.0,
    "eps_estimate_current_year": 1.81,
    "eps_estimate_next_quarter": 0.46,
    "fifty_day_moving_average": 57.24,
    "fifty_two_week_high": 61.73,
    "fifty_two_week_low": 43.49,
    "percent_change_from_200_day_moving_average": -0.025,
    "percent_change_from_50_day_moving_average": -0.0276,
    "shares_owned": "N/A",
    "short_ratio": 10.94,
    "two_hundred_day_moving_average": 57.09,
    "volume": 504689.0,
    "market_cap": 4010000000.0,
    "price_to_sales_ttm": 2.97,
    "price_to_book_mrq": 4.21,
    "roa_ttm": 0.0645,
    "roe_ttm": 0.1255,
    "shares_outstanding": 72000000.0,
    "pcnt_held_by_insiders": 0.0174,
    "pcnt_held_by_institutions": 0.903,
    "pcnt_short_of_float": 0.0451,
    "operating_cash_flow_ttm": 185500000.0,
    "levered_cash_flow_ttm": 127490000.0,
    "book_value_per_share_mrq": 13.74,
    "next_earnings_announcement_date": [
      "2015-10-28",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "West Pharmaceutical Services, Inc."
  },
  "WX": {
    "p_e_ratio": 31.8,
    "peg_ratio": 2.75,
    "earnings_per_share": 1.36,
    "ebitda": 133530000.0,
    "eps_estimate_current_year": 1.6,
    "eps_estimate_next_quarter": 0.44,
    "fifty_day_moving_average": 42.73,
    "fifty_two_week_high": 46.14,
    "fifty_two_week_low": 32.4,
    "percent_change_from_200_day_moving_average": 0.0406,
    "percent_change_from_50_day_moving_average": 0.012199999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.41,
    "two_hundred_day_moving_average": 41.56,
    "volume": 317656.0,
    "market_cap": 3070000000.0,
    "price_to_sales_ttm": 4.18,
    "price_to_book_mrq": 3.66,
    "roa_ttm": 0.046,
    "roe_ttm": 0.1331,
    "shares_outstanding": 70930000.0,
    "pcnt_held_by_insiders": 0.0678,
    "pcnt_held_by_institutions": 0.904,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 11.9,
    "next_earnings_announcement_date": [
      "2015-11-10",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Medical Laboratories & Research",
    "company_name": "WuXi PharmaTech (Cayman) Inc."
  },
  "XBIT": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.04,
    "ebitda": -27280000.0,
    "eps_estimate_current_year": "N/A",
    "eps_estimate_next_quarter": 0.0,
    "fifty_day_moving_average": 17.35,
    "fifty_two_week_high": 32.5,
    "fifty_two_week_low": 13.64,
    "percent_change_from_200_day_moving_average": -0.1128,
    "percent_change_from_50_day_moving_average": -0.0254,
    "shares_owned": "N/A",
    "short_ratio": 13.4,
    "two_hundred_day_moving_average": 19.06,
    "volume": 42709.0,
    "market_cap": 542020000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 4.47,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 32049999.999999996,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0707,
    "operating_cash_flow_ttm": -22070000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.87,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XBiotech, Inc."
  },
  "XENE": {
    "p_e_ratio": 17.46,
    "peg_ratio": -1.6,
    "earnings_per_share": 0.48,
    "ebitda": 3640000.0,
    "eps_estimate_current_year": -0.57,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 9.62,
    "fifty_two_week_high": 23.5,
    "fifty_two_week_low": 8.22,
    "percent_change_from_200_day_moving_average": -0.3299,
    "percent_change_from_50_day_moving_average": -0.122,
    "shares_owned": "N/A",
    "short_ratio": 1.82,
    "two_hundred_day_moving_average": 12.61,
    "volume": 59860.0,
    "market_cap": 120720000.0,
    "price_to_sales_ttm": 4.69,
    "price_to_book_mrq": 1.9,
    "roa_ttm": 0.0271,
    "roe_ttm": 0.053099999999999994,
    "shares_outstanding": 14290000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.004,
    "operating_cash_flow_ttm": -4640000.0,
    "levered_cash_flow_ttm": -155250.0,
    "book_value_per_share_mrq": 4.51,
    "next_earnings_announcement_date": [
      "2015-12-14",
      "2015-12-18"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenon Pharmaceuticals Inc."
  },
  "XENT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -1.52,
    "earnings_per_share": -0.92,
    "ebitda": -20180000.0,
    "eps_estimate_current_year": -0.88,
    "eps_estimate_next_quarter": -0.13,
    "fifty_day_moving_average": 26.2,
    "fifty_two_week_high": 32.85,
    "fifty_two_week_low": 15.0,
    "percent_change_from_200_day_moving_average": -0.2141,
    "percent_change_from_50_day_moving_average": -0.1984,
    "shares_owned": "N/A",
    "short_ratio": 3.21,
    "two_hundred_day_moving_average": 26.72,
    "volume": 492615.0,
    "market_cap": 587790000.0,
    "price_to_sales_ttm": 12.99,
    "price_to_book_mrq": 4.56,
    "roa_ttm": -0.1549,
    "roe_ttm": -0.2805,
    "shares_outstanding": 27990000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0705,
    "operating_cash_flow_ttm": -16760000.000000002,
    "levered_cash_flow_ttm": -13000000.0,
    "book_value_per_share_mrq": 5.08,
    "next_earnings_announcement_date": [
      "2015-11-03",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "Intersect ENT, Inc."
  },
  "XLRN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -1.56,
    "ebitda": -52950000.0,
    "eps_estimate_current_year": -1.22,
    "eps_estimate_next_quarter": -0.05,
    "fifty_day_moving_average": 30.49,
    "fifty_two_week_high": 48.5,
    "fifty_two_week_low": 20.0,
    "percent_change_from_200_day_moving_average": -0.155,
    "percent_change_from_50_day_moving_average": -0.10439999999999999,
    "shares_owned": "N/A",
    "short_ratio": 8.97,
    "two_hundred_day_moving_average": 32.32,
    "volume": 296469.0,
    "market_cap": 902840000.0,
    "price_to_sales_ttm": 55.77,
    "price_to_book_mrq": 6.94,
    "roa_ttm": -0.1769,
    "roe_ttm": -0.32689999999999997,
    "shares_outstanding": 33060000.000000004,
    "pcnt_held_by_insiders": 0.7737,
    "pcnt_held_by_institutions": 0.249,
    "pcnt_short_of_float": 0.11789999999999999,
    "operating_cash_flow_ttm": -52750000.0,
    "levered_cash_flow_ttm": -30970000.0,
    "book_value_per_share_mrq": 4.23,
    "next_earnings_announcement_date": [
      "2015-11-05",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Acceleron Pharma, Inc."
  },
  "XNCR": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.67,
    "ebitda": -21700000.0,
    "eps_estimate_current_year": -0.74,
    "eps_estimate_next_quarter": -0.17,
    "fifty_day_moving_average": 17.63,
    "fifty_two_week_high": 24.82,
    "fifty_two_week_low": 9.0,
    "percent_change_from_200_day_moving_average": -0.18230000000000002,
    "percent_change_from_50_day_moving_average": -0.1607,
    "shares_owned": "N/A",
    "short_ratio": 7.86,
    "two_hundred_day_moving_average": 18.1,
    "volume": 442668.0,
    "market_cap": 598990000.0,
    "price_to_sales_ttm": 74.19,
    "price_to_book_mrq": 4.13,
    "roa_ttm": -0.1134,
    "roe_ttm": -0.2016,
    "shares_outstanding": 40470000.0,
    "pcnt_held_by_insiders": 0.3357,
    "pcnt_held_by_institutions": 0.48,
    "pcnt_short_of_float": 0.0663,
    "operating_cash_flow_ttm": -19590000.0,
    "levered_cash_flow_ttm": -11810000.0,
    "book_value_per_share_mrq": 4.01,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xencor, Inc."
  },
  "XNPT": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.57,
    "earnings_per_share": -0.87,
    "ebitda": -52260000.0,
    "eps_estimate_current_year": -1.45,
    "eps_estimate_next_quarter": -0.36,
    "fifty_day_moving_average": 5.96,
    "fifty_two_week_high": 9.6,
    "fifty_two_week_low": 3.86,
    "percent_change_from_200_day_moving_average": -0.4132,
    "percent_change_from_50_day_moving_average": -0.34759999999999996,
    "shares_owned": "N/A",
    "short_ratio": 8.4,
    "two_hundred_day_moving_average": 6.63,
    "volume": 1578883.0,
    "market_cap": 245370000.0,
    "price_to_sales_ttm": 4.86,
    "price_to_book_mrq": 5.04,
    "roa_ttm": -0.1945,
    "roe_ttm": -0.7347,
    "shares_outstanding": 63080000.0,
    "pcnt_held_by_insiders": 0.0917,
    "pcnt_held_by_institutions": 0.9259999999999999,
    "pcnt_short_of_float": 0.1133,
    "operating_cash_flow_ttm": -64840000.0,
    "levered_cash_flow_ttm": -49150000.0,
    "book_value_per_share_mrq": 0.82,
    "next_earnings_announcement_date": [
      "2015-11-02",
      "2015-11-06"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Xenoport, Inc."
  },
  "XOMA": {
    "p_e_ratio": "N/A",
    "peg_ratio": -0.07,
    "earnings_per_share": -0.707,
    "ebitda": -82550000.0,
    "eps_estimate_current_year": -0.64,
    "eps_estimate_next_quarter": -0.1,
    "fifty_day_moving_average": 0.824,
    "fifty_two_week_high": 5.95,
    "fifty_two_week_low": 0.69,
    "percent_change_from_200_day_moving_average": -0.706241,
    "percent_change_from_50_day_moving_average": -0.015898000000000002,
    "shares_owned": "N/A",
    "short_ratio": 8.36,
    "two_hundred_day_moving_average": 2.7604,
    "volume": 2990147.0,
    "market_cap": 96160000.0,
    "price_to_sales_ttm": 7.52,
    "price_to_book_mrq": "N/A",
    "roa_ttm": -0.6995,
    "roe_ttm": "N/A",
    "shares_outstanding": 118580000.0,
    "pcnt_held_by_insiders": 0.284,
    "pcnt_held_by_institutions": 0.552,
    "pcnt_short_of_float": 0.3837,
    "operating_cash_flow_ttm": -73810000.0,
    "levered_cash_flow_ttm": -40350000.0,
    "book_value_per_share_mrq": -0.27,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "XOMA Corporation"
  },
  "XON": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.46,
    "ebitda": -123510000.0,
    "eps_estimate_current_year": -0.33,
    "eps_estimate_next_quarter": -0.15,
    "fifty_day_moving_average": 46.08,
    "fifty_two_week_high": 69.45,
    "fifty_two_week_low": 16.13,
    "percent_change_from_200_day_moving_average": -0.1565,
    "percent_change_from_50_day_moving_average": -0.1462,
    "shares_owned": "N/A",
    "short_ratio": 5.69,
    "two_hundred_day_moving_average": 46.64,
    "volume": 2809921.0,
    "market_cap": 4510000000.0,
    "price_to_sales_ttm": 36.85,
    "price_to_book_mrq": 10.17,
    "roa_ttm": -0.1329,
    "roe_ttm": -0.11800000000000001,
    "shares_outstanding": 114610000.0,
    "pcnt_held_by_insiders": 0.0044,
    "pcnt_held_by_institutions": 0.858,
    "pcnt_short_of_float": 0.26289999999999997,
    "operating_cash_flow_ttm": -45240000.0,
    "levered_cash_flow_ttm": -131889999.99999999,
    "book_value_per_share_mrq": 4.33,
    "next_earnings_announcement_date": [
      "2015-11-11",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Intrexon Corporation"
  },
  "XRAY": {
    "p_e_ratio": 27.74,
    "peg_ratio": 2.45,
    "earnings_per_share": 1.87,
    "ebitda": 572690000.0,
    "eps_estimate_current_year": 2.59,
    "eps_estimate_next_quarter": 0.65,
    "fifty_day_moving_average": 53.66,
    "fifty_two_week_high": 57.61,
    "fifty_two_week_low": 43.83,
    "percent_change_from_200_day_moving_average": -0.009399999999999999,
    "percent_change_from_50_day_moving_average": -0.0323,
    "shares_owned": "N/A",
    "short_ratio": 5.87,
    "two_hundred_day_moving_average": 52.42,
    "volume": 1607615.0,
    "market_cap": 7260000000.0,
    "price_to_sales_ttm": 2.64,
    "price_to_book_mrq": 3.18,
    "roa_ttm": 0.0588,
    "roe_ttm": 0.1094,
    "shares_outstanding": 139810000.0,
    "pcnt_held_by_insiders": 0.12269999999999999,
    "pcnt_held_by_institutions": 0.7979999999999999,
    "pcnt_short_of_float": 0.047,
    "operating_cash_flow_ttm": 551400000.0,
    "levered_cash_flow_ttm": 401640000.0,
    "book_value_per_share_mrq": 16.56,
    "next_earnings_announcement_date": [
      "2015-10-27",
      "2015-11-02"
    ],
    "sector": "Healthcare",
    "industry": "Medical Instruments & Supplies",
    "company_name": "DENTSPLY International Inc."
  },
  "XTLB": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.24,
    "ebitda": -1860000.0,
    "eps_estimate_current_year": -0.02,
    "eps_estimate_next_quarter": -0.01,
    "fifty_day_moving_average": 1.8,
    "fifty_two_week_high": 5.0,
    "fifty_two_week_low": 1.48,
    "percent_change_from_200_day_moving_average": -0.21030000000000001,
    "percent_change_from_50_day_moving_average": -0.11109999999999999,
    "shares_owned": "N/A",
    "short_ratio": 0.97,
    "two_hundred_day_moving_average": 2.03,
    "volume": 72.0,
    "market_cap": 20070000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 2.67,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 12540000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": 0.011000000000000001,
    "pcnt_short_of_float": "N/A",
    "operating_cash_flow_ttm": "N/A",
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 0.6,
    "next_earnings_announcement_date": null,
    "sector": "N/A",
    "industry": "N/A",
    "company_name": "XTL Biopharmaceuticals Ltd."
  },
  "XXII": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.22,
    "ebitda": -14300000.0,
    "eps_estimate_current_year": -0.13,
    "eps_estimate_next_quarter": -0.02,
    "fifty_day_moving_average": 0.79,
    "fifty_two_week_high": 2.78,
    "fifty_two_week_low": 0.56,
    "percent_change_from_200_day_moving_average": -0.0559,
    "percent_change_from_50_day_moving_average": 0.0947,
    "shares_owned": "N/A",
    "short_ratio": 7.78,
    "two_hundred_day_moving_average": 0.91,
    "volume": 157879.0,
    "market_cap": 60740000.0,
    "price_to_sales_ttm": 20.29,
    "price_to_book_mrq": 3.65,
    "roa_ttm": -0.5424,
    "roe_ttm": -1.0678,
    "shares_outstanding": 70620000.0,
    "pcnt_held_by_insiders": 0.384,
    "pcnt_held_by_institutions": 0.065,
    "pcnt_short_of_float": 0.0387,
    "operating_cash_flow_ttm": -7950000.0,
    "levered_cash_flow_ttm": -5540000.0,
    "book_value_per_share_mrq": 0.25,
    "next_earnings_announcement_date": [
      "2015-11-12",
      "2015-11-16"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "22nd Century Group, Inc."
  },
  "ZFGN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.31,
    "ebitda": -55850000.0,
    "eps_estimate_current_year": -2.9,
    "eps_estimate_next_quarter": -0.88,
    "fifty_day_moving_average": 38.33,
    "fifty_two_week_high": 55.36,
    "fifty_two_week_low": 16.01,
    "percent_change_from_200_day_moving_average": -0.0147,
    "percent_change_from_50_day_moving_average": -0.043899999999999995,
    "shares_owned": "N/A",
    "short_ratio": 7.94,
    "two_hundred_day_moving_average": 37.2,
    "volume": 269916.0,
    "market_cap": 994080000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 5.33,
    "roa_ttm": -0.1942,
    "roe_ttm": -0.3429,
    "shares_outstanding": 27120000.0,
    "pcnt_held_by_insiders": 0.10210000000000001,
    "pcnt_held_by_institutions": 0.027999999999999997,
    "pcnt_short_of_float": 0.1578,
    "operating_cash_flow_ttm": -43470000.0,
    "levered_cash_flow_ttm": -25770000.0,
    "book_value_per_share_mrq": 7.6,
    "next_earnings_announcement_date": [
      "2015-11-09",
      "2015-11-13"
    ],
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zafgen, Inc."
  },
  "ZGNX": {
    "p_e_ratio": 16.53,
    "peg_ratio": -0.45,
    "earnings_per_share": 0.87,
    "ebitda": -99890000.0,
    "eps_estimate_current_year": -1.61,
    "eps_estimate_next_quarter": -0.81,
    "fifty_day_moving_average": 18.54,
    "fifty_two_week_high": 21.65,
    "fifty_two_week_low": 8.56,
    "percent_change_from_200_day_moving_average": -0.0231,
    "percent_change_from_50_day_moving_average": -0.2242,
    "shares_owned": "N/A",
    "short_ratio": 5.28,
    "two_hundred_day_moving_average": 14.72,
    "volume": 712482.0,
    "market_cap": 275660000.0,
    "price_to_sales_ttm": 8.55,
    "price_to_book_mrq": 3.03,
    "roa_ttm": -0.33390000000000003,
    "roe_ttm": -0.9168000000000001,
    "shares_outstanding": 23920000.0,
    "pcnt_held_by_insiders": 0.1197,
    "pcnt_held_by_institutions": 0.71,
    "pcnt_short_of_float": 0.1617,
    "operating_cash_flow_ttm": -82990000.0,
    "levered_cash_flow_ttm": -76010000.0,
    "book_value_per_share_mrq": 5.63,
    "next_earnings_announcement_date": [
      "2015-11-04",
      "2015-11-09"
    ],
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "Zogenix, Inc."
  },
  "ZIOP": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -0.98,
    "ebitda": -114510000.0,
    "eps_estimate_current_year": -0.47,
    "eps_estimate_next_quarter": -0.12,
    "fifty_day_moving_average": 10.17,
    "fifty_two_week_high": 14.4,
    "fifty_two_week_low": 2.31,
    "percent_change_from_200_day_moving_average": 0.002,
    "percent_change_from_50_day_moving_average": 0.0775,
    "shares_owned": "N/A",
    "short_ratio": 8.66,
    "two_hundred_day_moving_average": 10.94,
    "volume": 5709899.0,
    "market_cap": 1430000000.0,
    "price_to_sales_ttm": 1087.51,
    "price_to_book_mrq": 14.93,
    "roa_ttm": -0.8012999999999999,
    "roe_ttm": -1.4706000000000001,
    "shares_outstanding": 130850000.0,
    "pcnt_held_by_insiders": 0.0297,
    "pcnt_held_by_institutions": 0.555,
    "pcnt_short_of_float": 0.3233,
    "operating_cash_flow_ttm": -41770000.0,
    "levered_cash_flow_ttm": -65800000.0,
    "book_value_per_share_mrq": 0.85,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "ZIOPHARM Oncology, Inc."
  },
  "ZLTQ": {
    "p_e_ratio": 269.38,
    "peg_ratio": 23.06,
    "earnings_per_share": 0.13,
    "ebitda": 8480000.0,
    "eps_estimate_current_year": 0.05,
    "eps_estimate_next_quarter": 0.12,
    "fifty_day_moving_average": 34.54,
    "fifty_two_week_high": 38.49,
    "fifty_two_week_low": 20.54,
    "percent_change_from_200_day_moving_average": 0.09480000000000001,
    "percent_change_from_50_day_moving_average": 0.0059,
    "shares_owned": "N/A",
    "short_ratio": 8.52,
    "two_hundred_day_moving_average": 31.74,
    "volume": 878931.0,
    "market_cap": 1350000000.0,
    "price_to_sales_ttm": 6.31,
    "price_to_book_mrq": 18.04,
    "roa_ttm": 0.0397,
    "roe_ttm": 0.0761,
    "shares_outstanding": 38760000.0,
    "pcnt_held_by_insiders": 0.2808,
    "pcnt_held_by_institutions": 0.703,
    "pcnt_short_of_float": 0.18,
    "operating_cash_flow_ttm": 16700000.0,
    "levered_cash_flow_ttm": 12520000.0,
    "book_value_per_share_mrq": 1.92,
    "next_earnings_announcement_date": [
      "2015-10-26",
      "2015-10-30"
    ],
    "sector": "Healthcare",
    "industry": "Medical Appliances & Equipment",
    "company_name": "ZELTIQ Aesthetics, Inc."
  },
  "ZSAN": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.51,
    "ebitda": -14710000.0,
    "eps_estimate_current_year": -2.36,
    "eps_estimate_next_quarter": -0.64,
    "fifty_day_moving_average": 8.01,
    "fifty_two_week_high": 12.4,
    "fifty_two_week_low": 6.45,
    "percent_change_from_200_day_moving_average": -0.2402,
    "percent_change_from_50_day_moving_average": -0.1724,
    "shares_owned": "N/A",
    "short_ratio": 14.12,
    "two_hundred_day_moving_average": 8.73,
    "volume": 24820.0,
    "market_cap": 79330000.0,
    "price_to_sales_ttm": 80.4,
    "price_to_book_mrq": 2.02,
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 11970000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.0176,
    "operating_cash_flow_ttm": -15960000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": 3.54,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Biotechnology",
    "company_name": "Zosano Pharma Corporation"
  },
  "ZSPH": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -4.17,
    "ebitda": -82680000.0,
    "eps_estimate_current_year": -4.44,
    "eps_estimate_next_quarter": -1.13,
    "fifty_day_moving_average": 59.69,
    "fifty_two_week_high": 84.85,
    "fifty_two_week_low": 31.07,
    "percent_change_from_200_day_moving_average": 0.2256,
    "percent_change_from_50_day_moving_average": 0.09970000000000001,
    "shares_owned": "N/A",
    "short_ratio": 6.93,
    "two_hundred_day_moving_average": 53.56,
    "volume": 454487.0,
    "market_cap": 1650000000.0,
    "price_to_sales_ttm": "N/A",
    "price_to_book_mrq": 7.58,
    "roa_ttm": -0.2696,
    "roe_ttm": -0.5134000000000001,
    "shares_outstanding": 25120000.0,
    "pcnt_held_by_insiders": 0.1741,
    "pcnt_held_by_institutions": 0.10300000000000001,
    "pcnt_short_of_float": 0.2137,
    "operating_cash_flow_ttm": -72280000.0,
    "levered_cash_flow_ttm": -41550000.0,
    "book_value_per_share_mrq": 9.1,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Major",
    "company_name": "ZS Pharma, Inc."
  },
  "ZYNE": {
    "p_e_ratio": "N/A",
    "peg_ratio": 0.0,
    "earnings_per_share": -2.36,
    "ebitda": -7030000.0,
    "eps_estimate_current_year": -1.66,
    "eps_estimate_next_quarter": -0.35,
    "fifty_day_moving_average": 0.0,
    "fifty_two_week_high": 18.15,
    "fifty_two_week_low": 15.54,
    "percent_change_from_200_day_moving_average": "+inf%",
    "percent_change_from_50_day_moving_average": "+inf%",
    "shares_owned": "N/A",
    "short_ratio": 0.29,
    "two_hundred_day_moving_average": 0.0,
    "volume": 132354.0,
    "market_cap": 140440000.0,
    "price_to_sales_ttm": 239.18,
    "price_to_book_mrq": "N/A",
    "roa_ttm": "N/A",
    "roe_ttm": "N/A",
    "shares_outstanding": 8730000.0,
    "pcnt_held_by_insiders": "N/A",
    "pcnt_held_by_institutions": "N/A",
    "pcnt_short_of_float": 0.010700000000000001,
    "operating_cash_flow_ttm": -6380000.0,
    "levered_cash_flow_ttm": "N/A",
    "book_value_per_share_mrq": -5.5,
    "next_earnings_announcement_date": null,
    "sector": "Healthcare",
    "industry": "Drugs - Generic",
    "company_name": "Zynerba Pharmaceuticals, Inc."
  }
}